
<html lang="en"     class="pb-page"  data-request-id="354b4109-6c2b-49b1-9060-6ca5e80ff321"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;article:article:10.1021/acs.jmedchem.5b00229;website:website:acspubs;issue:issue:10.1021/jmcmar.2015.58.issue-19;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Strategies for the Discovery of Target-Specific or Isoform-Selective Modulators" /></meta><meta name="dc.Creator" content="Peng  Zhan" /></meta><meta name="dc.Creator" content="Yukihiro  Itoh" /></meta><meta name="dc.Creator" content="Takayoshi  Suzuki" /></meta><meta name="dc.Creator" content="Xinyong  Liu" /></meta><meta name="dc.Description" content="Currently, the creation of class- and isoform-selective modulators of biologically important targets is a particularly challenging problem because different isoforms within a protein family often s..." /></meta><meta name="Description" content="Currently, the creation of class- and isoform-selective modulators of biologically important targets is a particularly challenging problem because different isoforms within a protein family often s..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="July 1, 2015" /></meta><meta name="dc.Type" content="review-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.5b00229" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2015 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.5b00229" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.5b00229" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.5b00229" /></link>
        
    
    

<title>Strategies for the Discovery of Target-Specific or Isoform-Selective Modulators | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.5b00229" /></meta><meta property="og:title" content="Strategies for the Discovery of Target-Specific or Isoform-Selective Modulators" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00229/20151002/images/large/jm-2015-00229v_0033.jpeg" /></meta><meta property="og:description" content="Currently, the creation of class- and isoform-selective modulators of biologically important targets is a particularly challenging problem because different isoforms within a protein family often show striking similarity in spatial quaternary structure, especially at the catalytic sites or binding pockets. Therefore, an understanding of both the precise three-dimensional structure of the target protein and the mechanisms of action of modulators is important for developing more effective and selective agents. In this Perspective, we discuss currently available rational design strategies for obtaining class- and isoform-selective inhibitors and we illustrate these strategies with the aid of specific examples from the recent literature. The strategies covered include: (1) target-derived (-dependent) de novo drug discovery methodologies, and (2) follow-on derivatization approaches from initially identified active molecules (hit-to-lead and lead-to-candidate efforts). We also comment on prospects for further development and integration of strategies to achieve target-specific or isoform-selective inhibition." /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta><meta name="twitter:description" content="Currently, the creation of class- and isoform-selective modulators of biologically important targets is a particularly challenging problem because different isoforms within a protein family often show striking similarity in spatial quaternary structure, especially at the catalytic sites or binding pockets. Therefore, an understanding of both the precise three-dimensional structure of the target protein and the mechanisms of action of modulators is important for developing more effective and selective agents. In this Perspective, we discuss currently available rational design strategies for obtaining class- and isoform-selective inhibitors and we illustrate these strategies with the aid of specific examples from the recent literature. The strategies covered include: (1) target-derived (-dependent) de novo drug discovery methodologies, and (2) follow-on derivatization approaches from initially identified active molecules (hit-to-lead and lead-to-candidate efforts). We also comment on prospects for further development and integration of strategies to achieve target-specific or isoform-selective inhibition." /></meta><meta name="twitter:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00229/20151002/images/large/jm-2015-00229v_0033.jpeg" /></meta><meta name="twitter:title" content="Strategies for the Discovery of Target-Specific or Isoform-Selective Modulators" /></meta>
        
            <meta property="og:type" content="Article" /></meta>
        

        
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.5b00229"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/ke1q~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-6ee29527b3d8ff00a106.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.5b00229">
            
        





































    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-12/achre4.2021.54.issue-12/20210615/achre4.2021.54.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-6/amrcda.2021.2.issue-6/20210625/amrcda.2021.2.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-6/aabmcb.2021.4.issue-6/20210621/aabmcb.2021.4.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-6/aaembp.2021.3.issue-6/20210622/aaembp.2021.3.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-6/aaemcq.2021.4.issue-6/20210628/aaemcq.2021.4.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-25/aamick.2021.13.issue-25/20210630/aamick.2021.13.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-6/aanmf6.2021.4.issue-6/20210625/aanmf6.2021.4.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-6/aapmcd.2021.3.issue-6/20210611/aapmcd.2021.3.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-6/abseba.2021.7.issue-6/20210614/abseba.2021.7.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-12/accacs.2021.11.issue-12/20210618/accacs.2021.11.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-6/acscii.2021.7.issue-6/20210623/acscii.2021.7.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-6/acbcct.2021.16.issue-6/20210618/acbcct.2021.16.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-3/achsc5.2021.28.issue-3/20210524/achsc5.2021.28.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-12/acncdm.2021.12.issue-12/20210616/acncdm.2021.12.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-6/aesccq.2021.5.issue-6/20210617/aesccq.2021.5.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-6/aelccp.2021.6.issue-6/20210611/aelccp.2021.6.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-6/aeecco.2021.1.issue-6/20210611/aeecco.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-6/aewcaa.2021.1.issue-6/20210611/aewcaa.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-5/afsthl.2021.1.issue-5/20210618/afsthl.2021.1.issue-5.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-6/aidcbc.2021.7.issue-6/20210611/aidcbc.2021.7.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-6/amlccd.2021.10.issue-6/20210615/amlccd.2021.10.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-6/amlcef.2021.3.issue-6/20210607/amlcef.2021.3.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-6/amclct.2021.12.issue-6/20210610/amclct.2021.12.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-6/ancac3.2021.15.issue-6/20210622/ancac3.2021.15.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-25/acsodf.2021.6.issue-25/20210629/acsodf.2021.6.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-6/apchd5.2021.8.issue-6/20210616/apchd5.2021.8.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-6/ascefj.2021.6.issue-6/20210625/ascefj.2021.6.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-25/ascecg.2021.9.issue-25/20210628/ascecg.2021.9.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-6/asbcd6.2021.10.issue-6/20210618/asbcd6.2021.10.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-25/ancham.2021.93.issue-25/20210629/ancham.2021.93.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-25/bichaw.2021.60.issue-25/20210629/bichaw.2021.60.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-6/bcches.2021.32.issue-6/20210616/bcches.2021.32.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-6/bomaf6.2021.22.issue-6/20210614/bomaf6.2021.22.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-24/cgeabj.2021.99.issue-24/20210628-01/cgeabj.2021.99.issue-24.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-6/crtoec.2021.34.issue-6/20210621/crtoec.2021.34.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-12/chreay.2021.121.issue-12/20210623/chreay.2021.121.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-12/cmatex.2021.33.issue-12/20210622/cmatex.2021.33.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-6/cgdefu.2021.21.issue-6/20210602/cgdefu.2021.21.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-12/enfuem.2021.35.issue-12/20210617/enfuem.2021.35.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-12/esthag.2021.55.issue-12/20210615/esthag.2021.55.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-6/estlcu.2021.8.issue-6/20210608/estlcu.2021.8.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-25/iecred.2021.60.issue-25/20210630/iecred.2021.60.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-12/inocaj.2021.60.issue-12/20210621/inocaj.2021.60.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-6/jaaucr.2021.1.issue-6/20210628/jaaucr.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-25/jafcau.2021.69.issue-25/20210630/jafcau.2021.69.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-6/jceaax.2021.66.issue-6/20210610/jceaax.2021.66.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-6/jceda8.2021.98.issue-6/20210608/jceda8.2021.98.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-6/jcisd8.2021.61.issue-6/20210628/jcisd8.2021.61.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-6/jctcce.2021.17.issue-6/20210608/jctcce.2021.17.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-12/jmcmar.2021.64.issue-12/20210624/jmcmar.2021.64.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-6/jnprdf.2021.84.issue-6/20210625/jnprdf.2021.84.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-12/joceah.2021.86.issue-12/20210618/joceah.2021.86.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-24/jpcafh.2021.125.issue-24/20210624/jpcafh.2021.125.issue-24.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-24/jpcbfk.2021.125.issue-24/20210624/jpcbfk.2021.125.issue-24.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-24/jpccck.2021.125.issue-24/20210624/jpccck.2021.125.issue-24.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-24/jpclcd.2021.12.issue-24/20210624/jpclcd.2021.12.issue-24.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-6/jprobs.2021.20.issue-6/20210604/jprobs.2021.20.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-25/jacsat.2021.143.issue-25/20210630/jacsat.2021.143.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-6/jamsef.2021.32.issue-6/20210602/jamsef.2021.32.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-25/langd5.2021.37.issue-25/20210629/langd5.2021.37.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-12/mamobx.2021.54.issue-12/20210622/mamobx.2021.54.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-6/mpohbp.2021.18.issue-6/20210607/mpohbp.2021.18.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-12/nalefd.2021.21.issue-12/20210623/nalefd.2021.21.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-12/orlef7.2021.23.issue-12/20210618/orlef7.2021.23.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-6/oprdfk.2021.25.issue-6/20210618/oprdfk.2021.25.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-12/orgnd7.2021.40.issue-12/20210628/orgnd7.2021.40.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.5b00229&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.5b00229&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.5b00229&amp;href=/doi/10.1021/acs.jmedchem.5b00229" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2015</span><span class="cit-fg-volume">, 58</span><span class="cit-fg-issue">, 19</span><span class="cit-fg-pageRange">, 7611-7633</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/58/19" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><span class="content-navigation__contentType">Perspective</span><a href="/doi/10.1021/acs.jmedchem.5b00386" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Strategies for the Discovery of Target-Specific or Isoform-Selective Modulators</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Peng++Zhan">Peng Zhan</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yukihiro++Itoh">Yukihiro Itoh</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Takayoshi++Suzuki">Takayoshi Suzuki</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Xinyong++Liu">Xinyong Liu</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">Department of Medicinal Chemistry, Key Laboratory of Chemical Biology (Ministry of Education), School of Pharmaceutical Sciences, Shandong University, 44 West Culture Road, 250012 Jinan, Shandong, P. R. China</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">Graduate School of Medical Science, Kyoto Prefectural University of Medicine, 1-5 Shimogamohangi-Cho, Sakyo-Ku, Kyoto 606-0823, Japan</span></div><div class="aff-info" id="aff3"><span class="aff-symbol">§</span> <span class="aff-text">CREST, Japan Science and Technology Agency (JST), 4-1-8 Honcho, Kawaguchi, Saitama 332-0012, Japan</span></div><div class="corresp-info"><strong>*</strong>For P.Z.: E-mail, <a href="/cdn-cgi/l/email-protection#c4beaca5aab4a1aaa3f5fdfcf684b7a0b1eaa1a0b1eaa7aa"><span class="__cf_email__" data-cfemail="13697b727d63767d74222a2b21536077663d7677663d707d">[email protected]</span></a></div><div class="corresp-info"><strong>*</strong>For T.Z.: E-mail, <a href="/cdn-cgi/l/email-protection#1063656a657b7964507b7f647f3e7b60653d7d3e71733e7a60"><span class="__cf_email__" data-cfemail="3744424d425c5e43775c584358195c47421a5a195654195d47">[email protected]</span></a></div><div class="corresp-info"><strong>*</strong>For X.-Y.L.: E-mail, <a href="/cdn-cgi/l/email-protection#f088999e899f9e979cb0839485de959485de939e"><span class="__cf_email__" data-cfemail="4e36272037212029220e3d2a3b602b2a3b602d20">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.5b00229&amp;href=/doi/10.1021%2Facs.jmedchem.5b00229" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2015</span></span><span class="cit-volume">, 58</span><span class="cit-issue">, 19</span><span class="cit-pageRange">, 7611–7633</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">June 18, 2015</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>9 February 2015</li><li><span class="item_label"><b>Published</b> online</span>1 July 2015</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 8 October 2015</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.5b00229" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b00229</a></div><div class="article_header-article-copyright"><strong>Copyright © 2015 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D7611%26pageCount%3D23%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DPeng%2BZhan%252C%2BYukihiro%2BItoh%252C%2BTakayoshi%2BSuzuki%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D58%26issueNum%3D19%26contentID%3Dacs.jmedchem.5b00229%26title%3DStrategies%2Bfor%2Bthe%2BDiscovery%2Bof%2BTarget-Specific%2Bor%2BIsoform-Selective%2BModulators%26numPages%3D23%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D7633%26publicationDate%3DOctober%2B2015">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.5b00229"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">3715</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">33</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.5b00229" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Strategies for the Discovery of Target-Specific or Isoform-Selective Modulators&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Peng&quot;,&quot;last_name&quot;:&quot;Zhan&quot;},{&quot;first_name&quot;:&quot;Yukihiro&quot;,&quot;last_name&quot;:&quot;Itoh&quot;},{&quot;first_name&quot;:&quot;Takayoshi&quot;,&quot;last_name&quot;:&quot;Suzuki&quot;},{&quot;first_name&quot;:&quot;Xinyong&quot;,&quot;last_name&quot;:&quot;Liu&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2015&quot;,&quot;month&quot;:&quot;07&quot;,&quot;day&quot;:&quot;01&quot;,&quot;issue&quot;:&quot;19&quot;,&quot;volume&quot;:&quot;58&quot;,&quot;pages&quot;:&quot;7611-7633&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.5b00229&quot;},&quot;abstract&quot;:&quot;Currently, the creation of class- and isoform-selective modulators of biologically important targets is a particularly challenging problem because different isoforms within a protein family often show striking similarity in spatial quaternary structure, especially at the catalytic sites or binding pockets. Therefore, an understanding of both the precise three-dimensional structure of the target protein and the mechanisms of action of modulators is important for developing more effective and selective agents. In this Perspective, we discuss currently available rational design strategies for obtaining class- and isoform-selective inhibitors and we illustrate these strategies with the aid of specific examples from the recent literature. The strategies covered include: (1) target-derived (-dependent) de novo drug discovery methodologies, and (2) follow-on derivatization approaches from initially identified active molecules (hit-to-lead and lead-to-candidate efforts). We also comment on prospects for further devel&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.5b00229&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.5b00229" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.5b00229&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.5b00229" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.5b00229&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.5b00229" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.5b00229&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.5b00229&amp;href=/doi/10.1021/acs.jmedchem.5b00229" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.5b00229" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.5b00229" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (4 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b00229&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.5b00229%26sid%3Dliteratum%253Aachs%26pmid%3D26086931%26genre%3Darticle%26aulast%3DZhan%26date%3D2015%26atitle%3DStrategies%2Bfor%2Bthe%2BDiscovery%2Bof%2BTarget-Specific%2Bor%2BIsoform-Selective%2BModulators%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D58%26issue%3D19%26spage%3D7611%26epage%3D7633%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=291711" title="Selectivity">Selectivity</a>,</li><li><a href="/action/doSearch?ConceptID=291352" title="Screening assays">Screening assays</a>,</li><li><a href="/action/doSearch?ConceptID=292202" title="Drug discovery">Drug discovery</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/58/19" title="Go to Volume 58, Issue 19"><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/jmcmar.2015.58.issue-19/20151008/jmcmar.2015.58.issue-19.largecover.jpg" alt="Go to Volume 58, Issue 19"/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00229/20151002/images/medium/jm-2015-00229v_0033.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00229/20151002/images/large/jm-2015-00229v_0033.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00229&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Currently, the creation of class- and isoform-selective modulators of biologically important targets is a particularly challenging problem because different isoforms within a protein family often show striking similarity in spatial quaternary structure, especially at the catalytic sites or binding pockets. Therefore, an understanding of both the precise three-dimensional structure of the target protein and the mechanisms of action of modulators is important for developing more effective and selective agents. In this Perspective, we discuss currently available rational design strategies for obtaining class- and isoform-selective inhibitors and we illustrate these strategies with the aid of specific examples from the recent literature. The strategies covered include: (1) target-derived (-dependent) de novo drug discovery methodologies, and (2) follow-on derivatization approaches from initially identified active molecules (hit-to-lead and lead-to-candidate efforts). We also comment on prospects for further development and integration of strategies to achieve target-specific or isoform-selective inhibition.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">1 Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_58260" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_58260" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The members of families of multifunctional enzymes, including epigenetic enzymes such as histone deacetylases (HDACs) and protein kinases such as phosphoinositide-3 kinases (PI3Ks), tankyrases (TNKSs), and nitric oxide synthases (NOSs), often have extraordinarily diverse cellular functions and are therefore compelling biotargets for the treatment of serious diseases such as cancer, diabetes, immune and inflammatory disorders, cardiovascular disease, and neurodegeneration.<a onclick="showRef(event, 'ref1 ref2 ref3 ref4 ref5 ref6 ref7'); return false;" href="javascript:void(0);" class="ref ref1 ref2 ref3 ref4 ref5 ref6 ref7">(1-7)</a> The state-of-the-art in structural and biochemical investigations of these multi-isoform enzyme families, as well as the family architectures, has been well reviewed elsewhere.<a onclick="showRef(event, 'ref1 ref2 ref3 ref4 ref5 ref6 ref7'); return false;" href="javascript:void(0);" class="ref ref1 ref2 ref3 ref4 ref5 ref6 ref7">(1-7)</a></div><div class="NLM_p">However, the results of clinical trials of chemical modulators of specific enzyme targets within these families have often been disappointing because of effects such as insufficiently specific inhibition, off-target activities, and toxicity. Insufficient selectivity is thus one of the major bottlenecks in new drug development, although there are also other issues, including limited efficacy and the emergence of acquired drug resistance. Therefore, it is extremely important to discover potent inhibitors with strict subtype selectivity, not only as candidate therapeutic drugs but also as chemical tools to elucidate the roles of specific isoforms in human diseases and for mechanistic studies at the molecular level. However, it is tremendously challenging to identify modulators that are selective for one isoform of a large protein family containing homologous active sites; for example, the kinase family contains more than 500 isozymes, which generally have highly conserved ATP catalytic sites. It is not too much to say that the discovery of selective isoform inhibitors is currently at the heart of medicinal chemistry and chemical biology.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> Thus, to address the formidable challenge presented by the specific molecular recognition of single protein targets within complex, multicomponent biological systems, we require highly sophisticated drug design strategies.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a></div><div class="NLM_p">Early discoveries of target-specific or isoform-selective agents were usually made by means of trial-and-error approaches, but these are time-consuming and unreliable. Therefore, there is increasing interest in rational design strategies. In this Perspective, we provide an overview of currently available design strategies to obtain selective modulators (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>), with illustrative examples. Consequently, the many selective inhibitors discovered serentipitously or by trial-and-error are not included in this Perspective.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00229/20151002/images/medium/jm-2015-00229v_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00229/20151002/images/large/jm-2015-00229v_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Schematic overview of medicinal–chemical strategies for discovery of target-specific or isoform-selective inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00229/20151002/images/large/jm-2015-00229v_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00229&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">2 Target-Dependent de Novo Discovery of Target-Specific or Isoform-Selective Inhibitors</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_50482" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_50482" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Recent advances in the understanding of protein–ligand interactions and structural bioinformatics of molecular recognition have encouraged rapid discovery of potent and selective molecules for therapeutically relevant targets. Over the past decade, a variety of strategies and techniques have been developed to facilitate de novo design of target-specific or isozyme-selective inhibitors with high potential for further modification.</div><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i3" class="anchor-spacer"></div><h3 class="article-section__title" id="_i3">2.1 Structure-Based de Novo Design</h3><div class="NLM_p">The structure-based approach is intrinsically limited owing to the inherent structural flexibility of proteins. Moreover, the active site pockets of isozymes are usually highly conserved, making the structure-based rational design of the isoform-selective inhibitor even more challenging.</div><div class="NLM_p">Nitric oxide synthase (NOS) represents a highly druggable family of biotargets that have received great attention in recent years. Structure-based drug design has played a crucial role in the identification of isoform-selective NOS inhibitors. Starting with previously developed nitroarginine-containing dipeptides, novel selective neuronal nitric oxide synthase (nNOS) inhibitors have been created by using combinations of structure-based drug design, minimal pharmacophoric elements, and the fragment-hopping concept.<a onclick="showRef(event, 'ref9 ref10'); return false;" href="javascript:void(0);" class="ref ref9 ref10">(9, 10)</a> The fundamental idea of this strategy is derivatization of a basic pharmacophoric component, taking into account the structures of the sites determining ligand binding and isoform selectivity. For the nNOS studies, a basic fragment library, a bioisostere library, a side chain library, a toxicophore library, and a set of rules for metabolic stability were employed to construct focused fragment libraries and then the fragments were connected. To meet hydrophobicity/steric constraint requirements, the 2-aminopyridine motif was selected as a basic core. Finally, a small molecule <b>1</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>) with a new chemical scaffold was identified.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> Compound <b>1</b> showed nNOS-inhibitory activity at nanomolar concentration, with more than 1000-fold selectivity for nNOS over other NOS isoforms. Interestingly, the selectivity of dipeptide/peptidomimetic binders for nNOS over endothelial nitric oxide synthase (eNOS) was investigated by crystallographic analysis, and the results indicated that a small-molecular compound with a constrained conformation, such as <b>1</b>, could exactly mimic the mode of action of the dipeptide inhibitors of nNOS. Unlike the traditional de novo approach, which may not encompass the whole biologically relevant chemical space of the target enzyme, selection of the scaffold in the new approach is based on the nature of the target protein, the type of enzyme-catalyzed reaction, the size and shape of the catalytic site, and the availability of suitable reactive functional moieties or cofactors.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00229/20151002/images/medium/jm-2015-00229v_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00229/20151002/images/large/jm-2015-00229v_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Structure of inhibitor <b>1</b> (colored in yellow) complexed with nNOS (heme domain) (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3B3N">3B3N</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00229/20151002/images/large/jm-2015-00229v_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00229&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4">2.2 Mechanism-Based Drug Design</h3><div class="NLM_p">A detailed understanding of the interaction between the target protein and its ligands provides a good basis for improving the selectivity and affinity of inhibitors through mechanism-based drug design. This approach is well illustrated by the discovery of lysine-specific demethylase <b>1</b> (LSD1, or KDM1A)-selective inhibitors.<a onclick="showRef(event, 'ref11 ref12'); return false;" href="javascript:void(0);" class="ref ref11 ref12">(11, 12)</a></div><div class="NLM_p">LSD1 is a flavin-dependent amine oxidase that catalyzes oxidative removal of one or two methyl group(s) from the methyl-lysine-4 side chain of histone H3 (H3K4) (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>a). In 2006, peptide-based compound (<b>2</b>) containing a propargylamine functionality was identified as a selective, mechanism-based inactivator of LSD1, exhibiting time-dependent suppression of LSD1 activity.<a onclick="showRef(event, 'ref13 ref14'); return false;" href="javascript:void(0);" class="ref ref13 ref14">(13, 14)</a> Mass spectrometric analysis showed that <b>2</b> interacts covalently with FAD (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>b). Since then, it has been used as a lead compound for anticancer drug discovery and as a tool for probing the mechanism and biological functions of LSD1.</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00229/20151002/images/medium/jm-2015-00229v_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00229/20151002/images/large/jm-2015-00229v_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Proposed mechanisms of (a) LSD1 catalysis and (b) activation of <b>2</b>, leading to inactivation of LSD1 by flavin modification.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00229/20151002/images/large/jm-2015-00229v_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00229&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Compound <b>3</b> (phenylcyclopropylamine, PCPA), which is an inhibitor of monoamine oxidases (MAOs; also FAD-dependent enzymes, like LSD1), was also identified as a weak and nonselective LSD1 inhibitor that binds directly to the catalytic site.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> Superposition of the FAD–PCPA conjugate (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2UXX">2UXX</a>) and the reduced FAD–<i>N</i>-propargyl lysine peptide conjugate (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2UXN">2UXN</a>) on the active site of LSD1 (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>) led to the discovery of novel small-molecular LSD1-selective inhibitors <b>4</b> and <b>5</b>.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> Notably, compounds <b>4</b> and <b>5</b> showed inhibition of in vivo H3K4-methylating activity and antiproliferative potency against cancer cells. It can be anticipated that the similarity in the active sites and structural properties of LSD1 and MAO will prompt investigation of more anti-MAO agents as potential selective LSD1 inhibitors.</div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00229/20151002/images/medium/jm-2015-00229v_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00229/20151002/images/large/jm-2015-00229v_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. (a) Crystallographic overlays of reduced FAD–<i>N</i>-propargyl lysine peptide conjugate (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2UXN">2UXN</a>) (green and blue) and FAD–PCPA conjugate (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2UXX">2UXX</a>) (magenta) in the catalytic site of LSD1. For the sake of clarity, amino acid residues in the catalytic site are omitted. (b) Chemical structures and in vitro inhibitory activities of compounds <b>3</b>–<b>5</b> toward LSD1 and MAO-A/B.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00229/20151002/images/large/jm-2015-00229v_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00229&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">On the basis of this concept of LSD1-targeted PCPA delivery, a series of novel LSD1 inhibitors was designed and synthesized. First, it was confirmed that peptide (<b>6</b>) inhibits LSD1 efficiently and selectively by delivering PCPA directly to the LSD1 active site, i.e., the inhibition occurs by formation of the FAD–PCPA conjugate with concomitant release of the peptide carrier (<b>7</b>).<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> Then, the same strategy was utilized to develop nonpeptide small-molecular LSD1 inhibitors (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>). These molecules showed potent LSD1-selective inhibitory activity via LSD1-targeted PCPA delivery in enzymatic assays, and they also displayed potent growth-inhibitory activity toward cancer cell lines. Among them, compound <b>8</b> is a potent LSD1 inhibitor (IC<sub>50</sub> = 0.30 μM), being at least 100-fold more active than PCPA itself (IC<sub>50</sub> = 31 μM) without inhibiting MAO-A (IC<sub>50</sub> > 25 μM). Thus, compound <b>8</b> is a promising candidate for hit-to-lead follow-up in the anticancer drug discovery process.</div><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00229/20151002/images/medium/jm-2015-00229v_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00229/20151002/images/large/jm-2015-00229v_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Discovery of mechanism-based LSD1-selective inactivators.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00229/20151002/images/large/jm-2015-00229v_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00229&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5">2.3 Target-Templated Dynamic Combinatorial Chemistry</h3><div class="NLM_p">The dynamic combinatorial/covalent chemistry (DCC) technique has been employed to selectively assemble ligands with optimum molecular fit around a suitable target from a mixture of all possible combinations of the available components under thermodynamic control by taking advantage of structural information. This target-guided synthetic methodology (TGS) enables efficient generation of novel small-molecular ligands for drug discovery, i.e., selective inhibitors can be identified by screening a complex compound mixture in the presence of the selected protein template.<a onclick="showRef(event, 'ref17 ref18'); return false;" href="javascript:void(0);" class="ref ref17 ref18">(17, 18)</a></div><div class="NLM_p">Since the introduction of this technique in the mid-1990s, many reversible covalent reactions have been used in the construction of dynamic constitutional libraries (DCLs), including reactions of imines, hydrazones, and disulfides. Recently, a DCL targeting carbonic anhydrase isozyme-specific inhibitors was developed.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> As shown in Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>, the DCL was assembled under thermodynamic control by using reversible amino-carbonyl/imine reaction and screened for binders to the metalloenzyme carbonic anhydrase (CA). There are 15 human (h) CA isoforms, and in this work, the DCL was screened in parallel for binders to hCAI and hCA II (Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>).<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> When hCAI or hCA II is added to the DCL, the composition of the DCL (<b>9a</b>, <b>9b</b>, <b>10a</b>, <b>10b</b>, <b>11a</b>, <b>11b</b>) adjusts to minimize the free energy of the overall system, resulting in amplification of selective ligands of the target protein.</div><figure id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00229/20151002/images/medium/jm-2015-00229v_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00229/20151002/images/large/jm-2015-00229v_0006.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Identification of carbonic acid isozyme-selective binders from a dynamic constitutional library. Target-driven self-screening of inhibitors occurs until the system reaches a thermodynamic minimum.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00229/20151002/images/large/jm-2015-00229v_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00229&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00229/20151002/images/medium/jm-2015-00229v_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00229/20151002/images/large/jm-2015-00229v_0007.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Target-guided assembly of selective binders via azide–alkyne 1,3-dipolar cycloaddition.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00229/20151002/images/large/jm-2015-00229v_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00229&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In situ click chemistry is another TGS method for fast and efficient production of potential enzymatic inhibitors. A well-known example is the assembly of complementary alkyne and azide building blocks at binding sites of the target via a Huisgen alkyne–azide 1,3-dipolar cycloaddition reaction, as illustrated in Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>. This strategy can be divided into three stages: (i) small building blocks do not react with each other in the absence of a target protein but bind to adjacent subsites, (ii) the proximity of alkyne and azide groups is conducive to 1,3-dipolar cycloaddition, and (iii) the resulting triazole displays very high binding affinity with the target protein. In 2012, in situ click chemistry of alkyne and azide building blocks on acetylcholine-binding protein templates (AChBPs; structural mimics of the extracellular domain of nicotinic acetylcholine receptors) afforded a series of triazole-based selective agonists for the α7 nicotinic acetylcholine receptor.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a></div><div class="NLM_p">In 2010, it was reported that a CuI complex of HDAC8 could accelerate selective azide–alkyne cycloaddition reaction, and HDAC inhibitor (<b>12</b>) was identified as a more potent inhibitor than either of its component parts alone (Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a>). This example of in situ inhibitor formation provided a precedent for applying in situ click chemistry to obtain inhibitors of highly active protein-based catalysts.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a></div><figure id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00229/20151002/images/medium/jm-2015-00229v_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00229/20151002/images/large/jm-2015-00229v_0008.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Discovery of HDAC8 inhibitor (<b>12</b>) via protein-templated click chemistry.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00229/20151002/images/large/jm-2015-00229v_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00229&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6">2.4 Virtual Screening</h3><div class="NLM_p">In recent years, structure-based virtual screening (usually involving a combination of structure-based drug design and computational docking) has become an attractive alternative to traditional high-throughput screening (HTS) for early stage hit discovery in both the pharmaceutical industry and academia. Although it relies heavily on knowledge of the three-dimensional structure of the target protein, it is an effective, low-cost, labor-saving strategy for drug discovery.<a onclick="showRef(event, 'ref22 ref23 ref24'); return false;" href="javascript:void(0);" class="ref ref22 ref23 ref24">(22-24)</a> In 2012, a series of selective aldo-keto reductase AKR1C1 and AKR1C3 inhibitors with novel scaffolds (exemplified by <b>13</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a>) was discovered through virtual HTS of a fragment library, followed by bioactivity assays with human aldo-keto reductases 1C1–1C4 (AKR1C1–AKR1C4).<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a></div><figure id="fig9" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00229/20151002/images/medium/jm-2015-00229v_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00229/20151002/images/large/jm-2015-00229v_0009.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Selective aldo-keto reductase AKR1C1 and AKR1C3 inhibitor.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00229/20151002/images/large/jm-2015-00229v_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00229&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">To find novel butyrylcholinesterase (BChE) inhibitors, a hierarchical virtual screening protocol was performed followed by bioactivity assay of an initial subset of top-ranked molecules (40 members). Compound (+)-<b>14</b> was found to be the most active, inhibiting BChE at low nanomolar concentration (IC<sub>50</sub> = 21.3 nM), inhibiting amyloid β1–42 peptide self-induced aggregation into fibrils by 61.7% at 10 μM and protecting SH-SY5Y cells against amyloid-β-induced toxicity. The structure of human BChE complexed with (+)-<b>14</b> (dissociation constant of 2.7 nM) was solved (Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a>) and is expected to be useful for optimization of small-molecular BChE inhibitors.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a></div><figure id="fig10" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00229/20151002/images/medium/jm-2015-00229v_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00229/20151002/images/large/jm-2015-00229v_0010.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Crystal structure of compound (+)-<b>14</b> complexed with human BChE (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4TPK">4TPK</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00229/20151002/images/large/jm-2015-00229v_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00229&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">It should be noted that molecular docking may not reflect the real physical process of binding and in some cases may generate questionable structures despite a high score.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> Issues such as conformational flexibility of protein and conformational change upon ligand binding (induced fit) should be considered in docking simulation, and consequently computational algorithms can be extremely resource-intensive.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a></div><div class="NLM_p last">One of the key limitations in target-based de novo drug design is the limited number of available crystal structures of subfamily enzyme members. Availability of detailed structural information for whole enzyme families in the future will be extremely useful in the design of selective inhibitors for individual isoforms.</div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i7">3 Discovery of Target-Specific or Isoform-Selective Inhibitors via Derivatization Approaches</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_57741" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_57741" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec3_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8">3.1 Conversion of Substrates to Selective Inhibitors</h3><div class="NLM_p">Fragment-based drug discovery (FBDD) has emerged as a powerful strategy for drug discovery starting from simple substrate fragments.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> This strategy involves screening a relatively small library of substrate derivatives to identify novel scaffold leads for subsequent iterative optimization of potency and selectivity.</div><div class="NLM_p">Development of isoform-selective epigenetic modulators is of great biological and medical interest, and the substrate-based fragment derivatization approach has been applied to the development of small-molecular selective inhibitors of histone deacetylase (HDAC), sirtuin (SIRT), and Jumonji C domain-containing histone demethylases (JHDMs) (Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a>).<a onclick="showRef(event, 'ref29 ref30 ref31 ref32 ref33 ref34'); return false;" href="javascript:void(0);" class="ref ref29 ref30 ref31 ref32 ref33 ref34">(29-34)</a></div><figure id="fig11" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00229/20151002/images/medium/jm-2015-00229v_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00229/20151002/images/large/jm-2015-00229v_0011.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. Substrate-based approach to design of isoform-selective inhibitors of epigenetic enzymes. The initial substrates <b>15</b> and <b>25</b> are used in the commercially available assay kits.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00229/20151002/images/large/jm-2015-00229v_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00229&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In enzyme-inhibitory assays using HDAC1, HDAC4, and HDAC6, compounds <b>17</b>–<b>19</b>, which were derived from HDAC6-selective substrate <b>15</b>, showed selective inhibitory activity for HDAC6 over HDAC1 and HDAC4.<a onclick="showRef(event, 'ref29 ref30'); return false;" href="javascript:void(0);" class="ref ref29 ref30">(29, 30)</a></div><div class="NLM_p">As regards SIRT inhibitors, compound <b>21</b>, bearing an ethoxycarbonyl moiety at the α-position to the acetamide of acetylated lysine substrate analogue <b>20</b>, showed potent activity in an in vitro recombinant SIRT1 inhibitory assay, with high selectivity over SIRT2 and SIRT3. Mechanistic studies through kinetic analysis, mass spectroscopy (MS), and computation revealed that the enol form of <b>21</b> nucleophilically attacks NAD<sup>+</sup> in the SIRT active site to form the stable <b>21</b>–ADP-ribose adduct, resulting in potent enzyme inhibition. Compound <b>21</b> induced a dose-dependent increase of p53 acetylation in human HCT116 cells (colon cancer), indicating that it inhibits SIRT1 at the cellular level.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a></div><div class="NLM_p">Inspired by the binding modes of <b>22</b> (suramin) and <b>23</b> (nicotinamide) (Figure <a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">12</a>), a focused library of fragments that contain structural features from either suramin or nicotinamide was recently constructed and biochemically evaluated, leading to the discovery of compound <b>25</b> with potent SIRT2-inhibitory activity (48 nM) and selectivity for SIRT2 over SIRT1 and SIRT3. Compound <b>25</b> concentration- and time-dependently increased the in vitro acetylation level of α-tubulin (a well-validated SIRT2 substrate). Further kinetic investigation indicated that this molecule functions as a competitive binder with respect to peptide substrate and most likely as a noncompetitive binder with respect to NAD<sup>+</sup>.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> These molecules represent leads for an important new class of epigenetic modulators with potential application as anticancer agents.</div><figure id="fig12" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00229/20151002/images/medium/jm-2015-00229v_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00229/20151002/images/large/jm-2015-00229v_0012.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 12. Crystal structures of (a) human sirtuin homologue <b>5</b> complexed with <b>26</b> (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2NYR">2NYR</a>) and (b) sirtuin 2-deacetylated peptide complexed with <b>23</b> and 2′-<i>O</i>-acetyl adenosine-5-diphosphoribose (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2H4J">2H4J</a>). (c) Superposition of the binding modes of <b>22</b> and <b>23</b>. For the sake of clarity, amino acid residues in the active site are omitted.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00229/20151002/images/large/jm-2015-00229v_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00229&amp;id=fig12"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The ability of JHDMs to selectively recognize their targets has been elegantly addressed by means of structural biology studies.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> On the basis of the enzymatic mechanism and the crystal structures of JHDMs complexed with α-ketoglutarate substrate, a potential JHDM-selective small-molecule inhibitor <b>26</b> was identified which contains a methyllysine analogue (substrate mimic), an α-ketoglutarate mimic (cofactor isostere), and a linker combining these two fragments (Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a>).<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> Its methyl ester prodrug, methylstat (<b>27</b>), selectively inhibits JHDMs in cells and may be a useful functional probe in epigenetics studies.</div><div class="NLM_p">In addition, a substrate-based approach (substrate activity screening, SAS) has been employed to uncover novel nonpeptidic selective inhibitors of striatal-enriched protein tyrosine phosphatase (STEP). Optimization of substrate scaffolds (exemplified by <b>28</b>) led to the discovery of several STEP inhibitors active at single-digit micromolar concentration (exemplified by <b>29</b>) and with greater than 20-fold selectivity over dual specificity phosphatases and multiple tyrosine phosphatases (Figure <a data-tab="pane-pcw-Figures" href="#fig13" id="" class=" internalNav">13</a>). Compound <b>29</b> significantly inhibited STEP in rat cortical neurons.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> The potency, small size, and synthetic accessibility of this compound class will encourage medicinal chemists to further explore this series of STEP inhibitors.</div><figure id="fig13" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 13</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00229/20151002/images/medium/jm-2015-00229v_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00229/20151002/images/large/jm-2015-00229v_0013.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 13. Fragment-based approach to the design of substrate-derived STEP-selective inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00229/20151002/images/large/jm-2015-00229v_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00229&amp;id=fig13"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9">3.2 Bidentate-Binding (Bisubstrate) Inhibitors Exploiting Noncatalytic Interactions</h3><div class="NLM_p">Protein kinases are one of the most heavily hit therapeutic target families, but the high structural and sequence homology of kinase isoforms, especially at the conserved ATP binding site, inherently result in polypharmacology and low selectivity. To find selective kinase inhibitors as both pharmacological tools and safer therapeutic candidates, a bidentate-binding (bivalent) strategy that simultaneously utilizes binding at the ATP hinge site and at a unique pocket outside the ATP cleft has been employed.<a onclick="showRef(event, 'ref31 ref36 ref37 ref38 ref39 ref40 ref41'); return false;" href="javascript:void(0);" class="ref ref31 ref36 ref37 ref38 ref39 ref40 ref41">(31, 36, 37-41)</a> The principal advantage of bisubstrate inhibitors is their ability to bind at plural sites on the kinase surface, resulting in increased affinity and selectivity compared with traditional active site-targeted inhibitors.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> In this section, we illustrate the usefulness of this approach by discussing its application to various targets, including kinase.</div><div class="NLM_p">An X-ray crystal structure analysis of phosphodiesterase 2 (PDE2) complexed with a highly selective inhibitor <b>31</b> (BAY60–7550),<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> a derivative of hit <b>30</b>, showed that <b>31</b> binds not only to the PDE2 active site by employing the traditional glutamine-switch substrate-binding mode but also to an induced hydrophobic site (namely, the H-pocket) that does not exist in apo PDE2A (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4HTZ">4HTZ</a>). Affinity profiling by molecular modeling indicated that binding to the H-pocket makes a major contribution to the overall binding affinity and thereby improves the selectivity of this inhibitor for PDE2 (Figure <a data-tab="pane-pcw-Figures" href="#fig14" id="" class=" internalNav">14</a>).<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> This clearly illustrates the value of induced, noncatalytic binding sites for obtaining high selectivity.</div><figure id="fig14" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 14</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00229/20151002/images/medium/jm-2015-00229v_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00229/20151002/images/large/jm-2015-00229v_0014.jpeg" id="gr14" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 14. Derivation of <b>31</b> from a virtual hit molecule <b>30</b> and structure of PDE2A complexed with <b>31</b> (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4HTX">4HTX</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00229/20151002/images/large/jm-2015-00229v_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00229&amp;id=fig14"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">HTS for matrix metalloproteinase 13 (MMP-13)-inhibitory activity yielded a moderately active quinazoline-2-carboxamide (<b>32</b>) (IC<sub>50</sub> = 12 nM) (Figure <a data-tab="pane-pcw-Figures" href="#fig15" id="" class=" internalNav">15</a>). The X-ray crystal structure of the complex of <b>32</b> with MMP-13 catalytic domain (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3WV2">3WV2</a>) revealed the structural basis for the high selectivity.<a onclick="showRef(event, 'ref44 ref45'); return false;" href="javascript:void(0);" class="ref ref44 ref45">(44, 45)</a> In MMP–inhibitor complexes, a hydrogen bond is frequently observed between the ligand and the backbone amide of Leu and Ala residues flanking the catalytic site. Because the S1′ pocket of MMPs displays the highest variability in shape and length, it has been widely used to modulate ligand selectivity.<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> On the basis of the three-dimensional structure of the protein target, a series of potent MMP-13 selective inhibitors was optimized to occupy the distinct deep S1′ pocket and adjacent side pocket. Among them, quinazoline-2-carboxamide derivative <b>33</b> exhibited potent inhibitory activity (IC<sub>50</sub> = 0.0039 nM) and high selectivity (greater than 41000-fold) over other MMPs (MMP-1, -2, -3, -7, -8, -9, -10, -14, and TACE).<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> Further structural evolution of the fused pyrimidine scaffold led to thieno[2,3-<i>d</i>]pyrimidine-2-carboxamides as highly active and selective MMP-13 inhibitors, exemplified by <b>34</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig15" id="" class=" internalNav">15</a>).<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> X-ray structure analysis of MMP-13 complexed with <b>33</b> (the PDB code was not disclosed) confirmed that this molecule is buried deep in the S1′ pocket owing to a β-sheet-type H-bonding interaction with the main chain of MMP-13 (Thr245 and Thr247) spanning the S1′ pocket and also interacts with an additional S1′ side pocket (S1″ pocket) in MMP-13 without interacting with the catalytic zinc (it does not contain a zinc binding group, ZBG) (Figure <a data-tab="pane-pcw-Figures" href="#fig15" id="" class=" internalNav">15</a>).<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> Furthermore, no overt toxicity was seen in a preliminary repeated-dose oral toxicity study of compound <b>33</b> in rats. Monosodium salt of <b>33</b> is an orally bioavailable MMP-13 inhibitor and greatly reduced release of degradation products (CTX-II) from articular cartilage into the joint cavity in an in vivo rat MIA model in a single oral dose study.<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a></div><figure id="fig15" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 15</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00229/20151002/images/medium/jm-2015-00229v_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00229/20151002/images/large/jm-2015-00229v_0015.jpeg" id="gr15" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 15. Discovery of highly potent and selective fused pyrimidine-based MMP-13 inhibitors without any ZBG.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00229/20151002/images/large/jm-2015-00229v_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00229&amp;id=fig15"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Cyclin-dependent kinases (CDKs) are serine/threonine protein kinases that function as key regulatory proteins in progression of the cell cycle. The hit compound <b>35</b> discovered by HTS was a weak inhibitor (IC<sub>50</sub> = 15 μM). Structure-based modification of <b>35</b> was then conducted, aiming to utilize the untapped chemical space identified in the structure of the CDK2 complex with <b>35</b> (PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3QQK">3QQK</a>). This yielded a series of highly potent and selective diaminothiazole inhibitors of CDK2 (IC<sub>50</sub> = 0.9–1.5 nM). Notably, compound <b>36</b> displayed high selectivity for CDK2 and CDK5 over CDK1, CDK4, CDK6, and CDK9 (Figure <a data-tab="pane-pcw-Figures" href="#fig16" id="" class=" internalNav">16</a>). Compound <b>36</b> suppressed the proliferation of 13 cancer cell lines with IC<sub>50</sub> values ranging from 0.27 to 6.9 μM, in line with observations of complete inhibition of retinoblastoma phosphorylation and induction of apoptosis.<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> Structure determination of the complex of CDK2 with <b>36</b> (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3QXP">3QXP</a>) provided new structural insights into the CDK2 inhibitor selectivity and confirmed the usefulness of structure-based design to obtain isozyme-selective inhibitors.</div><figure id="fig16" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Figure 16</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00229/20151002/images/medium/jm-2015-00229v_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00229/20151002/images/large/jm-2015-00229v_0016.jpeg" id="gr16" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 16. Co-crystal structures of CDK2 with hit <b>35</b> (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3QQK">3QQK</a>) and diaminothiazole <b>36</b> (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3QXP">3QXP</a>), which is a highly selective inhibitor of CDK2/5.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00229/20151002/images/large/jm-2015-00229v_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00229&amp;id=fig16"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10">3.3 Structure-Guided Optimization of Isoform-Preferential Interactions</h3><div class="NLM_p">On the basis of the solved crystal structures of target protein–ligand complexes, favorable and unfavorable interactions can now be analyzed by means of computer-aided molecular modeling and dynamics simulation. Favorable interactions or critical amino acids can also be targeted by designing molecular scaffolds with appropriate three-dimensional shapes to afford increased binding affinity and selectivity.</div><div class="NLM_p">For example, crystallographic analysis of phosphodiesterase-9 (PDE9) identified Tyr424, a unique residue of PDE8 and PDE9, as a potential target for improvement of the selectivity of PDE9 inhibitors. Indeed, on the basis of a combination of structure-based design and computational docking, a new series of PDE9 inhibitors with a 6-amino-pyrazolopyrimidinone scaffold (exemplified by compound <b>37</b>) was developed. Among them, <b>38</b> showed IC<sub>50</sub> values of 21 nM and 3.3 μM for PDE9 and PDE5, respectively, with about 3 orders of magnitude selectivity over other PDE isoforms. The structure of the complex of PDE9 catalytic domain with <b>38</b> (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4GH6">4GH6</a>) was solved, and it revealed direct H-bonding between Tyr424 and <b>38</b>, which was considered to account for the high selectivity for PDE9 over other PDE isoforms (Figure <a data-tab="pane-pcw-Figures" href="#fig17" id="" class=" internalNav">17</a>).<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a></div><figure id="fig17" data-index="17" class="article__inlineFigure"><h2 class="fig-label">Figure 17</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00229/20151002/images/medium/jm-2015-00229v_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00229/20151002/images/large/jm-2015-00229v_0017.jpeg" id="gr17" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 17. Structure-based design of highly selective PDE9 inhibitor <b>38</b> from lead <b>37</b> (the selectivity panel data were not provided in the original paper) (a) and the crystal structure of the complex of the PDE9 catalytic domain with <b>38</b> (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4GH6">4GH6</a>); (b) for a surface presentation; (c) for a stick model. The Tyr424 is emphasized by large bold font.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00229/20151002/images/large/jm-2015-00229v_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00229&amp;id=fig17"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Isoform-selective antagonists of phosphoinositide 3-kinases (PI3Ks) have potential value in cell biology and clinical practice. For example, PI3Kα is an oncogene in human tumors. A cysteine residue is present in PI3Kα (Cys862) but not in other P13K isoforms. Targeting this cysteine might therefore be a means to achieve selective covalent inhibition of PI3Kα. Through structure-based drug design from <b>39</b> (GDC-0941),<a onclick="showRef(event, 'cit49a'); return false;" href="javascript:void(0);" class="ref cit49a">(49a)</a> a targeted covalent inhibitor <b>40</b> (CNX-1351) was designed and synthesized, and indeed, it potently and selectively inhibited PI3Kα. The results of MS and X-ray crystallography (PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3ZIM">3ZIM</a>) confirmed the validity of the design strategy (Figure <a data-tab="pane-pcw-Figures" href="#fig18" id="" class=" internalNav">18</a>). Compound <b>40</b> also potently (EC<sub>50</sub> < 100 nM) and selectively inhibited signaling in PI3Kα-dependent cancer cell lines, resulting in robust antiproliferative activity (GI<sub>50</sub> < 100 nM).<a onclick="showRef(event, 'cit49b'); return false;" href="javascript:void(0);" class="ref cit49b">(49b)</a></div><figure id="fig18" data-index="18" class="article__inlineFigure"><h2 class="fig-label">Figure 18</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00229/20151002/images/medium/jm-2015-00229v_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00229/20151002/images/large/jm-2015-00229v_0018.jpeg" id="gr18" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 18. Design of a potent and isoform-selective covalent PI3Kα inhibitor <b>40</b> and X-ray structure of the complex of PI3Kα with <b>40</b> (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3ZIM">3ZIM</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00229/20151002/images/large/jm-2015-00229v_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00229&amp;id=fig18"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Covalent linkage formation has been employed in various approved drugs.<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> In general, this strategy requires that the target protein should contain a reactive residue that is unusual or nonconserved among other isoforms.</div><div class="NLM_p">On the basis of the X-ray structure of PI3Kβ complexed with a pan-PI3K inhibitor (PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2Y3A">2Y3A</a>) and the fact that Asp862 is a nonconserved amino acid residue unique to the β isoform (Gln, Lys, and Asn residues occupy this position in PI3Kα, γ, and δ, respectively), a series of aminoacyl-triazines (exemplified by <b>42</b>) derived from the pan-PI3K inhibitor <b>41</b> (ZSTK474) were identified as potent and PI3Kβ-selective inhibitors;<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> they also showed strong inhibition of cellular Akt phosphorylation and growth of PTEN-deficient MD-MBA-468 cells (Figure <a data-tab="pane-pcw-Figures" href="#fig19" id="" class=" internalNav">19</a>). Within this series, the <span class="smallcaps smallerCapital">l</span>-amino acyl compounds preferentially inhibited PI3Kβ while their <span class="smallcaps smallerCapital">d</span>-counterparts preferentially inhibited PI3Kδ. The mechanism of the inhibition was investigated by using site-directed mutants, and Asp862 was confirmed to play a key role.</div><figure id="fig19" data-index="19" class="article__inlineFigure"><h2 class="fig-label">Figure 19</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00229/20151002/images/medium/jm-2015-00229v_0019.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00229/20151002/images/large/jm-2015-00229v_0019.jpeg" id="gr19" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 19. Design of isoform-selective PI3Kβ inhibitor <b>42</b> targeting nonconserved Asp862 of PI3Kβ.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00229/20151002/images/large/jm-2015-00229v_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00229&amp;id=fig19"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">An overlay of the structures of the sulfonylpiperazine skeleton (<b>43</b>) and an HTS hit (<b>44</b>) in their complexes with PI3Kγ displayed a high degree of overlap. This was exploited to design novel hybrid analogues, such as <b>45</b>, as selective, potent, and orally bioavailable leads (Figure <a data-tab="pane-pcw-Figures" href="#fig20" id="" class=" internalNav">20</a>).<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a></div><figure id="fig20" data-index="20" class="article__inlineFigure"><h2 class="fig-label">Figure 20</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00229/20151002/images/medium/jm-2015-00229v_0020.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00229/20151002/images/large/jm-2015-00229v_0020.jpeg" id="gr20" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 20. (a) Design of novel hybrid molecule <b>45</b> as a PI3Kγ-selective inhibitor. (b) Superimposed complexes of PI3Kγ with <b>43</b> (pink, PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4ANV">4ANV</a>) and with <b>44</b> (green, PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4ANU">4ANU</a>). (c) Structure of <b>45</b> complexed with PI3Kγ (yellow, PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4ANW">4ANW</a>). (d) Superposition of all three X-ray crystal structures.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00229/20151002/images/large/jm-2015-00229v_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00229&amp;id=fig20"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Vps34 (a lipid PI3K class III isoform) is involved in vesicle trafficking and autophagy and is therefore an interesting target for cancer treatment.<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a> Starting with tetrahydropyrimidopyrimidinone-based hit molecule <b>46</b>, structural optimization resulted in the identification of Vps34 inhibitors <b>47</b> (SAR405) and <b>48</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig21" id="" class=" internalNav">21</a>). These molecules displayed potent inhibition of Vps34 with extremely high selectivity. The X-ray structures of the complexes of these two molecules with human Vps34, in combination with sequence alignment of the catalytic sites of Vps34 and class I PI3K α, β, δ, and γ, demonstrated unique binding modes and molecular interactions of <b>47</b> and <b>48</b> in the ATP-binding cleft of Vps34, and the results illustrate well how the unique molecular characteristics of the morpholine synthon bestowed selectivity toward class I PI3Ks.<a onclick="showRef(event, 'ref54 ref55'); return false;" href="javascript:void(0);" class="ref ref54 ref55">(54, 55)</a> Compound <b>48</b> showed promising in vivo PK parameters in mouse and induced sustained inhibition of Vps34 upon acute administration.<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a></div><figure id="fig21" data-index="21" class="article__inlineFigure"><h2 class="fig-label">Figure 21</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00229/20151002/images/medium/jm-2015-00229v_0021.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00229/20151002/images/large/jm-2015-00229v_0021.jpeg" id="gr21" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 21. Design of tetrahydropyrimidopyrimidinone-based selective Vps34 inhibitors and binding modes of compounds <b>47</b> and <b>48</b> complexed with VPS34 (PDB codes <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4OYS">4OYS</a> and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4UWL">4UWL</a>, respectively).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00229/20151002/images/large/jm-2015-00229v_0021.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00229&amp;id=fig21"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Most of the heat shock protein 90 (HSP90) inhibitors are pan-inhibitors of HSP90α/β and also to some extent the other two HSP90 isoforms, TRAP1 (a mitochondrial HSP90 isoform) and GRP94 (an ER-resident Hsp90 isoform). The recently determined X-ray structure of GRP94 demonstrated that this protein contains a unique secondary binding site (π-rich pocket) that could provide an opportunity to design isoform-selective inhibitors. It was hypothesized that the pan-HSP90 inhibitor <b>49</b> (Radamide, RDA) (Figure <a data-tab="pane-pcw-Figures" href="#fig22" id="" class=" internalNav">22</a>) analogues containing a more hydrophobic mimic of the quinone connected to resorcinol via a <i>cis</i>-amide bioisostere could afford GRP94-selective inhibitors. Consequently, structure-based modification of <b>49</b> (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2FXS">2FXS</a>) was carried out, and compound <b>50</b> was obtained as a potent inhibitor of GRP94 with selectivity for GRP94 over HSP90α/β (Figure <a data-tab="pane-pcw-Figures" href="#fig22" id="" class=" internalNav">22</a>).<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a> Compound <b>50</b> contains a phenyl ring appended to an imidazole ring, which serves as a <i>cis</i>-amide surrogate. The preferred orientation of the phenyl ring was postulated to interact with the unique GRP94 π-rich pocket to achieve excellent selectivity. Compound <b>50</b> also inhibited trafficking of Toll-like receptors (TLRs) to the cell membrane of HEK293 cells expressing GRP94 in a cellular assay (IC<sub>50</sub> = 32 nM). It did not inhibit cytosolic HSP90α/β client proteins (AKT or CRAF) and had no effect on cell viability in the same concentration range.</div><figure id="fig22" data-index="22" class="article__inlineFigure"><h2 class="fig-label">Figure 22</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00229/20151002/images/medium/jm-2015-00229v_0022.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00229/20151002/images/large/jm-2015-00229v_0022.jpeg" id="gr22" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 22. Design of a selective Grp94 inhibitor <b>50</b> targeting the unique π-rich pocket.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00229/20151002/images/large/jm-2015-00229v_0022.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00229&amp;id=fig22"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Through a systematic investigation of the kinome, Pro455 and Asn457 in spleen tyrosine kinase (Syk) ATP binding site were identified as a rare combination among sequence-aligned kinases. It was hypothesized that the spatial proximity of Pro455 and Asn457 could be utilized to design Syk-selective inhibitors that would interact with both residues simultaneously, affording high selectivity for Syk over other isozymes. On the basis of the above analysis and starting with lead compound <b>51</b>, thiazolopyrimidine analogue <b>52</b> was discovered as a selective Syk inhibitor. The X-ray structure of the complex of <b>52</b> (depicted in green) with Syk confirmed that this molecule targeted Pro455 and Asn457 (Figure <a data-tab="pane-pcw-Figures" href="#fig23" id="" class=" internalNav">23</a>).<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a></div><figure id="fig23" data-index="23" class="article__inlineFigure"><h2 class="fig-label">Figure 23</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00229/20151002/images/medium/jm-2015-00229v_0023.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00229/20151002/images/large/jm-2015-00229v_0023.jpeg" id="gr23" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 23. Design of thiazolopyrimidine <b>52</b>. The structure of the complex with Syk (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4FYO">4FYO</a>) is shown with Pro455 and Asn457 highlighted in red.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00229/20151002/images/large/jm-2015-00229v_0023.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00229&amp;id=fig23"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In the overlay of the X-ray structures of the complexes of tyrosine-protein kinase 2 (TYK2) and Janus kinase 2 (JAK2) with the lead molecule 4-aminopyridine benzamide <b>53</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig24" id="" class=" internalNav">24</a>), there is a clear difference of P-loop conformations between TYK2 and JAK2. Further, the positively charged arginine (Arg901) in TYK2 is replaced by neutral glutamine (Gln853) in JAK2. In theory, this difference can be used to improve the TYK2 selectivity of <b>53</b>. Initial modeling showed that substitution at the C2-site of the cyclopropylamide moiety could afford a vector to access this domain. Further structure-based optimization eventually led to the discovery of a highly potent, selective, and orally bioavailable TYK2 inhibitor <b>54</b>. Compound <b>54</b> showed statistically significant knockdown of interferon-γ (IFNγ) in a mouse IL-12 PK/PD model assay, indicating that selective suppression of TYK2 kinase activity should be sufficient to suppress the in vivo IL-12 pathway. This study suggested that selectivity could be achieved not only by directly targeting sequence differences but also by utilizing the overall discrepancy in P-loop conformation or flexibility.<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a></div><figure id="fig24" data-index="24" class="article__inlineFigure"><h2 class="fig-label">Figure 24</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00229/20151002/images/medium/jm-2015-00229v_0024.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00229/20151002/images/large/jm-2015-00229v_0024.jpeg" id="gr24" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 24. Design of TYK2 selective inhibitor <b>54</b> based on structural overlay of TYK2 (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4GIH">4GIH</a>) and JAK2 (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4GMY">4GMY</a>) complexes with lead compound <b>53</b> (TYK2 pink, JAK2 green), highlighting the discrepancy of P-loop conformations between TYK2 and JAK2 and the sequence difference (Arg901 versus Gln853) in the cyclopropylamide target site.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00229/20151002/images/large/jm-2015-00229v_0024.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00229&amp;id=fig24"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">X-ray structures of a C-2 methyl analogue <b>55</b> complexed with JAK1 (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4EHZ">4EHZ</a>) and JAK2 (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4F09">4F09</a>) revealed differential protein–ligand interactions between these two isozymes, providing an opportunity for improving selectivity (Figure <a data-tab="pane-pcw-Figures" href="#fig23" id="" class=" internalNav">23</a>). Structure-based design culminated in the identification of a C-2 hydroxyethyl imidazopyrrolopyridine derivative <b>56</b> as a potent JAK1 inhibitor with high selectivity over JAK2. Compound <b>56</b> showed favorable physicochemical properties in a range of preclinical studies and was active in a rat CIA model. X-ray structures of the complexes of <b>56</b> with JAK1 and JAK2 (Figure <a data-tab="pane-pcw-Figures" href="#fig25" id="" class=" internalNav">25</a>c,d) demonstrated that the C-2 (<i>R</i>)-hydroxyethyl moiety interacts differently with the Glu966 and Asp939 residues, accounting for the remarkable selectivity.<a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">(59)</a></div><figure id="fig25" data-index="25" class="article__inlineFigure"><h2 class="fig-label">Figure 25</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00229/20151002/images/medium/jm-2015-00229v_0025.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00229/20151002/images/large/jm-2015-00229v_0025.jpeg" id="gr25" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 25. (a) X-ray structure of complex of <b>55</b> with JAK1 (blue, Glu966 from structure <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4EHZ">4EHZ</a>) overlaid with the corresponding structure of JAK2 (yellow, Asp939 from PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4F09">4F09</a>) to show the pivotal residue difference. (b) Design of imidazopyrrolopyridine (<b>56</b>) as a JAK1-selective inhibitor. (c) X-ray structure of the complex of <b>56</b> with JAK1 (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4IVB">4IVB</a>). (d) X-ray structure of the complex of <b>56</b> with JAK2 (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4IVA">4IVA</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00229/20151002/images/large/jm-2015-00229v_0025.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00229&amp;id=fig25"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Compounds <b>57</b> and <b>58</b>, two initial leads with the 5<i>H</i>-pyrrolo[2,3-<i>b</i>]pyrazine scaffold, were potent ATP-competitive inhibitors of JAKs but lacked selectivity among JAK isoforms. It was recognized that a cysteine residue (Cys909) in JAK3 is replaced by serine at the same position in both JAK1 and JAK2. On the basis of this difference, it was hypothesized that a hydrophobic moiety located in this area of the binding pocket should form fewer unfavorable contacts with cysteine in JAK3 than with serine (and its water network) in the other JAK isoforms, which might result in improved selectivity. Computational and crystallographic analysis suggested that the phenyl ether moiety of <b>57</b> possessed a favorable vector to reach Cys909 (Figure <a data-tab="pane-pcw-Figures" href="#fig26" id="" class=" internalNav">26</a>). Further computer-aided, structure-based design in the light of these theoretical results led to the discovery of <b>59</b>, which displayed potent and selective inhibition of JAK3.<a onclick="showRef(event, 'ref60'); return false;" href="javascript:void(0);" class="ref ref60">(60)</a></div><figure id="fig26" data-index="26" class="article__inlineFigure"><h2 class="fig-label">Figure 26</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00229/20151002/images/medium/jm-2015-00229v_0026.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00229/20151002/images/large/jm-2015-00229v_0026.jpeg" id="gr26" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 26. Design of JAK3-selective inhibitor <b>59</b> via structure-based modification of initial phenyl ether.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00229/20151002/images/large/jm-2015-00229v_0026.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00229&amp;id=fig26"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Selective inhibitors of epigenetic proteins are potential therapeutic agents for a diverse range of pathological conditions, including many kinds of cancer. As in the case of the kinase family, all the isoforms of epigenetic proteins usually have nearly identical catalytic domains (active sites), and chemical inhibitors of these epigenetic enzymes usually carry analogous structural motifs, making structure-based isoform-selective drug design a challenging problem. In the following section, we examine several scenarios in which crystallography and/or molecular modeling could contribute to the development of selective agents (Figure <a data-tab="pane-pcw-Figures" href="#fig27" id="" class=" internalNav">27</a>).</div><figure id="fig27" data-index="27" class="article__inlineFigure"><h2 class="fig-label">Figure 27</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00229/20151002/images/medium/jm-2015-00229v_0027.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00229/20151002/images/large/jm-2015-00229v_0027.jpeg" id="gr27" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 27. Discovery of selective epigenetic inhibitors via structure-based drug design combined with homology modeling.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00229/20151002/images/large/jm-2015-00229v_0027.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00229&amp;id=fig27"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">It was demonstrated by molecular modeling that structural differences in the catalytic channels and rim region of HDAC6 and HDAC1 afforded a potential basis for rational design of isoform-selective HDAC inhibitors. According to the pharmacophore model for the existing HDAC inhibitors (exemplified by SAHA), a series of carbazole hydroxamic acids with alkylaryl and alkyl linkers was prepared, culminating in the discovery of <b>61</b> (tubastatin A) as a potent and selective inhibitor of HDAC6 (Figure <a data-tab="pane-pcw-Figures" href="#fig27" id="" class=" internalNav">27</a>).<a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">(61)</a></div><div class="NLM_p">In 2010, rational drug design principles combined with homology modeling of JMJD2 were utilized to develop selective JMJD2 inhibitors based on the structure of <i>N</i>-oxalylglycine (NOG, <b>62</b>). A novel hydroxamate analogue <b>63</b> bearing a tertiary amine showed 500-fold higher JMJD2C-inhibitory potency and over 9100-fold greater selectivity for JMJD2C than the lead structure NOG (<b>62</b>).<a onclick="showRef(event, 'ref62'); return false;" href="javascript:void(0);" class="ref ref62">(62)</a> Similarly, in 2012, in the same lab, homology models of human sirtuin 1 (SIRT1) and sirtuin 2 (SIRT2) were used to lead <b>64</b> to 3′-phenethyloxy-2-anilinobenzamides such as <b>65</b> and <b>66</b>, which exhibit more than 3.5-fold greater SIRT2-inhibitory potency and over 35-fold higher selectivity for SIRT2 compared with <b>67</b> (AGK2), a previously identified SIRT2-selective inhibitor.<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a> The ligand–enzyme interactions were studied in detail by molecular docking to understand the SAR and to obtain structural clues for further optimization.</div><div class="NLM_p">Because differences in the ligand-binding sites of estrogen receptor (ER) subtypes α and β are small, the discovery of subtype-selective inhibitors is particularly challenging. To search for additional preferred interactions that might improve ER binding affinity or selectivity, modeling analysis of the ERβ-binding cavity with compound <b>68</b> (the simplest member of the salaldox B class of previously developed salicylaldoxime-based ERβ agonists) was performed. The modeling study identified an empty hydrophobic subpocket delimited by Leu301 and Phe356 in ERβ around the aldoxime hydrogen atom of compound <b>68</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig28" id="" class=" internalNav">28</a>). Therefore, a suitable small lipophilic group (methyl, ethyl, or trifluoromethyl) was introduced into compound <b>68</b> to fill this cavity, culminating in the identification of a new salicylketoxime compound <b>69a</b> with remarkably high subtype-selective binding affinities for ERβ in both in vitro cell-free assays and cell-based assays.<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a></div><figure id="fig28" data-index="28" class="article__inlineFigure"><h2 class="fig-label">Figure 28</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00229/20151002/images/medium/jm-2015-00229v_0028.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00229/20151002/images/large/jm-2015-00229v_0028.jpeg" id="gr28" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 28. Design of highly selective salicylketoxime-based estrogen receptor β agonists.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00229/20151002/images/large/jm-2015-00229v_0028.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00229&amp;id=fig28"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">In summary, refinement of the basic skeleton of existing bioactive molecules combined with introduction of isoform-preferred substituents is an accepted approach in medicinal chemistry to find novel compounds with increased selectivity. The availability of crystal structures is also useful to provide insights for design of inhibitors with improved selectivity profiles. A key requirement for future work will be to understand in detail how the subtle structural differences between isozymes influence the interaction with ligands.</div></div><div id="sec3_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11">3.4 Conformational Restriction</h3><div class="NLM_p">Conformation restriction has been widely utilized in contemporary drug design to obtain potent and selective agents. Flexible binders are considered to suffer an entropic penalty upon binding due to the freezing of rotatable bonds. Thus, the conformation restriction strategy may increase inhibitory potency by stabilizing a favorable binding conformation (therefore reducing the entropic penalty on binding to the target) or may improve isoform selectivity by eliminating bioactive conformers that give undesired biological responses. Besides, from the viewpoint of ligand efficiency, conformational control could be a very atom-efficient way to improve binding affinity without introducing additional interactions. Because of these advantages, the conformation restriction strategy has attracted considerable attention in recent drug discovery.<a onclick="showRef(event, 'ref65'); return false;" href="javascript:void(0);" class="ref ref65">(65)</a></div><div class="NLM_p">Compound <b>70</b> containing a chiral <i>trans</i>-cyclopropane unit is a selective inhibitor of γ-aminobutyric acid (GABA) transporter (GAT) subtypes BGT-1 (betaine/GABA transporter-1) and GAT-3. Compound <b>70</b> was developed by applying a three-dimensional, diversity-oriented conformational restriction strategy. Further conformational restriction of <b>70</b> with the rigid bicyclo[3.1.0]hexane platform afforded the first highly selective BGT-1 inhibitor <b>71</b> (IC<sub>50</sub> = 0.59 μM) (Figure <a data-tab="pane-pcw-Figures" href="#fig29" id="" class=" internalNav">29</a>).<a onclick="showRef(event, 'ref66'); return false;" href="javascript:void(0);" class="ref ref66">(66)</a></div><figure id="fig29" data-index="29" class="article__inlineFigure"><h2 class="fig-label">Figure 29</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00229/20151002/images/medium/jm-2015-00229v_0029.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00229/20151002/images/large/jm-2015-00229v_0029.jpeg" id="gr29" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 29. Conformationally restricted bioactive molecules.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00229/20151002/images/large/jm-2015-00229v_0029.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00229&amp;id=fig29"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The structure-based conformational restriction strategy has also been applied to the discovery of highly selective inhibitors of CBP/p300 bromodomains<a onclick="showRef(event, 'ref67'); return false;" href="javascript:void(0);" class="ref ref67">(67)</a> and plasmin inhibitors.<a onclick="showRef(event, 'ref68'); return false;" href="javascript:void(0);" class="ref ref68">(68)</a> Compound <b>72</b>, identified by means of a stereochemical (asymmetric geometry) diversity-oriented conformational restriction strategy, was found to be a highly active inhibitor of CBP and p300 BRDs (<i>K</i><sub>d</sub> = 0.021 and 0.032 μM, respectively) and displayed more than 40-fold selectivity for CBP over the other BRD isoforms.<a onclick="showRef(event, 'ref67'); return false;" href="javascript:void(0);" class="ref ref67">(67)</a> The ring-constrained bis-triazole compound <b>73</b> selectively inhibited plasmin and plasma kallikrein with <i>K</i><sub>i</sub> values of 0.77 and 2.4 nM, respectively, while it displayed low potency against the related trypsin-like serine proteases thrombin, activated protein C, and factor Xa.<a onclick="showRef(event, 'ref68'); return false;" href="javascript:void(0);" class="ref ref68">(68)</a></div><div class="NLM_p">Consideration of the biochemical mechanisms of bacterial resistance indicated that it might be feasible to design a conformationally constrained oligosaccharide that would retain antibiotic activity without being susceptible to enzymatic inactivation (the major biochemical mechanism of bacterial resistance). In the light of this theoretical analysis, several aminoglycosides, including <b>75</b> and <b>76</b>, fixed in the ribosome-bound “bioactive” conformation, were prepared based on the lead compound <b>74</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig30" id="" class=" internalNav">30</a>). The conformational constraint had only a modest influence on their binding with rRNA. However, it had a substantial influence on enzymatic inactivation. Thus, rational design of ring-restricted aminoglycosides has been considered to be a novel approach to overcome bacterial resistance.<a onclick="showRef(event, 'ref69'); return false;" href="javascript:void(0);" class="ref ref69">(69)</a></div><figure id="fig30" data-index="30" class="article__inlineFigure"><h2 class="fig-label">Figure 30</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00229/20151002/images/medium/jm-2015-00229v_0030.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00229/20151002/images/large/jm-2015-00229v_0030.jpeg" id="gr30" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 30. Schematic representation of conformationally restricted aminoglycosides.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00229/20151002/images/large/jm-2015-00229v_0030.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00229&amp;id=fig30"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Thus, forced adoption of a preferential conformation by appropriate use of chiral centers and macrocyclization can result in higher selectivity.</div></div><div id="sec3_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12">3.5 Rapid Assembly and Screening of Focused Combinatorial Fragment Libraries</h3><div class="NLM_p">As described above, fragment-based drug discovery is a powerful method to discover small-molecular modulators of biological targets. In recent years, diversity-oriented synthesis (DOS) of small chemical entities based on privileged fragments has emerged as a new strategy for exploring the interactions between chemistry and biology.<a onclick="showRef(event, 'ref70'); return false;" href="javascript:void(0);" class="ref ref70">(70)</a> DOS affords spatially well-defined compounds that can be utilized not only as chemical tools for protein targets of interest but also as selective modulators of certain disease processes. Integrated high-throughput synthesis and screening of a focused library based on privileged heterocyclic or peptide fragments has been employed to seek bioactive molecules targeting epigenetic proteins such as the first cyclic tetrapeptide-derived HDAC6-selective inhibitors.<a onclick="showRef(event, 'ref71 ref72'); return false;" href="javascript:void(0);" class="ref ref71 ref72">(71, 72)</a></div><div class="NLM_p">Consequently, it is a key challenge in contemporary drug discovery to develop HTS-amenable organic reactions suitable for high-speed synthesis of diverse chemical libraries. In recent years, new synthetic concepts and methodologies have been developed. Notably, click chemistry is a powerful tool for chemical synthesis with outstanding bioorthogonality properties: it is rapid, biocompatible, and highly specific. Among the extant click reactions, copper(I)-catalyzed azide–alkyne [3 + 2] dipolar cycloaddition (CuAAC) is one of the most versatile reactions, allowing for the preparation of 1,4-functionalized triazole products in high yields under mild reaction conditions; it has become one of the most widely used reactions in chemical biology and medicinal chemistry.<a onclick="showRef(event, 'ref73'); return false;" href="javascript:void(0);" class="ref ref73">(73)</a></div><div class="NLM_p">The use of pharmacophores of existing pan-inhibitors is a crucial strategy in generating candidate libraries. From a medicinal chemistry point of view, most HDAC inhibitors fall into a widely accepted pharmacophoric model (Figure <a data-tab="pane-pcw-Figures" href="#fig31" id="" class=" internalNav">31</a>), which consists of a capping moiety (Cap) capable of interacting with residues on the rim of the HDAC catalytic tunnel, a zinc-binding group (ZBG) capable of chelating the Zn<sup>2+</sup> ion at the bottom of the catalytic subpocket, and a hydrophobic linker connecting the two (exemplified by SAHA) (Figure <a data-tab="pane-pcw-Figures" href="#fig31" id="" class=" internalNav">31</a>).<a onclick="showRef(event, 'ref2 ref74'); return false;" href="javascript:void(0);" class="ref ref2 ref74">(2, 74)</a></div><figure id="fig31" data-index="31" class="article__inlineFigure"><h2 class="fig-label">Figure 31</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00229/20151002/images/medium/jm-2015-00229v_0031.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00229/20151002/images/large/jm-2015-00229v_0031.jpeg" id="gr31" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 31. Identification of highly selective and potent epigenetic inhibitors by using click chemistry-based combinatorial fragment assembly.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00229/20151002/images/large/jm-2015-00229v_0031.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00229&amp;id=fig31"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">On the basis of this pharmacophoric model, isoform-selective HDAC inhibitors have been identified. Two 1,2,3-triazole-based libraries of HDAC inhibitor candidates were constructed by using CuAAC reactions between alkynes bearing ZBG as pharmacomodulating elements (warheads) and diversified azide fragments as cap structures. The “clicked” triazole libraries were sufficiently pure and therefore could be used directly for biological screenings (using DMSO stock solutions of compounds), and this led to the identification of HDAC8-selective inhibitor <b>77</b> (C149) and HDAC3-selective inhibitors <b>78</b> (T247) and <b>79</b> (T326) (Figure <a data-tab="pane-pcw-Figures" href="#fig31" id="" class=" internalNav">31</a>).<a onclick="showRef(event, 'ref75 ref76'); return false;" href="javascript:void(0);" class="ref ref75 ref76">(75, 76)</a> These compounds also showed selective inhibition of HDAC8 or HDAC3 in cell-based assays and exerted growth-inhibitory effects on cancer cells. Furthermore, computational modeling revealed key interactions between HDAC8/3 and inhibitors, suggesting a rational basis for the observed selectivity.</div><div class="NLM_p">However, it is still particularly challenging to obtain high selectivity among the 11 zinc-dependent HDAC isoforms (for instance, selectivity between HDAC1 and 2, which show very close structural similarities).</div><div class="NLM_p">Analogously, a series of 114 SIRT inhibitor candidates was prepared using the CuAAC reaction of two 2-anilinobenzamide-containing alkynes (as pharmacophoric elements) with 57 azide building blocks. Two SIRT2-selective binders, <b>81</b> (A1B11) and <b>82</b> (A2B57), were identified by rapid screening. These compounds were more SIRT2-selective than the existing SIRT2 inhibitor <b>67</b> (AGK2).<a onclick="showRef(event, 'ref77'); return false;" href="javascript:void(0);" class="ref ref77">(77)</a> These studies in Suzuki’s lab confirmed the robustness and efficiency of the click chemistry approach for lead discovery and structural optimization of isozyme-selective inhibitors targeting epigenetic proteins.</div><div class="NLM_p">As described above, one approach for enhancing the potency and selectivity of initial hit molecules is formation of a covalent bond with a nucleophilic residue that is specific to a desired target and ideally without off-targets. JAK3 is the only Janus kinase containing a cysteine residue in the solvent-exposed front domain. Therefore, introduction of an electrophilic covalent tag to replace the nitrile group in <b>83</b> (Ruxolitinib) was considered a promising approach to selectively address this JAK3 isozyme. To prepare a JAK3 screening library of Ruxolitinib-derived molecules lacking the nitrile moiety, the pyrazole core in <b>83</b> was replaced with a 1,4-substituted triazole surrogate accessible by means of CuAAC reaction (Figure <a data-tab="pane-pcw-Figures" href="#fig32" id="" class=" internalNav">32</a>). In parallel syntheses, the most convenient protocol is to perform the reaction in centrifuge tubes, which allowed retrieval of the product by centrifugation. This avoids the need to transfer the suspension after precipitation. Moreover, the centrifugation method avoids the possibility of filter plugging and is very suitable for automation. Application of this approach led to the discovery of an active JAK3 inhibitor <b>84</b> (IC<sub>50</sub> = 35 nM) with high selectivity over other JAKs isoforms, probably via a covalent binding mechanism.<a onclick="showRef(event, 'ref78'); return false;" href="javascript:void(0);" class="ref ref78">(78)</a></div><figure id="fig32" data-index="32" class="article__inlineFigure"><h2 class="fig-label">Figure 32</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00229/20151002/images/medium/jm-2015-00229v_0032.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00229/20151002/images/large/jm-2015-00229v_0032.jpeg" id="gr32" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 32. Application of the CuAAC reaction to construct a library of <b>83</b>-derived triazole derivatives, coupled with rapid screening.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00229/20151002/images/large/jm-2015-00229v_0032.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00229&amp;id=fig32"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i13">4 Conclusions and Prospects</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_04484" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_04484" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The generation of potent and selective modulators will continue to be central to deciphering the physiological functions of isozymes and to the development of new therapeutic agents for many diseases. In this Perspective, we have focused on strategies for the discovery of target-specific or isoform-selective inhibitors and have illustrated these strategies by describing interesting examples ranging from structure/mechanism-based de novo design to rapid assembly and screening of focused combinatorial fragment libraries for the design of potentially highly selective modulators. Further development of these and other strategies or technologies may ultimately allow us to design completely isoform-selective compounds in a rational and effective manner, which has important implications for the discovery of selective modulators of ion channels, nuclear receptors, GPCRs, and many other biotargets.</div><div class="NLM_p">HTS of compound libraries is time- and resource-consuming, and considerable efforts must be invested in trial-and-error screening, profiling, and selecting the most promising candidates for further investigation. On the other hand, dynamic combinatorial chemistry (DCC) employs reversible covalent or noncovalent interactions between a set of small fragments to provide a mixture of reversibly reacting building blocks under thermodynamic control, but, in such a solution-phase approach it is important avoid the use of additional reagents in order to avoid possible adverse effects in subsequent in situ biochemical evaluations, and this in turn limits the choice of applicable reactions, as well as the scale of the practically attainable libraries. Therefore, rational design of inhibitors targeting isozymes via structure-based or mechanism-based approaches and virtual screening techniques can provide significant benefits. However, this requires a detailed understanding of the interplay among the many factors governing the binding of ligands to the target site.</div><div class="NLM_p">Compared with HTS of drug-like compounds, fragment (substrate) screening has frequently afforded high hit rates against a variety of targets in spite of the smaller size of the libraries. The first issue that needs to be confronted is the specificity of substrates or inhibitor fragments. While the compact structures of fragments can minimize steric hindrance during binding with the target, this may also favor interaction with binding pockets in unrelated targets, resulting in impaired specificity.<a onclick="showRef(event, 'ref79'); return false;" href="javascript:void(0);" class="ref ref79">(79)</a> Careful structural analysis of complexes of the target with loose binders could offer clues to a suitable decoration pattern for previously identified substrates or fragments. There are also indications that spatially well-defined compounds (such as the chiral cyclopropane ring) with multiple chiral centers in the substrate or fragment scaffolds may have greater potential for elaboration into selective binders of biotargets.<a onclick="showRef(event, 'ref65'); return false;" href="javascript:void(0);" class="ref ref65">(65)</a></div><div class="NLM_p">Selection of appropriate design principles, such as the bisubstrate (bivalent) approach or conformational restriction, depending upon the nature of the isozyme family in question, is also important in the optimization of existing pan-inhibitors or in the conversion of substrates to selective inhibitors. Exploitation of isoform-preferred interactions also provides a rational tool for structure-guided design of inhibitors with distinct selectivity profiles, especially for proteins with highly similar structures and sequences. These approaches are at the forefront of medicinal chemistry research.</div><div class="NLM_p">A relatively new strategy in the identification of target-specific or isoform-selective inhibitors of a number of biological targets is the rapid assembly and in situ screening of focused combinatorial fragment libraries. Because a purification procedure is not required after library assembly by means of the CuAAC reaction, medicinal chemists can explore the relevant chemical space around a certain scaffold in a quick and efficient manner. Nevertheless, the possibility of false positives and negatives must be considered. For instance, copper will be present in the samples to be assayed in in situ screening, so it is important to examine the effects of copper salts at the highest expected concentration as a control. Also, it is still necessary to extend the scope of synthetic strategies to generate diverse libraries of alkyne/azide-bearing building blocks (key components in click chemistry).</div><div class="NLM_p">It should be pointed out that optimization of target selectivity should be coupled with optimization of potency. Some of the techniques discussed here might be useful in generating compounds that are both potent and selective.</div><div class="NLM_p">The residence time of a drug on its target after binding is one of the key parameters of sustained efficiency and selectivity. Therefore, the binding kinetics of ligand–target complexes, namely the association rate (<i>k</i><sub>on</sub>) and dissociation rate (<i>k</i><sub>off</sub>), should be measured at an early stage of drug development. Many approved drugs appear to fall into one of two categories: (i) slow binding but with a long residence time, and (ii) fast binding but with a short residence time.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> In recent years, there has been a growing interest in the discovery of time-dependent selective inhibitors.<a onclick="showRef(event, 'ref80 ref81'); return false;" href="javascript:void(0);" class="ref ref80 ref81">(80, 81)</a></div><div class="NLM_p">Covalent interaction with the target protein offers significant pharmacological advantages. Covalent ligand–target interactions have the benefit of higher binding energies, prolonged duration of the pharmacological effect (drug-target residence time) and potential for improved selectivity. However, a challenge in developing covalent inhibitors is to identify suitable reactive functional moieties (“warheads”); usually such moieties require a level of electrophilicity that does not make them so reactive as to be promiscuous.<a onclick="showRef(event, 'ref82'); return false;" href="javascript:void(0);" class="ref ref82">(82)</a></div><div class="NLM_p">It should be emphasized that different protein isoforms, e.g., among kinases, HDACs and other epigenetic protein families, exhibit a great variety of tissue distributions, expression profiles, and subcellular locations in healthy versus diseased cells. Usually, these isozymes are components of sophisticated multiprotein complexes in cells, and the observed selectivity of binders or substrates toward isolated enzymes may be different from that toward biomacromolecular complexes in cells, adding a further layer of complexity to the discovery of genuine selective inhibitors.<a onclick="showRef(event, 'ref2 ref83 ref84'); return false;" href="javascript:void(0);" class="ref ref2 ref83 ref84">(2, 83, 84)</a> Therefore, screening for inhibitor specificity using multiprotein complexes rather than purified proteins or the addition of requisite protein–protein interaction assays is advocated. Basically, a very detailed understanding of the complex physiology of isoforms, cellular, and cell-type specific protein complexes (protein–protein interactions) and their substrates and modulators at the molecular level plays a central role in the design of highly potent and selective inhibitors.</div><div class="NLM_p last">Nevertheless, we believe these problems are not intractable; development of integrated strategies to design highly selective bioactive molecules for specific molecular recognition in complex biological systems is already under way and may ultimately make it feasible to precisely manipulate and control many biological processes.</div></div><div class="NLM_back"><div class="NLM_notes" id="notes-2"><p class="first last">The authors declare no competing financial interest.</p></div><div class="NLM_notes" id="notes-1"><span class="title" id="d93920444e1383">Notes</span><p class="last">All figures showing binding modes were produced with PyMol (<a href="http://www.pymol.org" class="extLink">www.pymol.org</a>).</p></div><div class="article_supporting-info" id=""></div><div class="testing" data-doi="10.1021/acs.jmedchem.5b00229" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_51822" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_51822" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Peng Zhan</span> - <span class="hlFld-Affiliation affiliation">Department
of Medicinal Chemistry, Key Laboratory of Chemical Biology (Ministry
of Education), School of Pharmaceutical Sciences, Shandong University, 44 West Culture Road, 250012 Jinan, Shandong, P.
R. China</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#c0baa8a1aeb0a5aea7f1f9f8f280b3a4b5eea5a4b5eea3ae"><span class="__cf_email__" data-cfemail="a1dbc9c0cfd1c4cfc690989993e1d2c5d48fc4c5d48fc2cf">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Takayoshi Suzuki</span> - <span class="hlFld-Affiliation affiliation">Graduate
School of Medical Science, Kyoto Prefectural
University of Medicine, 1-5 Shimogamohangi-Cho, Sakyo-Ku, Kyoto 606-0823, Japan</span>; 
    <span class="hlFld-Affiliation affiliation">CREST, Japan Science and Technology Agency
(JST), 4-1-8 Honcho, Kawaguchi, Saitama 332-0012, Japan</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#7300060906181a0733181c071c5d1803065e1e5d12105d1903"><span class="__cf_email__" data-cfemail="4231373837292b3602292d362d6c2932376f2f6c23216c2832">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xinyong Liu</span> - <span class="hlFld-Affiliation affiliation">Department
of Medicinal Chemistry, Key Laboratory of Chemical Biology (Ministry
of Education), School of Pharmaceutical Sciences, Shandong University, 44 West Culture Road, 250012 Jinan, Shandong, P.
R. China</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#552d3c3b2c3a3b3239152631207b3031207b363b"><span class="__cf_email__" data-cfemail="fa8293948395949d96ba899e8fd49f9e8fd49994">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yukihiro Itoh</span> - <span class="hlFld-Affiliation affiliation">Graduate
School of Medical Science, Kyoto Prefectural
University of Medicine, 1-5 Shimogamohangi-Cho, Sakyo-Ku, Kyoto 606-0823, Japan</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><p>The authors declare no competing financial interest.<br /></br></p></li></ul></div><div class="bio" rid="ath1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="biographies">Biographies</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_44866" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_44866" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><figure id="ath1" data-index="33" class="article__inlineFigure"><h2 class="fig-label">Peng Zhan</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00229&amp;id=BIO-d7e1674-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Peng Zhan</b> obtained his B.Sc. degree from Shandong University, China, in 2005. Then he earned his M.Sc. degree and Ph.D. in medicinal chemistry from Shandong University in 2008 and 2010, respectively. He subsequently joined the research group of Professor Xinyong Liu as a Lecturer (2010–2012). From 2012 to 2014, he worked as a Postdoctoral Fellow funded by JSPS (Japan Society for the Promotion of Science) in the Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Japan. He is now working as an associate professor in the lab of Professor Xinyong Liu. His research interests involve the discovery of novel antiviral, anticancer, and neurodegenerative diseases-related agents based on rational drug design and combinatorial chemistry approaches.</p></figure></div><div class="bio" rid="ath2"><figure id="ath2" data-index="34" class="article__inlineFigure"><h2 class="fig-label">Yukihiro Itoh</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00229&amp;id=BIO-d7e1679-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Yukihiro Itoh</b> obtained his Ph.D. in pharmaceutical sciences from the University of Tokyo (2011). Subsequently, he worked as a research associate at the Scripps Research Institute (2011–2012). During that time, he was a Research Fellow of the Japan Society for the Promotion of Science (2010–2012). He is currently an Assistant Professor at the Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Japan (2012 to present). His research interests are focused on medicinal chemistry and chemical biology, including synthesis of bioactive small molecules, analysis of the mechanisms of their interaction with biological targets, and mechanisms of pharmacological action.</p></figure></div><div class="bio" rid="ath3"><figure id="ath3" data-index="35" class="article__inlineFigure"><h2 class="fig-label">Takayoshi Suzuki</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00229&amp;id=BIO-d7e1684-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Takayoshi Suzuki</b> received his B.Sc. and M.Sc. from the University of Tokyo (1995 and 1997, respectively) and then became a Researcher at Japan Tobacco Inc. (1997–2002). He subsequently joined the Graduate School of Pharmaceutical Sciences, Nagoya City University, as an Assistant Professor (2003–2009) and Lecturer (2009–2011). During that time, he received his Ph.D. from the Graduate School of Pharmaceutical Sciences, the University of Tokyo. He is currently a full Professor at the Graduate School of Medical Science, Kyoto Prefectural University of Medicine (2011 to present). His research interests are in the areas of medicinal chemistry and bioorganic chemistry.</p></figure></div><div class="bio" rid="ath4"><figure id="ath4" data-index="36" class="article__inlineFigure"><h2 class="fig-label">Xinyong Liu</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00229&amp;id=BIO-d7e1689-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Xinyong Liu</b> received his B.Sc. and M.Sc. degrees from School of Pharmaceutical Sciences, Shandong University, in 1984 and in 1991, respectively. From 1997 to 1999 he worked at Instituto de Quimica Medica (CSIC) in Spain as a senior visiting scholar. He obtained his Ph.D. from Shandong University in 2004. He is currently a full Professor of the Institute of Medicinal Chemistry, Shandong University. His research interests include rational drug design, synthesis, and antiviral evaluation of a variety of molecules that interact with specific enzymes and receptors in the viral life cycle (HIV, HBV, HCV, and FluV). Other ongoing programs include the molecular modification and structure–activity relationships study of some natural products to treat cardiovascular diseases and drug delivery research using PEGylated small-molecular agents.</p></figure></div><div class="ack" id="ACK-d7e1694-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i19">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_20451" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_20451" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We gratefully acknowledge financial support from the National Natural Science Foundation of China (NSFC nos. 81102320, 81273354), Key Project of NSFC for International Cooperation (no. 81420108027), Research Fund for the Doctoral Program of Higher Education of China (nos. 20110131130005, 20110131120037), The Science and Technology Development Project of Shandong Province (no. 2014GSF118012), China Postdoctoral Science Foundation funded special project (no. 2012T50584), Postdoctoral Fellow Allowance (ID no. P12418) from Japan Society for the Promotion of Science (JSPS), JST CREST program, Takeda Science Foundation, Mochida Memorial Foundation for Medical and Pharmaceutical Research, Scientific Research from JSPS, the Tokyo Biochemical Research Foundation (T.S.), and the Uehara Memorial Foundation (T.S.).</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i20" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i20"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i21" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i21"> Abbreviations Used</h2><tr><td class="NLM_term">AChBPs</td><td class="NLM_def"><p class="first last">acetylcholine-binding protein templates</p></td></tr><tr><td class="NLM_term">BChE</td><td class="NLM_def"><p class="first last">butyrylcholinesterase</p></td></tr><tr><td class="NLM_term">CA</td><td class="NLM_def"><p class="first last">carbonic anhydrase</p></td></tr><tr><td class="NLM_term">CDKs</td><td class="NLM_def"><p class="first last">cyclin-dependent kinases</p></td></tr><tr><td class="NLM_term">CuAAC</td><td class="NLM_def"><p class="first last">copper(I) catalyzed azide–alkyne [3 + 2] dipolar cycloaddition</p></td></tr><tr><td class="NLM_term">DCC</td><td class="NLM_def"><p class="first last">dynamic combinatorial/covalent chemistry</p></td></tr><tr><td class="NLM_term">DCLs</td><td class="NLM_def"><p class="first last">dynamic constitutional libraries</p></td></tr><tr><td class="NLM_term">DOS</td><td class="NLM_def"><p class="first last">diversity-oriented synthesis</p></td></tr><tr><td class="NLM_term">ER</td><td class="NLM_def"><p class="first last">estrogen receptor</p></td></tr><tr><td class="NLM_term">FBDD</td><td class="NLM_def"><p class="first last">fragment-based drug discovery</p></td></tr><tr><td class="NLM_term">GABA</td><td class="NLM_def"><p class="first last">γ-aminobutyric acid</p></td></tr><tr><td class="NLM_term">GAT</td><td class="NLM_def"><p class="first last">GABA transporter</p></td></tr><tr><td class="NLM_term">HDACs</td><td class="NLM_def"><p class="first last">histone deacetylases</p></td></tr><tr><td class="NLM_term">HSP90</td><td class="NLM_def"><p class="first last">heat shock protein 90</p></td></tr><tr><td class="NLM_term">HTS</td><td class="NLM_def"><p class="first last">high-throughput screening</p></td></tr><tr><td class="NLM_term">IFNγ</td><td class="NLM_def"><p class="first last">interferon-γ</p></td></tr><tr><td class="NLM_term">JAK2</td><td class="NLM_def"><p class="first last">Janus kinase 2</p></td></tr><tr><td class="NLM_term">JHDMs</td><td class="NLM_def"><p class="first last">Jumonji C domain-containing histone demethylases</p></td></tr><tr><td class="NLM_term">LSD1</td><td class="NLM_def"><p class="first last">lysine-specific demethylase 1</p></td></tr><tr><td class="NLM_term">MAOs</td><td class="NLM_def"><p class="first last">monoamine oxidases</p></td></tr><tr><td class="NLM_term">MMPs</td><td class="NLM_def"><p class="first last">matrix metalloproteinases</p></td></tr><tr><td class="NLM_term">NOG</td><td class="NLM_def"><p class="first last"><i>N</i>-oxalylglycine</p></td></tr><tr><td class="NLM_term">NOS</td><td class="NLM_def"><p class="first last">nitric oxide synthase</p></td></tr><tr><td class="NLM_term">nNOS</td><td class="NLM_def"><p class="first last">neuronal nitric oxide synthase</p></td></tr><tr><td class="NLM_term">PCPA</td><td class="NLM_def"><p class="first last">phenylcyclopropylamine</p></td></tr><tr><td class="NLM_term">PDEs</td><td class="NLM_def"><p class="first last">phosphodiesterases</p></td></tr><tr><td class="NLM_term">PI3K</td><td class="NLM_def"><p class="first last">phosphoinositide-3 kinase</p></td></tr><tr><td class="NLM_term">SIRTs</td><td class="NLM_def"><p class="first last">sirtuins</p></td></tr><tr><td class="NLM_term">TGS</td><td class="NLM_def"><p class="first last">target-guided synthetic methodology</p></td></tr><tr><td class="NLM_term">TLRs</td><td class="NLM_def"><p class="first last">Toll-like receptors</p></td></tr><tr><td class="NLM_term">STEP</td><td class="NLM_def"><p class="first last">striatal-enriched protein tyrosine phosphatase</p></td></tr><tr><td class="NLM_term">Syk</td><td class="NLM_def"><p class="first last">spleen tyrosine kinase</p></td></tr><tr><td class="NLM_term">TNKSs</td><td class="NLM_def"><p class="first last">tankyrases</p></td></tr><tr><td class="NLM_term">TYK2</td><td class="NLM_def"><p class="first last">tyrosine-protein kinase 2</p></td></tr><tr><td class="NLM_term">ZBG</td><td class="NLM_def"><p class="first last">zinc-binding group</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i22">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_17048" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_17048" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 84 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Morphy, R.</span><span> </span><span class="NLM_article-title">Selectively nonselective kinase inhibition: striking the right balance</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">1413</span><span class="NLM_x">–</span> <span class="NLM_lpage">1437</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm901132v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00229&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtlWmtbfF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=1413-1437&author=R.+Morphy&title=Selectively+nonselective+kinase+inhibition%3A+striking+the+right+balance"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1aR"><div class="casContent"><span class="casTitleNuber">1a</span><div class="casTitle"><span class="NLM_cas:atitle">Selectively Nonselective Kinase Inhibition: Striking the Right Balance</span></div><div class="casAuthors">Morphy, Richard</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1413-1437</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Marketed kinase inhibitors (MKIs) can deliver superior efficacy compared to inhibitors with high specificity for a single kinase, and the recent introduction of several MKIs to the market opens the door to a new era of safer and effective anticancer therapy.  The key to combining high efficacy with acceptable safety is to inhibit multiple targets in a selectively nonselective fashion.  Strategies for intentionally designing MKIs are emerging, but the field is still in its infancy and we are as medicinal chemists currently on the steepest part of the learning curve.  MTDD can be time-consuming and expensive, and we need to become more proficient first at identifying disease-relevant target combinations and second at discovering MKIs that combine optimal physicochem. and biol. properties.  Bold and innovative medicinal chem. strategies are required to tackle "difficult combinations" where the disease rationale is compelling but where it is a struggle to combine all the desired attributes of an oral MKI drug into a single mol.  At present it is unclear to what extent MKIs with highly tuned selectivity profiles can be rationally designed, particularly for targets that are unrelated by sequence.  In addn. to the well-known selectivity challenge, the physicochem. property profiles of AT P-competitive MKIs can be inherently challenging and limited scope for patentability can also be a serious hindrance.  On the plus side, the amt. of kinase-specific structural information is growing very rapidly, and ultimately this may reveal distinct features and design rules that enable a medicinal chemist to rationally modify and refine the profile of MKIs.  In addn., increasing SAR knowledge is emerging from large scale panel screening with the binding profiles starting to reveal to medicinal chemists how chem. structure affects cross-reactivity across large parts of the kinome.  The merit of MKIs compared with single kinase inhibitors is a subject of controversy in drug discovery that is unlikely to be resolved in the near future.  At the start of a new MTDD project, a rigorous debate needs to take place as to whether it makes more sense to seek a combination of highly selective agents or a DML.  Many factors need to be taken into account in this decision such as the no., similarity, and promiscuity of the targets in the profile and the disease area.  Conformational plasticity and the occurrence of multiple binding modes complicate the in silico prediction of kinase polypharmacol. based solely upon protein structure.  The use of ligand-based similarity to assess the feasibility of a given combination can add real value.  Currently, serendipity plays a significant role in MKI discovery and many, if not most, MKIs have been discovered by chance during the search for selective inhibitors.  Medicinal chemists need to be alert to the possibilities when a surprising combination is found by chance.  To exploit such serendipity, you need a good appreciation of when you have a sufficiently high quality starting compd. and then you need to be able to make and test sufficient analogs to explore your new disease-based hypothesis.  MKIs are costly to develop and are consequently priced at a premium level, so they will need to show clear improvements in order to get reimbursement.  There have already been problems with reimbursement for some MKIs in some markets due to concerns from funding bodies over insufficient efficacy.  The true value of MKIs relative to other anticancer drugs still has to be established, and the results from recent clin. trials have been mixed.  Despite the broad activity profile of many MKIs, the patient response can be inconsistent and unpredictable.  The identification of predictive biomarkers of response or resistance is a crit. step to ascertain which specific combination of targets produces a significant clin. benefit with respect to specific tumor types.  More clin. feedback is needed to facilitate the design of the next generation of inhibitors with more precisely defined profiles.  Although it might seem immeasurably distant at the present time, the ultimate goal should be to derive the prerequisite knowledge and tools so that MTDD becomes a rational endeavor rather than a black box approach that relies upon serendipity.  This will help banish claims that MKIs are merely dirty, nonspecific drugs with insufficient specificity for treating a wider range of human diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-L-NWmtdikbVg90H21EOLACvtfcHk0lhW1fkplJsz8Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtlWmtbfF&md5=3c915b5debf9d005993c8ad31c68bc2e</span></div><a href="/servlet/linkout?suffix=cit1a&amp;dbid=16384&amp;doi=10.1021%2Fjm901132v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901132v%26sid%3Dliteratum%253Aachs%26aulast%3DMorphy%26aufirst%3DR.%26atitle%3DSelectively%2520nonselective%2520kinase%2520inhibition%253A%2520striking%2520the%2520right%2520balance%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D1413%26epage%3D1437" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit1b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Jeong, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kwon, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hong, S.</span><span> </span><span class="NLM_article-title">Selective and potent small-molecule inhibitors of PI3Ks</span> <span class="citation_source-journal">Future Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">737</span><span class="NLM_x">–</span> <span class="NLM_lpage">756</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00229&amp;key=10.4155%2Ffmc.14.28" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00229&amp;key=24941870" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00229&amp;key=1%3ACAS%3A528%3ADC%252BC2cXpvFCrsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2014&pages=737-756&author=Y.+Jeongauthor=D.+Kwonauthor=S.+Hong&title=Selective+and+potent+small-molecule+inhibitors+of+PI3Ks"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1bR"><div class="casContent"><span class="casTitleNuber">1b</span><div class="casTitle"><span class="NLM_cas:atitle">Selective and potent small-molecule inhibitors of PI3Ks</span></div><div class="casAuthors">Jeong, Yujeong; Kwon, Daeil; Hong, Sungwoo</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">737-756</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">A review.  Class I PI3Ks are composed of four catalytic subunit variants (p110α, p110β, p110δ and p110γ).  The PI3K pathway is among the most frequently activated pathways in many diseases, and has emerged as an attractive target for drug development, in particular for the treatment of many human cancers including breast, prostate, ovarian, gastric, colon and hepatocellular cancers.  One of the challenges in the discovery of drugs that target kinases is designing small-mol. inhibitors that are sufficiently selective to minimize off-target activity and reduce the risk of potential toxicity.  This review explores the current landscape of PI3K-selective inhibitor development and highlights recent advances in achieving selectivity for PI3Ks over other protein kinases, with an emphasis on available structural information.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9ZY08eojS4bVg90H21EOLACvtfcHk0lhW1fkplJsz8Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXpvFCrsb0%253D&md5=f683c444e4bfb9e325a43819617b39d3</span></div><a href="/servlet/linkout?suffix=cit1b&amp;dbid=16384&amp;doi=10.4155%2Ffmc.14.28&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc.14.28%26sid%3Dliteratum%253Aachs%26aulast%3DJeong%26aufirst%3DY.%26aulast%3DKwon%26aufirst%3DD.%26aulast%3DHong%26aufirst%3DS.%26atitle%3DSelective%2520and%2520potent%2520small-molecule%2520inhibitors%2520of%2520PI3Ks%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2014%26volume%3D6%26spage%3D737%26epage%3D756" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit1c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Hojjat-Farsangi, M.</span><span> </span><span class="NLM_article-title">Small-molecule inhibitors of the receptor tyrosine kinases: promising tools for targeted cancer therapies</span> <span class="citation_source-journal">Int. J. Mol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">13768</span><span class="NLM_x">–</span> <span class="NLM_lpage">13801</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00229&amp;key=10.3390%2Fijms150813768" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00229&amp;key=25110867" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00229&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhslyqu7zI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2014&pages=13768-13801&author=M.+Hojjat-Farsangi&title=Small-molecule+inhibitors+of+the+receptor+tyrosine+kinases%3A+promising+tools+for+targeted+cancer+therapies"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1cR"><div class="casContent"><span class="casTitleNuber">1c</span><div class="casTitle"><span class="NLM_cas:atitle">Small-molecule inhibitors of the receptor tyrosine kinases: promising tools for targeted cancer therapies</span></div><div class="casAuthors">Hojjat-Farsangi, Mohammad</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Molecular Sciences</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">13768-13801, 34</span>CODEN:
                <span class="NLM_cas:coden">IJMCFK</span>;
        ISSN:<span class="NLM_cas:issn">1422-0067</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">A review.  Chemotherapeutic and cytotoxic drugs are widely used in the treatment of cancer.  In spite of the improvements in the life quality of patients, their effectiveness is compromised by several disadvantages.  This represents a demand for developing new effective strategies with focusing on tumor cells and min. side effects.  Targeted cancer therapies and personalized medicine have been defined as a new type of emerging treatments.  Small mol. inhibitors (SMIs) are among the most effective drugs for targeted cancer therapy.  The growing no. of approved SMIs of receptor tyrosine kinases (RTKs) i.e., tyrosine kinase inhibitors (TKIs) in the clin. oncol. imply the increasing attention and application of these therapeutic tools.  Most of the current approved RTK-TKIs in preclin. and clin. settings are multi-targeted inhibitors with several side effects.  Only a few specific/selective RTK-TKIs have been developed for the treatment of cancer patients.  Specific/selective RTK-TKIs have shown less deleterious effects compared to multi-targeted inhibitors.  This review intends to highlight the importance of specific/selective TKIs for future development with less side effects and more manageable agents.  This article provides an overview of: (1) the characteristics and function of RTKs and TKIs; (2) the recent advances in the improvement of specific/selective RTK-TKIs in preclin. or clin. settings; and (3) emerging RTKs for targeted cancer therapies by TKIs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr0oFHs0APBNrVg90H21EOLACvtfcHk0lhW1fkplJsz8Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhslyqu7zI&md5=08836c25f587f44f2843abc6b2d3587f</span></div><a href="/servlet/linkout?suffix=cit1c&amp;dbid=16384&amp;doi=10.3390%2Fijms150813768&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fijms150813768%26sid%3Dliteratum%253Aachs%26aulast%3DHojjat-Farsangi%26aufirst%3DM.%26atitle%3DSmall-molecule%2520inhibitors%2520of%2520the%2520receptor%2520tyrosine%2520kinases%253A%2520promising%2520tools%2520for%2520targeted%2520cancer%2520therapies%26jtitle%3DInt.%2520J.%2520Mol.%2520Sci.%26date%3D2014%26volume%3D15%26spage%3D13768%26epage%3D13801" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit1d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Dymock, B. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, E. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chu-Farseeva, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, L.</span><span> </span><span class="NLM_article-title">Selective JAK inhibitors</span> <span class="citation_source-journal">Future Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">1439</span><span class="NLM_x">–</span> <span class="NLM_lpage">1471</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00229&amp;key=10.4155%2Ffmc.14.92" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1d&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00229&amp;key=25329199" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00229&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhslOhu7jI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2014&pages=1439-1471&author=B.+W.+Dymockauthor=E.+G.+Yangauthor=Y.+Chu-Farseevaauthor=L.+Yao&title=Selective+JAK+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1dR"><div class="casContent"><span class="casTitleNuber">1d</span><div class="casTitle"><span class="NLM_cas:atitle">Selective JAK inhibitors</span></div><div class="casAuthors">Dymock, Brian W.; Yang, Eugene Guorong; Chu-Farseeva, Yuyi; Yao, Lianbin</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1439-1471</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">A review.  Consisting of four members, JAK1, JAK2, JAK3 and TYK2, the JAK kinases have emerged as important targets for proliferative and immune-inflammatory disorders.  Recent progress in the discovery of selective inhibitors has been significant, with selective compds. now reported for each isoform.  This article summarizes the current state-of-the-art with a discussion of the most recently described selective compds.  X-ray co-crystal structures reveal the mol. reasons for the obsd. biochem. selectivity.  A concluding anal. of JAK inhibitors in the clinic highlights increased clin. trial activity and diversity of indications.  Selective JAK inhibitors, as single agents or in combination regimens, have a very promising future in the treatment of oncol., immune and inflammatory diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo6G9eFT7Ww27Vg90H21EOLACvtfcHk0lhW1fkplJsz8Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhslOhu7jI&md5=343aa75228918e6e4e063adb1fed96f1</span></div><a href="/servlet/linkout?suffix=cit1d&amp;dbid=16384&amp;doi=10.4155%2Ffmc.14.92&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc.14.92%26sid%3Dliteratum%253Aachs%26aulast%3DDymock%26aufirst%3DB.%2BW.%26aulast%3DYang%26aufirst%3DE.%2BG.%26aulast%3DChu-Farseeva%26aufirst%3DY.%26aulast%3DYao%26aufirst%3DL.%26atitle%3DSelective%2520JAK%2520inhibitors%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2014%26volume%3D6%26spage%3D1439%26epage%3D1471" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Falkenberg, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnstone, R. W.</span><span> </span><span class="NLM_article-title">Histone deacetylases and their inhibitors in cancer, neurological diseases and immune disorders</span> <span class="citation_source-journal">Nature Rev. Drug. Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">673</span><span class="NLM_x">–</span> <span class="NLM_lpage">691</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2014&pages=673-691&author=K.+J.+Falkenbergauthor=R.+W.+Johnstone&title=Histone+deacetylases+and+their+inhibitors+in+cancer%2C+neurological+diseases+and+immune+disorders"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFalkenberg%26aufirst%3DK.%2BJ.%26aulast%3DJohnstone%26aufirst%3DR.%2BW.%26atitle%3DHistone%2520deacetylases%2520and%2520their%2520inhibitors%2520in%2520cancer%252C%2520neurological%2520diseases%2520and%2520immune%2520disorders%26jtitle%3DNature%2520Rev.%2520Drug.%2520Discovery%26date%3D2014%26volume%3D13%26spage%3D673%26epage%3D691" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit2b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Suzuki, T.</span><span> </span><span class="NLM_article-title">Explorative study on isoform-selective histone deacetylase inhibitors</span> <span class="citation_source-journal">Chem. Pharm. Bull.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">897</span><span class="NLM_x">–</span> <span class="NLM_lpage">906</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2009&pages=897-906&author=T.+Suzuki&title=Explorative+study+on+isoform-selective+histone+deacetylase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSuzuki%26aufirst%3DT.%26atitle%3DExplorative%2520study%2520on%2520isoform-selective%2520histone%2520deacetylase%2520inhibitors%26jtitle%3DChem.%2520Pharm.%2520Bull.%26date%3D2009%26volume%3D57%26spage%3D897%26epage%3D906" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Alterio, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Fiore, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D’Ambrosio, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Supuran, C. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Simone, G.</span><span> </span><span class="NLM_article-title">Multiple binding modes of inhibitors to carbonic anhydrases: how to design specific drugs targeting 15 different isoforms?</span> <span class="citation_source-journal">Chem. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">112</span><span class="NLM_x">, </span> <span class="NLM_fpage">4421</span><span class="NLM_x">–</span> <span class="NLM_lpage">4468</span></span><div class="citationLinks">[<a href="/doi/10.1021/cr200176r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=112&publication_year=2012&pages=4421-4468&author=V.+Alterioauthor=A.+Di+Fioreauthor=K.+D%E2%80%99Ambrosioauthor=C.+T.+Supuranauthor=G.+De+Simone&title=Multiple+binding+modes+of+inhibitors+to+carbonic+anhydrases%3A+how+to+design+specific+drugs+targeting+15+different+isoforms%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1021%2Fcr200176r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr200176r%26sid%3Dliteratum%253Aachs%26aulast%3DAlterio%26aufirst%3DV.%26aulast%3DDi%2BFiore%26aufirst%3DA.%26aulast%3DD%25E2%2580%2599Ambrosio%26aufirst%3DK.%26aulast%3DSupuran%26aufirst%3DC.%2BT.%26aulast%3DDe%2BSimone%26aufirst%3DG.%26atitle%3DMultiple%2520binding%2520modes%2520of%2520inhibitors%2520to%2520carbonic%2520anhydrases%253A%2520how%2520to%2520design%2520specific%2520drugs%2520targeting%252015%2520different%2520isoforms%253F%26jtitle%3DChem.%2520Rev.%26date%3D2012%26volume%3D112%26spage%3D4421%26epage%3D4468" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Bhat, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tummalapalli, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rotella, D. P.</span><span> </span><span class="NLM_article-title">Progress in the discovery and development of heat shock protein 90 (Hsp90) Inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">8718</span><span class="NLM_x">–</span> <span class="NLM_lpage">8728</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm500823a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00229&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsVSnsrfK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=8718-8728&author=R.+Bhatauthor=S.+R.+Tummalapalliauthor=D.+P.+Rotella&title=Progress+in+the+discovery+and+development+of+heat+shock+protein+90+%28Hsp90%29+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Progress in the Discovery and Development of Heat Shock Protein 90 (Hsp90) Inhibitors</span></div><div class="casAuthors">Bhat, Rohit; Tummalapalli, Sreedhar R.; Rotella, David P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">8718-8728</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The discovery and clin. development of heat shock protein 90 (Hsp90) inhibitors continue to progress.  A no. of Hsp90 inhibitors are in clin. trials, and preclin. discoveries of new chemotypes that bind to distinct regions in the protein as well as isoform selective compds. are active areas of research.  This review will highlight progress in the field since 2010.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-SwLv_-B9xLVg90H21EOLACvtfcHk0li8ScAjqenVhA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsVSnsrfK&md5=132784687bbbcf62cfa8fe04a22577ce</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1021%2Fjm500823a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm500823a%26sid%3Dliteratum%253Aachs%26aulast%3DBhat%26aufirst%3DR.%26aulast%3DTummalapalli%26aufirst%3DS.%2BR.%26aulast%3DRotella%26aufirst%3DD.%2BP.%26atitle%3DProgress%2520in%2520the%2520discovery%2520and%2520development%2520of%2520heat%2520shock%2520protein%252090%2520%2528Hsp90%2529%2520Inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D8718%26epage%3D8728" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Erdal, E. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Litzinger, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ji, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silverman, R. B.</span><span> </span><span class="NLM_article-title">Selective neuronal nitric oxide synthase inhibitors</span> <span class="citation_source-journal">Curr. Top Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">603</span><span class="NLM_x">–</span> <span class="NLM_lpage">624</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00229&amp;key=10.2174%2F1568026054679317" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00229&amp;key=16101423" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00229&amp;key=1%3ACAS%3A528%3ADC%252BD2MXpsFGhtr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2005&pages=603-624&author=E.+P.+Erdalauthor=E.+A.+Litzingerauthor=J.+Seoauthor=Y.+Zhuauthor=H.+Jiauthor=R.+B.+Silverman&title=Selective+neuronal+nitric+oxide+synthase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Selective neuronal nitric oxide synthase inhibitors</span></div><div class="casAuthors">Erdal, Erik P.; Litzinger, Elizabeth A.; Seo, Jiwon; Zhu, Yaoqiu; Ji, Haitao; Silverman, Richard B.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">603-624</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  This review includes the non-patent literature up to Oct. 2004 that deals with selective neuronal nitric oxide synthase inhibitors (highest potency is for the neuronal isoenzyme).  Some non-selective inhibitors or selective inducible nitric oxide synthase inhibitors are mentioned if they are related to compds. that are discussed; structures of these compds. generally are not given.  In vitro inhibition consts. are given either as IC50 values or as Ki values.  An IC50 value, the inhibitor concn. that produces 50% inhibition in the presence of a const. concn. of substrate, is obtained by extrapolation of several rate data points to 50% inhibition.  Ki values are derived from several types of plots that relate the concn. of inhibitor with enzyme velocity in the presence of a variety of substrate concns.  The Ki value can be estd. from the IC50 value.  Although the two inhibition consts. are related, they are not the same; generally, the reported Ki values tend to be lower than the IC50 values.  If specifics are desired about how the data were collected, then the reader will have to look in the literature cited.  No attempt was made to be exhaustive in citing all refs. related to specific inhibitors; rather, examples of literature refs. are given for each inhibitor described.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrD4wFCjsRzF7Vg90H21EOLACvtfcHk0li8ScAjqenVhA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXpsFGhtr4%253D&md5=c338f82141c7af37470fd1cf9afecc75</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.2174%2F1568026054679317&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568026054679317%26sid%3Dliteratum%253Aachs%26aulast%3DErdal%26aufirst%3DE.%2BP.%26aulast%3DLitzinger%26aufirst%3DE.%2BA.%26aulast%3DSeo%26aufirst%3DJ.%26aulast%3DZhu%26aufirst%3DY.%26aulast%3DJi%26aufirst%3DH.%26aulast%3DSilverman%26aufirst%3DR.%2BB.%26atitle%3DSelective%2520neuronal%2520nitric%2520oxide%2520synthase%2520inhibitors%26jtitle%3DCurr.%2520Top%2520Med.%2520Chem.%26date%3D2005%26volume%3D5%26spage%3D603%26epage%3D624" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Zhan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Itoh, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span> </span><span class="NLM_article-title">Recent advances in the structure-based rational design of TNKSIs</span> <span class="citation_source-journal">Mol. Biosyst.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">2783</span><span class="NLM_x">–</span> <span class="NLM_lpage">2799</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00229&amp;key=10.1039%2FC4MB00385C" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00229&amp;key=25211064" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00229&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsVersLbP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2014&pages=2783-2799&author=P.+Zhanauthor=Y.+Songauthor=Y.+Itohauthor=T.+Suzukiauthor=X.+Liu&title=Recent+advances+in+the+structure-based+rational+design+of+TNKSIs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Recent advances in the structure-based rational design of TNKSIs</span></div><div class="casAuthors">Zhan, Peng; Song, Yu'ning; Itoh, Yukihiro; Suzuki, Takayoshi; Liu, Xinyong</div><div class="citationInfo"><span class="NLM_cas:title">Molecular BioSystems</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2783-2799</span>CODEN:
                <span class="NLM_cas:coden">MBOIBW</span>;
        ISSN:<span class="NLM_cas:issn">1742-2051</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A review.  Human tankyrases 1 and 2 (TNKS1/2) are attractive pharmacol. biotargets, esp. for the treatment of specific types of cancer.  This article provides a fairly comprehensive overview of the structural biol. of the TNKS-inhibitor complex and the current medicinal chem. strategies being used in the structure-based rational design of tankyrase-specific inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoKsymkDwCMxLVg90H21EOLACvtfcHk0ljLrPxhrS9yMQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsVersLbP&md5=ff91450e15ffa81a39ef5667f300d77b</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1039%2FC4MB00385C&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC4MB00385C%26sid%3Dliteratum%253Aachs%26aulast%3DZhan%26aufirst%3DP.%26aulast%3DSong%26aufirst%3DY.%26aulast%3DItoh%26aufirst%3DY.%26aulast%3DSuzuki%26aufirst%3DT.%26aulast%3DLiu%26aufirst%3DX.%26atitle%3DRecent%2520advances%2520in%2520the%2520structure-based%2520rational%2520design%2520of%2520TNKSIs%26jtitle%3DMol.%2520Biosyst.%26date%3D2014%26volume%3D10%26spage%3D2783%26epage%3D2799" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Thinnes, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">England, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawamura, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chowdhury, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schofield, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hopkinson, R. J.</span><span> </span><span class="NLM_article-title">Targeting histone lysine demethylases—progress, challenges, and the future</span> <span class="citation_source-journal">Biochim. Biophys. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">1839</span><span class="NLM_x">, </span> <span class="NLM_fpage">1416</span><span class="NLM_x">–</span> <span class="NLM_lpage">1432</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1839&publication_year=2014&pages=1416-1432&author=C.+C.+Thinnesauthor=K.+S.+Englandauthor=A.+Kawamuraauthor=R.+Chowdhuryauthor=C.+J.+Schofieldauthor=R.+J.+Hopkinson&title=Targeting+histone+lysine+demethylases%E2%80%94progress%2C+challenges%2C+and+the+future"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DThinnes%26aufirst%3DC.%2BC.%26aulast%3DEngland%26aufirst%3DK.%2BS.%26aulast%3DKawamura%26aufirst%3DA.%26aulast%3DChowdhury%26aufirst%3DR.%26aulast%3DSchofield%26aufirst%3DC.%2BJ.%26aulast%3DHopkinson%26aufirst%3DR.%2BJ.%26atitle%3DTargeting%2520histone%2520lysine%2520demethylases%25E2%2580%2594progress%252C%2520challenges%252C%2520and%2520the%2520future%26jtitle%3DBiochim.%2520Biophys.%2520Acta%26date%3D2014%26volume%3D1839%26spage%3D1416%26epage%3D1432" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit7b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Højfeldt, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agger, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Helin, K.</span><span> </span><span class="NLM_article-title">Histone lysine demethylases as targets for anticancer therapy</span> <span class="citation_source-journal">Nature Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">917</span><span class="NLM_x">–</span> <span class="NLM_lpage">930</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2013&pages=917-930&author=J.+W.+H%C3%B8jfeldtauthor=K.+Aggerauthor=K.+Helin&title=Histone+lysine+demethylases+as+targets+for+anticancer+therapy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DH%25C3%25B8jfeldt%26aufirst%3DJ.%2BW.%26aulast%3DAgger%26aufirst%3DK.%26aulast%3DHelin%26aufirst%3DK.%26atitle%3DHistone%2520lysine%2520demethylases%2520as%2520targets%2520for%2520anticancer%2520therapy%26jtitle%3DNature%2520Rev.%2520Drug%2520Discovery%26date%3D2013%26volume%3D12%26spage%3D917%26epage%3D930" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Huggins, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sherman, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tidor, B.</span><span> </span><span class="NLM_article-title">Rational approaches to improving selectivity in drug design</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">1424</span><span class="NLM_x">–</span> <span class="NLM_lpage">1444</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm2010332" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00229&amp;key=1%3ACAS%3A528%3ADC%252BC38XmtFWktg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=1424-1444&author=D.+J.+Hugginsauthor=W.+Shermanauthor=B.+Tidor&title=Rational+approaches+to+improving+selectivity+in+drug+design"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Rational Approaches to Improving Selectivity in Drug Design</span></div><div class="casAuthors">Huggins, David J.; Sherman, Woody; Tidor, Bruce</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1424-1444</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Rational Approaches to improving selectivity in Drug Design are reviewed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJv9AbW-c3TbVg90H21EOLACvtfcHk0ljLrPxhrS9yMQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmtFWktg%253D%253D&md5=5b7bf49f9f96a05adad4d42f63739252</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1021%2Fjm2010332&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm2010332%26sid%3Dliteratum%253Aachs%26aulast%3DHuggins%26aufirst%3DD.%2BJ.%26aulast%3DSherman%26aufirst%3DW.%26aulast%3DTidor%26aufirst%3DB.%26atitle%3DRational%2520approaches%2520to%2520improving%2520selectivity%2520in%2520drug%2520design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D1424%26epage%3D1444" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Ji, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stanton, B. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Igarashi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martásek, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roman, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poulos, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silverman, R. B.</span><span> </span><span class="NLM_article-title">Minimal pharmacophoric elements and fragment hopping, an approach directed at molecular diversity and isozyme selectivity. Design of selective neuronal nitric oxide synthase inhibitors</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">130</span><span class="NLM_x">, </span> <span class="NLM_fpage">3900</span><span class="NLM_x">–</span> <span class="NLM_lpage">3914</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja0772041" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=130&publication_year=2008&pages=3900-3914&author=H.+Jiauthor=B.+Z.+Stantonauthor=J.+Igarashiauthor=H.+Liauthor=P.+Mart%C3%A1sekauthor=L.+J.+Romanauthor=T.+L.+Poulosauthor=R.+B.+Silverman&title=Minimal+pharmacophoric+elements+and+fragment+hopping%2C+an+approach+directed+at+molecular+diversity+and+isozyme+selectivity.+Design+of+selective+neuronal+nitric+oxide+synthase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1021%2Fja0772041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja0772041%26sid%3Dliteratum%253Aachs%26aulast%3DJi%26aufirst%3DH.%26aulast%3DStanton%26aufirst%3DB.%2BZ.%26aulast%3DIgarashi%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DMart%25C3%25A1sek%26aufirst%3DP.%26aulast%3DRoman%26aufirst%3DL.%2BJ.%26aulast%3DPoulos%26aufirst%3DT.%2BL.%26aulast%3DSilverman%26aufirst%3DR.%2BB.%26atitle%3DMinimal%2520pharmacophoric%2520elements%2520and%2520fragment%2520hopping%252C%2520an%2520approach%2520directed%2520at%2520molecular%2520diversity%2520and%2520isozyme%2520selectivity.%2520Design%2520of%2520selective%2520neuronal%2520nitric%2520oxide%2520synthase%2520inhibitors%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2008%26volume%3D130%26spage%3D3900%26epage%3D3914" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Ji, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martásek, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roman, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poulos, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silverman, R. B.</span><span> </span><span class="NLM_article-title">Discovery of highly potent and selective inhibitors of neuronal nitric oxide synthase by fragment hopping</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">779</span><span class="NLM_x">–</span> <span class="NLM_lpage">797</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm801220a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=779-797&author=H.+Jiauthor=H.+Liauthor=P.+Mart%C3%A1sekauthor=L.+J.+Romanauthor=T.+L.+Poulosauthor=R.+B.+Silverman&title=Discovery+of+highly+potent+and+selective+inhibitors+of+neuronal+nitric+oxide+synthase+by+fragment+hopping"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1021%2Fjm801220a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm801220a%26sid%3Dliteratum%253Aachs%26aulast%3DJi%26aufirst%3DH.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DMart%25C3%25A1sek%26aufirst%3DP.%26aulast%3DRoman%26aufirst%3DL.%2BJ.%26aulast%3DPoulos%26aufirst%3DT.%2BL.%26aulast%3DSilverman%26aufirst%3DR.%2BB.%26atitle%3DDiscovery%2520of%2520highly%2520potent%2520and%2520selective%2520inhibitors%2520of%2520neuronal%2520nitric%2520oxide%2520synthase%2520by%2520fragment%2520hopping%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D779%26epage%3D797" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Suzuki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyata, N.</span><span> </span><span class="NLM_article-title">Lysine demethylases inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">8236</span><span class="NLM_x">–</span> <span class="NLM_lpage">8250</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm201048w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00229&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht1OrtrnF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=8236-8250&author=T.+Suzukiauthor=N.+Miyata&title=Lysine+demethylases+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Lysine Demethylases Inhibitors</span></div><div class="casAuthors">Suzuki, Takayoshi; Miyata, Naoki</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">8236-8250</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review, on the use of lysine demethylases inhibitors in therapy of various diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGplp9MjSdvnn7Vg90H21EOLACvtfcHk0li3fUZJCd6wgA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht1OrtrnF&md5=194d4bbc2e52672f5d5f019de0bb760c</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1021%2Fjm201048w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201048w%26sid%3Dliteratum%253Aachs%26aulast%3DSuzuki%26aufirst%3DT.%26aulast%3DMiyata%26aufirst%3DN.%26atitle%3DLysine%2520demethylases%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D8236%26epage%3D8250" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Khan, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyata, N.</span><span> </span><span class="NLM_article-title">An overview of phenylcyclopropylamine derivatives: biochemical and biological significance and recent developments</span> <span class="citation_source-journal">Med. Res. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">873</span><span class="NLM_x">–</span> <span class="NLM_lpage">910</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00229&amp;key=10.1002%2Fmed.21269" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00229&amp;key=22893613" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00229&amp;key=1%3ACAS%3A528%3ADC%252BC3sXptFersL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2013&pages=873-910&author=M.+N.+Khanauthor=T.+Suzukiauthor=N.+Miyata&title=An+overview+of+phenylcyclopropylamine+derivatives%3A+biochemical+and+biological+significance+and+recent+developments"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">An Overview of Phenylcyclopropylamine Derivatives: Biochemical and Biological Significance and Recent Developments</span></div><div class="casAuthors">Khan, Mohammed Naseer Ahmed; Suzuki, Takayoshi; Miyata, Naoki</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Research Reviews</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">873-910</span>CODEN:
                <span class="NLM_cas:coden">MRREDD</span>;
        ISSN:<span class="NLM_cas:issn">0198-6325</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review.  Trans-2-Phencylcyclopropylamine (2-PCPA), a potent, clin. used antidepressant, affects monoamine neurotransmitter levels by inhibiting the main metabolizing enzymes, monoamine oxidases (MAOs).  However, the antidepressant action of this compd. was not fully explained by its effects on MAOs due to its wide variety of biol. effects. 2-PCPA also affects depression-assocd. pathophysiol. pathways, and linked with increased levels of trace amines in brain, upregulation of GABAB receptors (where GABA is gamma amino butyric acid), modulation of phospholipid metab., and interference with various cytochrome P 450 (CYP) enzymes.  Consequently, despite its adverse effects and limited clin. applicability, 2-PCPA has attracted interest as a structural scaffold for the development of mechanism-based inhibitors of various enzymes, including lysine-specific demethylase 1 (LSD1), which is a possible target for cancer chemotherapy.  In the recent years, many reports have appeared in the literature based on 2-PCPA scaffold and their potential medicinal implications.  This review mainly focuses on the medicinal chem. aspects including drug design, structure-activity relationships (SAR), biol. and biochem. properties, and mechanism of actions of 2-PCPA and its derivs.  Furthermore, we also highlight recent advance in this area and discuss their future applications for beneficial therapeutic effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqIZJFRem7GlrVg90H21EOLACvtfcHk0li3fUZJCd6wgA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXptFersL0%253D&md5=d257f3b954efb33ae6f824c254ae1c30</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1002%2Fmed.21269&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmed.21269%26sid%3Dliteratum%253Aachs%26aulast%3DKhan%26aufirst%3DM.%2BN.%26aulast%3DSuzuki%26aufirst%3DT.%26aulast%3DMiyata%26aufirst%3DN.%26atitle%3DAn%2520overview%2520of%2520phenylcyclopropylamine%2520derivatives%253A%2520biochemical%2520and%2520biological%2520significance%2520and%2520recent%2520developments%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D2013%26volume%3D33%26spage%3D873%26epage%3D910" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Culhane, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szewczuk, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Da, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marmorstein, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cole, P. A.</span><span> </span><span class="NLM_article-title">A mechanism-based inactivator for histone demethylase LSD1</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">128</span><span class="NLM_x">, </span> <span class="NLM_fpage">4536</span><span class="NLM_x">–</span> <span class="NLM_lpage">4537</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja0602748" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=128&publication_year=2006&pages=4536-4537&author=J.+C.+Culhaneauthor=L.+M.+Szewczukauthor=X.+Liuauthor=G.+Daauthor=R.+Marmorsteinauthor=P.+A.+Cole&title=A+mechanism-based+inactivator+for+histone+demethylase+LSD1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1021%2Fja0602748&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja0602748%26sid%3Dliteratum%253Aachs%26aulast%3DCulhane%26aufirst%3DJ.%2BC.%26aulast%3DSzewczuk%26aufirst%3DL.%2BM.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DDa%26aufirst%3DG.%26aulast%3DMarmorstein%26aufirst%3DR.%26aulast%3DCole%26aufirst%3DP.%2BA.%26atitle%3DA%2520mechanism-based%2520inactivator%2520for%2520histone%2520demethylase%2520LSD1%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2006%26volume%3D128%26spage%3D4536%26epage%3D4537" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Szewczuk, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Culhane, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Majumdar, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cole, P. A.</span><span> </span><span class="NLM_article-title">Mechanistic analysis of a suicide inactivator of histone demethylase LSD1</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">6892</span><span class="NLM_x">–</span> <span class="NLM_lpage">6902</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi700414b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00229&amp;key=1%3ACAS%3A528%3ADC%252BD2sXlsVSgt7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2007&pages=6892-6902&author=L.+M.+Szewczukauthor=J.+C.+Culhaneauthor=M.+Yangauthor=A.+Majumdarauthor=H.+Yuauthor=P.+A.+Cole&title=Mechanistic+analysis+of+a+suicide+inactivator+of+histone+demethylase+LSD1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanistic Analysis of a Suicide Inactivator of Histone Demethylase LSD1</span></div><div class="casAuthors">Szewczuk, Lawrence M.; Culhane, Jeffrey C.; Yang, Maojun; Majumdar, Ananya; Yu, Hongtao; Cole, Philip A.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">6892-6902</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Lysine-specific demethylase 1 (LSD1) is a transcriptional repressor and a flavin-dependent amine oxidase that is responsible for the removal of Me from lysine 4 of histone H3.  In this study, we characterize the mechanism and scope of LSD1 inhibition by a propargylamine-derivatized histone H3 substrate (1).  Unlike aziridinyl and cyclopropylamine-derivatized histone H3 peptide substrate analogs, compd. 1 appears to covalently modify and irreversibly inactivate LSD1 with high potency.  Accompanying this inactivation is a spectroscopic change, which shifts the absorbance max. to 392 nm.  Spectral changes assocd. with the 1-LSD1 complex and reactivity to decreased pH and sodium borohydride treatment were suggestive of a structure involving a flavin-linked inhibitor conjugate between N5 of the flavin and the terminal carbon of the inhibitor.  Using a 13C-labeled inhibitor, NMR anal. of the 1-flavin conjugate was consistent with this structural assignment.  Kinetic anal. of the spectroscopic shift induced by 1 showed that the flavin adduct formed in a reaction with kinetic consts. similar to those of the LSD1 inactivation process.  Taken together, these data support a mechanism of LSD1 inactivation by 1 involving amine oxidn. followed by Michael addn. to the propargylic imine.  We further examd. the potential for a biotinylated analog of 1 (1-Btn) to be used as a tool in affinity pulldown expts.  Using 1-Btn, it was feasible to selectively pull down spiked and endogenous LSD1 from HeLa cell nuclear exts., setting the stage for activity-based demethylase proteomics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo2nUlBCS3LG7Vg90H21EOLACvtfcHk0li3fUZJCd6wgA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXlsVSgt7Y%253D&md5=97eaa358443717b9f5b1214b4aebe807</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1021%2Fbi700414b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi700414b%26sid%3Dliteratum%253Aachs%26aulast%3DSzewczuk%26aufirst%3DL.%2BM.%26aulast%3DCulhane%26aufirst%3DJ.%2BC.%26aulast%3DYang%26aufirst%3DM.%26aulast%3DMajumdar%26aufirst%3DA.%26aulast%3DYu%26aufirst%3DH.%26aulast%3DCole%26aufirst%3DP.%2BA.%26atitle%3DMechanistic%2520analysis%2520of%2520a%2520suicide%2520inactivator%2520of%2520histone%2520demethylase%2520LSD1%26jtitle%3DBiochemistry%26date%3D2007%26volume%3D46%26spage%3D6892%26epage%3D6902" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Ueda, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mino, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsumoto, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakagawa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hasegawa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sasaki, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mizukami, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyata, N.</span><span> </span><span class="NLM_article-title">Identification of cell-active lysine specific demethylase 1-selective inhibitors</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">131</span><span class="NLM_x">, </span> <span class="NLM_fpage">17536</span><span class="NLM_x">–</span> <span class="NLM_lpage">17537</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja907055q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=131&publication_year=2009&pages=17536-17537&author=R.+Uedaauthor=T.+Suzukiauthor=K.+Minoauthor=H.+Tsumotoauthor=H.+Nakagawaauthor=M.+Hasegawaauthor=R.+Sasakiauthor=T.+Mizukamiauthor=N.+Miyata&title=Identification+of+cell-active+lysine+specific+demethylase+1-selective+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Fja907055q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja907055q%26sid%3Dliteratum%253Aachs%26aulast%3DUeda%26aufirst%3DR.%26aulast%3DSuzuki%26aufirst%3DT.%26aulast%3DMino%26aufirst%3DK.%26aulast%3DTsumoto%26aufirst%3DH.%26aulast%3DNakagawa%26aufirst%3DH.%26aulast%3DHasegawa%26aufirst%3DM.%26aulast%3DSasaki%26aufirst%3DR.%26aulast%3DMizukami%26aufirst%3DT.%26aulast%3DMiyata%26aufirst%3DN.%26atitle%3DIdentification%2520of%2520cell-active%2520lysine%2520specific%2520demethylase%25201-selective%2520inhibitors%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2009%26volume%3D131%26spage%3D17536%26epage%3D17537" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Ogasawara, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Itoh, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsumoto, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kakizawa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mino, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukuhara, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakagawa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hasegawa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sasaki, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mizukami, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyata, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, T.</span><span> </span><span class="NLM_article-title">Lysine-specific demethylase 1-selective inactivators: protein-targeted drug delivery mechanism</span> <span class="citation_source-journal">Angew. Chem., Int. Ed. Engl.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">8620</span><span class="NLM_x">–</span> <span class="NLM_lpage">8624</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2013&pages=8620-8624&author=D.+Ogasawaraauthor=Y.+Itohauthor=H.+Tsumotoauthor=T.+Kakizawaauthor=K.+Minoauthor=K.+Fukuharaauthor=H.+Nakagawaauthor=M.+Hasegawaauthor=R.+Sasakiauthor=T.+Mizukamiauthor=N.+Miyataauthor=T.+Suzuki&title=Lysine-specific+demethylase+1-selective+inactivators%3A+protein-targeted+drug+delivery+mechanism"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOgasawara%26aufirst%3DD.%26aulast%3DItoh%26aufirst%3DY.%26aulast%3DTsumoto%26aufirst%3DH.%26aulast%3DKakizawa%26aufirst%3DT.%26aulast%3DMino%26aufirst%3DK.%26aulast%3DFukuhara%26aufirst%3DK.%26aulast%3DNakagawa%26aufirst%3DH.%26aulast%3DHasegawa%26aufirst%3DM.%26aulast%3DSasaki%26aufirst%3DR.%26aulast%3DMizukami%26aufirst%3DT.%26aulast%3DMiyata%26aufirst%3DN.%26aulast%3DSuzuki%26aufirst%3DT.%26atitle%3DLysine-specific%2520demethylase%25201-selective%2520inactivators%253A%2520protein-targeted%2520drug%2520delivery%2520mechanism%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%2520Engl.%26date%3D2013%26volume%3D52%26spage%3D8620%26epage%3D8624" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Lewis, W. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, L. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grynszpan, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Radić, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carlier, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finn, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharpless, K. B.</span><span> </span><span class="NLM_article-title">Click chemistry in situ: acetylcholinesterase as a reaction vessel for the selective assembly of a femtomolar inhibitor from an array of building blocks</span> <span class="citation_source-journal">Angew. Chem., Int. Ed. Engl.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">1053</span><span class="NLM_x">–</span> <span class="NLM_lpage">1057</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2002&pages=1053-1057&author=W.+G.+Lewisauthor=L.+G.+Greenauthor=F.+Grynszpanauthor=Z.+Radi%C4%87author=P.+R.+Carlierauthor=P.+Taylorauthor=M.+G.+Finnauthor=K.+B.+Sharpless&title=Click+chemistry+in+situ%3A+acetylcholinesterase+as+a+reaction+vessel+for+the+selective+assembly+of+a+femtomolar+inhibitor+from+an+array+of+building+blocks"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLewis%26aufirst%3DW.%2BG.%26aulast%3DGreen%26aufirst%3DL.%2BG.%26aulast%3DGrynszpan%26aufirst%3DF.%26aulast%3DRadi%25C4%2587%26aufirst%3DZ.%26aulast%3DCarlier%26aufirst%3DP.%2BR.%26aulast%3DTaylor%26aufirst%3DP.%26aulast%3DFinn%26aufirst%3DM.%2BG.%26aulast%3DSharpless%26aufirst%3DK.%2BB.%26atitle%3DClick%2520chemistry%2520in%2520situ%253A%2520acetylcholinesterase%2520as%2520a%2520reaction%2520vessel%2520for%2520the%2520selective%2520assembly%2520of%2520a%2520femtomolar%2520inhibitor%2520from%2520an%2520array%2520of%2520building%2520blocks%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%2520Engl.%26date%3D2002%26volume%3D41%26spage%3D1053%26epage%3D1057" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Manetsch, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krasiński, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Radić, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raushel, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharpless, K. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolb, H. C.</span><span> </span><span class="NLM_article-title">In situ click chemistry: enzyme inhibitors made to their own specifications</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">126</span><span class="NLM_x">, </span> <span class="NLM_fpage">12809</span><span class="NLM_x">–</span> <span class="NLM_lpage">12818</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja046382g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00229&amp;key=1%3ACAS%3A528%3ADC%252BD2cXns1Kmtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=126&publication_year=2004&pages=12809-12818&author=R.+Manetschauthor=A.+Krasi%C5%84skiauthor=Z.+Radi%C4%87author=J.+Raushelauthor=P.+Taylorauthor=K.+B.+Sharplessauthor=H.+C.+Kolb&title=In+situ+click+chemistry%3A+enzyme+inhibitors+made+to+their+own+specifications"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">In Situ Click Chemistry: Enzyme Inhibitors Made to Their Own Specifications</span></div><div class="casAuthors">Manetsch, Roman; Krasinski, Antoni; Radic, Zoran; Raushel, Jessica; Taylor, Palmer; Sharpless, K. Barry; Kolb, Hartmuth C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">126</span>
        (<span class="NLM_cas:issue">40</span>),
    <span class="NLM_cas:pages">12809-12818</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The in situ click chem. approach to lead discovery employs the biol. target itself for assembling inhibitors from complementary building block reagents via irreversible connection chem.  The present publication discusses the optimization of this target-guided strategy using acetylcholinesterase (AChE) as a test system.  The application of liq. chromatog. with mass spectroscopic detection in the selected ion mode for product identification greatly enhanced the sensitivity and reliability of this method.  It enabled the testing of multicomponent mixts., which may dramatically increase the in situ screening throughput.  In addn. to the previously reported in situ product syn-TZ2PA6, the authors discovered three new inhibitors, syn-TZ2PA5, syn-TA2PZ6, and syn-TA2PZ5, derived from tacrine and phenylphenanthridinium azides and acetylenes, in the reactions with Electrophorus electricus and mouse AChE.  All in situ-generated compds. were extremely potent AChE inhibitors, because of the presence of multiple sites of interaction, which include the newly formed triazole nexus as a significant pharmacophore.  Safety issues in handling the potentially neurotoxic inhibitors are also discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpHHAh34oMn8LVg90H21EOLACvtfcHk0likD7Bcww-hwA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXns1Kmtb4%253D&md5=d5803f0257cab7958e1bd482b1f66313</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Fja046382g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja046382g%26sid%3Dliteratum%253Aachs%26aulast%3DManetsch%26aufirst%3DR.%26aulast%3DKrasi%25C5%2584ski%26aufirst%3DA.%26aulast%3DRadi%25C4%2587%26aufirst%3DZ.%26aulast%3DRaushel%26aufirst%3DJ.%26aulast%3DTaylor%26aufirst%3DP.%26aulast%3DSharpless%26aufirst%3DK.%2BB.%26aulast%3DKolb%26aufirst%3DH.%2BC.%26atitle%3DIn%2520situ%2520click%2520chemistry%253A%2520enzyme%2520inhibitors%2520made%2520to%2520their%2520own%2520specifications%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2004%26volume%3D126%26spage%3D12809%26epage%3D12818" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Nasr, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petit, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vullo, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winum, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Supuran, C. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barboiu, M.</span><span> </span><span class="NLM_article-title">Carbonic anhydrase-encoded dynamic constitutional libraries: toward the discovery of isozyme-specific inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">4853</span><span class="NLM_x">–</span> <span class="NLM_lpage">4859</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm900449v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00229&amp;key=1%3ACAS%3A528%3ADC%252BD1MXotF2ruro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=4853-4859&author=G.+Nasrauthor=E.+Petitauthor=D.+Vulloauthor=J.+Y.+Winumauthor=C.+T.+Supuranauthor=M.+Barboiu&title=Carbonic+anhydrase-encoded+dynamic+constitutional+libraries%3A+toward+the+discovery+of+isozyme-specific+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Carbonic Anhydrase-Encoded Dynamic Constitutional Libraries: Toward the Discovery of Isozyme-Specific Inhibitors</span></div><div class="casAuthors">Nasr, Gihane; Petit, Eddy; Vullo, Daniela; Winum, Jean-Yves; Supuran, Claudiu T.; Barboiu, Mihail</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">4853-4859</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A constitutional dynamic library (CDL) was generated under thermodn. control by using the amino-carbonyl/imine interconversion as reversible chem., combined with noncovalent bonding within the active site of the metalloenzyme carbonic anhydrase (CA, EC 4.2.1.1).  Considering the pharmacol. importance to find isoform-selective CA inhibitors (CAIs), two of the 15 human (h) isoform, i.e., hCAI and hCA II, have been subjected to a parallel screening of the same CDL.  The use of parallel constitutional screening of CDL chem. for the discovery of enzyme inhibitors is straightforward and it might provide initial insights toward the generation of efficient classes of selective, high affinity inhibitors.  We demonstrate here that the high selectivity and specificity of inhibiting the hCA I and hCA II isoenzymes with some of the detected hits may be used to describe a complex constitutional behavior through component selection from the dynamic library, driven by the selective binding to the specific isoform active site.  These results also point to the possibility of modulating the drug discovery methods by constitutional recomposition induced by a specific enzymic target.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoT_jl-EY6mgbVg90H21EOLACvtfcHk0likD7Bcww-hwA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXotF2ruro%253D&md5=1f928d3994682815692e117881d6e6d0</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fjm900449v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900449v%26sid%3Dliteratum%253Aachs%26aulast%3DNasr%26aufirst%3DG.%26aulast%3DPetit%26aufirst%3DE.%26aulast%3DVullo%26aufirst%3DD.%26aulast%3DWinum%26aufirst%3DJ.%2BY.%26aulast%3DSupuran%26aufirst%3DC.%2BT.%26aulast%3DBarboiu%26aufirst%3DM.%26atitle%3DCarbonic%2520anhydrase-encoded%2520dynamic%2520constitutional%2520libraries%253A%2520toward%2520the%2520discovery%2520of%2520isozyme-specific%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D4853%26epage%3D4859" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Yamauchi, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gomez, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grimster, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dufouil, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nemecz, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fotsing, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ho, K. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Talley, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharpless, K. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fokin, V. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, P.</span><span> </span><span class="NLM_article-title">Synthesis of selective agonists for the α7 nicotinic acetylcholine receptor with in situ click-chemistry on acetylcholine-binding protein templates</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">82</span><span class="NLM_x">, </span> <span class="NLM_fpage">687</span><span class="NLM_x">–</span> <span class="NLM_lpage">699</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=2012&pages=687-699&author=J.+G.+Yamauchiauthor=K.+Gomezauthor=N.+Grimsterauthor=M.+Dufouilauthor=A.+Nemeczauthor=J.+R.+Fotsingauthor=K.+Y.+Hoauthor=T.+T.+Talleyauthor=K.+B.+Sharplessauthor=V.+V.+Fokinauthor=P.+Taylor&title=Synthesis+of+selective+agonists+for+the+%CE%B17+nicotinic+acetylcholine+receptor+with+in+situ+click-chemistry+on+acetylcholine-binding+protein+templates"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYamauchi%26aufirst%3DJ.%2BG.%26aulast%3DGomez%26aufirst%3DK.%26aulast%3DGrimster%26aufirst%3DN.%26aulast%3DDufouil%26aufirst%3DM.%26aulast%3DNemecz%26aufirst%3DA.%26aulast%3DFotsing%26aufirst%3DJ.%2BR.%26aulast%3DHo%26aufirst%3DK.%2BY.%26aulast%3DTalley%26aufirst%3DT.%2BT.%26aulast%3DSharpless%26aufirst%3DK.%2BB.%26aulast%3DFokin%26aufirst%3DV.%2BV.%26aulast%3DTaylor%26aufirst%3DP.%26atitle%3DSynthesis%2520of%2520selective%2520agonists%2520for%2520the%2520%25CE%25B17%2520nicotinic%2520acetylcholine%2520receptor%2520with%2520in%2520situ%2520click-chemistry%2520on%2520acetylcholine-binding%2520protein%2520templates%26jtitle%3DMol.%2520Pharmacol.%26date%3D2012%26volume%3D82%26spage%3D687%26epage%3D699" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Suzuki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ota, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kasuya, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mutsuga, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawamura, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsumoto, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakagawa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finn, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyata, N.</span><span> </span><span class="NLM_article-title">An unexpected example of protein-templated click chemistry</span> <span class="citation_source-journal">Angew. Chem., Int. Ed. Engl.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">6817</span><span class="NLM_x">–</span> <span class="NLM_lpage">6820</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2010&pages=6817-6820&author=T.+Suzukiauthor=Y.+Otaauthor=Y.+Kasuyaauthor=M.+Mutsugaauthor=Y.+Kawamuraauthor=H.+Tsumotoauthor=H.+Nakagawaauthor=M.+G.+Finnauthor=N.+Miyata&title=An+unexpected+example+of+protein-templated+click+chemistry"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSuzuki%26aufirst%3DT.%26aulast%3DOta%26aufirst%3DY.%26aulast%3DKasuya%26aufirst%3DY.%26aulast%3DMutsuga%26aufirst%3DM.%26aulast%3DKawamura%26aufirst%3DY.%26aulast%3DTsumoto%26aufirst%3DH.%26aulast%3DNakagawa%26aufirst%3DH.%26aulast%3DFinn%26aufirst%3DM.%2BG.%26aulast%3DMiyata%26aufirst%3DN.%26atitle%3DAn%2520unexpected%2520example%2520of%2520protein-templated%2520click%2520chemistry%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%2520Engl.%26date%3D2010%26volume%3D49%26spage%3D6817%26epage%3D6820" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Danishuddin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khan, A. U.</span><span> </span><span class="NLM_article-title">Structure based virtual screening to discover putative drug candidates: necessary considerations and successful case studies</span> <span class="citation_source-journal">Methods</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">71C</span><span class="NLM_x">, </span> <span class="NLM_fpage">135</span><span class="NLM_x">–</span> <span class="NLM_lpage">145</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71C&publication_year=2015&pages=135-145&author=M.+Danishuddinauthor=A.+U.+Khan&title=Structure+based+virtual+screening+to+discover+putative+drug+candidates%3A+necessary+considerations+and+successful+case+studies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDanishuddin%26aufirst%3DM.%26aulast%3DKhan%26aufirst%3DA.%2BU.%26atitle%3DStructure%2520based%2520virtual%2520screening%2520to%2520discover%2520putative%2520drug%2520candidates%253A%2520necessary%2520considerations%2520and%2520successful%2520case%2520studies%26jtitle%3DMethods%26date%3D2015%26volume%3D71C%26spage%3D135%26epage%3D145" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Braga, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alves, V. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silva, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nascimento, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silva, F. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liao, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrade, C. H.</span><span> </span><span class="NLM_article-title">Virtual screening strategies in medicinal chemistry: the state of the art and current challenges</span> <span class="citation_source-journal">Curr. Top Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">1899</span><span class="NLM_x">–</span> <span class="NLM_lpage">1912</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00229&amp;key=10.2174%2F1568026614666140929120749" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00229&amp;key=25262801" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00229&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvVGgtL%252FF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2014&pages=1899-1912&author=R.+C.+Bragaauthor=V.+M.+Alvesauthor=A.+C.+Silvaauthor=M.+N.+Nascimentoauthor=F.+C.+Silvaauthor=L.+M.+Liaoauthor=C.+H.+Andrade&title=Virtual+screening+strategies+in+medicinal+chemistry%3A+the+state+of+the+art+and+current+challenges"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Virtual Screening Strategies in Medicinal Chemistry: The State of the Art and Current Challenges</span></div><div class="casAuthors">Braga, Rodolpho C.; Alves, Vinicius M.; Silva, Arthur C.; Nascimento, Marilia N.; Silva, Flavia C.; Liao, Luciano M.; Andrade, Carolina H.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">1899-1912</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Virtual screening (VS) techniques are well-established tools in the modern drug discovery process, mainly used for hit finding in drug discovery.  The availability of knowledge of structural information, which includes an increasing no. of 3D protein structures and the readiness of free databases of com. available small mols., provides a broad platform for VS.  This review summarizes the current developments in VS regarding chem. databases and highlights the achievements as well as the challenges with an emphasis on a recent example of the successful application for the identification of new hits for sterol 14α-demethylase (CYP51) of Trypanosoma cruzi.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpCv7qZgDBPl7Vg90H21EOLACvtfcHk0lgn0M1t3vkEAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvVGgtL%252FF&md5=b2784bfe2b9e14f0fe87ff8b66a7db6e</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.2174%2F1568026614666140929120749&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568026614666140929120749%26sid%3Dliteratum%253Aachs%26aulast%3DBraga%26aufirst%3DR.%2BC.%26aulast%3DAlves%26aufirst%3DV.%2BM.%26aulast%3DSilva%26aufirst%3DA.%2BC.%26aulast%3DNascimento%26aufirst%3DM.%2BN.%26aulast%3DSilva%26aufirst%3DF.%2BC.%26aulast%3DLiao%26aufirst%3DL.%2BM.%26aulast%3DAndrade%26aufirst%3DC.%2BH.%26atitle%3DVirtual%2520screening%2520strategies%2520in%2520medicinal%2520chemistry%253A%2520the%2520state%2520of%2520the%2520art%2520and%2520current%2520challenges%26jtitle%3DCurr.%2520Top%2520Med.%2520Chem.%26date%3D2014%26volume%3D14%26spage%3D1899%26epage%3D1912" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Lionta, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spyrou, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vassilatis, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cournia, Z.</span><span> </span><span class="NLM_article-title">Structure-based virtual screening for drug discovery: principles, applications and recent advances</span> <span class="citation_source-journal">Curr. Top Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">1923</span><span class="NLM_x">–</span> <span class="NLM_lpage">1938</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00229&amp;key=10.2174%2F1568026614666140929124445" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00229&amp;key=25262799" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00229&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvVGgt7fJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2014&pages=1923-1938&author=E.+Liontaauthor=G.+Spyrouauthor=D.+K.+Vassilatisauthor=Z.+Cournia&title=Structure-based+virtual+screening+for+drug+discovery%3A+principles%2C+applications+and+recent+advances"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Based Virtual Screening for Drug Discovery: Principles, Applications and Recent Advances</span></div><div class="casAuthors">Lionta, Evanthia; Spyrou, George; Vassilatis, Demetrios K.; Cournia, Zoe</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">1923-1938</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Structure-based drug discovery (SBDD) is becoming an essential tool in assisting fast and cost-efficient lead discovery and optimization.  The application of rational, structure-based drug design is proven to be more efficient than the traditional way of drug discovery since it aims to understand the mol. basis of a disease and utilizes the knowledge of the three-dimensional structure of the biol. target in the process.  In this review, we focus on the principles and applications of Virtual Screening (VS) within the context of SBDD and examine different procedures ranging from the initial stages of the process that include receptor and library pre-processing, to docking, scoring and post-processing of top scoring hits.  Recent improvements in structure-based virtual screening (SBVS) efficiency through ensemble docking, induced fit and consensus docking are also discussed.  The review highlights advances in the field within the framework of several success studies that have led to nM inhibition directly from VS and provides recent trends in library design as well as discusses limitations of the method.  Applications of SBVS in the design of substrates for engineered proteins that enable the discovery of new metabolic and signal transduction pathways and the design of inhibitors of multifunctional proteins are also reviewed.  Finally, we contribute two promising VS protocols recently developed by us that aim to increase inhibitor selectivity.  In the first protocol, we describe the discovery of micromolar inhibitors through SBVS designed to inhibit the mutant H1047R PI3Kα kinase.  Second, we discuss a strategy for the identification of selective binders for the RXRα nuclear receptor.  In this protocol, a set of target structures is constructed for ensemble docking based on binding site shape characterization and clustering, aiming to enhance the hit rate of selective inhibitors for the desired protein target through the SBVS process.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGps80ptfisjzLVg90H21EOLACvtfcHk0lgn0M1t3vkEAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvVGgt7fJ&md5=0550a396dd011adf52699b091548345b</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.2174%2F1568026614666140929124445&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568026614666140929124445%26sid%3Dliteratum%253Aachs%26aulast%3DLionta%26aufirst%3DE.%26aulast%3DSpyrou%26aufirst%3DG.%26aulast%3DVassilatis%26aufirst%3DD.%2BK.%26aulast%3DCournia%26aufirst%3DZ.%26atitle%3DStructure-based%2520virtual%2520screening%2520for%2520drug%2520discovery%253A%2520principles%252C%2520applications%2520and%2520recent%2520advances%26jtitle%3DCurr.%2520Top%2520Med.%2520Chem.%26date%3D2014%26volume%3D14%26spage%3D1923%26epage%3D1938" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Brožič, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turk, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adeniji, A. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Konc, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janežič, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Penning, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lanišnik Rižner, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gobec, S.</span><span> </span><span class="NLM_article-title">Selective inhibitors of aldo-keto reductases AKR1C1 and AKR1C3 discovered by virtual screening of a fragment library</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">7417</span><span class="NLM_x">–</span> <span class="NLM_lpage">7424</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm300841n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=7417-7424&author=P.+Bro%C5%BEi%C4%8Dauthor=S.+Turkauthor=A.+O.+Adenijiauthor=J.+Koncauthor=D.+Jane%C5%BEi%C4%8Dauthor=T.+M.+Penningauthor=T.+Lani%C5%A1nik+Ri%C5%BEnerauthor=S.+Gobec&title=Selective+inhibitors+of+aldo-keto+reductases+AKR1C1+and+AKR1C3+discovered+by+virtual+screening+of+a+fragment+library"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fjm300841n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300841n%26sid%3Dliteratum%253Aachs%26aulast%3DBro%25C5%25BEi%25C4%258D%26aufirst%3DP.%26aulast%3DTurk%26aufirst%3DS.%26aulast%3DAdeniji%26aufirst%3DA.%2BO.%26aulast%3DKonc%26aufirst%3DJ.%26aulast%3DJane%25C5%25BEi%25C4%258D%26aufirst%3DD.%26aulast%3DPenning%26aufirst%3DT.%2BM.%26aulast%3DLani%25C5%25A1nik%2BRi%25C5%25BEner%26aufirst%3DT.%26aulast%3DGobec%26aufirst%3DS.%26atitle%3DSelective%2520inhibitors%2520of%2520aldo-keto%2520reductases%2520AKR1C1%2520and%2520AKR1C3%2520discovered%2520by%2520virtual%2520screening%2520of%2520a%2520fragment%2520library%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D7417%26epage%3D7424" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Brus, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Košak, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turk, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pišlar, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coquelle, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kos, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stojan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colletier, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gobec, S.</span><span> </span><span class="NLM_article-title">Discovery, biological evaluation, and crystal structure of a novel nanomolar selective butyrylcholinesterase inhibitor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">8167</span><span class="NLM_x">–</span> <span class="NLM_lpage">8179</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm501195e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=8167-8179&author=B.+Brusauthor=U.+Ko%C5%A1akauthor=S.+Turkauthor=A.+Pi%C5%A1larauthor=N.+Coquelleauthor=J.+Kosauthor=J.+Stojanauthor=J.+P.+Colletierauthor=S.+Gobec&title=Discovery%2C+biological+evaluation%2C+and+crystal+structure+of+a+novel+nanomolar+selective+butyrylcholinesterase+inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fjm501195e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501195e%26sid%3Dliteratum%253Aachs%26aulast%3DBrus%26aufirst%3DB.%26aulast%3DKo%25C5%25A1ak%26aufirst%3DU.%26aulast%3DTurk%26aufirst%3DS.%26aulast%3DPi%25C5%25A1lar%26aufirst%3DA.%26aulast%3DCoquelle%26aufirst%3DN.%26aulast%3DKos%26aufirst%3DJ.%26aulast%3DStojan%26aufirst%3DJ.%26aulast%3DColletier%26aufirst%3DJ.%2BP.%26aulast%3DGobec%26aufirst%3DS.%26atitle%3DDiscovery%252C%2520biological%2520evaluation%252C%2520and%2520crystal%2520structure%2520of%2520a%2520novel%2520nanomolar%2520selective%2520butyrylcholinesterase%2520inhibitor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D8167%26epage%3D8179" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Chen, Y.</span><span> </span><span class="NLM_article-title">Beware of docking!</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">78</span><span class="NLM_x">–</span> <span class="NLM_lpage">95</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2015&pages=78-95&author=Y.+Chen&title=Beware+of+docking%21"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DY.%26atitle%3DBeware%2520of%2520docking%2521%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2015%26volume%3D36%26spage%3D78%26epage%3D95" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Wang, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Z. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, L. R.</span><span> </span><span class="NLM_article-title">Fragment-based drug discovery and molecular docking in drug design</span> <span class="citation_source-journal">Curr. Pharm. Biotechnol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">11</span><span class="NLM_x">–</span> <span class="NLM_lpage">25</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00229&amp;key=10.2174%2F1389201015666141122204532" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00229&amp;key=25420726" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00229&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtVSqtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2015&pages=11-25&author=T.+Wangauthor=M.+B.+Wuauthor=Z.+J.+Chenauthor=H.+Chenauthor=J.+P.+Linauthor=L.+R.+Yang&title=Fragment-based+drug+discovery+and+molecular+docking+in+drug+design"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Fragment-Based Drug Discovery and Molecular Docking in Drug Design</span></div><div class="casAuthors">Wang, Tao; Wu, Mian-Bin; Chen, Zheng-Jie; Chen, Hua; Lin, Jian-Ping; Yang, Li-Rong</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Biotechnology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">11-25</span>CODEN:
                <span class="NLM_cas:coden">CPBUBP</span>;
        ISSN:<span class="NLM_cas:issn">1389-2010</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Fragment-based drug discovery (FBDD) has caused a revolution in the process of drug discovery and design, with many FBDD leads being developed into clin. trials or approved in the past few years.  Compared with traditional high-throughput screening, it displays obvious advantages such as efficiently covering chem. space, achieving higher hit rates, and so forth.  In this review, we focus on the most recent developments of FBDD for improving drug discovery, illustrating the process and the importance of FBDD.  In particular, the computational strategies applied in the process of FBDD and mol.-docking programs are highlighted elaborately.  In most cases, docking is used for predicting the ligand-receptor interaction modes and hit identification by structure-based virtual screening.  The successful cases of typical significance and the hits identified most recently are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQSeYpk6Wbo7Vg90H21EOLACvtfcHk0liAUeNlhqBEJQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtVSqtL0%253D&md5=78c46f9ca06912a710a5d9ed0a22fe37</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.2174%2F1389201015666141122204532&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1389201015666141122204532%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DT.%26aulast%3DWu%26aufirst%3DM.%2BB.%26aulast%3DChen%26aufirst%3DZ.%2BJ.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DLin%26aufirst%3DJ.%2BP.%26aulast%3DYang%26aufirst%3DL.%2BR.%26atitle%3DFragment-based%2520drug%2520discovery%2520and%2520molecular%2520docking%2520in%2520drug%2520design%26jtitle%3DCurr.%2520Pharm.%2520Biotechnol.%26date%3D2015%26volume%3D16%26spage%3D11%26epage%3D25" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Suzuki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kouketsu, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Itoh, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hisakawa, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maeda, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshida, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakagawa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyata, N.</span><span> </span><span class="NLM_article-title">Highly potent and selective histone deacetylase 6 inhibitors designed based on a small-molecular substrate</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">4809</span><span class="NLM_x">–</span> <span class="NLM_lpage">4812</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm060554y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=4809-4812&author=T.+Suzukiauthor=A.+Kouketsuauthor=Y.+Itohauthor=S.+Hisakawaauthor=S.+Maedaauthor=M.+Yoshidaauthor=H.+Nakagawaauthor=N.+Miyata&title=Highly+potent+and+selective+histone+deacetylase+6+inhibitors+designed+based+on+a+small-molecular+substrate"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Fjm060554y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060554y%26sid%3Dliteratum%253Aachs%26aulast%3DSuzuki%26aufirst%3DT.%26aulast%3DKouketsu%26aufirst%3DA.%26aulast%3DItoh%26aufirst%3DY.%26aulast%3DHisakawa%26aufirst%3DS.%26aulast%3DMaeda%26aufirst%3DS.%26aulast%3DYoshida%26aufirst%3DM.%26aulast%3DNakagawa%26aufirst%3DH.%26aulast%3DMiyata%26aufirst%3DN.%26atitle%3DHighly%2520potent%2520and%2520selective%2520histone%2520deacetylase%25206%2520inhibitors%2520designed%2520based%2520on%2520a%2520small-molecular%2520substrate%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D4809%26epage%3D4812" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Itoh, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kouketsu, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maeda, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshida, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakagawa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyata, N.</span><span> </span><span class="NLM_article-title">Design, synthesis, structure–selectivity relationship, and effect on human cancer cells of a novel series of histone deacetylase 6-selective inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">5425</span><span class="NLM_x">–</span> <span class="NLM_lpage">5438</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm7009217" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=5425-5438&author=Y.+Itohauthor=T.+Suzukiauthor=A.+Kouketsuauthor=N.+Suzukiauthor=S.+Maedaauthor=M.+Yoshidaauthor=H.+Nakagawaauthor=N.+Miyata&title=Design%2C+synthesis%2C+structure%E2%80%93selectivity+relationship%2C+and+effect+on+human+cancer+cells+of+a+novel+series+of+histone+deacetylase+6-selective+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Fjm7009217&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm7009217%26sid%3Dliteratum%253Aachs%26aulast%3DItoh%26aufirst%3DY.%26aulast%3DSuzuki%26aufirst%3DT.%26aulast%3DKouketsu%26aufirst%3DA.%26aulast%3DSuzuki%26aufirst%3DN.%26aulast%3DMaeda%26aufirst%3DS.%26aulast%3DYoshida%26aufirst%3DM.%26aulast%3DNakagawa%26aufirst%3DH.%26aulast%3DMiyata%26aufirst%3DN.%26atitle%3DDesign%252C%2520synthesis%252C%2520structure%25E2%2580%2593selectivity%2520relationship%252C%2520and%2520effect%2520on%2520human%2520cancer%2520cells%2520of%2520a%2520novel%2520series%2520of%2520histone%2520deacetylase%25206-selective%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D5425%26epage%3D5438" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Asaba, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ueda, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsumoto, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakagawa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyata, N.</span><span> </span><span class="NLM_article-title">Inhibition of human sirtuins by in situ generation of an acetylated lysine–ADP–ribose conjugate</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">131</span><span class="NLM_x">, </span> <span class="NLM_fpage">6989</span><span class="NLM_x">–</span> <span class="NLM_lpage">6996</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja807083y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=131&publication_year=2009&pages=6989-6996&author=T.+Asabaauthor=T.+Suzukiauthor=R.+Uedaauthor=H.+Tsumotoauthor=H.+Nakagawaauthor=N.+Miyata&title=Inhibition+of+human+sirtuins+by+in+situ+generation+of+an+acetylated+lysine%E2%80%93ADP%E2%80%93ribose+conjugate"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Fja807083y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja807083y%26sid%3Dliteratum%253Aachs%26aulast%3DAsaba%26aufirst%3DT.%26aulast%3DSuzuki%26aufirst%3DT.%26aulast%3DUeda%26aufirst%3DR.%26aulast%3DTsumoto%26aufirst%3DH.%26aulast%3DNakagawa%26aufirst%3DH.%26aulast%3DMiyata%26aufirst%3DN.%26atitle%3DInhibition%2520of%2520human%2520sirtuins%2520by%2520in%2520situ%2520generation%2520of%2520an%2520acetylated%2520lysine%25E2%2580%2593ADP%25E2%2580%2593ribose%2520conjugate%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2009%26volume%3D131%26spage%3D6989%26epage%3D6996" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Cui, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamal, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ai, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">More, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, L.</span><span> </span><span class="NLM_article-title">Discovery of potent and selective sirtuin 2 (SIRT2) inhibitors using a fragment-based approach</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">8340</span><span class="NLM_x">–</span> <span class="NLM_lpage">8357</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm500777s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00229&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsFCjsLfL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=8340-8357&author=H.+Cuiauthor=Z.+Kamalauthor=T.+Aiauthor=Y.+Xuauthor=S.+S.+Moreauthor=D.+J.+Wilsonauthor=L.+Chen&title=Discovery+of+potent+and+selective+sirtuin+2+%28SIRT2%29+inhibitors+using+a+fragment-based+approach"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Potent and Selective Sirtuin 2 (SIRT2) Inhibitors Using a Fragment-Based Approach</span></div><div class="casAuthors">Cui, Huaqing; Kamal, Zeeshan; Ai, Teng; Xu, Yanli; More, Swati S.; Wilson, Daniel J.; Chen, Liqiang</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">8340-8357</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Sirtuin 2 (SIRT2) is one of the sirtuins, a family of NAD+-dependent deacetylases that act on a variety of histone and non-histone substrates.  Accumulating biol. functions and potential therapeutic applications have drawn interest in the discovery and development of SIRT2 inhibitors.  Herein we report our discovery of novel SIRT2 inhibitors using a fragment-based approach.  Inspired by the purported close binding proximity of suramin and nicotinamide, we prepd. two sets of fragments, namely, the naphthylamide sulfonic acids and the naphthalene-benzamides and -nicotinamides.  Biochem. evaluation of these two series provided structure-activity relationship (SAR) information, which led to the design of (5-benzamidonaphthalen-1/2-yloxy)nicotinamide derivs.  Among these inhibitors, one compd. exhibited high anti-SIRT2 activity (48 nM) and excellent selectivity for SIRT2 over SIRT1 and SIRT3.  In vitro, it also increased the acetylation level of α-tubulin, a well-established SIRT2 substrate, in both concn.- and time-dependent manners.  Further kinetic studies revealed that this compd. behaves as a competitive inhibitor against the peptide substrate and most likely as a noncompetitive inhibitor against NAD+.  Taken together, these results indicate that we have discovered a potent and selective SIRT2 inhibitor whose novel structure merits further exploration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgdLtR3ic38bVg90H21EOLACvtfcHk0lg6I9Cz8ISm-g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsFCjsLfL&md5=6831830798aa6518ca02e3780c49b4cd</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Fjm500777s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm500777s%26sid%3Dliteratum%253Aachs%26aulast%3DCui%26aufirst%3DH.%26aulast%3DKamal%26aufirst%3DZ.%26aulast%3DAi%26aufirst%3DT.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DMore%26aufirst%3DS.%2BS.%26aulast%3DWilson%26aufirst%3DD.%2BJ.%26aulast%3DChen%26aufirst%3DL.%26atitle%3DDiscovery%2520of%2520potent%2520and%2520selective%2520sirtuin%25202%2520%2528SIRT2%2529%2520inhibitors%2520using%2520a%2520fragment-based%2520approach%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D8340%26epage%3D8357" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Pilka, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">James, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lisztwan, J. H.</span><span> </span><span class="NLM_article-title">Structural definitions of Jumonji family demethylase selectivity</span> <span class="citation_source-journal">Drug Discovery Today.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">743</span><span class="NLM_x">–</span> <span class="NLM_lpage">749</span><span class="refDoi"> DOI: 10.1016/j.drudis.2014.12.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00229&amp;key=10.1016%2Fj.drudis.2014.12.013" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2014&pages=743-749&author=E.+S.+Pilkaauthor=T.+Jamesauthor=J.+H.+Lisztwan&title=Structural+definitions+of+Jumonji+family+demethylase+selectivity&doi=10.1016%2Fj.drudis.2014.12.013"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2014.12.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2014.12.013%26sid%3Dliteratum%253Aachs%26aulast%3DPilka%26aufirst%3DE.%2BS.%26aulast%3DJames%26aufirst%3DT.%26aulast%3DLisztwan%26aufirst%3DJ.%2BH.%26atitle%3DStructural%2520definitions%2520of%2520Jumonji%2520family%2520demethylase%2520selectivity%26jtitle%3DDrug%2520Discovery%2520Today.%26date%3D2014%26volume%3D20%26spage%3D743%26epage%3D749%26doi%3D10.1016%2Fj.drudis.2014.12.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Luo, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kubicek, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Myllyharju, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tumber, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ng, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Che, K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Podoll, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heightman, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oppermann, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schreiber, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span> </span><span class="NLM_article-title">A selective inhibitor and probe of the cellular functions of Jumonji C domain-containing histone demethylases</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">133</span><span class="NLM_x">, </span> <span class="NLM_fpage">9451</span><span class="NLM_x">–</span> <span class="NLM_lpage">9456</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja201597b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00229&amp;key=1%3ACAS%3A528%3ADC%252BC3MXmslGmurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=133&publication_year=2011&pages=9451-9456&author=X.+Luoauthor=Y.+Liuauthor=S.+Kubicekauthor=J.+Myllyharjuauthor=A.+Tumberauthor=S.+Ngauthor=K.+H.+Cheauthor=J.+Podollauthor=T.+D.+Heightmanauthor=U.+Oppermannauthor=S.+L.+Schreiberauthor=X.+Wang&title=A+selective+inhibitor+and+probe+of+the+cellular+functions+of+Jumonji+C+domain-containing+histone+demethylases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">A Selective Inhibitor and Probe of the Cellular Functions of Jumonji C Domain-Containing Histone Demethylases</span></div><div class="casAuthors">Luo, Xue-Lai; Liu, Yong-Xiang; Kubicek, Stefan; Myllyharju, Johanna; Tumber, Anthony; Ng, Stanley; Che, Ka-Hing; Podoll, Jessica; Heightman, Tom D.; Oppermann, Udo; Schreiber, Stuart L.; Wang, Xiang</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">133</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">9451-9456</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Histone methylations are important chromatin marks that regulate gene expression, genomic stability, DNA repair, and genomic imprinting.  Histone demethylases are the most recent family of histone-modifying enzymes discovered.  Here, we report the characterization of a small-mol. inhibitor of Jumonji C domain-contg. histone demethylases.  The inhibitor derives from a structure-based design and preferentially inhibits the subfamily of tri-Me lysine demethylases.  Its Me ester prodrug, methylstat, selectively inhibits Jumonji C domain-contg. his-tone demethylases in cells and may be a useful small-mol. probe of chromatin and its role in epigenetics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrcmCdVvaIpq7Vg90H21EOLACvtfcHk0lh7VTe01EWsiA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXmslGmurg%253D&md5=ad50a692dfab85e1bcce77acc14b7b5a</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Fja201597b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja201597b%26sid%3Dliteratum%253Aachs%26aulast%3DLuo%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DKubicek%26aufirst%3DS.%26aulast%3DMyllyharju%26aufirst%3DJ.%26aulast%3DTumber%26aufirst%3DA.%26aulast%3DNg%26aufirst%3DS.%26aulast%3DChe%26aufirst%3DK.%2BH.%26aulast%3DPodoll%26aufirst%3DJ.%26aulast%3DHeightman%26aufirst%3DT.%2BD.%26aulast%3DOppermann%26aufirst%3DU.%26aulast%3DSchreiber%26aufirst%3DS.%2BL.%26aulast%3DWang%26aufirst%3DX.%26atitle%3DA%2520selective%2520inhibitor%2520and%2520probe%2520of%2520the%2520cellular%2520functions%2520of%2520Jumonji%2520C%2520domain-containing%2520histone%2520demethylases%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2011%26volume%3D133%26spage%3D9451%26epage%3D9456" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Baguley, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, H. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chatterjee, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nairn, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lombroso, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellman, J. A.</span><span> </span><span class="NLM_article-title">Substrate-based fragment identification for the development of selective, nonpeptidic inhibitors of striatal-enriched protein tyrosine phosphatase</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">7636</span><span class="NLM_x">–</span> <span class="NLM_lpage">7650</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm401037h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=7636-7650&author=T.+D.+Baguleyauthor=H.+C.+Xuauthor=M.+Chatterjeeauthor=A.+C.+Nairnauthor=P.+J.+Lombrosoauthor=J.+A.+Ellman&title=Substrate-based+fragment+identification+for+the+development+of+selective%2C+nonpeptidic+inhibitors+of+striatal-enriched+protein+tyrosine+phosphatase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35a&amp;dbid=16384&amp;doi=10.1021%2Fjm401037h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401037h%26sid%3Dliteratum%253Aachs%26aulast%3DBaguley%26aufirst%3DT.%2BD.%26aulast%3DXu%26aufirst%3DH.%2BC.%26aulast%3DChatterjee%26aufirst%3DM.%26aulast%3DNairn%26aufirst%3DA.%2BC.%26aulast%3DLombroso%26aufirst%3DP.%2BJ.%26aulast%3DEllman%26aufirst%3DJ.%2BA.%26atitle%3DSubstrate-based%2520fragment%2520identification%2520for%2520the%2520development%2520of%2520selective%252C%2520nonpeptidic%2520inhibitors%2520of%2520striatal-enriched%2520protein%2520tyrosine%2520phosphatase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D7636%26epage%3D7650" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit35b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Baguley, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, H. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chatterjee, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nairn, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lombroso, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellman, J. A.</span><span> </span><span class="NLM_article-title">Correction to substrate-based fragment identification for the development of selective, nonpeptidic inhibitors of striatal-enriched protein tyrosine phosphatase</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">10564</span><span class="NLM_x">–</span> <span class="NLM_lpage">10564</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm5018847" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=10564-10564&author=T.+D.+Baguleyauthor=H.+C.+Xuauthor=M.+Chatterjeeauthor=A.+C.+Nairnauthor=P.+J.+Lombrosoauthor=J.+A.+Ellman&title=Correction+to+substrate-based+fragment+identification+for+the+development+of+selective%2C+nonpeptidic+inhibitors+of+striatal-enriched+protein+tyrosine+phosphatase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35b&amp;dbid=16384&amp;doi=10.1021%2Fjm5018847&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm5018847%26sid%3Dliteratum%253Aachs%26aulast%3DBaguley%26aufirst%3DT.%2BD.%26aulast%3DXu%26aufirst%3DH.%2BC.%26aulast%3DChatterjee%26aufirst%3DM.%26aulast%3DNairn%26aufirst%3DA.%2BC.%26aulast%3DLombroso%26aufirst%3DP.%2BJ.%26aulast%3DEllman%26aufirst%3DJ.%2BA.%26atitle%3DCorrection%2520to%2520substrate-based%2520fragment%2520identification%2520for%2520the%2520development%2520of%2520selective%252C%2520nonpeptidic%2520inhibitors%2520of%2520striatal-enriched%2520protein%2520tyrosine%2520phosphatase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D10564%26epage%3D10564" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Lavogina, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Enkvist, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uri, A.</span><span> </span><span class="NLM_article-title">Bisubstrate inhibitors of protein kinases: from principle to practical applications</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">23</span><span class="NLM_x">–</span> <span class="NLM_lpage">34</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2010&pages=23-34&author=D.+Lavoginaauthor=E.+Enkvistauthor=A.+Uri&title=Bisubstrate+inhibitors+of+protein+kinases%3A+from+principle+to+practical+applications"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLavogina%26aufirst%3DD.%26aulast%3DEnkvist%26aufirst%3DE.%26aulast%3DUri%26aufirst%3DA.%26atitle%3DBisubstrate%2520inhibitors%2520of%2520protein%2520kinases%253A%2520from%2520principle%2520to%2520practical%2520applications%26jtitle%3DChemMedChem%26date%3D2010%26volume%3D5%26spage%3D23%26epage%3D34" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Lamba, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghosh, I.</span><span> </span><span class="NLM_article-title">New directions in targeting protein kinases: focusing upon true allosteric and bivalent inhibitors</span> <span class="citation_source-journal">Curr. Pharm. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">2936</span><span class="NLM_x">–</span> <span class="NLM_lpage">2945</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00229&amp;key=10.2174%2F138161212800672813" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00229&amp;key=22571662" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00229&amp;key=1%3ACAS%3A528%3ADC%252BC38XovFaltrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2012&pages=2936-2945&author=V.+Lambaauthor=I.+Ghosh&title=New+directions+in+targeting+protein+kinases%3A+focusing+upon+true+allosteric+and+bivalent+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">New directions in targeting protein kinases: focusing upon true allosteric and bivalent inhibitors</span></div><div class="casAuthors">Lamba, Vandana; Ghosh, Indraneel</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">2936-2945</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Over the past decade, therapeutics that target subsets of the 518 human protein kinases have played a vital role in the fight against cancer.  Protein kinases are typically targeted at the ATP-binding cleft by type I and II inhibitors; however, the high sequence and structural homol. shared by protein kinases, esp. at the ATP-binding site, inherently leads to polypharmacol.  In order to discover or design truly selective protein kinase inhibitors as both pharmacol. reagents and safer therapeutic leads, new efforts are needed to target kinases outside the ATP cleft.  Recent advances include the serendipitous discovery of type III inhibitors that bind a site proximal to the ATP pocket as well as the truly allosteric type IV inhibitors that target protein kinases distal to the substrate-binding pocket.  These new classes of inhibitors are often selective, but usually display moderate affinities.  Here, the authors discuss the different classes of inhibitors with an emphasis on bisubstrate and bivalent inhibitors (type V) that combine different inhibitor classes.  These inhibitors have the potential to couple the high affinity and potency of traditional active site-targeted small-mol. inhibitors with the selectivity of inhibitors that target the protein kinase surface outside ATP cleft.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpkIIgeMxhCrrVg90H21EOLACvtfcHk0lhG-xtEsc4-gA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XovFaltrk%253D&md5=36a44e36709507b5053bfdfe7d09e5e9</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.2174%2F138161212800672813&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138161212800672813%26sid%3Dliteratum%253Aachs%26aulast%3DLamba%26aufirst%3DV.%26aulast%3DGhosh%26aufirst%3DI.%26atitle%3DNew%2520directions%2520in%2520targeting%2520protein%2520kinases%253A%2520focusing%2520upon%2520true%2520allosteric%2520and%2520bivalent%2520inhibitors%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2012%26volume%3D18%26spage%3D2936%26epage%3D2945" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Ekambaram, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Enkvist, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaasa, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kasari, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raidaru, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knapp, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uri, A.</span><span> </span><span class="NLM_article-title">Selective bisubstrate inhibitors with sub-nanomolar affinity for protein kinase Pim-1</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">909</span><span class="NLM_x">–</span> <span class="NLM_lpage">913</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=909-913&author=R.+Ekambaramauthor=E.+Enkvistauthor=A.+Vaasaauthor=M.+Kasariauthor=G.+Raidaruauthor=S.+Knappauthor=A.+Uri&title=Selective+bisubstrate+inhibitors+with+sub-nanomolar+affinity+for+protein+kinase+Pim-1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEkambaram%26aufirst%3DR.%26aulast%3DEnkvist%26aufirst%3DE.%26aulast%3DVaasa%26aufirst%3DA.%26aulast%3DKasari%26aufirst%3DM.%26aulast%3DRaidaru%26aufirst%3DG.%26aulast%3DKnapp%26aufirst%3DS.%26aulast%3DUri%26aufirst%3DA.%26atitle%3DSelective%2520bisubstrate%2520inhibitors%2520with%2520sub-nanomolar%2520affinity%2520for%2520protein%2520kinase%2520Pim-1%26jtitle%3DChemMedChem%26date%3D2013%26volume%3D8%26spage%3D909%26epage%3D913" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">van Wandelen, L. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Ameijde, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ismail-Ali, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Ufford, H. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vijftigschild, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beekman, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, N. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruijtenbeek, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liskamp, R. M.</span><span> </span><span class="NLM_article-title">Cell-penetrating bisubstrate-based protein kinase C inhibitors</span> <span class="citation_source-journal">ACS Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">1479</span><span class="NLM_x">–</span> <span class="NLM_lpage">1487</span></span><div class="citationLinks">[<a href="/doi/10.1021/cb300709g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=1479-1487&author=L.+T.+van+Wandelenauthor=J.+van+Ameijdeauthor=A.+F.+Ismail-Aliauthor=H.+C.+van+Uffordauthor=L.+A.+Vijftigschildauthor=J.+M.+Beekmanauthor=N.+I.+Martinauthor=R.+Ruijtenbeekauthor=R.+M.+Liskamp&title=Cell-penetrating+bisubstrate-based+protein+kinase+C+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Fcb300709g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb300709g%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2BWandelen%26aufirst%3DL.%2BT.%26aulast%3Dvan%2BAmeijde%26aufirst%3DJ.%26aulast%3DIsmail-Ali%26aufirst%3DA.%2BF.%26aulast%3Dvan%2BUfford%26aufirst%3DH.%2BC.%26aulast%3DVijftigschild%26aufirst%3DL.%2BA.%26aulast%3DBeekman%26aufirst%3DJ.%2BM.%26aulast%3DMartin%26aufirst%3DN.%2BI.%26aulast%3DRuijtenbeek%26aufirst%3DR.%26aulast%3DLiskamp%26aufirst%3DR.%2BM.%26atitle%3DCell-penetrating%2520bisubstrate-based%2520protein%2520kinase%2520C%2520inhibitors%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2013%26volume%3D8%26spage%3D1479%26epage%3D1487" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Poot, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Ameijde, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slijper, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van den Berg, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hilhorst, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruijtenbeek, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rijkers, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liskamp, R. M.</span><span> </span><span class="NLM_article-title">Development of selective bisubstrate-based inhibitors against protein kinase C (PKC) isozymes by using dynamic peptide microarrays</span> <span class="citation_source-journal">ChemBioChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">2042</span><span class="NLM_x">–</span> <span class="NLM_lpage">2051</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2009&pages=2042-2051&author=A.+J.+Pootauthor=J.+van+Ameijdeauthor=M.+Slijperauthor=A.+van+den+Bergauthor=R.+Hilhorstauthor=R.+Ruijtenbeekauthor=D.+T.+Rijkersauthor=R.+M.+Liskamp&title=Development+of+selective+bisubstrate-based+inhibitors+against+protein+kinase+C+%28PKC%29+isozymes+by+using+dynamic+peptide+microarrays"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPoot%26aufirst%3DA.%2BJ.%26aulast%3Dvan%2BAmeijde%26aufirst%3DJ.%26aulast%3DSlijper%26aufirst%3DM.%26aulast%3Dvan%2Bden%2BBerg%26aufirst%3DA.%26aulast%3DHilhorst%26aufirst%3DR.%26aulast%3DRuijtenbeek%26aufirst%3DR.%26aulast%3DRijkers%26aufirst%3DD.%2BT.%26aulast%3DLiskamp%26aufirst%3DR.%2BM.%26atitle%3DDevelopment%2520of%2520selective%2520bisubstrate-based%2520inhibitors%2520against%2520protein%2520kinase%2520C%2520%2528PKC%2529%2520isozymes%2520by%2520using%2520dynamic%2520peptide%2520microarrays%26jtitle%3DChemBioChem%26date%3D2009%26volume%3D10%26spage%3D2042%26epage%3D2051" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">van Wandelen, L. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Ameijde, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mady, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wammes, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bode, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poot, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruijtenbeek, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liskamp, R. M.</span><span> </span><span class="NLM_article-title">Directed modulation of protein kinase C isozyme selectivity with bisubstrate-based inhibitors</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">2113</span><span class="NLM_x">–</span> <span class="NLM_lpage">2121</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=2113-2121&author=L.+T.+van+Wandelenauthor=J.+van+Ameijdeauthor=A.+S.+Madyauthor=A.+E.+Wammesauthor=A.+Bodeauthor=A.+J.+Pootauthor=R.+Ruijtenbeekauthor=R.+M.+Liskamp&title=Directed+modulation+of+protein+kinase+C+isozyme+selectivity+with+bisubstrate-based+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2BWandelen%26aufirst%3DL.%2BT.%26aulast%3Dvan%2BAmeijde%26aufirst%3DJ.%26aulast%3DMady%26aufirst%3DA.%2BS.%26aulast%3DWammes%26aufirst%3DA.%2BE.%26aulast%3DBode%26aufirst%3DA.%26aulast%3DPoot%26aufirst%3DA.%2BJ.%26aulast%3DRuijtenbeek%26aufirst%3DR.%26aulast%3DLiskamp%26aufirst%3DR.%2BM.%26atitle%3DDirected%2520modulation%2520of%2520protein%2520kinase%2520C%2520isozyme%2520selectivity%2520with%2520bisubstrate-based%2520inhibitors%26jtitle%3DChemMedChem%26date%3D2012%26volume%3D7%26spage%3D2113%26epage%3D2121" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Song, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rai, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Clercq, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span> </span><span class="NLM_article-title">Multivalent agents: a novel concept and preliminary practice in anti-HIV drug discovery</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">815</span><span class="NLM_x">–</span> <span class="NLM_lpage">832</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00229&amp;key=23116144" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00229&amp;key=1%3ACAS%3A528%3ADC%252BC3sXlt1Ggs7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2013&pages=815-832&author=Y.+Songauthor=P.+Zhanauthor=X.+Liauthor=D.+Raiauthor=E.+De+Clercqauthor=X.+Liu&title=Multivalent+agents%3A+a+novel+concept+and+preliminary+practice+in+anti-HIV+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Multivalent agents: a novel concept and preliminary practice in anti-HIV drug discovery</span></div><div class="casAuthors">Song, Yu-ning; Zhan, Peng; Li, Xiao; Rai, Diwakar; De Clercq, Erik; Liu, Xinyong</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">815-832</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The term multivalency (polyvalency) in the biol. science is defined as the simultaneous binding of multiple ligands to one receptor (or multiple receptors to one ligand).  The possibility of gaining potency and selectivity was significantly increased through the use of multivalent ligand as a homo- or hetero-dimer, thus multivalent ligands provided a more attractive strategy to design novel anti-HIV agents with therapeutic applications.  Moreover, similar to phenomenon of multivalency, an alternative strategy is called the "mixed sites inhibitor", viz. a single mol. that possesses enough chem. space to maximize interactions with its complementary binding pocket, or to bind simultaneously in more than one regions in a target.  Actually, the addn. of a third heterocyclic nucleus to the parent compd. resulted in "mixed sites" anti-HIV agents with broad spectrum of activities against the mutant HIV-1 strains.  Based on current representative examples, the present article provided a brief review on the rationale for the design of different classes of multivalency anti-HIV agents and also discussed the advantages over their monomeric counterparts, providing a novel paradigm to facilitate the development of anti-HIV/AIDS therapeutic agents in treatment of HIV infected community.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfeQQtvZeCCbVg90H21EOLACvtfcHk0ljrEzkZGWCIBw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXlt1Ggs7o%253D&md5=118fe3f5df6cced753c2e27fdcf77112</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSong%26aufirst%3DY.%26aulast%3DZhan%26aufirst%3DP.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DRai%26aufirst%3DD.%26aulast%3DDe%2BClercq%26aufirst%3DE.%26aulast%3DLiu%26aufirst%3DX.%26atitle%3DMultivalent%2520agents%253A%2520a%2520novel%2520concept%2520and%2520preliminary%2520practice%2520in%2520anti-HIV%2520drug%2520discovery%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2013%26volume%3D20%26spage%3D815%26epage%3D832" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Zhu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dai, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Q.</span><span> </span><span class="NLM_article-title">X-ray crystal structure of phosphodiesterase 2 in complex with a highly selective, nanomolar inhibitor reveals a binding-induced pocket important for selectivity</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">135</span><span class="NLM_x">, </span> <span class="NLM_fpage">11708</span><span class="NLM_x">–</span> <span class="NLM_lpage">11711</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja404449g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=135&publication_year=2013&pages=11708-11711&author=J.+Zhuauthor=Q.+Yangauthor=D.+Daiauthor=Q.+Huang&title=X-ray+crystal+structure+of+phosphodiesterase+2+in+complex+with+a+highly+selective%2C+nanomolar+inhibitor+reveals+a+binding-induced+pocket+important+for+selectivity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1021%2Fja404449g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja404449g%26sid%3Dliteratum%253Aachs%26aulast%3DZhu%26aufirst%3DJ.%26aulast%3DYang%26aufirst%3DQ.%26aulast%3DDai%26aufirst%3DD.%26aulast%3DHuang%26aufirst%3DQ.%26atitle%3DX-ray%2520crystal%2520structure%2520of%2520phosphodiesterase%25202%2520in%2520complex%2520with%2520a%2520highly%2520selective%252C%2520nanomolar%2520inhibitor%2520reveals%2520a%2520binding-induced%2520pocket%2520important%2520for%2520selectivity%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2013%26volume%3D135%26spage%3D11708%26epage%3D11711" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">Fabre, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramos, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Pascual-Teresa, B.</span><span> </span><span class="NLM_article-title">Targeting matrix metalloproteinases: exploring the dynamics of the S1′ pocket in the design of selective, small molecule inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">10205</span><span class="NLM_x">–</span> <span class="NLM_lpage">10219</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm500505f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=10205-10219&author=B.+Fabreauthor=A.+Ramosauthor=B.+de+Pascual-Teresa&title=Targeting+matrix+metalloproteinases%3A+exploring+the+dynamics+of+the+S1%E2%80%B2+pocket+in+the+design+of+selective%2C+small+molecule+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1021%2Fjm500505f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm500505f%26sid%3Dliteratum%253Aachs%26aulast%3DFabre%26aufirst%3DB.%26aulast%3DRamos%26aufirst%3DA.%26aulast%3Dde%2BPascual-Teresa%26aufirst%3DB.%26atitle%3DTargeting%2520matrix%2520metalloproteinases%253A%2520exploring%2520the%2520dynamics%2520of%2520the%2520S1%25E2%2580%25B2%2520pocket%2520in%2520the%2520design%2520of%2520selective%252C%2520small%2520molecule%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D10205%26epage%3D10219" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Nara, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sato, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naito, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mototani, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oki, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamoto, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuno, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santou, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kanzaki, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terauchi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uchikawa, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kori, M.</span><span> </span><span class="NLM_article-title">Discovery of novel, highly potent and selective quinazoline-2-carboxamide-based matrix metalloproteinase (MMP)-13 inhibitors without zinc binding group using structure-based design approach</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">8886</span><span class="NLM_x">–</span> <span class="NLM_lpage">8902</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm500981k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=8886-8902&author=H.+Naraauthor=K.+Satoauthor=T.+Naitoauthor=H.+Mototaniauthor=H.+Okiauthor=Y.+Yamamotoauthor=H.+Kunoauthor=T.+Santouauthor=N.+Kanzakiauthor=J.+Terauchiauthor=O.+Uchikawaauthor=M.+Kori&title=Discovery+of+novel%2C+highly+potent+and+selective+quinazoline-2-carboxamide-based+matrix+metalloproteinase+%28MMP%29-13+inhibitors+without+zinc+binding+group+using+structure-based+design+approach"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1021%2Fjm500981k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm500981k%26sid%3Dliteratum%253Aachs%26aulast%3DNara%26aufirst%3DH.%26aulast%3DSato%26aufirst%3DK.%26aulast%3DNaito%26aufirst%3DT.%26aulast%3DMototani%26aufirst%3DH.%26aulast%3DOki%26aufirst%3DH.%26aulast%3DYamamoto%26aufirst%3DY.%26aulast%3DKuno%26aufirst%3DH.%26aulast%3DSantou%26aufirst%3DT.%26aulast%3DKanzaki%26aufirst%3DN.%26aulast%3DTerauchi%26aufirst%3DJ.%26aulast%3DUchikawa%26aufirst%3DO.%26aulast%3DKori%26aufirst%3DM.%26atitle%3DDiscovery%2520of%2520novel%252C%2520highly%2520potent%2520and%2520selective%2520quinazoline-2-carboxamide-based%2520matrix%2520metalloproteinase%2520%2528MMP%2529-13%2520inhibitors%2520without%2520zinc%2520binding%2520group%2520using%2520structure-based%2520design%2520approach%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D8886%26epage%3D8902" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group">Nara, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sato, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naito, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mototani, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oki, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamoto, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuno, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santou, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kanzaki, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terauchi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uchikawa, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kori, M.</span><span> </span><span class="NLM_article-title">Thieno[2,3-<i>d</i>]pyrimidine-2-carboxamides bearing a carboxybenzene group at 5-position: highly potent, selective, and orally available MMP-13 inhibitors interacting with the S1″ binding site</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">5487</span><span class="NLM_x">–</span> <span class="NLM_lpage">5505</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2014&pages=5487-5505&author=H.+Naraauthor=K.+Satoauthor=T.+Naitoauthor=H.+Mototaniauthor=H.+Okiauthor=Y.+Yamamotoauthor=H.+Kunoauthor=T.+Santouauthor=N.+Kanzakiauthor=J.+Terauchiauthor=O.+Uchikawaauthor=M.+Kori&title=Thieno%5B2%2C3-d%5Dpyrimidine-2-carboxamides+bearing+a+carboxybenzene+group+at+5-position%3A+highly+potent%2C+selective%2C+and+orally+available+MMP-13+inhibitors+interacting+with+the+S1%E2%80%B3+binding+site"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNara%26aufirst%3DH.%26aulast%3DSato%26aufirst%3DK.%26aulast%3DNaito%26aufirst%3DT.%26aulast%3DMototani%26aufirst%3DH.%26aulast%3DOki%26aufirst%3DH.%26aulast%3DYamamoto%26aufirst%3DY.%26aulast%3DKuno%26aufirst%3DH.%26aulast%3DSantou%26aufirst%3DT.%26aulast%3DKanzaki%26aufirst%3DN.%26aulast%3DTerauchi%26aufirst%3DJ.%26aulast%3DUchikawa%26aufirst%3DO.%26aulast%3DKori%26aufirst%3DM.%26atitle%3DThieno%255B2%252C3-d%255Dpyrimidine-2-carboxamides%2520bearing%2520a%2520carboxybenzene%2520group%2520at%25205-position%253A%2520highly%2520potent%252C%2520selective%252C%2520and%2520orally%2520available%2520MMP-13%2520inhibitors%2520interacting%2520with%2520the%2520S1%25E2%2580%25B3%2520binding%2520site%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2014%26volume%3D22%26spage%3D5487%26epage%3D5505" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group">Schonbrunn, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Betzi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alam, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Becker, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Francis, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chakrasali, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jakkaraj, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kazi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sebti, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cubitt, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gebhard, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hazlehurst, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tash, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Georg, G. I.</span><span> </span><span class="NLM_article-title">Development of highly potent and selective diaminothiazole inhibitors of cyclin-dependent kinases</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">3768</span><span class="NLM_x">–</span> <span class="NLM_lpage">3782</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm301234k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00229&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmtF2jtb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=3768-3782&author=E.+Schonbrunnauthor=S.+Betziauthor=R.+Alamauthor=M.+P.+Martinauthor=A.+Beckerauthor=H.+Hanauthor=R.+Francisauthor=R.+Chakrasaliauthor=S.+Jakkarajauthor=A.+Kaziauthor=S.+M.+Sebtiauthor=C.+L.+Cubittauthor=A.+W.+Gebhardauthor=L.+A.+Hazlehurstauthor=J.+S.+Tashauthor=G.+I.+Georg&title=Development+of+highly+potent+and+selective+diaminothiazole+inhibitors+of+cyclin-dependent+kinases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Development of Highly Potent and Selective Diaminothiazole Inhibitors of Cyclin-Dependent Kinases</span></div><div class="casAuthors">Schonbrunn, Ernst; Betzi, Stephane; Alam, Riazul; Martin, Mathew P.; Becker, Andreas; Han, Huijong; Francis, Rawle; Chakrasali, Ramappa; Jakkaraj, Sudhakar; Kazi, Aslamuzzaman; Sebti, Said M.; Cubitt, Christopher L.; Gebhard, Anthony W.; Hazlehurst, Lori A.; Tash, Joseph S.; Georg, Gunda I.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">3768-3782</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Diaminothiazoles such as I were prepd. as inhibitors of cyclin-dependent kinase 2 (CDK2) for potential use as antitumor agents and as male contraceptive agents based on the optimization of a hit compd. with weak inhibitory activity (IC50 = 15 μM) discovered by high-throughput screening.  Using cocrystal structures of 35 diaminothiazoles with CDK2, the structure-activity relations of diaminothiazoles for CDK2 inhibition were detd. and used to find I.  I was tested for inhibition against a panel of 339 kinases; cyclin-dependent kinases were inhibited selectively, particularly CDK2 and CDK5 over CDK9, CDK1, CDK4, and CDK6.  I inhibited the proliferation of 13 out of 15 cancer cell lines with IC50 values of 0.27-6.9 μM; the antiproliferative activity correlated to complete suppression of retinoblastoma phosphorylation and the onset of apoptosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpeM-VFFhEenrVg90H21EOLACvtfcHk0liaKvJGP8GvFw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmtF2jtb8%253D&md5=067bdf2349f9cd853b83d19131e0770f</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1021%2Fjm301234k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301234k%26sid%3Dliteratum%253Aachs%26aulast%3DSchonbrunn%26aufirst%3DE.%26aulast%3DBetzi%26aufirst%3DS.%26aulast%3DAlam%26aufirst%3DR.%26aulast%3DMartin%26aufirst%3DM.%2BP.%26aulast%3DBecker%26aufirst%3DA.%26aulast%3DHan%26aufirst%3DH.%26aulast%3DFrancis%26aufirst%3DR.%26aulast%3DChakrasali%26aufirst%3DR.%26aulast%3DJakkaraj%26aufirst%3DS.%26aulast%3DKazi%26aufirst%3DA.%26aulast%3DSebti%26aufirst%3DS.%2BM.%26aulast%3DCubitt%26aufirst%3DC.%2BL.%26aulast%3DGebhard%26aufirst%3DA.%2BW.%26aulast%3DHazlehurst%26aufirst%3DL.%2BA.%26aulast%3DTash%26aufirst%3DJ.%2BS.%26aulast%3DGeorg%26aufirst%3DG.%2BI.%26atitle%3DDevelopment%2520of%2520highly%2520potent%2520and%2520selective%2520diaminothiazole%2520inhibitors%2520of%2520cyclin-dependent%2520kinases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D3768%26epage%3D3782" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group">Meng, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hou, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shao, Y. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, P. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cai, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, H. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wan, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ke, H.</span><span> </span><span class="NLM_article-title">Structure-based discovery of highly selective phosphodiesterase-9A inhibitors and implications for inhibitor design</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">8549</span><span class="NLM_x">–</span> <span class="NLM_lpage">8558</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm301189c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00229&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtlGktbzJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=8549-8558&author=F.+Mengauthor=J.+Houauthor=Y.+X.+Shaoauthor=P.+Y.+Wuauthor=M.+Huangauthor=X.+Zhuauthor=Y.+Caiauthor=Z.+Liauthor=J.+Xuauthor=P.+Liuauthor=H.+B.+Luoauthor=Y.+Wanauthor=H.+Ke&title=Structure-based+discovery+of+highly+selective+phosphodiesterase-9A+inhibitors+and+implications+for+inhibitor+design"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Based Discovery of Highly Selective Phosphodiesterase-9A Inhibitors and Implications for Inhibitor Design</span></div><div class="casAuthors">Meng, Fei; Hou, Jing; Shao, Yong-Xian; Wu, Pei-Ying; Huang, Manna; Zhu, Xinhai; Cai, Yonghong; Li, Zhe; Xu, Jie; Liu, Peiqing; Luo, Hai-Bin; Wan, Yiqian; Ke, Hengming</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">8549-8558</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A new series of phosphodiesterase-9 (PDE9) inhibitors that contain a scaffold of 6-amino-pyrazolopyrimidinone have been discovered by a combination of structure-based design and computational docking.  This procedure significantly saved the load of chem. synthesis and is an effective method for the discovery of inhibitors.  The best compd. 28 (I) has an IC50 of 21 nM and 3.3 μM, resp., for PDE9 and PDE5 and about 3 orders of magnitude of selectivity against other PDE families.  The crystal structure of the PDE9 catalytic domain in complex with 28 has been detd. and shows a hydrogen bond between 28 and Tyr424.  This hydrogen bond may account for the 860-fold selectivity of 28 against PDE1B, in comparison with about 30-fold selectivity of BAY73-6691.  Thus, our studies suggest that Tyr424, a unique residue of PDE8 and PDE9, is a potential target for improvement of selectivity of PDE9 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXPtJ-cQVCabVg90H21EOLACvtfcHk0lhA66OOdHn5Xw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtlGktbzJ&md5=ed8c37d784c80b040c51c9e2b40e2d99</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1021%2Fjm301189c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301189c%26sid%3Dliteratum%253Aachs%26aulast%3DMeng%26aufirst%3DF.%26aulast%3DHou%26aufirst%3DJ.%26aulast%3DShao%26aufirst%3DY.%2BX.%26aulast%3DWu%26aufirst%3DP.%2BY.%26aulast%3DHuang%26aufirst%3DM.%26aulast%3DZhu%26aufirst%3DX.%26aulast%3DCai%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DXu%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DP.%26aulast%3DLuo%26aufirst%3DH.%2BB.%26aulast%3DWan%26aufirst%3DY.%26aulast%3DKe%26aufirst%3DH.%26atitle%3DStructure-based%2520discovery%2520of%2520highly%2520selective%2520phosphodiesterase-9A%2520inhibitors%2520and%2520implications%2520for%2520inhibitor%2520design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D8549%26epage%3D8558" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Folkes, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahmadi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alderton, W. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alix, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baker, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Box, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chuckowree, I. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clarke, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Depledge, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eccles, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friedman, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayes, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hancox, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kugendradas, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lensun, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olivero, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pergl-Wilson, G. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raynaud, F. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saghir, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salphati, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sohal, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ultsch, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valenti, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wallweber, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wan, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiesmann, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Workman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhyvoloup, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zvelebil, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shuttleworth, S. J.</span><span> </span><span class="NLM_article-title">The identification of 2-(1<i>H</i>-indazol-4-yl)-6-(4-methanesulfonyl-piperazin-1-ylmethyl)-4-morpholin-4-yl-thieno[3,2-<i>d</i>]pyrimidine (GDC-0941) as a potent, selective, orally bioavailable inhibitor of class I PI3 kinase for the treatment of cancer</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">5522</span><span class="NLM_x">–</span> <span class="NLM_lpage">5532</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm800295d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref49/cit49a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00229&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtVCmsr7E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=5522-5532&author=A.+J.+Folkesauthor=K.+Ahmadiauthor=W.+K.+Aldertonauthor=S.+Alixauthor=S.+J.+Bakerauthor=G.+Boxauthor=I.+S.+Chuckowreeauthor=P.+A.+Clarkeauthor=P.+Depledgeauthor=S.+A.+Ecclesauthor=L.+S.+Friedmanauthor=A.+Hayesauthor=T.+C.+Hancoxauthor=A.+Kugendradasauthor=L.+Lensunauthor=P.+Mooreauthor=A.+G.+Oliveroauthor=J.+Pangauthor=S.+Patelauthor=G.+H.+Pergl-Wilsonauthor=F.+I.+Raynaudauthor=A.+Robsonauthor=N.+Saghirauthor=L.+Salphatiauthor=S.+Sohalauthor=M.+H.+Ultschauthor=M.+Valentiauthor=H.+J.+Wallweberauthor=N.+C.+Wanauthor=C.+Wiesmannauthor=P.+Workmanauthor=A.+Zhyvoloupauthor=M.+J.+Zvelebilauthor=S.+J.+Shuttleworth&title=The+identification+of+2-%281H-indazol-4-yl%29-6-%284-methanesulfonyl-piperazin-1-ylmethyl%29-4-morpholin-4-yl-thieno%5B3%2C2-d%5Dpyrimidine+%28GDC-0941%29+as+a+potent%2C+selective%2C+orally+bioavailable+inhibitor+of+class+I+PI3+kinase+for+the+treatment+of+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49aR"><div class="casContent"><span class="casTitleNuber">49a</span><div class="casTitle"><span class="NLM_cas:atitle">The identification of 2-(1H-indazol-4-yl)-6-(4-methanesulfonyl-piperazin-1-ylmethyl)-4-morpholin-4-yl-thieno[3,2-d]pyrimidine (GDC-0941) as a potent, selective, orally bioavailable inhibitor of class I PI3 kinase for the treatment of cancer</span></div><div class="casAuthors">Folkes, Adrian J.; Ahmadi, Khatereh; Alderton, Wendy K.; Alix, Sonia; Baker, Stewart J.; Box, Gary; Chuckowree, Irina S.; Clarke, Paul A.; Depledge, Paul; Eccles, Suzanne A.; Friedman, Lori S.; Hayes, Angela; Hancox, Timothy C.; Kugendradas, Arumugam; Lensun, Letitia; Moore, Pauline; Olivero, Alan G.; Pang, Jodie; Patel, Sonal; Pergl-Wilson, Giles H.; Raynaud, Florence I.; Robson, Anthony; Saghir, Nahid; Salphati, Laurent; Sohal, Sukhjit; Ultsch, Mark H.; Valenti, Melanie; Wallweber, Heidi J. A.; Wan, Nan Chi; Wiesmann, Christian; Workman, Paul; Zhyvoloup, Alexander; Zvelebil, Marketa J.; Shuttleworth, Stephen J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">5522-5532</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Phosphatidylinositol-3-kinase (PI3K) is an important target in cancer due to the deregulation of the PI3K/Akt signaling pathway in a wide variety of tumors.  A series of thieno[3,2-d]pyrimidine derivs. were prepd. and evaluated as inhibitors of PI3 kinase p110α.  The synthesis, biol. activity, and further profiling of these compds. are described.  This work resulted in the discovery of GDC-0941 (I) which is a potent, selective, orally bioavailable inhibitor of PI3K and is currently being evaluated in human clin. trials for the treatment of cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojkFv29FXqO7Vg90H21EOLACvtfcHk0lhA66OOdHn5Xw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtVCmsr7E&md5=742084954685353ceaf18660ab3a0703</span></div><a href="/servlet/linkout?suffix=cit49a&amp;dbid=16384&amp;doi=10.1021%2Fjm800295d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800295d%26sid%3Dliteratum%253Aachs%26aulast%3DFolkes%26aufirst%3DA.%2BJ.%26aulast%3DAhmadi%26aufirst%3DK.%26aulast%3DAlderton%26aufirst%3DW.%2BK.%26aulast%3DAlix%26aufirst%3DS.%26aulast%3DBaker%26aufirst%3DS.%2BJ.%26aulast%3DBox%26aufirst%3DG.%26aulast%3DChuckowree%26aufirst%3DI.%2BS.%26aulast%3DClarke%26aufirst%3DP.%2BA.%26aulast%3DDepledge%26aufirst%3DP.%26aulast%3DEccles%26aufirst%3DS.%2BA.%26aulast%3DFriedman%26aufirst%3DL.%2BS.%26aulast%3DHayes%26aufirst%3DA.%26aulast%3DHancox%26aufirst%3DT.%2BC.%26aulast%3DKugendradas%26aufirst%3DA.%26aulast%3DLensun%26aufirst%3DL.%26aulast%3DMoore%26aufirst%3DP.%26aulast%3DOlivero%26aufirst%3DA.%2BG.%26aulast%3DPang%26aufirst%3DJ.%26aulast%3DPatel%26aufirst%3DS.%26aulast%3DPergl-Wilson%26aufirst%3DG.%2BH.%26aulast%3DRaynaud%26aufirst%3DF.%2BI.%26aulast%3DRobson%26aufirst%3DA.%26aulast%3DSaghir%26aufirst%3DN.%26aulast%3DSalphati%26aufirst%3DL.%26aulast%3DSohal%26aufirst%3DS.%26aulast%3DUltsch%26aufirst%3DM.%2BH.%26aulast%3DValenti%26aufirst%3DM.%26aulast%3DWallweber%26aufirst%3DH.%2BJ.%26aulast%3DWan%26aufirst%3DN.%2BC.%26aulast%3DWiesmann%26aufirst%3DC.%26aulast%3DWorkman%26aufirst%3DP.%26aulast%3DZhyvoloup%26aufirst%3DA.%26aulast%3DZvelebil%26aufirst%3DM.%2BJ.%26aulast%3DShuttleworth%26aufirst%3DS.%2BJ.%26atitle%3DThe%2520identification%2520of%25202-%25281H-indazol-4-yl%2529-6-%25284-methanesulfonyl-piperazin-1-ylmethyl%2529-4-morpholin-4-yl-thieno%255B3%252C2-d%255Dpyrimidine%2520%2528GDC-0941%2529%2520as%2520a%2520potent%252C%2520selective%252C%2520orally%2520bioavailable%2520inhibitor%2520of%2520class%2520I%2520PI3%2520kinase%2520for%2520the%2520treatment%2520of%2520cancer%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D5522%26epage%3D5532" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit49b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Nacht, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qiao, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheets, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, T.,  St</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Labenski, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mazdiyasni, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karp, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaturvedi, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhavsar, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niu, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Westlin, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petter, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Medikonda, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, J.</span><span> </span><span class="NLM_article-title">Discovery of a potent and isoform-selective targeted covalent inhibitor of the lipid kinase PI3Kα</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">712</span><span class="NLM_x">–</span> <span class="NLM_lpage">721</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm3008745" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref49/cit49b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00229&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhslWjsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=712-721&author=M.+Nachtauthor=L.+Qiaoauthor=M.+P.+Sheetsauthor=T.+Martinauthor=M.+Labenskiauthor=H.+Mazdiyasniauthor=R.+Karpauthor=Z.+Zhuauthor=P.+Chaturvediauthor=D.+Bhavsarauthor=D.+Niuauthor=W.+Westlinauthor=R.+C.+Petterauthor=A.+P.+Medikondaauthor=J.+Singh&title=Discovery+of+a+potent+and+isoform-selective+targeted+covalent+inhibitor+of+the+lipid+kinase+PI3K%CE%B1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49bR"><div class="casContent"><span class="casTitleNuber">49b</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a Potent and Isoform-Selective Targeted Covalent Inhibitor of the Lipid Kinase PI3Kα</span></div><div class="casAuthors">Nacht, Mariana; Qiao, Lixin; Sheets, Michael P.; St. Martin, Thia; Labenski, Matthew; Mazdiyasni, Hormoz; Karp, Russell; Zhu, Zhendong; Chaturvedi, Prasoon; Bhavsar, Deepa; Niu, Deqiang; Westlin, William; Petter, Russell C.; Medikonda, Aravind Prasad; Singh, Juswinder</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">712-721</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">PI3Kα has been identified as an oncogene in human tumors.  By use of rational drug design, a targeted covalent inhibitor 3 (CNX-1351) was created that potently and specifically inhibits PI3Kα.  We demonstrate, using mass spectrometry and X-ray crystallog., that the selective inhibitor covalently modifies PI3Kα on cysteine 862 (C862), an amino acid unique to the α isoform, and that PI3Kβ, -γ, and -δ are not covalently modified. 3 is able to potently (EC50 < 100 nM) and specifically inhibit signaling in PI3Kα-dependent cancer cell lines, and this leads to a potent antiproliferative effect (GI50 < 100 nM).  A covalent probe, 8 (CNX-1220), which selectively bonds to PI3Kα, was used to investigate the duration of occupancy of 3 with PI3Kα in vivo.  This is the first report of a PI3Kα-selective inhibitor, and these data demonstrate the biol. impact of selectively targeting PI3Kα.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpGrGxtOJ4wQbVg90H21EOLACvtfcHk0lhA66OOdHn5Xw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhslWjsr4%253D&md5=42bf6d9221fdb9eafe010064807d22b9</span></div><a href="/servlet/linkout?suffix=cit49b&amp;dbid=16384&amp;doi=10.1021%2Fjm3008745&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm3008745%26sid%3Dliteratum%253Aachs%26aulast%3DNacht%26aufirst%3DM.%26aulast%3DQiao%26aufirst%3DL.%26aulast%3DSheets%26aufirst%3DM.%2BP.%26aulast%3DMartin%26aufirst%3DT.%26aulast%3DLabenski%26aufirst%3DM.%26aulast%3DMazdiyasni%26aufirst%3DH.%26aulast%3DKarp%26aufirst%3DR.%26aulast%3DZhu%26aufirst%3DZ.%26aulast%3DChaturvedi%26aufirst%3DP.%26aulast%3DBhavsar%26aufirst%3DD.%26aulast%3DNiu%26aufirst%3DD.%26aulast%3DWestlin%26aufirst%3DW.%26aulast%3DPetter%26aufirst%3DR.%2BC.%26aulast%3DMedikonda%26aufirst%3DA.%2BP.%26aulast%3DSingh%26aufirst%3DJ.%26atitle%3DDiscovery%2520of%2520a%2520potent%2520and%2520isoform-selective%2520targeted%2520covalent%2520inhibitor%2520of%2520the%2520lipid%2520kinase%2520PI3K%25CE%25B1%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D712%26epage%3D721" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group">Schröder, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klinger, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oellien, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marhöfer, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duszenko, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selzer, P. M.</span><span> </span><span class="NLM_article-title">Docking-based virtual screening of covalently binding ligands: an orthogonal lead discovery approach</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">1478</span><span class="NLM_x">–</span> <span class="NLM_lpage">1490</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm3013932" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=1478-1490&author=J.+Schr%C3%B6derauthor=A.+Klingerauthor=F.+Oellienauthor=R.+J.+Marh%C3%B6ferauthor=M.+Duszenkoauthor=P.+M.+Selzer&title=Docking-based+virtual+screening+of+covalently+binding+ligands%3A+an+orthogonal+lead+discovery+approach"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1021%2Fjm3013932&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm3013932%26sid%3Dliteratum%253Aachs%26aulast%3DSchr%25C3%25B6der%26aufirst%3DJ.%26aulast%3DKlinger%26aufirst%3DA.%26aulast%3DOellien%26aufirst%3DF.%26aulast%3DMarh%25C3%25B6fer%26aufirst%3DR.%2BJ.%26aulast%3DDuszenko%26aufirst%3DM.%26aulast%3DSelzer%26aufirst%3DP.%2BM.%26atitle%3DDocking-based%2520virtual%2520screening%2520of%2520covalently%2520binding%2520ligands%253A%2520an%2520orthogonal%2520lead%2520discovery%2520approach%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D1478%26epage%3D1490" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group">Pinson, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chalmers, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jennings, I. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, P. E.</span><span> </span><span class="NLM_article-title"><span class="smallcaps smallerCapital">l</span>-Aminoacyl-triazine derivatives are isoform-selective PI3Kβ inhibitors that target non-conserved Asp862 of PI3Kβ</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">206</span><span class="NLM_x">–</span> <span class="NLM_lpage">210</span></span><div class="citationLinks">[<a href="/doi/10.1021/ml300336j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=206-210&author=J.+A.+Pinsonauthor=Z.+Zhengauthor=M.+S.+Millerauthor=D.+K.+Chalmersauthor=I.+G.+Jenningsauthor=P.+E.+Thompson&title=l-Aminoacyl-triazine+derivatives+are+isoform-selective+PI3K%CE%B2+inhibitors+that+target+non-conserved+Asp862+of+PI3K%CE%B2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1021%2Fml300336j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml300336j%26sid%3Dliteratum%253Aachs%26aulast%3DPinson%26aufirst%3DJ.%2BA.%26aulast%3DZheng%26aufirst%3DZ.%26aulast%3DMiller%26aufirst%3DM.%2BS.%26aulast%3DChalmers%26aufirst%3DD.%2BK.%26aulast%3DJennings%26aufirst%3DI.%2BG.%26aulast%3DThompson%26aufirst%3DP.%2BE.%26atitle%3Dl-Aminoacyl-triazine%2520derivatives%2520are%2520isoform-selective%2520PI3K%25CE%25B2%2520inhibitors%2520that%2520target%2520non-conserved%2520Asp862%2520of%2520PI3K%25CE%25B2%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D4%26spage%3D206%26epage%3D210" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group">Leahy, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buhr, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, H. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, B. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baik, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cannoy, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forsyth, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeong, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noson, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nuss, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brooks, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foster, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goon, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heald, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holst, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jaeger, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lam, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lougheed, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plonowski, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stout, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yakes, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamb, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raeber, O.</span><span> </span><span class="NLM_article-title">Discovery of a novel series of potent and orally bioavailable phosphoinositide 3-kinase γ inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">5467</span><span class="NLM_x">–</span> <span class="NLM_lpage">5482</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm300403a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=5467-5482&author=J.+W.+Leahyauthor=C.+A.+Buhrauthor=H.+W.+Johnsonauthor=B.+G.+Kimauthor=T.+Baikauthor=J.+Cannoyauthor=T.+P.+Forsythauthor=J.+W.+Jeongauthor=M.+S.+Leeauthor=S.+Maauthor=K.+Nosonauthor=L.+Wangauthor=M.+Williamsauthor=J.+M.+Nussauthor=E.+Brooksauthor=P.+Fosterauthor=L.+Goonauthor=N.+Healdauthor=C.+Holstauthor=C.+Jaegerauthor=S.+Lamauthor=J.+Lougheedauthor=L.+Nguyenauthor=A.+Plonowskiauthor=J.+Songauthor=T.+Stoutauthor=X.+Wuauthor=M.+F.+Yakesauthor=P.+Yuauthor=W.+Zhangauthor=P.+Lambauthor=O.+Raeber&title=Discovery+of+a+novel+series+of+potent+and+orally+bioavailable+phosphoinositide+3-kinase+%CE%B3+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1021%2Fjm300403a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300403a%26sid%3Dliteratum%253Aachs%26aulast%3DLeahy%26aufirst%3DJ.%2BW.%26aulast%3DBuhr%26aufirst%3DC.%2BA.%26aulast%3DJohnson%26aufirst%3DH.%2BW.%26aulast%3DKim%26aufirst%3DB.%2BG.%26aulast%3DBaik%26aufirst%3DT.%26aulast%3DCannoy%26aufirst%3DJ.%26aulast%3DForsyth%26aufirst%3DT.%2BP.%26aulast%3DJeong%26aufirst%3DJ.%2BW.%26aulast%3DLee%26aufirst%3DM.%2BS.%26aulast%3DMa%26aufirst%3DS.%26aulast%3DNoson%26aufirst%3DK.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DWilliams%26aufirst%3DM.%26aulast%3DNuss%26aufirst%3DJ.%2BM.%26aulast%3DBrooks%26aufirst%3DE.%26aulast%3DFoster%26aufirst%3DP.%26aulast%3DGoon%26aufirst%3DL.%26aulast%3DHeald%26aufirst%3DN.%26aulast%3DHolst%26aufirst%3DC.%26aulast%3DJaeger%26aufirst%3DC.%26aulast%3DLam%26aufirst%3DS.%26aulast%3DLougheed%26aufirst%3DJ.%26aulast%3DNguyen%26aufirst%3DL.%26aulast%3DPlonowski%26aufirst%3DA.%26aulast%3DSong%26aufirst%3DJ.%26aulast%3DStout%26aufirst%3DT.%26aulast%3DWu%26aufirst%3DX.%26aulast%3DYakes%26aufirst%3DM.%2BF.%26aulast%3DYu%26aufirst%3DP.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DLamb%26aufirst%3DP.%26aulast%3DRaeber%26aufirst%3DO.%26atitle%3DDiscovery%2520of%2520a%2520novel%2520series%2520of%2520potent%2520and%2520orally%2520bioavailable%2520phosphoinositide%25203-kinase%2520%25CE%25B3%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D5467%26epage%3D5482" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group">Bago, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malik, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munson, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prescott, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sommer, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shpiro, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cross, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ganley, I. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alessi, D. R.</span><span> </span><span class="NLM_article-title">Characterization of VPS34-IN1, a selective inhibitor of Vps34, reveals that the phosphatidylinositol 3-phosphate-binding SGK3 protein kinase is a downstream target of class III phosphoinositide 3-kinase</span> <span class="citation_source-journal">Biochem. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">463</span><span class="NLM_x">, </span> <span class="NLM_fpage">413</span><span class="NLM_x">–</span> <span class="NLM_lpage">427</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=463&publication_year=2014&pages=413-427&author=R.+Bagoauthor=N.+Malikauthor=M.+J.+Munsonauthor=A.+R.+Prescottauthor=P.+Daviesauthor=E.+Sommerauthor=N.+Shpiroauthor=R.+Wardauthor=D.+Crossauthor=I.+G.+Ganleyauthor=D.+R.+Alessi&title=Characterization+of+VPS34-IN1%2C+a+selective+inhibitor+of+Vps34%2C+reveals+that+the+phosphatidylinositol+3-phosphate-binding+SGK3+protein+kinase+is+a+downstream+target+of+class+III+phosphoinositide+3-kinase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBago%26aufirst%3DR.%26aulast%3DMalik%26aufirst%3DN.%26aulast%3DMunson%26aufirst%3DM.%2BJ.%26aulast%3DPrescott%26aufirst%3DA.%2BR.%26aulast%3DDavies%26aufirst%3DP.%26aulast%3DSommer%26aufirst%3DE.%26aulast%3DShpiro%26aufirst%3DN.%26aulast%3DWard%26aufirst%3DR.%26aulast%3DCross%26aufirst%3DD.%26aulast%3DGanley%26aufirst%3DI.%2BG.%26aulast%3DAlessi%26aufirst%3DD.%2BR.%26atitle%3DCharacterization%2520of%2520VPS34-IN1%252C%2520a%2520selective%2520inhibitor%2520of%2520Vps34%252C%2520reveals%2520that%2520the%2520phosphatidylinositol%25203-phosphate-binding%2520SGK3%2520protein%2520kinase%2520is%2520a%2520downstream%2520target%2520of%2520class%2520III%2520phosphoinositide%25203-kinase%26jtitle%3DBiochem.%2520J.%26date%3D2014%26volume%3D463%26spage%3D413%26epage%3D427" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group">Ronan, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flamand, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vescovi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dureuil, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Durand, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fassy, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bachelot, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamberton, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathieu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertrand, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marquette, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">El-Ahmad, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Filoche-Romme, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schio, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia-Echeverria, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goulaouic, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pasquier, B.</span><span> </span><span class="NLM_article-title">A highly potent and selective Vps34 inhibitor alters vesicle trafficking and autophagy</span> <span class="citation_source-journal">Nature Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">1013</span><span class="NLM_x">–</span> <span class="NLM_lpage">1019</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00229&amp;key=10.1038%2Fnchembio.1681" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00229&amp;key=25326666" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00229&amp;key=1%3ACAS%3A280%3ADC%252BC2M3hs1entQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2014&pages=1013-1019&author=B.+Ronanauthor=O.+Flamandauthor=L.+Vescoviauthor=C.+Dureuilauthor=L.+Durandauthor=F.+Fassyauthor=M.+F.+Bachelotauthor=A.+Lambertonauthor=M.+Mathieuauthor=T.+Bertrandauthor=J.+P.+Marquetteauthor=Y.+El-Ahmadauthor=B.+Filoche-Rommeauthor=L.+Schioauthor=C.+Garcia-Echeverriaauthor=H.+Goulaouicauthor=B.+Pasquier&title=A+highly+potent+and+selective+Vps34+inhibitor+alters+vesicle+trafficking+and+autophagy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">A highly potent and selective Vps34 inhibitor alters vesicle trafficking and autophagy</span></div><div class="casAuthors">Ronan Baptiste; Flamand Odile; Vescovi Lionel; Dureuil Christine; Durand Laurence; Fassy Florence; Bachelot Marie-France; Lamberton Annabelle; El-Ahmad Youssef; Filoche-Romme Bruno; Schio Laurent; Garcia-Echeverria Carlos; Goulaouic Helene; Pasquier Benoit; Mathieu Magali; Bertrand Thomas; Marquette Jean-Pierre</div><div class="citationInfo"><span class="NLM_cas:title">Nature chemical biology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1013-9</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Vps34 is a phosphoinositide 3-kinase (PI3K) class III isoform that has attracted major attention over the recent years because of its role in autophagy.  Herein we describe the biological characterization of SAR405, which is a low-molecular-mass kinase inhibitor of Vps34 (KD 1.5 nM).  This compound has an exquisite protein and lipid kinase selectivity profile that is explained by its unique binding mode and molecular interactions within the ATP binding cleft of human Vps34.  To the best of our knowledge, this is the first potent and specific Vps34 inhibitor described so far.  Our results demonstrate that inhibition of Vps34 kinase activity by SAR405 affects both late endosome-lysosome compartments and prevents autophagy.  Moreover, we show that the concomitant inhibition of Vps34 and mTOR, with SAR405 and the US Food and Drug Administration-approved mTOR inhibitor everolimus, results in synergistic antiproliferative activity in renal tumor cell lines, indicating a potential clinical application in cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT3zbvEvL2MUGxpATR2EQURfW6udTcc2eaPEsH8pvRIsLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2M3hs1entQ%253D%253D&md5=78caac15b0577c3d834dbd7951ded33b</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.1681&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.1681%26sid%3Dliteratum%253Aachs%26aulast%3DRonan%26aufirst%3DB.%26aulast%3DFlamand%26aufirst%3DO.%26aulast%3DVescovi%26aufirst%3DL.%26aulast%3DDureuil%26aufirst%3DC.%26aulast%3DDurand%26aufirst%3DL.%26aulast%3DFassy%26aufirst%3DF.%26aulast%3DBachelot%26aufirst%3DM.%2BF.%26aulast%3DLamberton%26aufirst%3DA.%26aulast%3DMathieu%26aufirst%3DM.%26aulast%3DBertrand%26aufirst%3DT.%26aulast%3DMarquette%26aufirst%3DJ.%2BP.%26aulast%3DEl-Ahmad%26aufirst%3DY.%26aulast%3DFiloche-Romme%26aufirst%3DB.%26aulast%3DSchio%26aufirst%3DL.%26aulast%3DGarcia-Echeverria%26aufirst%3DC.%26aulast%3DGoulaouic%26aufirst%3DH.%26aulast%3DPasquier%26aufirst%3DB.%26atitle%3DA%2520highly%2520potent%2520and%2520selective%2520Vps34%2520inhibitor%2520alters%2520vesicle%2520trafficking%2520and%2520autophagy%26jtitle%3DNature%2520Chem.%2520Biol.%26date%3D2014%26volume%3D10%26spage%3D1013%26epage%3D1019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group">Pasquier, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">El-Ahmad, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Filoche-Rommé, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dureuil, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fassy, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abecassis, P. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathieu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertrand, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benard, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrière, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">El Batti, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Letallec, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sonnefraud, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brollo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delbarre, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loyau, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pilorge, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richepin, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arigon, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Labrosse, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clément, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Durand, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Combet, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perraut, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leroy, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gay, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lefrançois, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bretin, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marquette, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michot, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caron, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castell, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schio, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCort, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goulaouic, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia-Echeverria, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ronan, B.</span><span> </span><span class="NLM_article-title">Discovery of (2<i>S</i>)-8-[(3<i>R</i>)-3-methylmorpholin-4-yl]-1-(3-methyl-2-oxobutyl)-2-(trifluoromethyl)-3,4-dihydro-2<i>H</i>-pyrimido[1,2-<i>a</i>]pyrimidin-6-one: a novel potent and selective inhibitor of Vps34 for the treatment of solid tumors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">376</span><span class="NLM_x">–</span> <span class="NLM_lpage">400</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm5013352" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=376-400&author=B.+Pasquierauthor=Y.+El-Ahmadauthor=B.+Filoche-Romm%C3%A9author=C.+Dureuilauthor=F.+Fassyauthor=P.+Y.+Abecassisauthor=M.+Mathieuauthor=T.+Bertrandauthor=T.+Benardauthor=C.+Barri%C3%A8reauthor=S.+El+Battiauthor=J.+P.+Letallecauthor=V.+Sonnefraudauthor=M.+Brolloauthor=L.+Delbarreauthor=V.+Loyauauthor=F.+Pilorgeauthor=L.+Bertinauthor=P.+Richepinauthor=J.+Arigonauthor=J.+R.+Labrosseauthor=J.+Cl%C3%A9mentauthor=F.+Durandauthor=R.+Combetauthor=P.+Perrautauthor=V.+Leroyauthor=F.+Gayauthor=D.+Lefran%C3%A7oisauthor=F.+Bretinauthor=J.+P.+Marquetteauthor=N.+Michotauthor=A.+Caronauthor=C.+Castellauthor=L.+Schioauthor=G.+McCortauthor=H.+Goulaouicauthor=C.+Garcia-Echeverriaauthor=B.+Ronan&title=Discovery+of+%282S%29-8-%5B%283R%29-3-methylmorpholin-4-yl%5D-1-%283-methyl-2-oxobutyl%29-2-%28trifluoromethyl%29-3%2C4-dihydro-2H-pyrimido%5B1%2C2-a%5Dpyrimidin-6-one%3A+a+novel+potent+and+selective+inhibitor+of+Vps34+for+the+treatment+of+solid+tumors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1021%2Fjm5013352&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm5013352%26sid%3Dliteratum%253Aachs%26aulast%3DPasquier%26aufirst%3DB.%26aulast%3DEl-Ahmad%26aufirst%3DY.%26aulast%3DFiloche-Romm%25C3%25A9%26aufirst%3DB.%26aulast%3DDureuil%26aufirst%3DC.%26aulast%3DFassy%26aufirst%3DF.%26aulast%3DAbecassis%26aufirst%3DP.%2BY.%26aulast%3DMathieu%26aufirst%3DM.%26aulast%3DBertrand%26aufirst%3DT.%26aulast%3DBenard%26aufirst%3DT.%26aulast%3DBarri%25C3%25A8re%26aufirst%3DC.%26aulast%3DEl%2BBatti%26aufirst%3DS.%26aulast%3DLetallec%26aufirst%3DJ.%2BP.%26aulast%3DSonnefraud%26aufirst%3DV.%26aulast%3DBrollo%26aufirst%3DM.%26aulast%3DDelbarre%26aufirst%3DL.%26aulast%3DLoyau%26aufirst%3DV.%26aulast%3DPilorge%26aufirst%3DF.%26aulast%3DBertin%26aufirst%3DL.%26aulast%3DRichepin%26aufirst%3DP.%26aulast%3DArigon%26aufirst%3DJ.%26aulast%3DLabrosse%26aufirst%3DJ.%2BR.%26aulast%3DCl%25C3%25A9ment%26aufirst%3DJ.%26aulast%3DDurand%26aufirst%3DF.%26aulast%3DCombet%26aufirst%3DR.%26aulast%3DPerraut%26aufirst%3DP.%26aulast%3DLeroy%26aufirst%3DV.%26aulast%3DGay%26aufirst%3DF.%26aulast%3DLefran%25C3%25A7ois%26aufirst%3DD.%26aulast%3DBretin%26aufirst%3DF.%26aulast%3DMarquette%26aufirst%3DJ.%2BP.%26aulast%3DMichot%26aufirst%3DN.%26aulast%3DCaron%26aufirst%3DA.%26aulast%3DCastell%26aufirst%3DC.%26aulast%3DSchio%26aufirst%3DL.%26aulast%3DMcCort%26aufirst%3DG.%26aulast%3DGoulaouic%26aufirst%3DH.%26aulast%3DGarcia-Echeverria%26aufirst%3DC.%26aulast%3DRonan%26aufirst%3DB.%26atitle%3DDiscovery%2520of%2520%25282S%2529-8-%255B%25283R%2529-3-methylmorpholin-4-yl%255D-1-%25283-methyl-2-oxobutyl%2529-2-%2528trifluoromethyl%2529-3%252C4-dihydro-2H-pyrimido%255B1%252C2-a%255Dpyrimidin-6-one%253A%2520a%2520novel%2520potent%2520and%2520selective%2520inhibitor%2520of%2520Vps34%2520for%2520the%2520treatment%2520of%2520solid%2520tumors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D376%26epage%3D400" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group">Duerfeldt, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peterson, L. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maynard, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ng, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eletto, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ostrovsky, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shinogle, H. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Argon, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicchitta, C. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blagg, B. S.</span><span> </span><span class="NLM_article-title">Development of a Grp94 inhibitor</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">134</span><span class="NLM_x">, </span> <span class="NLM_fpage">9796</span><span class="NLM_x">–</span> <span class="NLM_lpage">9804</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja303477g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00229&amp;key=1%3ACAS%3A528%3ADC%252BC38XnslGqsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=134&publication_year=2012&pages=9796-9804&author=A.+S.+Duerfeldtauthor=L.+B.+Petersonauthor=J.+C.+Maynardauthor=C.+L.+Ngauthor=D.+Elettoauthor=O.+Ostrovskyauthor=H.+E.+Shinogleauthor=D.+S.+Mooreauthor=Y.+Argonauthor=C.+V.+Nicchittaauthor=B.+S.+Blagg&title=Development+of+a+Grp94+inhibitor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Development of a Grp94 inhibitor</span></div><div class="casAuthors">Duerfeldt, Adam S.; Peterson, Laura B.; Maynard, Jason C.; Ng, Chun Leung; Eletto, Davide; Ostrovsky, Olga; Shinogle, Heather E.; Moore, David S.; Argon, Yair; Nicchitta, Christopher V.; Blagg, Brian S. J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">134</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">9796-9804</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Heat shock protein 90 (Hsp90) represents a promising therapeutic target for the treatment of cancer and other diseases.  Unfortunately, results from clin. trials have been disappointing as off-target effects and toxicities have been obsd.  These detriments may be a consequence of pan-Hsp90 inhibition, as all clin. evaluated Hsp90 inhibitors simultaneously disrupt all four human Hsp90 isoforms.  Using a structure-based approach, we designed an inhibitor of Grp94, the ER-resident Hsp90.  The effect manifested by compd. (I) on several Grp94 and Hsp90α/β (cytosolic isoforms) clients were investigated.  Compd. I prevented intracellular trafficking of the Toll receptor, inhibited the secretion of IGF-II, affected the conformation of Grp94, and suppressed Drosophila larval growth, all Grp94-dependent processes.  In contrast, compd. I had no effect on cell viability or cytosolic Hsp90α/β client proteins at similar concns.  The design, synthesis, and evaluation of I are described herein.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoayCAvZU_mzrVg90H21EOLACvtfcHk0lhx2nE7PXKJWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XnslGqsLw%253D&md5=00c0b3f15f2cfd04658225c8a6fb708d</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1021%2Fja303477g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja303477g%26sid%3Dliteratum%253Aachs%26aulast%3DDuerfeldt%26aufirst%3DA.%2BS.%26aulast%3DPeterson%26aufirst%3DL.%2BB.%26aulast%3DMaynard%26aufirst%3DJ.%2BC.%26aulast%3DNg%26aufirst%3DC.%2BL.%26aulast%3DEletto%26aufirst%3DD.%26aulast%3DOstrovsky%26aufirst%3DO.%26aulast%3DShinogle%26aufirst%3DH.%2BE.%26aulast%3DMoore%26aufirst%3DD.%2BS.%26aulast%3DArgon%26aufirst%3DY.%26aulast%3DNicchitta%26aufirst%3DC.%2BV.%26aulast%3DBlagg%26aufirst%3DB.%2BS.%26atitle%3DDevelopment%2520of%2520a%2520Grp94%2520inhibitor%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2012%26volume%3D134%26spage%3D9796%26epage%3D9804" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group">Lucas, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldstein, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hermann, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuglstatter, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luk, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Padilla, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slade, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villaseñor, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wanner, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liao, C.</span><span> </span><span class="NLM_article-title">Rational design of highly selective spleen tyrosine kinase inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">10414</span><span class="NLM_x">–</span> <span class="NLM_lpage">10423</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm301367c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=10414-10423&author=M.+C.+Lucasauthor=D.+M.+Goldsteinauthor=J.+C.+Hermannauthor=A.+Kuglstatterauthor=W.+Liuauthor=K.+C.+Lukauthor=F.+Padillaauthor=M.+Sladeauthor=A.+G.+Villase%C3%B1orauthor=J.+Wannerauthor=W.+Xieauthor=X.+Zhangauthor=C.+Liao&title=Rational+design+of+highly+selective+spleen+tyrosine+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1021%2Fjm301367c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301367c%26sid%3Dliteratum%253Aachs%26aulast%3DLucas%26aufirst%3DM.%2BC.%26aulast%3DGoldstein%26aufirst%3DD.%2BM.%26aulast%3DHermann%26aufirst%3DJ.%2BC.%26aulast%3DKuglstatter%26aufirst%3DA.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DLuk%26aufirst%3DK.%2BC.%26aulast%3DPadilla%26aufirst%3DF.%26aulast%3DSlade%26aufirst%3DM.%26aulast%3DVillase%25C3%25B1or%26aufirst%3DA.%2BG.%26aulast%3DWanner%26aufirst%3DJ.%26aulast%3DXie%26aufirst%3DW.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DLiao%26aufirst%3DC.%26atitle%3DRational%2520design%2520of%2520highly%2520selective%2520spleen%2520tyrosine%2520kinase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D10414%26epage%3D10423" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group">Liang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Abbema, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balazs, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrett, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berezhkovsky, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blair, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delarosa, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeVoss, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Driscoll, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eigenbrot, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghilardi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibbons, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halladay, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohli, P. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyssikatos, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mantik, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menghrajani, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sambrone, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shia, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shin, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sohn, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsui, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ultsch, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, B. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magnuson, S.</span><span> </span><span class="NLM_article-title">Lead optimization of a 4-aminopyridine benzamide scaffold to identify potent, selective, and orally bioavailable TYK2 inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">4521</span><span class="NLM_x">–</span> <span class="NLM_lpage">4536</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm400266t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=4521-4536&author=J.+Liangauthor=A.+van+Abbemaauthor=M.+Balazsauthor=K.+Barrettauthor=L.+Berezhkovskyauthor=W.+Blairauthor=C.+Changauthor=D.+Delarosaauthor=J.+DeVossauthor=J.+Driscollauthor=C.+Eigenbrotauthor=N.+Ghilardiauthor=P.+Gibbonsauthor=J.+Halladayauthor=A.+Johnsonauthor=P.+B.+Kohliauthor=Y.+Laiauthor=Y.+Liuauthor=J.+Lyssikatosauthor=P.+Mantikauthor=K.+Menghrajaniauthor=J.+Murrayauthor=I.+Pengauthor=A.+Sambroneauthor=S.+Shiaauthor=Y.+Shinauthor=J.+Smithauthor=S.+Sohnauthor=V.+Tsuiauthor=M.+Ultschauthor=L.+C.+Wuauthor=Y.+Xiaoauthor=W.+Yangauthor=J.+Youngauthor=B.+Zhangauthor=B.+Y.+Zhuauthor=S.+Magnuson&title=Lead+optimization+of+a+4-aminopyridine+benzamide+scaffold+to+identify+potent%2C+selective%2C+and+orally+bioavailable+TYK2+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1021%2Fjm400266t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400266t%26sid%3Dliteratum%253Aachs%26aulast%3DLiang%26aufirst%3DJ.%26aulast%3Dvan%2BAbbema%26aufirst%3DA.%26aulast%3DBalazs%26aufirst%3DM.%26aulast%3DBarrett%26aufirst%3DK.%26aulast%3DBerezhkovsky%26aufirst%3DL.%26aulast%3DBlair%26aufirst%3DW.%26aulast%3DChang%26aufirst%3DC.%26aulast%3DDelarosa%26aufirst%3DD.%26aulast%3DDeVoss%26aufirst%3DJ.%26aulast%3DDriscoll%26aufirst%3DJ.%26aulast%3DEigenbrot%26aufirst%3DC.%26aulast%3DGhilardi%26aufirst%3DN.%26aulast%3DGibbons%26aufirst%3DP.%26aulast%3DHalladay%26aufirst%3DJ.%26aulast%3DJohnson%26aufirst%3DA.%26aulast%3DKohli%26aufirst%3DP.%2BB.%26aulast%3DLai%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DLyssikatos%26aufirst%3DJ.%26aulast%3DMantik%26aufirst%3DP.%26aulast%3DMenghrajani%26aufirst%3DK.%26aulast%3DMurray%26aufirst%3DJ.%26aulast%3DPeng%26aufirst%3DI.%26aulast%3DSambrone%26aufirst%3DA.%26aulast%3DShia%26aufirst%3DS.%26aulast%3DShin%26aufirst%3DY.%26aulast%3DSmith%26aufirst%3DJ.%26aulast%3DSohn%26aufirst%3DS.%26aulast%3DTsui%26aufirst%3DV.%26aulast%3DUltsch%26aufirst%3DM.%26aulast%3DWu%26aufirst%3DL.%2BC.%26aulast%3DXiao%26aufirst%3DY.%26aulast%3DYang%26aufirst%3DW.%26aulast%3DYoung%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DB.%26aulast%3DZhu%26aufirst%3DB.%2BY.%26aulast%3DMagnuson%26aufirst%3DS.%26atitle%3DLead%2520optimization%2520of%2520a%25204-aminopyridine%2520benzamide%2520scaffold%2520to%2520identify%2520potent%252C%2520selective%252C%2520and%2520orally%2520bioavailable%2520TYK2%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D4521%26epage%3D4536" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group">Zak, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hurley, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, S. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergeron, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrett, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balazs, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blair, W. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bull, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chakravarty, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crackett, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deshmukh, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeVoss, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dragovich, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eigenbrot, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellwood, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaines, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghilardi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibbons, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gradl, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gribling, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamman, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harstad, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hewitt, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kenny, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koehler, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bir Kohli, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Labadie, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, W. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liimatta, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mendonca, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narukulla, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pulk, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reeve, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Savage, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shia, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steffek, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ubhayakar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Abbema, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aliagas, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Avitabile-Woo, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kulagowski, J. J.</span><span> </span><span class="NLM_article-title">Identification of C-2 hydroxyethyl imidazopyrrolopyridines as potent JAK1 inhibitors with favorable physicochemical properties and high selectivity over JAK2</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">4764</span><span class="NLM_x">–</span> <span class="NLM_lpage">4785</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm4004895" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=4764-4785&author=M.+Zakauthor=C.+A.+Hurleyauthor=S.+I.+Wardauthor=P.+Bergeronauthor=K.+Barrettauthor=M.+Balazsauthor=W.+S.+Blairauthor=R.+Bullauthor=P.+Chakravartyauthor=C.+Changauthor=P.+Crackettauthor=G.+Deshmukhauthor=J.+DeVossauthor=P.+S.+Dragovichauthor=C.+Eigenbrotauthor=C.+Ellwoodauthor=S.+Gainesauthor=N.+Ghilardiauthor=P.+Gibbonsauthor=S.+Gradlauthor=P.+Griblingauthor=C.+Hammanauthor=E.+Harstadauthor=P.+Hewittauthor=A.+Johnsonauthor=T.+Johnsonauthor=J.+R.+Kennyauthor=M.+F.+Koehlerauthor=P.+Bir+Kohliauthor=S.+Labadieauthor=W.+P.+Leeauthor=J.+Liaoauthor=M.+Liimattaauthor=R.+Mendoncaauthor=R.+Narukullaauthor=R.+Pulkauthor=A.+Reeveauthor=S.+Savageauthor=S.+Shiaauthor=M.+Steffekauthor=S.+Ubhayakarauthor=A.+van+Abbemaauthor=I.+Aliagasauthor=B.+Avitabile-Wooauthor=Y.+Xiaoauthor=J.+Yangauthor=J.+J.+Kulagowski&title=Identification+of+C-2+hydroxyethyl+imidazopyrrolopyridines+as+potent+JAK1+inhibitors+with+favorable+physicochemical+properties+and+high+selectivity+over+JAK2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1021%2Fjm4004895&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm4004895%26sid%3Dliteratum%253Aachs%26aulast%3DZak%26aufirst%3DM.%26aulast%3DHurley%26aufirst%3DC.%2BA.%26aulast%3DWard%26aufirst%3DS.%2BI.%26aulast%3DBergeron%26aufirst%3DP.%26aulast%3DBarrett%26aufirst%3DK.%26aulast%3DBalazs%26aufirst%3DM.%26aulast%3DBlair%26aufirst%3DW.%2BS.%26aulast%3DBull%26aufirst%3DR.%26aulast%3DChakravarty%26aufirst%3DP.%26aulast%3DChang%26aufirst%3DC.%26aulast%3DCrackett%26aufirst%3DP.%26aulast%3DDeshmukh%26aufirst%3DG.%26aulast%3DDeVoss%26aufirst%3DJ.%26aulast%3DDragovich%26aufirst%3DP.%2BS.%26aulast%3DEigenbrot%26aufirst%3DC.%26aulast%3DEllwood%26aufirst%3DC.%26aulast%3DGaines%26aufirst%3DS.%26aulast%3DGhilardi%26aufirst%3DN.%26aulast%3DGibbons%26aufirst%3DP.%26aulast%3DGradl%26aufirst%3DS.%26aulast%3DGribling%26aufirst%3DP.%26aulast%3DHamman%26aufirst%3DC.%26aulast%3DHarstad%26aufirst%3DE.%26aulast%3DHewitt%26aufirst%3DP.%26aulast%3DJohnson%26aufirst%3DA.%26aulast%3DJohnson%26aufirst%3DT.%26aulast%3DKenny%26aufirst%3DJ.%2BR.%26aulast%3DKoehler%26aufirst%3DM.%2BF.%26aulast%3DBir%2BKohli%26aufirst%3DP.%26aulast%3DLabadie%26aufirst%3DS.%26aulast%3DLee%26aufirst%3DW.%2BP.%26aulast%3DLiao%26aufirst%3DJ.%26aulast%3DLiimatta%26aufirst%3DM.%26aulast%3DMendonca%26aufirst%3DR.%26aulast%3DNarukulla%26aufirst%3DR.%26aulast%3DPulk%26aufirst%3DR.%26aulast%3DReeve%26aufirst%3DA.%26aulast%3DSavage%26aufirst%3DS.%26aulast%3DShia%26aufirst%3DS.%26aulast%3DSteffek%26aufirst%3DM.%26aulast%3DUbhayakar%26aufirst%3DS.%26aulast%3Dvan%2BAbbema%26aufirst%3DA.%26aulast%3DAliagas%26aufirst%3DI.%26aulast%3DAvitabile-Woo%26aufirst%3DB.%26aulast%3DXiao%26aufirst%3DY.%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DKulagowski%26aufirst%3DJ.%2BJ.%26atitle%3DIdentification%2520of%2520C-2%2520hydroxyethyl%2520imidazopyrrolopyridines%2520as%2520potent%2520JAK1%2520inhibitors%2520with%2520favorable%2520physicochemical%2520properties%2520and%2520high%2520selectivity%2520over%2520JAK2%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D4764%26epage%3D4785" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group">Jaime-Figueroa, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Vicente, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hermann, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jahangir, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuglstatter, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lynch, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menke, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shao, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soth, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vu, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yee, C.</span><span> </span><span class="NLM_article-title">Discovery of a series of novel 5<i>H</i>-pyrrolo[2,3-<i>b</i>]pyrazine-2-phenyl ethers, as potent JAK3 kinase inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem, Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">2522</span><span class="NLM_x">–</span> <span class="NLM_lpage">2526</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=2522-2526&author=S.+Jaime-Figueroaauthor=J.+De+Vicenteauthor=J.+Hermannauthor=A.+Jahangirauthor=S.+Jinauthor=A.+Kuglstatterauthor=S.+M.+Lynchauthor=J.+Menkeauthor=L.+Niuauthor=V.+Patelauthor=A.+Shaoauthor=M.+Sothauthor=M.+D.+Vuauthor=C.+Yee&title=Discovery+of+a+series+of+novel+5H-pyrrolo%5B2%2C3-b%5Dpyrazine-2-phenyl+ethers%2C+as+potent+JAK3+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJaime-Figueroa%26aufirst%3DS.%26aulast%3DDe%2BVicente%26aufirst%3DJ.%26aulast%3DHermann%26aufirst%3DJ.%26aulast%3DJahangir%26aufirst%3DA.%26aulast%3DJin%26aufirst%3DS.%26aulast%3DKuglstatter%26aufirst%3DA.%26aulast%3DLynch%26aufirst%3DS.%2BM.%26aulast%3DMenke%26aufirst%3DJ.%26aulast%3DNiu%26aufirst%3DL.%26aulast%3DPatel%26aufirst%3DV.%26aulast%3DShao%26aufirst%3DA.%26aulast%3DSoth%26aufirst%3DM.%26aulast%3DVu%26aufirst%3DM.%2BD.%26aulast%3DYee%26aufirst%3DC.%26atitle%3DDiscovery%2520of%2520a%2520series%2520of%2520novel%25205H-pyrrolo%255B2%252C3-b%255Dpyrazine-2-phenyl%2520ethers%252C%2520as%2520potent%2520JAK3%2520kinase%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem%252C%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D2522%26epage%3D2526" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group">Butler, K. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brochier, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vistoli, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Langley, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kozikowski, A. P.</span><span> </span><span class="NLM_article-title">Rational design and simple chemistry yield a superior, neuroprotective HDAC6 inhibitor, tubastatin A</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">132</span><span class="NLM_x">, </span> <span class="NLM_fpage">10842</span><span class="NLM_x">–</span> <span class="NLM_lpage">10846</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja102758v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00229&amp;key=1%3ACAS%3A528%3ADC%252BC3cXos1ers7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=132&publication_year=2010&pages=10842-10846&author=K.+V.+Butlerauthor=J.+Kalinauthor=C.+Brochierauthor=G.+Vistoliauthor=B.+Langleyauthor=A.+P.+Kozikowski&title=Rational+design+and+simple+chemistry+yield+a+superior%2C+neuroprotective+HDAC6+inhibitor%2C+tubastatin+A"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Rational Design and Simple Chemistry Yield a Superior, Neuroprotective HDAC6 Inhibitor, Tubastatin A</span></div><div class="casAuthors">Butler, Kyle V.; Kalin, Jay; Brochier, Camille; Vistoli, Guilio; Langley, Brett; Kozikowski, Alan P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">132</span>
        (<span class="NLM_cas:issue">31</span>),
    <span class="NLM_cas:pages">10842-10846</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Structure-based drug design combined with homol. modeling techniques were used to develop potent inhibitors of HDAC6 that display superior selectivity for the HDAC6 isoenzyme compared to other inhibitors.  These inhibitors can be assembled in a few synthetic steps, and thus are readily scaled up for in vivo studies.  An optimized compd. from this series, designated Tubastatin A, was tested in primary cortical neuron cultures in which it was found to induce elevated levels of acetylated α-tubulin, but not histone, consistent with its HDAC6 selectivity.  Tubastatin A also conferred dose-dependent protection in primary cortical neuron cultures against glutathione depletion-induced oxidative stress.  Importantly, when given alone at all concns. tested, this hydroxamate-contg. HDAC6-selective compd. displayed no neuronal toxicity, thus, forecasting the potential application of this agent and its analogs to neurodegenerative conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGruEaJPWQfjH7Vg90H21EOLACvtfcHk0lgHLgQdTVrotQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXos1ers7k%253D&md5=f0cc68bb68f94ad1ef48f88cc6b57129</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1021%2Fja102758v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja102758v%26sid%3Dliteratum%253Aachs%26aulast%3DButler%26aufirst%3DK.%2BV.%26aulast%3DKalin%26aufirst%3DJ.%26aulast%3DBrochier%26aufirst%3DC.%26aulast%3DVistoli%26aufirst%3DG.%26aulast%3DLangley%26aufirst%3DB.%26aulast%3DKozikowski%26aufirst%3DA.%2BP.%26atitle%3DRational%2520design%2520and%2520simple%2520chemistry%2520yield%2520a%2520superior%252C%2520neuroprotective%2520HDAC6%2520inhibitor%252C%2520tubastatin%2520A%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2010%26volume%3D132%26spage%3D10842%26epage%3D10846" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group">Hamada, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mino, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koseki, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oehme, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flamme, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ozasa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Itoh, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogasawara, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Komaarashi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kato, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsumoto, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakagawa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hasegawa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sasaki, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mizukami, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyata, N.</span><span> </span><span class="NLM_article-title">Design, synthesis, enzyme-inhibitory activity, and effect on human cancer cells of a novel series of jumonji domain-containing protein 2 histone demethylase inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">5629</span><span class="NLM_x">–</span> <span class="NLM_lpage">5638</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm1003655" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00229&amp;key=1%3ACAS%3A528%3ADC%252BC3cXovVCis7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=5629-5638&author=S.+Hamadaauthor=T.+Suzukiauthor=K.+Minoauthor=K.+Kosekiauthor=F.+Oehmeauthor=I.+Flammeauthor=H.+Ozasaauthor=Y.+Itohauthor=D.+Ogasawaraauthor=H.+Komaarashiauthor=A.+Katoauthor=H.+Tsumotoauthor=H.+Nakagawaauthor=M.+Hasegawaauthor=R.+Sasakiauthor=T.+Mizukamiauthor=N.+Miyata&title=Design%2C+synthesis%2C+enzyme-inhibitory+activity%2C+and+effect+on+human+cancer+cells+of+a+novel+series+of+jumonji+domain-containing+protein+2+histone+demethylase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Design, Synthesis, Enzyme-Inhibitory Activity, and Effect on Human Cancer Cells of a Novel Series of Jumonji Domain-Containing Protein 2 Histone Demethylase Inhibitors</span></div><div class="casAuthors">Hamada, Shohei; Suzuki, Takayoshi; Mino, Koshiki; Koseki, Koichi; Oehme, Felix; Flamme, Ingo; Ozasa, Hiroki; Itoh, Yukihiro; Ogasawara, Daisuke; Komaarashi, Haruka; Kato, Aiko; Tsumoto, Hiroki; Nakagawa, Hidehiko; Hasegawa, Makoto; Sasaki, Ryuzo; Mizukami, Tamio; Miyata, Naoki</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">5629-5638</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Selective inhibitors of Jumonji domain-contg. protein (JMJD) histone demethylases are candidate anticancer agents as well as potential tools for elucidating the biol. functions of JMJDs.  On the basis of the crystal structure of JMJD2A and a homol. model of JMJD2C, we designed and prepd. a series of hydroxamate analogs bearing a tertiary amine.  Enzyme assays using JMJD2C, JMJD2A, and prolyl hydroxylases revealed that hydroxamate analog 8 is a potent and selective JMJD2 inhibitor, showing 500-fold greater JMJD2C-inhibitory activity and more than 9100-fold greater JMJD2C-selectivity compared with the lead compd. N-oxalylglycine 2.  Compds. 17 and 18, prodrugs of compd. 8, each showed synergistic growth inhibition of cancer cells in combination with an inhibitor of lysine-specific demethylase 1 (LSD1).  These findings suggest that combination treatment with JMJD2 inhibitors and LSD1 inhibitors may represent a novel strategy for anticancer chemotherapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoT6G3YdmcF_bVg90H21EOLACvtfcHk0lgSmXPv-1gXhQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXovVCis7o%253D&md5=f4ab3a75cb995d88668dd8527f554ea0</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1021%2Fjm1003655&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm1003655%26sid%3Dliteratum%253Aachs%26aulast%3DHamada%26aufirst%3DS.%26aulast%3DSuzuki%26aufirst%3DT.%26aulast%3DMino%26aufirst%3DK.%26aulast%3DKoseki%26aufirst%3DK.%26aulast%3DOehme%26aufirst%3DF.%26aulast%3DFlamme%26aufirst%3DI.%26aulast%3DOzasa%26aufirst%3DH.%26aulast%3DItoh%26aufirst%3DY.%26aulast%3DOgasawara%26aufirst%3DD.%26aulast%3DKomaarashi%26aufirst%3DH.%26aulast%3DKato%26aufirst%3DA.%26aulast%3DTsumoto%26aufirst%3DH.%26aulast%3DNakagawa%26aufirst%3DH.%26aulast%3DHasegawa%26aufirst%3DM.%26aulast%3DSasaki%26aufirst%3DR.%26aulast%3DMizukami%26aufirst%3DT.%26aulast%3DMiyata%26aufirst%3DN.%26atitle%3DDesign%252C%2520synthesis%252C%2520enzyme-inhibitory%2520activity%252C%2520and%2520effect%2520on%2520human%2520cancer%2520cells%2520of%2520a%2520novel%2520series%2520of%2520jumonji%2520domain-containing%2520protein%25202%2520histone%2520demethylase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D5629%26epage%3D5638" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group">Suzuki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khan, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawada, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Imai, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Itoh, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamatsuta, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tokuda, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takeuchi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seko, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakagawa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyata, N.</span><span> </span><span class="NLM_article-title">Design, synthesis, and biological activity of a novel series of human sirtuin-2-selective inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">5760</span><span class="NLM_x">–</span> <span class="NLM_lpage">5773</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm3002108" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=5760-5773&author=T.+Suzukiauthor=M.+N.+Khanauthor=H.+Sawadaauthor=E.+Imaiauthor=Y.+Itohauthor=K.+Yamatsutaauthor=N.+Tokudaauthor=J.+Takeuchiauthor=T.+Sekoauthor=H.+Nakagawaauthor=N.+Miyata&title=Design%2C+synthesis%2C+and+biological+activity+of+a+novel+series+of+human+sirtuin-2-selective+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1021%2Fjm3002108&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm3002108%26sid%3Dliteratum%253Aachs%26aulast%3DSuzuki%26aufirst%3DT.%26aulast%3DKhan%26aufirst%3DM.%2BN.%26aulast%3DSawada%26aufirst%3DH.%26aulast%3DImai%26aufirst%3DE.%26aulast%3DItoh%26aufirst%3DY.%26aulast%3DYamatsuta%26aufirst%3DK.%26aulast%3DTokuda%26aufirst%3DN.%26aulast%3DTakeuchi%26aufirst%3DJ.%26aulast%3DSeko%26aufirst%3DT.%26aulast%3DNakagawa%26aufirst%3DH.%26aulast%3DMiyata%26aufirst%3DN.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520biological%2520activity%2520of%2520a%2520novel%2520series%2520of%2520human%2520sirtuin-2-selective%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D5760%26epage%3D5773" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group">Paterni, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertini, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Granchi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tuccinardi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macchia, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinelli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caligiuri, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toffoli, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rizzolio, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carlson, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katzenellenbogen, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katzenellenbogen, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minutolo, F.</span><span> </span><span class="NLM_article-title">Highly selective salicylketoxime-based estrogen receptor β agonists display antiproliferative activities in a glioma model</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">1184</span><span class="NLM_x">–</span> <span class="NLM_lpage">1194</span><span class="refDoi"> DOI: 10.1021/jm501829f</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501829f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=1184-1194&author=I.+Paterniauthor=S.+Bertiniauthor=C.+Granchiauthor=T.+Tuccinardiauthor=M.+Macchiaauthor=A.+Martinelliauthor=I.+Caligiuriauthor=G.+Toffoliauthor=F.+Rizzolioauthor=K.+E.+Carlsonauthor=B.+S.+Katzenellenbogenauthor=J.+A.+Katzenellenbogenauthor=F.+Minutolo&title=Highly+selective+salicylketoxime-based+estrogen+receptor+%CE%B2+agonists+display+antiproliferative+activities+in+a+glioma+model&doi=10.1021%2Fjm501829f"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1021%2Fjm501829f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501829f%26sid%3Dliteratum%253Aachs%26aulast%3DPaterni%26aufirst%3DI.%26aulast%3DBertini%26aufirst%3DS.%26aulast%3DGranchi%26aufirst%3DC.%26aulast%3DTuccinardi%26aufirst%3DT.%26aulast%3DMacchia%26aufirst%3DM.%26aulast%3DMartinelli%26aufirst%3DA.%26aulast%3DCaligiuri%26aufirst%3DI.%26aulast%3DToffoli%26aufirst%3DG.%26aulast%3DRizzolio%26aufirst%3DF.%26aulast%3DCarlson%26aufirst%3DK.%2BE.%26aulast%3DKatzenellenbogen%26aufirst%3DB.%2BS.%26aulast%3DKatzenellenbogen%26aufirst%3DJ.%2BA.%26aulast%3DMinutolo%26aufirst%3DF.%26atitle%3DHighly%2520selective%2520salicylketoxime-based%2520estrogen%2520receptor%2520%25CE%25B2%2520agonists%2520display%2520antiproliferative%2520activities%2520in%2520a%2520glioma%2520model%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D1184%26epage%3D1194%26doi%3D10.1021%2Fjm501829f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit65"><span><span class="NLM_contrib-group">Fang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span> </span><span class="NLM_article-title">Conformational restriction: an effective tactic in ‘follow-on’-based drug discovery</span> <span class="citation_source-journal">Future Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">885</span><span class="NLM_x">–</span> <span class="NLM_lpage">901</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00229&amp;key=10.4155%2Ffmc.14.50" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00229&amp;key=24962281" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00229&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtVemsrzE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2014&pages=885-901&author=Z.+Fangauthor=Y.+Songauthor=P.+Zhanauthor=Q.+Zhangauthor=X.+Liu&title=Conformational+restriction%3A+an+effective+tactic+in+%E2%80%98follow-on%E2%80%99-based+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">Conformational restriction: an effective tactic in 'follow-on'-based drug discovery</span></div><div class="casAuthors">Fang, Zengjun; Song, Yu'ning; Zhan, Peng; Zhang, Qingzhu; Liu, Xinyong</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">885-901</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">A review.  The conformational restriction (rigidification) of a flexible ligand has often been a commonly used strategy in drug design, as it can minimize the entropic loss assocd. with the ligand adopting a preferred conformation for binding, which leads to enhanced potency for a given physiol. target, improved selectivity for isoforms and reduced the possibility of drug metab.  Therefore, the application of conformational restriction strategy is a core aspect of drug discovery and development that is widely practiced by medicinal chemists either deliberately or subliminally.  The present review will highlight current representative examples and a brief overview on the rational design of conformationally restricted agents as well as discuss its advantages over the flexible counterparts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoupMomfg9J_bVg90H21EOLACvtfcHk0lgSmXPv-1gXhQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtVemsrzE&md5=dcf5fa6cead84c77b3603c7e0800f49b</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.4155%2Ffmc.14.50&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc.14.50%26sid%3Dliteratum%253Aachs%26aulast%3DFang%26aufirst%3DZ.%26aulast%3DSong%26aufirst%3DY.%26aulast%3DZhan%26aufirst%3DP.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DLiu%26aufirst%3DX.%26atitle%3DConformational%2520restriction%253A%2520an%2520effective%2520tactic%2520in%2520%25E2%2580%2598follow-on%25E2%2580%2599-based%2520drug%2520discovery%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2014%26volume%3D6%26spage%3D885%26epage%3D901" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit66"><span><span class="NLM_contrib-group">Kobayashi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suemasa, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Igawa, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ide, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukuda, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abe, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arisawa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minami, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shuto, S.</span><span> </span><span class="NLM_article-title">Conformationally restricted GABA with bicyclo[3.1.0]hexane backbone as the first highly selective BGT-1 inhibitor</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">889</span><span class="NLM_x">–</span> <span class="NLM_lpage">893</span></span><div class="citationLinks">[<a href="/doi/10.1021/ml500134k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=889-893&author=T.+Kobayashiauthor=A.+Suemasaauthor=A.+Igawaauthor=S.+Ideauthor=H.+Fukudaauthor=H.+Abeauthor=M.+Arisawaauthor=M.+Minamiauthor=S.+Shuto&title=Conformationally+restricted+GABA+with+bicyclo%5B3.1.0%5Dhexane+backbone+as+the+first+highly+selective+BGT-1+inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1021%2Fml500134k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml500134k%26sid%3Dliteratum%253Aachs%26aulast%3DKobayashi%26aufirst%3DT.%26aulast%3DSuemasa%26aufirst%3DA.%26aulast%3DIgawa%26aufirst%3DA.%26aulast%3DIde%26aufirst%3DS.%26aulast%3DFukuda%26aufirst%3DH.%26aulast%3DAbe%26aufirst%3DH.%26aulast%3DArisawa%26aufirst%3DM.%26aulast%3DMinami%26aufirst%3DM.%26aulast%3DShuto%26aufirst%3DS.%26atitle%3DConformationally%2520restricted%2520GABA%2520with%2520bicyclo%255B3.1.0%255Dhexane%2520backbone%2520as%2520the%2520first%2520highly%2520selective%2520BGT-1%2520inhibitor%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D5%26spage%3D889%26epage%3D893" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref67'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="cit67"><span><span class="NLM_contrib-group">Hay, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fedorov, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singleton, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tallant, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wells, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Picaud, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Philpott, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monteiro, O. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogers, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conway, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rooney, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tumber, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yapp, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Filippakopoulos, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bunnage, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Müller, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knapp, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schofield, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brennan, P. E.</span><span> </span><span class="NLM_article-title">Discovery and optimization of small-molecule ligands for the CBP/p300 bromodomains</span> <span class="citation_source-journal">J. Am. Chem, Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">136</span><span class="NLM_x">, </span> <span class="NLM_fpage">9308</span><span class="NLM_x">–</span> <span class="NLM_lpage">9319</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja412434f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00229&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtVShsLvP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=136&publication_year=2014&pages=9308-9319&author=D.+A.+Hayauthor=O.+Fedorovauthor=S.+Martinauthor=D.+C.+Singletonauthor=C.+Tallantauthor=C.+Wellsauthor=S.+Picaudauthor=M.+Philpottauthor=O.+P.+Monteiroauthor=C.+M.+Rogersauthor=S.+J.+Conwayauthor=T.+P.+Rooneyauthor=A.+Tumberauthor=C.+Yappauthor=P.+Filippakopoulosauthor=M.+E.+Bunnageauthor=S.+M%C3%BCllerauthor=S.+Knappauthor=C.+J.+Schofieldauthor=P.+E.+Brennan&title=Discovery+and+optimization+of+small-molecule+ligands+for+the+CBP%2Fp300+bromodomains"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and Optimization of Small-Molecule Ligands for the CBP/p300 Bromodomains</span></div><div class="casAuthors">Hay, Duncan A.; Fedorov, Oleg; Martin, Sarah; Singleton, Dean C.; Tallant, Cynthia; Wells, Christopher; Picaud, Sarah; Philpott, Martin; Monteiro, Octovia P.; Rogers, Catherine M.; Conway, Stuart J.; Rooney, Timothy P. C.; Tumber, Anthony; Yapp, Clarence; Filippakopoulos, Panagis; Bunnage, Mark E.; Muller, Susanne; Knapp, Stefan; Schofield, Christopher J.; Brennan, Paul E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">136</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">9308-9319</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Small-mol. inhibitors that target bromodomains outside of the bromodomain and extra-terminal (BET) sub-family are lacking.  Here, the authors describe highly potent and selective ligands for the bromodomain module of the human lysine acetyl transferase CBP/p300, developed from a series of 5-isoxazolyl-benzimidazoles.  The starting point was a fragment hit, which was optimized into a more potent and selective lead using parallel synthesis employing Suzuki couplings, benzimidazole-forming reactions, and reductive aminations.  The selectivity of the lead compd. against other bromodomain family members was investigated using a thermal stability assay, which revealed some inhibition of the structurally related BET family members.  To address the BET selectivity issue, x-ray crystal structures of the lead compd. bound to the CREB binding protein (CBP) and the first bromodomain of BRD4 (BRD4(1)) were used to guide the design of more selective compds.  The crystal structures obtained revealed two distinct binding modes.  By varying the aryl substitution pattern and developing conformationally constrained analogs, selectivity for CBP over BRD4(1) was increased.  The optimized compd. is highly potent (Kd = 21 nM) and selective, displaying 40-fold selectivity over BRD4(1).  Cellular activity was demonstrated using fluorescence recovery after photo-bleaching (FRAP) and a p53 reporter assay.  The optimized compds. are cell-active and have nanomolar affinity for CBP/p300; therefore, they should be useful in studies investigating the biol. roles of CBP and p300 and to validate the CBP and p300 bromodomains as therapeutic targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqFzgs1DD4QZLVg90H21EOLACvtfcHk0liyjFCV8YH0_A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtVShsLvP&md5=e5da3e96a4d234453a481c7ee5e788f2</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1021%2Fja412434f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja412434f%26sid%3Dliteratum%253Aachs%26aulast%3DHay%26aufirst%3DD.%2BA.%26aulast%3DFedorov%26aufirst%3DO.%26aulast%3DMartin%26aufirst%3DS.%26aulast%3DSingleton%26aufirst%3DD.%2BC.%26aulast%3DTallant%26aufirst%3DC.%26aulast%3DWells%26aufirst%3DC.%26aulast%3DPicaud%26aufirst%3DS.%26aulast%3DPhilpott%26aufirst%3DM.%26aulast%3DMonteiro%26aufirst%3DO.%2BP.%26aulast%3DRogers%26aufirst%3DC.%2BM.%26aulast%3DConway%26aufirst%3DS.%2BJ.%26aulast%3DRooney%26aufirst%3DT.%2BP.%26aulast%3DTumber%26aufirst%3DA.%26aulast%3DYapp%26aufirst%3DC.%26aulast%3DFilippakopoulos%26aufirst%3DP.%26aulast%3DBunnage%26aufirst%3DM.%2BE.%26aulast%3DM%25C3%25BCller%26aufirst%3DS.%26aulast%3DKnapp%26aufirst%3DS.%26aulast%3DSchofield%26aufirst%3DC.%2BJ.%26aulast%3DBrennan%26aufirst%3DP.%2BE.%26atitle%3DDiscovery%2520and%2520optimization%2520of%2520small-molecule%2520ligands%2520for%2520the%2520CBP%252Fp300%2520bromodomains%26jtitle%3DJ.%2520Am.%2520Chem%252C%2520Soc.%26date%3D2014%26volume%3D136%26spage%3D9308%26epage%3D9319" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref68"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref68'); return false;" data-citation="" class="refNumLink">68</a></strong><div class="NLM_citation" id="cit68"><span><span class="NLM_contrib-group">Saupe, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steinmetzer, T.</span><span> </span><span class="NLM_article-title">A new strategy for the development of highly potent and selective plasmin inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">1171</span><span class="NLM_x">–</span> <span class="NLM_lpage">1180</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm2011996" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00229&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1Ohs7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=1171-1180&author=S.+M.+Saupeauthor=T.+Steinmetzer&title=A+new+strategy+for+the+development+of+highly+potent+and+selective+plasmin+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">A New Strategy for the Development of Highly Potent and Selective Plasmin Inhibitors</span></div><div class="casAuthors">Saupe, Sebastian M.; Steinmetzer, Torsten</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1171-1180</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A new structure-based strategy for the design of potent and selective plasmin inhibitors was developed.  These compds. could be prepd. by cyclizations between the P3 and P2 amino acid residues of substrate-analog inhibitors using metathesis or a copper-catalyzed azide alkyne cycloaddn. in combination with std. peptide couplings.  The most potent bis-triazole deriv. 10 inhibits plasmin and plasma kallikrein with Ki of 0.77 and 2.4 nM, resp., whereas it has poor activity against the related trypsin-like serine proteases thrombin, factor Xa, or activated protein C.  Modeling expts. revealed that inhibitor 10 adopts a compact and rigid structure that fits well into the relatively open active site of plasmin and plasma kallikrein, while it is rejected from sterically demanding residues present in loops of the other enzymes.  These results from modeling confirm the selectivity profile found for inhibitor 10 in enzyme kinetic studies.  Such compds. might be useful lead structures for the development of new antifibrinolytic drugs for use in cardiac surgery with cardiopulmonary bypass or organ transplantations to reduce bleeding complications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGquMb45usCgsrVg90H21EOLACvtfcHk0liyjFCV8YH0_A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1Ohs7k%253D&md5=d1e496b75545ee3ee4665ffdabe2f228</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1021%2Fjm2011996&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm2011996%26sid%3Dliteratum%253Aachs%26aulast%3DSaupe%26aufirst%3DS.%2BM.%26aulast%3DSteinmetzer%26aufirst%3DT.%26atitle%3DA%2520new%2520strategy%2520for%2520the%2520development%2520of%2520highly%2520potent%2520and%2520selective%2520plasmin%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D1171%26epage%3D1180" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref69"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref69'); return false;" data-citation="" class="refNumLink">69</a></strong><div class="NLM_citation" id="cit69"><span><span class="NLM_contrib-group">Bastida, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hidalgo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiara, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Torrado, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corzana, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pérez-Cañadillas, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Groves, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia-Junceda, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzalez, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jimenez-Barbero, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asensio, J. L.</span><span> </span><span class="NLM_article-title">Exploring the use of conformationally locked aminoglycosides as a new strategy to overcome bacterial resistance</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">128</span><span class="NLM_x">, </span> <span class="NLM_fpage">100</span><span class="NLM_x">–</span> <span class="NLM_lpage">116</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja0543144" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=128&publication_year=2006&pages=100-116&author=A.+Bastidaauthor=A.+Hidalgoauthor=J.+L.+Chiaraauthor=M.+Torradoauthor=F.+Corzanaauthor=J.+M.+P%C3%A9rez-Ca%C3%B1adillasauthor=P.+Grovesauthor=E.+Garcia-Juncedaauthor=C.+Gonzalezauthor=J.+Jimenez-Barberoauthor=J.+L.+Asensio&title=Exploring+the+use+of+conformationally+locked+aminoglycosides+as+a+new+strategy+to+overcome+bacterial+resistance"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1021%2Fja0543144&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja0543144%26sid%3Dliteratum%253Aachs%26aulast%3DBastida%26aufirst%3DA.%26aulast%3DHidalgo%26aufirst%3DA.%26aulast%3DChiara%26aufirst%3DJ.%2BL.%26aulast%3DTorrado%26aufirst%3DM.%26aulast%3DCorzana%26aufirst%3DF.%26aulast%3DP%25C3%25A9rez-Ca%25C3%25B1adillas%26aufirst%3DJ.%2BM.%26aulast%3DGroves%26aufirst%3DP.%26aulast%3DGarcia-Junceda%26aufirst%3DE.%26aulast%3DGonzalez%26aufirst%3DC.%26aulast%3DJimenez-Barbero%26aufirst%3DJ.%26aulast%3DAsensio%26aufirst%3DJ.%2BL.%26atitle%3DExploring%2520the%2520use%2520of%2520conformationally%2520locked%2520aminoglycosides%2520as%2520a%2520new%2520strategy%2520to%2520overcome%2520bacterial%2520resistance%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2006%26volume%3D128%26spage%3D100%26epage%3D116" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref70"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref70'); return false;" data-citation="" class="refNumLink">70</a></strong><div class="NLM_citation" id="cit70"><span><span class="NLM_contrib-group">Kim, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, S. B.</span><span> </span><span class="NLM_article-title">Privileged structures: efficient chemical “navigators” toward unexplored biologically relevant chemical spaces</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">136</span><span class="NLM_x">, </span> <span class="NLM_fpage">14629</span><span class="NLM_x">–</span> <span class="NLM_lpage">14638</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja508343a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=136&publication_year=2014&pages=14629-14638&author=J.+Kimauthor=H.+Kimauthor=S.+B.+Park&title=Privileged+structures%3A+efficient+chemical+%E2%80%9Cnavigators%E2%80%9D+toward+unexplored+biologically+relevant+chemical+spaces"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1021%2Fja508343a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja508343a%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DJ.%26aulast%3DKim%26aufirst%3DH.%26aulast%3DPark%26aufirst%3DS.%2BB.%26atitle%3DPrivileged%2520structures%253A%2520efficient%2520chemical%2520%25E2%2580%259Cnavigators%25E2%2580%259D%2520toward%2520unexplored%2520biologically%2520relevant%2520chemical%2520spaces%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2014%26volume%3D136%26spage%3D14629%26epage%3D14638" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref71"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref71'); return false;" data-citation="" class="refNumLink">71</a></strong><div class="NLM_citation" id="cit71"><span><span class="NLM_contrib-group">Olsen, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghadiri, M. R.</span><span> </span><span class="NLM_article-title">Discovery of potent and selective histone deacetylase inhibitors via focused combinatorial libraries of cyclic alpha3beta-tetrapeptides</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">7836</span><span class="NLM_x">–</span> <span class="NLM_lpage">7846</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm900850t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=7836-7846&author=C.+A.+Olsenauthor=M.+R.+Ghadiri&title=Discovery+of+potent+and+selective+histone+deacetylase+inhibitors+via+focused+combinatorial+libraries+of+cyclic+alpha3beta-tetrapeptides"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1021%2Fjm900850t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900850t%26sid%3Dliteratum%253Aachs%26aulast%3DOlsen%26aufirst%3DC.%2BA.%26aulast%3DGhadiri%26aufirst%3DM.%2BR.%26atitle%3DDiscovery%2520of%2520potent%2520and%2520selective%2520histone%2520deacetylase%2520inhibitors%2520via%2520focused%2520combinatorial%2520libraries%2520of%2520cyclic%2520alpha3beta-tetrapeptides%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D7836%26epage%3D7846" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref72"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref72'); return false;" data-citation="" class="refNumLink">72</a></strong><div class="NLM_citation" id="cit72"><span><span class="NLM_contrib-group">Baud, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leiser, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haus, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samlal, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petrucci, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunaratnam, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hughes, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buluwela, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turlais, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neidle, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyer-Almes, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fuchter, M. J.</span><span> </span><span class="NLM_article-title">Defining the mechanism of action and enzymatic selectivity of psammaplin A against its epigenetic targets</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">1731</span><span class="NLM_x">–</span> <span class="NLM_lpage">1750</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm2016182" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=1731-1750&author=M.+G.+Baudauthor=T.+Leiserauthor=P.+Hausauthor=S.+Samlalauthor=A.+C.+Wongauthor=R.+J.+Woodauthor=V.+Petrucciauthor=M.+Gunaratnamauthor=S.+M.+Hughesauthor=L.+Buluwelaauthor=F.+Turlaisauthor=S.+Neidleauthor=F.+J.+Meyer-Almesauthor=A.+J.+Whiteauthor=M.+J.+Fuchter&title=Defining+the+mechanism+of+action+and+enzymatic+selectivity+of+psammaplin+A+against+its+epigenetic+targets"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1021%2Fjm2016182&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm2016182%26sid%3Dliteratum%253Aachs%26aulast%3DBaud%26aufirst%3DM.%2BG.%26aulast%3DLeiser%26aufirst%3DT.%26aulast%3DHaus%26aufirst%3DP.%26aulast%3DSamlal%26aufirst%3DS.%26aulast%3DWong%26aufirst%3DA.%2BC.%26aulast%3DWood%26aufirst%3DR.%2BJ.%26aulast%3DPetrucci%26aufirst%3DV.%26aulast%3DGunaratnam%26aufirst%3DM.%26aulast%3DHughes%26aufirst%3DS.%2BM.%26aulast%3DBuluwela%26aufirst%3DL.%26aulast%3DTurlais%26aufirst%3DF.%26aulast%3DNeidle%26aufirst%3DS.%26aulast%3DMeyer-Almes%26aufirst%3DF.%2BJ.%26aulast%3DWhite%26aufirst%3DA.%2BJ.%26aulast%3DFuchter%26aufirst%3DM.%2BJ.%26atitle%3DDefining%2520the%2520mechanism%2520of%2520action%2520and%2520enzymatic%2520selectivity%2520of%2520psammaplin%2520A%2520against%2520its%2520epigenetic%2520targets%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D1731%26epage%3D1750" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref73"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref73'); return false;" data-citation="" class="refNumLink">73</a></strong><div class="NLM_citation" id="cit73"><span><span class="NLM_contrib-group">Holub, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirshenbaum, K.</span><span> </span><span class="NLM_article-title">Tricks with clicks: modification of peptidomimetic oligomers via copper-catalyzed azide–alkyne [3 + 2] cycloaddition</span> <span class="citation_source-journal">Chem. Soc. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">1325</span><span class="NLM_x">–</span> <span class="NLM_lpage">1337</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2010&pages=1325-1337&author=J.+M.+Holubauthor=K.+Kirshenbaum&title=Tricks+with+clicks%3A+modification+of+peptidomimetic+oligomers+via+copper-catalyzed+azide%E2%80%93alkyne+%5B3+%2B+2%5D+cycloaddition"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHolub%26aufirst%3DJ.%2BM.%26aulast%3DKirshenbaum%26aufirst%3DK.%26atitle%3DTricks%2520with%2520clicks%253A%2520modification%2520of%2520peptidomimetic%2520oligomers%2520via%2520copper-catalyzed%2520azide%25E2%2580%2593alkyne%2520%255B3%2520%252B%25202%255D%2520cycloaddition%26jtitle%3DChem.%2520Soc.%2520Rev.%26date%3D2010%26volume%3D39%26spage%3D1325%26epage%3D1337" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref74"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref74'); return false;" data-citation="" class="refNumLink">74</a></strong><div class="NLM_citation" id="cit74"><span><span class="NLM_contrib-group">Bose, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dai, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grant, S.</span><span> </span><span class="NLM_article-title">Histone deacetylase inhibitor (HDACI) mechanisms of action: emerging insights</span> <span class="citation_source-journal">Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">143</span><span class="NLM_x">, </span> <span class="NLM_fpage">323</span><span class="NLM_x">–</span> <span class="NLM_lpage">336</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00229&amp;key=10.1016%2Fj.pharmthera.2014.04.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00229&amp;key=24769080" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00229&amp;key=1%3ACAS%3A528%3ADC%252BC2cXnslGnt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=143&publication_year=2014&pages=323-336&author=P.+Boseauthor=Y.+Daiauthor=S.+Grant&title=Histone+deacetylase+inhibitor+%28HDACI%29+mechanisms+of+action%3A+emerging+insights"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit74R"><div class="casContent"><span class="casTitleNuber">74</span><div class="casTitle"><span class="NLM_cas:atitle">Histone deacetylase inhibitor (HDACI) mechanisms of action: Emerging insights</span></div><div class="casAuthors">Bose, Prithviraj; Dai, Yun; Grant, Steven</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">143</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">323-336</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Initially regarded as "epigenetic modifiers" acting predominantly through chromatin remodeling via histone acetylation, HDACIs, alternatively referred to as lysine deacetylase or simply deacetylase inhibitors, have since been recognized to exert multiple cytotoxic actions in cancer cells, often through acetylation of non-histone proteins.  Some well-recognized mechanisms of HDACI lethality include, in addn. to relaxation of DNA and de-repression of gene transcription, interference with chaperone protein function, free radical generation, induction of DNA damage, up-regulation of endogenous inhibitors of cell cycle progression, e.g., p21, and promotion of apoptosis.  Intriguingly, this class of agents is relatively selective for transformed cells, at least in pre-clin. studies.  In recent years, addnl. mechanisms of action of these agents have been uncovered.  For example, HDACIs interfere with multiple DNA repair processes, as well as disrupt cell cycle checkpoints, crit. to the maintenance of genomic integrity in the face of diverse genotoxic insults.  Despite their pre-clin. potential, the clin. use of HDACIs remains restricted to certain subsets of T-cell lymphoma.  Currently, it appears likely that the ultimate role of these agents will lie in rational combinations, only a few of which have been pursued in the clinic to date.  This review focuses on relatively recently identified mechanisms of action of HDACIs, with particular emphasis on those that relate to the DNA damage response (DDR), and discusses synergistic strategies combining HDACIs with several novel targeted agents that disrupt the DDR or antagonize anti-apoptotic proteins that could have implications for the future use of HDACIs in patients with cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr0OwGAuPo0CbVg90H21EOLACvtfcHk0ljEpDDlUHTxmA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXnslGnt7o%253D&md5=4ca75e79d226c760e847a876737a4f04</span></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1016%2Fj.pharmthera.2014.04.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pharmthera.2014.04.004%26sid%3Dliteratum%253Aachs%26aulast%3DBose%26aufirst%3DP.%26aulast%3DDai%26aufirst%3DY.%26aulast%3DGrant%26aufirst%3DS.%26atitle%3DHistone%2520deacetylase%2520inhibitor%2520%2528HDACI%2529%2520mechanisms%2520of%2520action%253A%2520emerging%2520insights%26jtitle%3DPharmacol.%2520Ther.%26date%3D2014%26volume%3D143%26spage%3D323%26epage%3D336" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref75"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref75'); return false;" data-citation="" class="refNumLink">75</a></strong><div class="NLM_citation" id="cit75"><span><span class="NLM_contrib-group">Suzuki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ota, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ri, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bando, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gotoh, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Itoh, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsumoto, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tatum, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mizukami, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakagawa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iida, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ueda, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shirahige, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyata, N.</span><span> </span><span class="NLM_article-title">Rapid discovery of highly potent and selective inhibitors of histone deacetylase 8 using click chemistry to generate candidate libraries</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">9562</span><span class="NLM_x">–</span> <span class="NLM_lpage">9575</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm300837y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00229&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsF2qtrfI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=9562-9575&author=T.+Suzukiauthor=Y.+Otaauthor=M.+Riauthor=M.+Bandoauthor=A.+Gotohauthor=Y.+Itohauthor=H.+Tsumotoauthor=P.+R.+Tatumauthor=T.+Mizukamiauthor=H.+Nakagawaauthor=S.+Iidaauthor=R.+Uedaauthor=K.+Shirahigeauthor=N.+Miyata&title=Rapid+discovery+of+highly+potent+and+selective+inhibitors+of+histone+deacetylase+8+using+click+chemistry+to+generate+candidate+libraries"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">Rapid Discovery of Highly Potent and Selective Inhibitors of Histone Deacetylase 8 Using Click Chemistry to Generate Candidate Libraries</span></div><div class="casAuthors">Suzuki, Takayoshi; Ota, Yosuke; Ri, Masaki; Bando, Masashige; Gotoh, Aogu; Itoh, Yukihiro; Tsumoto, Hiroki; Tatum, Prima R.; Mizukami, Tamio; Nakagawa, Hidehiko; Iida, Shinsuke; Ueda, Ryuzo; Shirahige, Katsuhiko; Miyata, Naoki</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">9562-9575</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">To find HDAC8-selective inhibitors, we designed a library of HDAC inhibitor candidates, each contg. a zinc-binding group that coordinates with the active-site zinc ion, linked via a triazole moiety to a capping structure that interacts with residues on the rim of the active site.  These compds. were synthesized by using click chem.  Screening identified HDAC8-selective inhibitors including (I) (IC50 = 0.070 μM), which was more potent than PCI-34058 (IC50 = 0.31 μM), a known HDAC8 inhibitor.  Mol. modeling suggested that the phenylthiomethyl group of I binds to a unique hydrophobic pocket of HDAC8, and the orientation of the phenylthiomethyl and hydroxamate moieties (fixed by the triazole moiety) is important for the potency and selectivity.  The inhibitors caused selective acetylation of cohesin in cells and exerted growth-inhibitory effects on T-cell lymphoma and neuroblastoma cells (GI50 = 3-80 μM).  These findings suggest that HDAC8-selective inhibitors have potential as anticancer agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpGB7i5Bnw337Vg90H21EOLACvtfcHk0li_bGKYBTeSfw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsF2qtrfI&md5=9b730c0469b62c3ebd93a5e58c520a12</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1021%2Fjm300837y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300837y%26sid%3Dliteratum%253Aachs%26aulast%3DSuzuki%26aufirst%3DT.%26aulast%3DOta%26aufirst%3DY.%26aulast%3DRi%26aufirst%3DM.%26aulast%3DBando%26aufirst%3DM.%26aulast%3DGotoh%26aufirst%3DA.%26aulast%3DItoh%26aufirst%3DY.%26aulast%3DTsumoto%26aufirst%3DH.%26aulast%3DTatum%26aufirst%3DP.%2BR.%26aulast%3DMizukami%26aufirst%3DT.%26aulast%3DNakagawa%26aufirst%3DH.%26aulast%3DIida%26aufirst%3DS.%26aulast%3DUeda%26aufirst%3DR.%26aulast%3DShirahige%26aufirst%3DK.%26aulast%3DMiyata%26aufirst%3DN.%26atitle%3DRapid%2520discovery%2520of%2520highly%2520potent%2520and%2520selective%2520inhibitors%2520of%2520histone%2520deacetylase%25208%2520using%2520click%2520chemistry%2520to%2520generate%2520candidate%2520libraries%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D9562%26epage%3D9575" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref76"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref76'); return false;" data-citation="" class="refNumLink">76</a></strong><div class="NLM_citation" id="cit76"><span><span class="NLM_contrib-group">Suzuki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kasuya, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Itoh, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ota, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asamitsu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakagawa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okamoto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyata, N.</span><span> </span><span class="NLM_article-title">Identification of highly selective and potent histone deacetylase 3 inhibitors using click chemistry-based combinatorial fragment assembly</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">e68669</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00229&amp;key=10.1371%2Fjournal.pone.0068669" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00229&amp;key=23874714" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00229&amp;key=1%3ACAS%3A528%3ADC%252BC3sXht1SgsrjF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=e68669&author=T.+Suzukiauthor=Y.+Kasuyaauthor=Y.+Itohauthor=Y.+Otaauthor=P.+Zhanauthor=K.+Asamitsuauthor=H.+Nakagawaauthor=T.+Okamotoauthor=N.+Miyata&title=Identification+of+highly+selective+and+potent+histone+deacetylase+3+inhibitors+using+click+chemistry-based+combinatorial+fragment+assembly"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit76R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of highly selective and potent histone deacetylase 3 inhibitors using click chemistry-based combinatorial fragment assembly</span></div><div class="casAuthors">Suzuki, Takayoshi; Kasuya, Yuki; Itoh, Yukihiro; Ota, Yosuke; Zhan, Peng; Asamitsu, Kaori; Nakagawa, Hidehiko; Okamoto, Takashi; Miyata, Naoki</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">e68669</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">To find histone deacetylase 3 (HDAC3)-selective inhibitors, a series of 504 candidates was assembled using "click chem.", by reacting nine alkynes bearing a zinc-binding group with 56 azide building blocks in the presence of Cu(I) catalyst.  Screening of the 504-member triazole library against HDAC3 and other HDAC isoenzymes led to the identification of potent and selective HDAC3 inhibitors T247 and T326.  These compds. showed potent HDAC3 inhibition with submicromolar IC50s, whereas they did not strongly inhibit other isoenzymes.  Compds. T247 and T326 also induced a dose-dependent selective increase of NF-κB acetylation in human colon cancer HCT116 cells, indicating selective inhibition of HDAC3 in the cells.  In addn., these HDAC3-selective inhibitors induced growth inhibition of cancer cells, and activated HIV gene expression in latent HIV-infected cells.  These findings indicate that HDAC3-selective inhibitors are promising candidates for anticancer drugs and antiviral agents.  This work also suggests the usefulness of the click chem. approach to find isoenzyme-selective HDAC inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr4CvS43ILxQLVg90H21EOLACvtfcHk0li_bGKYBTeSfw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXht1SgsrjF&md5=74d12c8fb1f06f8e00691415434fd929</span></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0068669&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0068669%26sid%3Dliteratum%253Aachs%26aulast%3DSuzuki%26aufirst%3DT.%26aulast%3DKasuya%26aufirst%3DY.%26aulast%3DItoh%26aufirst%3DY.%26aulast%3DOta%26aufirst%3DY.%26aulast%3DZhan%26aufirst%3DP.%26aulast%3DAsamitsu%26aufirst%3DK.%26aulast%3DNakagawa%26aufirst%3DH.%26aulast%3DOkamoto%26aufirst%3DT.%26aulast%3DMiyata%26aufirst%3DN.%26atitle%3DIdentification%2520of%2520highly%2520selective%2520and%2520potent%2520histone%2520deacetylase%25203%2520inhibitors%2520using%2520click%2520chemistry-based%2520combinatorial%2520fragment%2520assembly%26jtitle%3DPLoS%2520One%26date%3D2013%26volume%3D8%26spage%3De68669" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref77"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref77'); return false;" data-citation="" class="refNumLink">77</a></strong><div class="NLM_citation" id="cit77"><span><span class="NLM_contrib-group">Tatum, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawada, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ota, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Itoh, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ieda, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakagawa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyata, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, T.</span><span> </span><span class="NLM_article-title">Identification of novel SIRT2-selective inhibitors using a click chemistry approach</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">1871</span><span class="NLM_x">–</span> <span class="NLM_lpage">1874</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00229&amp;key=10.1016%2Fj.bmcl.2014.03.026" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00229&amp;key=24675380" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00229&amp;key=1%3ACAS%3A528%3ADC%252BC2cXltFKms7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2014&pages=1871-1874&author=P.+R.+Tatumauthor=H.+Sawadaauthor=Y.+Otaauthor=Y.+Itohauthor=P.+Zhanauthor=N.+Iedaauthor=H.+Nakagawaauthor=N.+Miyataauthor=T.+Suzuki&title=Identification+of+novel+SIRT2-selective+inhibitors+using+a+click+chemistry+approach"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit77R"><div class="casContent"><span class="casTitleNuber">77</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of novel SIRT2-selective inhibitors using a click chemistry approach</span></div><div class="casAuthors">Tatum, Prima R.; Sawada, Hideyuki; Ota, Yosuke; Itoh, Yukihiro; Zhan, Peng; Ieda, Naoya; Nakagawa, Hidehiko; Miyata, Naoki; Suzuki, Takayoshi</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1871-1874</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A series of 114 SIRT inhibitor candidates was assembled using 'click chem.', by reacting two alkynes bearing 2-anilinobenzamide pharmacophore with 57 azide building blocks in the presence of Cu(I) catalyst.  Screening identified two SIRT2-selective inhibitors, which were more SIRT2-selective than AGK2, a known SIRT2 inhibitor.  These findings will be useful for further development of SIRT2-selective inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqE99y-vBC6lLVg90H21EOLACvtfcHk0li_bGKYBTeSfw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXltFKms7s%253D&md5=59676924d20f19655d23b39f4799769a</span></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2014.03.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2014.03.026%26sid%3Dliteratum%253Aachs%26aulast%3DTatum%26aufirst%3DP.%2BR.%26aulast%3DSawada%26aufirst%3DH.%26aulast%3DOta%26aufirst%3DY.%26aulast%3DItoh%26aufirst%3DY.%26aulast%3DZhan%26aufirst%3DP.%26aulast%3DIeda%26aufirst%3DN.%26aulast%3DNakagawa%26aufirst%3DH.%26aulast%3DMiyata%26aufirst%3DN.%26aulast%3DSuzuki%26aufirst%3DT.%26atitle%3DIdentification%2520of%2520novel%2520SIRT2-selective%2520inhibitors%2520using%2520a%2520click%2520chemistry%2520approach%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D24%26spage%3D1871%26epage%3D1874" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref78"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref78'); return false;" data-citation="" class="refNumLink">78</a></strong><div class="NLM_citation" id="cit78"><span><span class="NLM_contrib-group">Gehringer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forster, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laufer, S. A.</span><span> </span><span class="NLM_article-title">Solution-phase parallel synthesis of Ruxolitinib-derived janus kinase inhibitors via copper catalyzed azide–alkyne cycloaddition</span> <span class="citation_source-journal">ACS Comb. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">5</span><span class="NLM_x">–</span> <span class="NLM_lpage">10</span></span><div class="citationLinks">[<a href="/doi/10.1021/co500122h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00229&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvFCisbnI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2015&pages=5-10&author=M.+Gehringerauthor=M.+Forsterauthor=S.+A.+Laufer&title=Solution-phase+parallel+synthesis+of+Ruxolitinib-derived+janus+kinase+inhibitors+via+copper+catalyzed+azide%E2%80%93alkyne+cycloaddition"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit78R"><div class="casContent"><span class="casTitleNuber">78</span><div class="casTitle"><span class="NLM_cas:atitle">Solution-Phase Parallel Synthesis of Ruxolitinib-Derived Janus Kinase Inhibitors via Copper-Catalyzed Azide-Alkyne Cycloaddition</span></div><div class="casAuthors">Gehringer, Matthias; Forster, Michael; Laufer, Stefan A.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Combinatorial Science</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">5-10</span>CODEN:
                <span class="NLM_cas:coden">ACSCCC</span>;
        ISSN:<span class="NLM_cas:issn">2156-8944</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A soln.-phase parallel synthesis of triazole-derived ruxolitinib analogs, e.g. I, was developed in the current study.  The method employs copper-catalyzed azide-alkyne cycloaddn. to build up the central triazole template.  Product isolation by pptn. and centrifugation is straightforward and yields high purity compds. suited for biol. profiling.  A simple protocol for accessing the terminal alkyne precursors in high yields was established and a library of ruxolitinib-like triazoles featuring diverse functional groups was prepd.  In addn., a model for the binding mode of ruxolitinib to Janus kinase (JAK) 2 is proposed.  In contrast to previous models, the pose explains the compd. selectivity for JAK1/JAK2 and is in accordance with published structure-activity data.  On this basis, a structure-based design hypothesis for inverting the selectivity profile of ruxolitinib is deduced.  Application of this strategy identified a moderately potent JAK3 inhibitor (35 nM) with high selectivity against other JAKs, potentially exploiting a covalent binding mode.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpm6Ts9duWGG7Vg90H21EOLACvtfcHk0lgFdIetPHTJgQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvFCisbnI&md5=5d2999fedb2dfef332c2e860a9e376e4</span></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1021%2Fco500122h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fco500122h%26sid%3Dliteratum%253Aachs%26aulast%3DGehringer%26aufirst%3DM.%26aulast%3DForster%26aufirst%3DM.%26aulast%3DLaufer%26aufirst%3DS.%2BA.%26atitle%3DSolution-phase%2520parallel%2520synthesis%2520of%2520Ruxolitinib-derived%2520janus%2520kinase%2520inhibitors%2520via%2520copper%2520catalyzed%2520azide%25E2%2580%2593alkyne%2520cycloaddition%26jtitle%3DACS%2520Comb.%2520Sci.%26date%3D2015%26volume%3D17%26spage%3D5%26epage%3D10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref79"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref79'); return false;" data-citation="" class="refNumLink">79</a></strong><div class="NLM_citation" id="cit79"><span><span class="NLM_contrib-group">Chen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shoichet, B. K.</span><span> </span><span class="NLM_article-title">Molecular docking and ligand specificity in fragment-based inhibitor discovery</span> <span class="citation_source-journal">Nature Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">358</span><span class="NLM_x">–</span> <span class="NLM_lpage">364</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00229&amp;key=10.1038%2Fnchembio.155" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00229&amp;key=19305397" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00229&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjsVCqt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2009&pages=358-364&author=Y.+Chenauthor=B.+K.+Shoichet&title=Molecular+docking+and+ligand+specificity+in+fragment-based+inhibitor+discovery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit79R"><div class="casContent"><span class="casTitleNuber">79</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular docking and ligand specificity in fragment-based inhibitor discovery</span></div><div class="casAuthors">Chen, Yu; Shoichet, Brian K.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">358-364</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Fragment screens have successfully identified new scaffolds in drug discovery, often with relatively high hit rates (5%) using small screening libraries (1,000-10,000 compds.).  This raises two questions: would other noteworthy chemotypes be found were one to screen all com. available fragments (>300,000), and does the success rate imply low specificity of fragments.  We used mol. docking to screen large libraries of fragments against CTX-M β-lactamase.  We identified ten millimolar-range inhibitors from the 69 compds. tested.  The docking poses corresponded closely to the crystallog. structures subsequently detd.  Notably, these initial low-affinity hits showed little specificity between CTX-M and an unrelated β-lactamase, AmpC, which is unusual among β-lactamase inhibitors.  This is consistent with the idea that the high hit rates among fragments correlate to a low initial specificity.  As the inhibitors were progressed, both specificity and affinity rose together, yielding to our knowledge the first micromolar-range noncovalent inhibitors against a class A β-lactamase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqO8zTkq9kMAbVg90H21EOLACvtfcHk0lgFdIetPHTJgQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjsVCqt7k%253D&md5=6ee8dd19d0b99599ea74eaf735483b1d</span></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.155&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.155%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DY.%26aulast%3DShoichet%26aufirst%3DB.%2BK.%26atitle%3DMolecular%2520docking%2520and%2520ligand%2520specificity%2520in%2520fragment-based%2520inhibitor%2520discovery%26jtitle%3DNature%2520Chem.%2520Biol.%26date%3D2009%26volume%3D5%26spage%3D358%26epage%3D364" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref80"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref80'); return false;" data-citation="" class="refNumLink">80</a></strong><div class="NLM_citation" id="cit80"><span><span class="NLM_contrib-group">Wagner, F. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fass, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joseph, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gale, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weïwer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCarren, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fisher, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaya, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, W. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reis, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hennig, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lemercier, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guan, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moyer, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scolnick, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haggarty, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsai, L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holson, E. B.</span><span> </span><span class="NLM_article-title">Kinetically selective inhibitors of histone deacetylase 2 (HDAC2) as cognition enhancers</span> <span class="citation_source-journal">Chem. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">804</span><span class="NLM_x">–</span> <span class="NLM_lpage">815</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00229&amp;key=10.1039%2FC4SC02130D" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00229&amp;key=25642316" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00229&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhslaqsLvO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=804-815&author=F.+F.+Wagnerauthor=Y.+L.+Zhangauthor=D.+M.+Fassauthor=N.+Josephauthor=J.+P.+Galeauthor=M.+We%C3%AFwerauthor=P.+McCarrenauthor=S.+L.+Fisherauthor=T.+Kayaauthor=W.+N.+Zhaoauthor=S.+A.+Reisauthor=K.+M.+Hennigauthor=M.+Thomasauthor=B.+C.+Lemercierauthor=M.+C.+Lewisauthor=J.+S.+Guanauthor=M.+P.+Moyerauthor=E.+Scolnickauthor=S.+J.+Haggartyauthor=L.+H.+Tsaiauthor=E.+B.+Holson&title=Kinetically+selective+inhibitors+of+histone+deacetylase+2+%28HDAC2%29+as+cognition+enhancers"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit80R"><div class="casContent"><span class="casTitleNuber">80</span><div class="casTitle"><span class="NLM_cas:atitle">Kinetically selective inhibitors of histone deacetylase 2 (HDAC2) as cognition enhancers</span></div><div class="casAuthors">Wagner, F. F.; Zhang, Y.-L.; Fass, D. M.; Joseph, N.; Gale, J. P.; Weiwer, M.; McCarren, P.; Fisher, S. L.; Kaya, T.; Zhao, W.-N.; Reis, S. A.; Hennig, K. M.; Thomas, M.; Lemercier, B. C.; Lewis, M. C.; Guan, J. S.; Moyer, M. P.; Scolnick, E.; Haggarty, S. J.; Tsai, L.-H.; Holson, E. B.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Science</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">804-815</span>CODEN:
                <span class="NLM_cas:coden">CSHCCN</span>;
        ISSN:<span class="NLM_cas:issn">2041-6520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Aiming towards the development of novel nootropic therapeutics to address the cognitive impairment common to a range of brain disorders, we set out to develop highly selective small mol. inhibitors of HDAC2, a chromatin modifying histone deacetylase implicated in memory formation and synaptic plasticity.  Novel ortho-aminoanilide inhibitors were designed and evaluated for their ability to selectively inhibit HDAC2 vs. the other Class I HDACs.  Kinetic and thermodn. binding properties were essential elements of our design strategy and two novel classes of ortho-aminoanilides, that exhibit kinetic selectivity (biased residence time) for HDAC2 vs. the highly homologous isoform HDAC1, were identified.  These kinetically selective HDAC2 inhibitors (BRD6688 and BRD4884) increased H4K12 and H3K9 histone acetylation in primary mouse neuronal cell culture assays, in the hippocampus of CK-p25 mice, a model of neurodegenerative disease, and rescued the assocd. memory deficits of these mice in a cognition behavioral model.  These studies demonstrate for the first time that selective pharmacol. inhibition of HDAC2 is feasible and that inhibition of the catalytic activity of this enzyme may serve as a therapeutic approach towards enhancing the learning and memory processes that are affected in many neurol. and psychiatric disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrwKZmK_p8gHrVg90H21EOLACvtfcHk0ljkNAx1eQtevA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhslaqsLvO&md5=1389a020df73e5bf79566c64c0bdd14c</span></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.1039%2FC4SC02130D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC4SC02130D%26sid%3Dliteratum%253Aachs%26aulast%3DWagner%26aufirst%3DF.%2BF.%26aulast%3DZhang%26aufirst%3DY.%2BL.%26aulast%3DFass%26aufirst%3DD.%2BM.%26aulast%3DJoseph%26aufirst%3DN.%26aulast%3DGale%26aufirst%3DJ.%2BP.%26aulast%3DWe%25C3%25AFwer%26aufirst%3DM.%26aulast%3DMcCarren%26aufirst%3DP.%26aulast%3DFisher%26aufirst%3DS.%2BL.%26aulast%3DKaya%26aufirst%3DT.%26aulast%3DZhao%26aufirst%3DW.%2BN.%26aulast%3DReis%26aufirst%3DS.%2BA.%26aulast%3DHennig%26aufirst%3DK.%2BM.%26aulast%3DThomas%26aufirst%3DM.%26aulast%3DLemercier%26aufirst%3DB.%2BC.%26aulast%3DLewis%26aufirst%3DM.%2BC.%26aulast%3DGuan%26aufirst%3DJ.%2BS.%26aulast%3DMoyer%26aufirst%3DM.%2BP.%26aulast%3DScolnick%26aufirst%3DE.%26aulast%3DHaggarty%26aufirst%3DS.%2BJ.%26aulast%3DTsai%26aufirst%3DL.%2BH.%26aulast%3DHolson%26aufirst%3DE.%2BB.%26atitle%3DKinetically%2520selective%2520inhibitors%2520of%2520histone%2520deacetylase%25202%2520%2528HDAC2%2529%2520as%2520cognition%2520enhancers%26jtitle%3DChem.%2520Sci.%26date%3D2015%26volume%3D6%26spage%3D804%26epage%3D815" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref81"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref81'); return false;" data-citation="" class="refNumLink">81</a></strong><div class="NLM_citation" id="cit81"><span><span class="NLM_contrib-group">Zhou, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, H. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, R.</span><span> </span><span class="NLM_article-title">Computational design of a time-dependent histone deacetylase 2 selective Inhibitor</span> <span class="citation_source-journal">ACS Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">687</span><span class="NLM_x">–</span> <span class="NLM_lpage">692</span><span class="refDoi"> DOI: 10.1021/cb500767c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cb500767c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00229&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsFGltw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&pages=687-692&author=J.+Zhouauthor=M.+Liauthor=N.+Chenauthor=S.+Wangauthor=H.+B.+Luoauthor=Y.+Zhangauthor=R.+Wu&title=Computational+design+of+a+time-dependent+histone+deacetylase+2+selective+Inhibitor&doi=10.1021%2Fcb500767c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit81R"><div class="casContent"><span class="casTitleNuber">81</span><div class="casTitle"><span class="NLM_cas:atitle">Computational Design of a Time-Dependent Histone Deacetylase 2 Selective Inhibitor</span></div><div class="casAuthors">Zhou, Jingwei; Li, Min; Chen, Nanhao; Wang, Shenglong; Luo, Hai-Bin; Zhang, Yingkai; Wu, Ruibo</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">687-692</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Development of isoform-selective histone deacetylase (HDAC) inhibitors is of great biol. and medical interest.  Among 11 zinc-dependent HDAC isoforms, it is particularly challenging to achieve isoform inhibition selectivity between HDAC1 and HDAC2 due to their very high structural similarities.  In this work, by developing and applying a novel de novo reaction-mechanism-based inhibitor design strategy to exploit the reactivity difference, the authors have discovered the first HDAC2-selective inhibitor, β-hydroxymethyl chalcone.  The bioassay expts. show that this new compd. has a unique time-dependent selective inhibition on HDAC2, leading to about 20-fold isoform-selectivity against HDAC1.  Furthermore, the ab initio QM/MM mol. dynamics simulations, a state-of-the-art approach to study reactions in biol. systems, have elucidated how the β-hydroxymethyl chalcone can achieve the distinct time-dependent inhibition toward HDAC2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoy6QHzO4UKiLVg90H21EOLACvtfcHk0ljkNAx1eQtevA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsFGltw%253D%253D&md5=0b924dd39e0a267dde2dbb166ac68177</span></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.1021%2Fcb500767c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb500767c%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DM.%26aulast%3DChen%26aufirst%3DN.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DLuo%26aufirst%3DH.%2BB.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DWu%26aufirst%3DR.%26atitle%3DComputational%2520design%2520of%2520a%2520time-dependent%2520histone%2520deacetylase%25202%2520selective%2520Inhibitor%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2015%26volume%3D10%26spage%3D687%26epage%3D692%26doi%3D10.1021%2Fcb500767c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref82"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref82'); return false;" data-citation="" class="refNumLink">82</a></strong><div class="NLM_citation" id="cit82"><span><span class="NLM_contrib-group">Jöst, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nitsche, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scholz, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roux, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klein, C. D.</span><span> </span><span class="NLM_article-title">Promiscuity and selectivity in covalent enzyme inhibition: a systematic study of electrophilic fragments</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">7590</span><span class="NLM_x">–</span> <span class="NLM_lpage">7599</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm5006918" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=7590-7599&author=C.+J%C3%B6stauthor=C.+Nitscheauthor=T.+Scholzauthor=L.+Rouxauthor=C.+D.+Klein&title=Promiscuity+and+selectivity+in+covalent+enzyme+inhibition%3A+a+systematic+study+of+electrophilic+fragments"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1021%2Fjm5006918&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm5006918%26sid%3Dliteratum%253Aachs%26aulast%3DJ%25C3%25B6st%26aufirst%3DC.%26aulast%3DNitsche%26aufirst%3DC.%26aulast%3DScholz%26aufirst%3DT.%26aulast%3DRoux%26aufirst%3DL.%26aulast%3DKlein%26aufirst%3DC.%2BD.%26atitle%3DPromiscuity%2520and%2520selectivity%2520in%2520covalent%2520enzyme%2520inhibition%253A%2520a%2520systematic%2520study%2520of%2520electrophilic%2520fragments%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D7590%26epage%3D7599" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref83"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref83'); return false;" data-citation="" class="refNumLink">83</a></strong><div class="NLM_citation" id="cit83"><span><span class="NLM_contrib-group">Arrowsmith, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bountra, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fish, P. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schapira, M.</span><span> </span><span class="NLM_article-title">Epigenetic protein families: a new frontier for drug discovery</span> <span class="citation_source-journal">Nature Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">384</span><span class="NLM_x">–</span> <span class="NLM_lpage">400</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2012&pages=384-400&author=C.+H.+Arrowsmithauthor=C.+Bountraauthor=P.+V.+Fishauthor=K.+Leeauthor=M.+Schapira&title=Epigenetic+protein+families%3A+a+new+frontier+for+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DArrowsmith%26aufirst%3DC.%2BH.%26aulast%3DBountra%26aufirst%3DC.%26aulast%3DFish%26aufirst%3DP.%2BV.%26aulast%3DLee%26aufirst%3DK.%26aulast%3DSchapira%26aufirst%3DM.%26atitle%3DEpigenetic%2520protein%2520families%253A%2520a%2520new%2520frontier%2520for%2520drug%2520discovery%26jtitle%3DNature%2520Rev.%2520Drug%2520Discovery%26date%3D2012%26volume%3D11%26spage%3D384%26epage%3D400" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref84"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref84'); return false;" data-citation="" class="refNumLink">84</a></strong><div class="NLM_citation" id="cit84a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Itoh, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyata, N.</span><span> </span><span class="NLM_article-title">Small-molecular modulators of cancer-associated epigenetic mechanisms</span> <span class="citation_source-journal">Mol. Biosyst.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">873</span><span class="NLM_x">–</span> <span class="NLM_lpage">96</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref84/cit84a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00229&amp;key=10.1039%2Fc3mb25410k" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref84/cit84a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00229&amp;key=23511667" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref84/cit84a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00229&amp;key=1%3ACAS%3A528%3ADC%252BC3sXltVOlsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2013&pages=873-96&author=Y.+Itohauthor=T.+Suzukiauthor=N.+Miyata&title=Small-molecular+modulators+of+cancer-associated+epigenetic+mechanisms"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit84aR"><div class="casContent"><span class="casTitleNuber">84a</span><div class="casTitle"><span class="NLM_cas:atitle">Small-molecular modulators of cancer-associated epigenetic mechanisms</span></div><div class="casAuthors">Itoh, Yukihiro; Suzuki, Takayoshi; Miyata, Naoki</div><div class="citationInfo"><span class="NLM_cas:title">Molecular BioSystems</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">873-896</span>CODEN:
                <span class="NLM_cas:coden">MBOIBW</span>;
        ISSN:<span class="NLM_cas:issn">1742-2051</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A review.  DNA methylation and posttranslational histone modifications regulate expression of various genes independently of changes in the DNA sequence.  Such epigenetic mechanisms play important roles in controlling cellular functions, including the cell cycle, immunoresponses and signal transduction.  On the other hand, epigenetic aberrations are assocd. with oncogenesis and proliferation of cancer cells, and epigenetic alterations have been identified in many human cancer cells.  Furthermore, chem.-biol. approaches have uncovered relationships between epigenetic dysregulation and cancer, and several small mols. that modulate epigenetic mechanisms have already been approved for cancer therapy.  In this review, we deal with chem. epigenetics relevant to cancer therapy, focusing esp. on small mols. that regulate epigenetic mechanisms related to DNA methylation and histone modification.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo76xFXo9kCe7Vg90H21EOLACvtfcHk0ljkNAx1eQtevA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXltVOlsr4%253D&md5=ecc7cd46637f6010872510329d51ac90</span></div><a href="/servlet/linkout?suffix=cit84a&amp;dbid=16384&amp;doi=10.1039%2Fc3mb25410k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc3mb25410k%26sid%3Dliteratum%253Aachs%26aulast%3DItoh%26aufirst%3DY.%26aulast%3DSuzuki%26aufirst%3DT.%26aulast%3DMiyata%26aufirst%3DN.%26atitle%3DSmall-molecular%2520modulators%2520of%2520cancer-associated%2520epigenetic%2520mechanisms%26jtitle%3DMol.%2520Biosyst.%26date%3D2013%26volume%3D9%26spage%3D873%26epage%3D96" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit84b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Suzuki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyata, N.</span><span> </span><span class="NLM_article-title">Epigenetic control using natural products and synthetic molecules</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">935</span><span class="NLM_x">–</span> <span class="NLM_lpage">958</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref84/cit84b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00229&amp;key=10.2174%2F092986706776361067" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref84/cit84b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00229&amp;key=16611076" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref84/cit84b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00229&amp;key=1%3ACAS%3A528%3ADC%252BD28Xislygsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2006&pages=935-958&author=T.+Suzukiauthor=N.+Miyata&title=Epigenetic+control+using+natural+products+and+synthetic+molecules"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit84bR"><div class="casContent"><span class="casTitleNuber">84b</span><div class="casTitle"><span class="NLM_cas:atitle">Epigenetic control using natural products and synthetic molecules</span></div><div class="casAuthors">Suzuki, Takayoshi; Miyata, Naoki</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">935-958</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The term epigenetics is defined as heritable changes in gene expression that occur without changes in DNA sequence.  Recently, it has been revealed that DNA methylation and histone modifications such as acetylation, methylation, and phosphorylation are epigenetic mechanisms according to this definition.  In other words, these posttranslational modifications are important factors in detg. when and where a gene will be expressed.  To date, several enzymes that catalyze DNA or histone modifications have been identified, such as DNA methyltransferases and histone deacetylases.  Inhibitors and activators of enzymes controlling epigenetic modifications are considered useful not only as tools for the elucidation of cellular and biol. phenomena, but also as therapeutic agents, since disruption of the balance of epigenetic networks is known to cause some disease states such as cancer.  In this review, the authors present natural products and synthetic mols. that inhibit or activate enzymes catalyzing DNA methylation or histone modifications, and discuss the potential of epigenetic therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqov1OglRSHGrVg90H21EOLACvtfcHk0lgr7U3aaQuVxg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xislygsbo%253D&md5=ba01be1244ce77f37d2fa55913618269</span></div><a href="/servlet/linkout?suffix=cit84b&amp;dbid=16384&amp;doi=10.2174%2F092986706776361067&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986706776361067%26sid%3Dliteratum%253Aachs%26aulast%3DSuzuki%26aufirst%3DT.%26aulast%3DMiyata%26aufirst%3DN.%26atitle%3DEpigenetic%2520control%2520using%2520natural%2520products%2520and%2520synthetic%2520molecules%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2006%26volume%3D13%26spage%3D935%26epage%3D958" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1a','cit1b','cit1c','cit1d'],'ref2':['cit2a','cit2b'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7a','cit7b'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35a','cit35b'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49a','cit49b'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64'],'ref65':['cit65'],'ref66':['cit66'],'ref67':['cit67'],'ref68':['cit68'],'ref69':['cit69'],'ref70':['cit70'],'ref71':['cit71'],'ref72':['cit72'],'ref73':['cit73'],'ref74':['cit74'],'ref75':['cit75'],'ref76':['cit76'],'ref77':['cit77'],'ref78':['cit78'],'ref79':['cit79'],'ref80':['cit80'],'ref81':['cit81'],'ref82':['cit82'],'ref83':['cit83'],'ref84':['cit84a','cit84b']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 33 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Yixiang Jiang, Guochao Chen, Xiao-Meng Li, Sha Liu, Gaofei Tian, Yuanyuan Li, Xin Li, Haitao Li, <span class="NLM_string-name hlFld-ContribAuthor">Xiang David Li</span>. </span><span class="cited-content_cbyCitation_article-title">Selective Targeting of AF9 YEATS Domain by Cyclopeptide Inhibitors with Preorganized Conformation. </span><span class="cited-content_cbyCitation_journal-name">Journal of the American Chemical Society</span><span> <strong>2020,</strong> <em>142 </em>
                                    (51)
                                     , 21450-21459. <a href="https://doi.org/10.1021/jacs.0c10324" title="DOI URL">https://doi.org/10.1021/jacs.0c10324</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jacs.0c10324&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjacs.0c10324%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520the%2520American%2520Chemical%2520Society%26atitle%3DSelective%252BTargeting%252Bof%252BAF9%252BYEATS%252BDomain%252Bby%252BCyclopeptide%252BInhibitors%252Bwith%252BPreorganized%252BConformation%26aulast%3DJiang%26aufirst%3DYixiang%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D05102020%26date%3D11122020%26volume%3D142%26issue%3D51%26spage%3D21450%26epage%3D21459" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Gaochan Wu, Tong Zhao, Dongwei Kang, Jian Zhang, Yuning Song, Vigneshwaran Namasivayam, Jacob Kongsted, Christophe Pannecouque, Erik De Clercq, Vasanthanathan Poongavanam, Xinyong Liu, <span class="NLM_string-name hlFld-ContribAuthor">Peng Zhan</span>. </span><span class="cited-content_cbyCitation_article-title">Overview of Recent Strategic Advances in Medicinal Chemistry. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (21)
                                     , 9375-9414. <a href="https://doi.org/10.1021/acs.jmedchem.9b00359" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b00359</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b00359&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b00359%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DOverview%252Bof%252BRecent%252BStrategic%252BAdvances%252Bin%252BMedicinal%252BChemistry%26aulast%3DWu%26aufirst%3DGaochan%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D26022019%26date%3D28052019%26date%3D03052019%26volume%3D62%26issue%3D21%26spage%3D9375%26epage%3D9414" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Joo-Youn Lee, Hyunkyung Cho, Sundarapandian Thangapandian, Chaemin Lim, Young-Jin Chun, Yoonji Lee, Sun Choi, <span class="NLM_string-name hlFld-ContribAuthor">Sanghee Kim</span>. </span><span class="cited-content_cbyCitation_article-title">Adaptable Small Ligand of CYP1 Enzymes for Use in Understanding the Structural Features Determining Isoform Selectivity. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2018,</strong> <em>9 </em>
                                    (12)
                                     , 1247-1252. <a href="https://doi.org/10.1021/acsmedchemlett.8b00409" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.8b00409</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.8b00409&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.8b00409%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DAdaptable%252BSmall%252BLigand%252Bof%252BCYP1%252BEnzymes%252Bfor%252BUse%252Bin%252BUnderstanding%252Bthe%252BStructural%252BFeatures%252BDetermining%252BIsoform%252BSelectivity%26aulast%3DLee%26aufirst%3DJoo-Youn%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D06092018%26date%3D29102018%26date%3D02112018%26date%3D29102018%26volume%3D9%26issue%3D12%26spage%3D1247%26epage%3D1252" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Xiaoyang Li, Yuri K. Peterson, Elizabeth S. Inks, Richard A. Himes, Jiaying Li, Yingjie Zhang, Xiujie Kong, <span class="NLM_string-name hlFld-ContribAuthor">C. James Chou</span>. </span><span class="cited-content_cbyCitation_article-title">Class I HDAC Inhibitors Display Different Antitumor Mechanism in Leukemia and Prostatic Cancer Cells Depending on Their p53 Status. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (6)
                                     , 2589-2603. <a href="https://doi.org/10.1021/acs.jmedchem.8b00136" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00136</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00136&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b00136%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DClass%252BI%252BHDAC%252BInhibitors%252BDisplay%252BDifferent%252BAntitumor%252BMechanism%252Bin%252BLeukemia%252Band%252BProstatic%252BCancer%252BCells%252BDepending%252Bon%252BTheir%252Bp53%252BStatus%26aulast%3DLi%26aufirst%3DXiaoyang%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D25012018%26date%3D09032018%26date%3D02032018%26volume%3D61%26issue%3D6%26spage%3D2589%26epage%3D2603" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Han  Ju</span>, <span class="hlFld-ContribAuthor ">Jian  Zhang</span>, <span class="hlFld-ContribAuthor ">Boshi  Huang</span>, <span class="hlFld-ContribAuthor ">Dongwei  Kang</span>, <span class="hlFld-ContribAuthor ">Bing  Huang</span>, <span class="hlFld-ContribAuthor ">Xinyong  Liu</span>, and <span class="hlFld-ContribAuthor ">Peng  Zhan</span>  . </span><span class="cited-content_cbyCitation_article-title">Inhibitors of Influenza Virus Polymerase Acidic (PA) Endonuclease: Contemporary Developments and Perspectives. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (9)
                                     , 3533-3551. <a href="https://doi.org/10.1021/acs.jmedchem.6b01227" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b01227</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b01227&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b01227%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DInhibitors%252Bof%252BInfluenza%252BVirus%252BPolymerase%252BAcidic%252B%252528PA%252529%252BEndonuclease%25253A%252BContemporary%252BDevelopments%252Band%252BPerspectives%26aulast%3DJu%26aufirst%3DHan%26date%3D2017%26date%3D2017%26date%3D2016%26date%3D13082016%26date%3D07022017%26date%3D11052017%26date%3D24012017%26volume%3D60%26issue%3D9%26spage%3D3533%26epage%3D3551" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xin  Chen</span>, <span class="hlFld-ContribAuthor ">John  Giraldes</span>, <span class="hlFld-ContribAuthor ">Elizabeth R.  Sprague</span>, <span class="hlFld-ContribAuthor ">Subarna  Shakya</span>, <span class="hlFld-ContribAuthor ">Zhuoliang  Chen</span>, <span class="hlFld-ContribAuthor ">Yaping  Wang</span>, <span class="hlFld-ContribAuthor ">Carol  Joud</span>, <span class="hlFld-ContribAuthor ">Simon  Mathieu</span>, <span class="hlFld-ContribAuthor ">Christine Hiu-Tung  Chen</span>, <span class="hlFld-ContribAuthor ">Christopher  Straub</span>, <span class="hlFld-ContribAuthor ">Jose  Duca</span>, <span class="hlFld-ContribAuthor ">Kristen  Hurov</span>, <span class="hlFld-ContribAuthor ">Yanqiu  Yuan</span>, <span class="hlFld-ContribAuthor ">Wenlin  Shao</span>, and <span class="hlFld-ContribAuthor ">B. Barry  Touré</span>  . </span><span class="cited-content_cbyCitation_article-title">“Addition” and “Subtraction”: Selectivity Design for Type II Maternal Embryonic Leucine Zipper Kinase Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (5)
                                     , 2155-2161. <a href="https://doi.org/10.1021/acs.jmedchem.7b00033" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b00033</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b00033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b00033%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3D%2525E2%252580%25259CAddition%2525E2%252580%25259D%252Band%252B%2525E2%252580%25259CSubtraction%2525E2%252580%25259D%25253A%252BSelectivity%252BDesign%252Bfor%252BType%252BII%252BMaternal%252BEmbryonic%252BLeucine%252BZipper%252BKinase%252BInhibitors%26aulast%3DChen%26aufirst%3DXin%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D09012017%26date%3D24022017%26date%3D09032017%26date%3D10022017%26volume%3D60%26issue%3D5%26spage%3D2155%26epage%3D2161" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Peng  Zhan</span>, <span class="hlFld-ContribAuthor ">Christophe  Pannecouque</span>, <span class="hlFld-ContribAuthor ">Erik  De Clercq</span>, and <span class="hlFld-ContribAuthor ">Xinyong  Liu</span>  . </span><span class="cited-content_cbyCitation_article-title">Anti-HIV Drug Discovery and Development: Current Innovations and Future Trends. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (7)
                                     , 2849-2878. <a href="https://doi.org/10.1021/acs.jmedchem.5b00497" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b00497</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b00497&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.5b00497%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DAnti-HIV%252BDrug%252BDiscovery%252Band%252BDevelopment%25253A%252BCurrent%252BInnovations%252Band%252BFuture%252BTrends%26aulast%3DZhan%26aufirst%3DPeng%26date%3D2016%26date%3D2015%26date%3D2015%26date%3D27032015%26date%3D05112015%26date%3D14042016%26date%3D28102015%26volume%3D59%26issue%3D7%26spage%3D2849%26epage%3D2878" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kai-Cheng  Hsu</span>, <span class="hlFld-ContribAuthor ">Jung-Chun  Chu</span>, <span class="hlFld-ContribAuthor ">Hui-Ju  Tseng</span>, <span class="hlFld-ContribAuthor ">Chia-I  Liu</span>, <span class="hlFld-ContribAuthor ">Hao-Ching  Wang</span>, <span class="hlFld-ContribAuthor ">Tony Eight  Lin</span>, <span class="hlFld-ContribAuthor ">Hong-Sheng  Lee</span>, <span class="hlFld-ContribAuthor ">Ling-Wei  Hsin</span>, <span class="hlFld-ContribAuthor ">Andrew H.-J.  Wang</span>, <span class="hlFld-ContribAuthor ">Chien-Huang  Lin</span>, <span class="hlFld-ContribAuthor ">Wei-Jan  Huang</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and biological evaluation of phenothiazine derivative-containing hydroxamic acids as potent class II histone deacetylase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>219 </em>, 113419. <a href="https://doi.org/10.1016/j.ejmech.2021.113419" title="DOI URL">https://doi.org/10.1016/j.ejmech.2021.113419</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2021.113419&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2021.113419%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bphenothiazine%252Bderivative-containing%252Bhydroxamic%252Bacids%252Bas%252Bpotent%252Bclass%252BII%252Bhistone%252Bdeacetylase%252Binhibitors%26aulast%3DHsu%26aufirst%3DKai-Cheng%26date%3D2021%26volume%3D219%26spage%3D113419" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Renata  Mikstacka</span>, <span class="hlFld-ContribAuthor ">Zbigniew  Dutkiewicz</span>. </span><span class="cited-content_cbyCitation_article-title">New Perspectives of CYP1B1 Inhibitors in the Light of Molecular Studies. </span><span class="cited-content_cbyCitation_journal-name">Processes</span><span> <strong>2021,</strong> <em>9 </em>
                                    (5)
                                     , 817. <a href="https://doi.org/10.3390/pr9050817" title="DOI URL">https://doi.org/10.3390/pr9050817</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/pr9050817&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fpr9050817%26sid%3Dliteratum%253Aachs%26jtitle%3DProcesses%26atitle%3DNew%252BPerspectives%252Bof%252BCYP1B1%252BInhibitors%252Bin%252Bthe%252BLight%252Bof%252BMolecular%252BStudies%26aulast%3DMikstacka%26aufirst%3DRenata%26date%3D2021%26date%3D2021%26volume%3D9%26issue%3D5%26spage%3D817" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiaosa  Chang</span>, <span class="hlFld-ContribAuthor ">Dejuan  Sun</span>, <span class="hlFld-ContribAuthor ">Danfeng  Shi</span>, <span class="hlFld-ContribAuthor ">Guan  Wang</span>, <span class="hlFld-ContribAuthor ">Yanmei  Chen</span>, <span class="hlFld-ContribAuthor ">Kai  Zhang</span>, <span class="hlFld-ContribAuthor ">Huidan  Tan</span>, <span class="hlFld-ContribAuthor ">Jie  Liu</span>, <span class="hlFld-ContribAuthor ">Bo  Liu</span>, <span class="hlFld-ContribAuthor ">Liang  Ouyang</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis, and biological evaluation of quinazolin-4(3H)-one derivatives co-targeting poly(ADP-ribose) polymerase-1 and bromodomain containing protein 4 for breast cancer therapy. </span><span class="cited-content_cbyCitation_journal-name">Acta Pharmaceutica Sinica B</span><span> <strong>2021,</strong> <em>11 </em>
                                    (1)
                                     , 156-180. <a href="https://doi.org/10.1016/j.apsb.2020.06.003" title="DOI URL">https://doi.org/10.1016/j.apsb.2020.06.003</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.apsb.2020.06.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.apsb.2020.06.003%26sid%3Dliteratum%253Aachs%26jtitle%3DActa%2520Pharmaceutica%2520Sinica%2520B%26atitle%3DDesign%25252C%252Bsynthesis%25252C%252Band%252Bbiological%252Bevaluation%252Bof%252Bquinazolin-4%2525283H%252529-one%252Bderivatives%252Bco-targeting%252Bpoly%252528ADP-ribose%252529%252Bpolymerase-1%252Band%252Bbromodomain%252Bcontaining%252Bprotein%252B4%252Bfor%252Bbreast%252Bcancer%252Btherapy%26aulast%3DChang%26aufirst%3DXiaosa%26date%3D2021%26volume%3D11%26issue%3D1%26spage%3D156%26epage%3D180" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yuya  Fujita</span>, <span class="hlFld-ContribAuthor ">Naoki  Matsuoka</span>, <span class="hlFld-ContribAuthor ">Jumpei  Temmoku</span>, <span class="hlFld-ContribAuthor ">Makiko  Furuya-Yashiro</span>, <span class="hlFld-ContribAuthor ">Tomoyuki  Asano</span>, <span class="hlFld-ContribAuthor ">Shuzo  Sato</span>, <span class="hlFld-ContribAuthor ">Haruki  Matsumoto</span>, <span class="hlFld-ContribAuthor ">Hiroshi  Watanabe</span>, <span class="hlFld-ContribAuthor ">Hideko  Kozuru</span>, <span class="hlFld-ContribAuthor ">Hiroshi  Yatsuhashi</span>, <span class="hlFld-ContribAuthor ">Atsushi  Kawakami</span>, <span class="hlFld-ContribAuthor ">Kiyoshi  Migita</span>. </span><span class="cited-content_cbyCitation_article-title">JAK inhibitors impair GM-CSF-mediated signaling in innate immune cells. </span><span class="cited-content_cbyCitation_journal-name">BMC Immunology</span><span> <strong>2020,</strong> <em>21 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/s12865-020-00365-w" title="DOI URL">https://doi.org/10.1186/s12865-020-00365-w</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s12865-020-00365-w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs12865-020-00365-w%26sid%3Dliteratum%253Aachs%26jtitle%3DBMC%2520Immunology%26atitle%3DJAK%252Binhibitors%252Bimpair%252BGM-CSF-mediated%252Bsignaling%252Bin%252Binnate%252Bimmune%252Bcells%26aulast%3DFujita%26aufirst%3DYuya%26date%3D2020%26date%3D2020%26volume%3D21%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wei  Luo</span>, <span class="hlFld-ContribAuthor ">Cherukupalli  Srinivasulu</span>, <span class="hlFld-ContribAuthor ">Xia  Hao</span>, <span class="hlFld-ContribAuthor ">Xinyong  Liu</span>, <span class="hlFld-ContribAuthor ">Peng  Zhan</span>. </span><span class="cited-content_cbyCitation_article-title">The increasing impact of Chinese innovative drug research on the global stage with a focus on drug discovery. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Drug Discovery</span><span> <strong>2020,</strong> <em>15 </em>
                                    (10)
                                     , 1115-1120. <a href="https://doi.org/10.1080/17460441.2020.1775577" title="DOI URL">https://doi.org/10.1080/17460441.2020.1775577</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/17460441.2020.1775577&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F17460441.2020.1775577%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Drug%2520Discovery%26atitle%3DThe%252Bincreasing%252Bimpact%252Bof%252BChinese%252Binnovative%252Bdrug%252Bresearch%252Bon%252Bthe%252Bglobal%252Bstage%252Bwith%252Ba%252Bfocus%252Bon%252Bdrug%252Bdiscovery%26aulast%3DLuo%26aufirst%3DWei%26date%3D2020%26date%3D2020%26volume%3D15%26issue%3D10%26spage%3D1115%26epage%3D1120" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ekta  Shirbhate</span>, <span class="hlFld-ContribAuthor ">Preeti  Patel</span>, <span class="hlFld-ContribAuthor ">Vijay K  Patel</span>, <span class="hlFld-ContribAuthor ">Ravichandran  Veerasamy</span>, <span class="hlFld-ContribAuthor ">Prabodh C  Sharma</span>, <span class="hlFld-ContribAuthor ">Harish  Rajak</span>. </span><span class="cited-content_cbyCitation_article-title">The combination of histone deacetylase inhibitors and radiotherapy: a promising novel approach for cancer treatment. </span><span class="cited-content_cbyCitation_journal-name">Future Oncology</span><span> <strong>2020,</strong> <em>16 </em>
                                    (30)
                                     , 2457-2469. <a href="https://doi.org/10.2217/fon-2020-0385" title="DOI URL">https://doi.org/10.2217/fon-2020-0385</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2217/fon-2020-0385&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2217%2Ffon-2020-0385%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Oncology%26atitle%3DThe%252Bcombination%252Bof%252Bhistone%252Bdeacetylase%252Binhibitors%252Band%252Bradiotherapy%25253A%252Ba%252Bpromising%252Bnovel%252Bapproach%252Bfor%252Bcancer%252Btreatment%26aulast%3DShirbhate%26aufirst%3DEkta%26date%3D2020%26volume%3D16%26issue%3D30%26spage%3D2457%26epage%3D2469" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Weike  Liao</span>, <span class="hlFld-ContribAuthor ">Zhongyuan  Wang</span>, <span class="hlFld-ContribAuthor ">Yufei  Han</span>, <span class="hlFld-ContribAuthor ">Yinliang  Qi</span>, <span class="hlFld-ContribAuthor ">Jiaan  Liu</span>, <span class="hlFld-ContribAuthor ">Juan  Xie</span>, <span class="hlFld-ContribAuthor ">Ye  Tian</span>, <span class="hlFld-ContribAuthor ">Qiancheng  Lei</span>, <span class="hlFld-ContribAuthor ">Rui  Chen</span>, <span class="hlFld-ContribAuthor ">Ming  Sun</span>, <span class="hlFld-ContribAuthor ">Lei  Tang</span>, <span class="hlFld-ContribAuthor ">Guowei  Gong</span>, <span class="hlFld-ContribAuthor ">Yanfang  Zhao</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and biological activity of novel 2,3,4,5-tetra-substituted thiophene derivatives as PI3Kα inhibitors with potent antitumor activity. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>197 </em>, 112309. <a href="https://doi.org/10.1016/j.ejmech.2020.112309" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112309</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112309&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112309%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bactivity%252Bof%252Bnovel%252B2%25252C3%25252C4%25252C5-tetra-substituted%252Bthiophene%252Bderivatives%252Bas%252BPI3K%2525CE%2525B1%252Binhibitors%252Bwith%252Bpotent%252Bantitumor%252Bactivity%26aulast%3DLiao%26aufirst%3DWeike%26date%3D2020%26volume%3D197%26spage%3D112309" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">. </span><span class="cited-content_cbyCitation_article-title">Drug Targets. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,, 1-96. <a href="https://doi.org/10.1002/9781119607311.ch1" title="DOI URL">https://doi.org/10.1002/9781119607311.ch1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9781119607311.ch1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9781119607311.ch1%26sid%3Dliteratum%253Aachs%26atitle%3DDrug%252BTargets%26date%3D2020%26date%3D2020%26spage%3D1%26epage%3D96%26pub%3DWiley%26atitle%3DMedicinal%252BChemistry%252Bfor%252BPractitioners%26aulast%3DLi%26aufirst%3DJie%2BJack%26date%3D2020%26date%3D2020%26volume%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Loredana  Cappellacci</span>, <span class="hlFld-ContribAuthor ">Diego R.  Perinelli</span>, <span class="hlFld-ContribAuthor ">Filippo  Maggi</span>, <span class="hlFld-ContribAuthor ">Mario  Grifantini</span>, <span class="hlFld-ContribAuthor ">Riccardo  Petrelli</span>. </span><span class="cited-content_cbyCitation_article-title">Recent Progress in Histone Deacetylase Inhibitors as Anticancer Agents. </span><span class="cited-content_cbyCitation_journal-name">Current Medicinal Chemistry</span><span> <strong>2020,</strong> <em>27 </em>
                                    (15)
                                     , 2449-2493. <a href="https://doi.org/10.2174/0929867325666181016163110" title="DOI URL">https://doi.org/10.2174/0929867325666181016163110</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/0929867325666181016163110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F0929867325666181016163110%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Medicinal%2520Chemistry%26atitle%3DRecent%252BProgress%252Bin%252BHistone%252BDeacetylase%252BInhibitors%252Bas%252BAnticancer%252BAgents%26aulast%3DCappellacci%26aufirst%3DLoredana%26date%3D2020%26volume%3D27%26issue%3D15%26spage%3D2449%26epage%3D2493" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">V. A.  Zolottsev</span>, <span class="hlFld-ContribAuthor ">A. S.  Latysheva</span>, <span class="hlFld-ContribAuthor ">V. S.  Pokrovsky</span>, <span class="hlFld-ContribAuthor ">I. I.  Khan</span>, <span class="hlFld-ContribAuthor ">R. L. M.  Almanza</span>, <span class="hlFld-ContribAuthor ">A. Y.  Misharin</span>. </span><span class="cited-content_cbyCitation_article-title">STEROID CONJUGATES AS POTENTIAL ANTI-CANCER AGENTS. </span><span class="cited-content_cbyCitation_journal-name">Russian Journal of Biotherapy</span><span> <strong>2020,</strong> <em>19 </em>
                                    (1)
                                     , 22-52. <a href="https://doi.org/10.17650/1726-9784-2019-19-1-22-52" title="DOI URL">https://doi.org/10.17650/1726-9784-2019-19-1-22-52</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.17650/1726-9784-2019-19-1-22-52&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.17650%2F1726-9784-2019-19-1-22-52%26sid%3Dliteratum%253Aachs%26jtitle%3DRussian%2520Journal%2520of%2520Biotherapy%26atitle%3DSTEROID%252BCONJUGATES%252BAS%252BPOTENTIAL%252BANTI-CANCER%252BAGENTS%26aulast%3DZolottsev%26aufirst%3DV.%2BA.%26date%3D2020%26date%3D2020%26volume%3D19%26issue%3D1%26spage%3D22%26epage%3D52" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yukihiro  Itoh</span>. </span><span class="cited-content_cbyCitation_article-title">Drug Discovery Researches on Modulators of Lysine-Modifying Enzymes Based on Strategic Chemistry Approaches. </span><span class="cited-content_cbyCitation_journal-name">Chemical and Pharmaceutical Bulletin</span><span> <strong>2020,</strong> <em>68 </em>
                                    (1)
                                     , 34-45. <a href="https://doi.org/10.1248/cpb.c19-00741" title="DOI URL">https://doi.org/10.1248/cpb.c19-00741</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1248/cpb.c19-00741&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1248%2Fcpb.c19-00741%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520and%2520Pharmaceutical%2520Bulletin%26atitle%3DDrug%252BDiscovery%252BResearches%252Bon%252BModulators%252Bof%252BLysine-Modifying%252BEnzymes%252BBased%252Bon%252BStrategic%252BChemistry%252BApproaches%26aulast%3DItoh%26aufirst%3DYukihiro%26date%3D2020%26volume%3D68%26issue%3D1%26spage%3D34%26epage%3D45" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lanlan  Jing</span>, <span class="hlFld-ContribAuthor ">Gaochan  Wu</span>, <span class="hlFld-ContribAuthor ">Xia  Hao</span>, <span class="hlFld-ContribAuthor ">Fisayo A.  Olotu</span>, <span class="hlFld-ContribAuthor ">Dongwei  Kang</span>, <span class="hlFld-ContribAuthor ">Chin Ho  Chen</span>, <span class="hlFld-ContribAuthor ">Kuo-Hsiung  Lee</span>, <span class="hlFld-ContribAuthor ">Mahmoud E.S.  Soliman</span>, <span class="hlFld-ContribAuthor ">Xinyong  Liu</span>, <span class="hlFld-ContribAuthor ">Yuning  Song</span>, <span class="hlFld-ContribAuthor ">Peng  Zhan</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of highly potent and selective Cdc25 protein phosphatases inhibitors from miniaturization click-chemistry-based combinatorial libraries. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>183 </em>, 111696. <a href="https://doi.org/10.1016/j.ejmech.2019.111696" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.111696</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.111696&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.111696%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DIdentification%252Bof%252Bhighly%252Bpotent%252Band%252Bselective%252BCdc25%252Bprotein%252Bphosphatases%252Binhibitors%252Bfrom%252Bminiaturization%252Bclick-chemistry-based%252Bcombinatorial%252Blibraries%26aulast%3DJing%26aufirst%3DLanlan%26date%3D2019%26volume%3D183%26spage%3D111696" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bing  Zhang</span>, <span class="hlFld-ContribAuthor ">Xiwen  Dai</span>, <span class="hlFld-ContribAuthor ">Ziyang  Bao</span>, <span class="hlFld-ContribAuthor ">Qing  Mao</span>, <span class="hlFld-ContribAuthor ">Yulin  Duan</span>, <span class="hlFld-ContribAuthor ">Yuwei  Yang</span>, <span class="hlFld-ContribAuthor ">Shaojie  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting the subpocket in xanthine oxidase: Design, synthesis, and biological evaluation of 2-[4-alkoxy-3-(1H-tetrazol-1-yl) phenyl]-6-oxo-1,6-dihydropyrimidine-5-carboxylic acid derivatives. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>181 </em>, 111559. <a href="https://doi.org/10.1016/j.ejmech.2019.07.062" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.07.062</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.07.062&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.07.062%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DTargeting%252Bthe%252Bsubpocket%252Bin%252Bxanthine%252Boxidase%25253A%252BDesign%25252C%252Bsynthesis%25252C%252Band%252Bbiological%252Bevaluation%252Bof%252B2-%25255B4-alkoxy-3-%2525281H-tetrazol-1-yl%252529%252Bphenyl%25255D-6-oxo-1%25252C6-dihydropyrimidine-5-carboxylic%252Bacid%252Bderivatives%26aulast%3DZhang%26aufirst%3DBing%26date%3D2019%26volume%3D181%26spage%3D111559" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xia  Hao</span>, <span class="hlFld-ContribAuthor ">Xiaofang  Zuo</span>, <span class="hlFld-ContribAuthor ">Dongwei  Kang</span>, <span class="hlFld-ContribAuthor ">Jian  Zhang</span>, <span class="hlFld-ContribAuthor ">Yuning  Song</span>, <span class="hlFld-ContribAuthor ">Xinyong  Liu</span>, <span class="hlFld-ContribAuthor ">Peng  Zhan</span>. </span><span class="cited-content_cbyCitation_article-title">Contemporary medicinal-chemistry strategies for discovery of blood coagulation factor Xa inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Drug Discovery</span><span> <strong>2019,</strong> <em>14 </em>
                                    (9)
                                     , 915-931. <a href="https://doi.org/10.1080/17460441.2019.1626821" title="DOI URL">https://doi.org/10.1080/17460441.2019.1626821</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/17460441.2019.1626821&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F17460441.2019.1626821%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Drug%2520Discovery%26atitle%3DContemporary%252Bmedicinal-chemistry%252Bstrategies%252Bfor%252Bdiscovery%252Bof%252Bblood%252Bcoagulation%252Bfactor%252BXa%252Binhibitors%26aulast%3DHao%26aufirst%3DXia%26date%3D2019%26date%3D2019%26volume%3D14%26issue%3D9%26spage%3D915%26epage%3D931" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Feifei  Yang</span>, <span class="hlFld-ContribAuthor ">Na  Zhao</span>, <span class="hlFld-ContribAuthor ">Di  Ge</span>, <span class="hlFld-ContribAuthor ">Yihua  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Next-generation of selective histone deacetylase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2019,</strong> <em>9 </em>
                                    (34)
                                     , 19571-19583. <a href="https://doi.org/10.1039/C9RA02985K" title="DOI URL">https://doi.org/10.1039/C9RA02985K</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C9RA02985K&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC9RA02985K%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DNext-generation%252Bof%252Bselective%252Bhistone%252Bdeacetylase%252Binhibitors%26aulast%3DYang%26aufirst%3DFeifei%26date%3D2019%26date%3D2019%26volume%3D9%26issue%3D34%26spage%3D19571%26epage%3D19583" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shuo  Zhang</span>, <span class="hlFld-ContribAuthor ">Jian  Zhang</span>, <span class="hlFld-ContribAuthor ">Ping  Gao</span>, <span class="hlFld-ContribAuthor ">Lin  Sun</span>, <span class="hlFld-ContribAuthor ">Yuning  Song</span>, <span class="hlFld-ContribAuthor ">Dongwei  Kang</span>, <span class="hlFld-ContribAuthor ">Xinyong  Liu</span>, <span class="hlFld-ContribAuthor ">Peng  Zhan</span>. </span><span class="cited-content_cbyCitation_article-title">Efficient drug discovery by rational lead hybridization based on crystallographic overlay. </span><span class="cited-content_cbyCitation_journal-name">Drug Discovery Today</span><span> <strong>2019,</strong> <em>24 </em>
                                    (3)
                                     , 805-813. <a href="https://doi.org/10.1016/j.drudis.2018.11.021" title="DOI URL">https://doi.org/10.1016/j.drudis.2018.11.021</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.drudis.2018.11.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.drudis.2018.11.021%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Discovery%2520Today%26atitle%3DEfficient%252Bdrug%252Bdiscovery%252Bby%252Brational%252Blead%252Bhybridization%252Bbased%252Bon%252Bcrystallographic%252Boverlay%26aulast%3DZhang%26aufirst%3DShuo%26date%3D2019%26volume%3D24%26issue%3D3%26spage%3D805%26epage%3D813" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lanlan  Jing</span>, <span class="hlFld-ContribAuthor ">Gaochan  Wu</span>, <span class="hlFld-ContribAuthor ">Dongwei  Kang</span>, <span class="hlFld-ContribAuthor ">Zhongxia  Zhou</span>, <span class="hlFld-ContribAuthor ">Yuning  Song</span>, <span class="hlFld-ContribAuthor ">Xinyong  Liu</span>, <span class="hlFld-ContribAuthor ">Peng  Zhan</span>. </span><span class="cited-content_cbyCitation_article-title">Contemporary medicinal-chemistry strategies for the discovery of selective butyrylcholinesterase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Drug Discovery Today</span><span> <strong>2019,</strong> <em>24 </em>
                                    (2)
                                     , 629-635. <a href="https://doi.org/10.1016/j.drudis.2018.11.012" title="DOI URL">https://doi.org/10.1016/j.drudis.2018.11.012</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.drudis.2018.11.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.drudis.2018.11.012%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Discovery%2520Today%26atitle%3DContemporary%252Bmedicinal-chemistry%252Bstrategies%252Bfor%252Bthe%252Bdiscovery%252Bof%252Bselective%252Bbutyrylcholinesterase%252Binhibitors%26aulast%3DJing%26aufirst%3DLanlan%26date%3D2019%26volume%3D24%26issue%3D2%26spage%3D629%26epage%3D635" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Han  Ju</span>, <span class="hlFld-ContribAuthor ">Peng  Zhan</span>, <span class="hlFld-ContribAuthor ">Xinyong  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Designing influenza polymerase acidic endonuclease inhibitors via ‘privileged scaffold’ re-evolution/refining strategy. </span><span class="cited-content_cbyCitation_journal-name">Future Medicinal Chemistry</span><span> <strong>2019,</strong> <em>11 </em>
                                    (4)
                                     , 265-268. <a href="https://doi.org/10.4155/fmc-2018-0489" title="DOI URL">https://doi.org/10.4155/fmc-2018-0489</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fmc-2018-0489&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffmc-2018-0489%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Medicinal%2520Chemistry%26atitle%3DDesigning%252Binfluenza%252Bpolymerase%252Bacidic%252Bendonuclease%252Binhibitors%252Bvia%252B%2525E2%252580%252598privileged%252Bscaffold%2525E2%252580%252599%252Bre-evolution%25252Frefining%252Bstrategy%26aulast%3DJu%26aufirst%3DHan%26date%3D2019%26volume%3D11%26issue%3D4%26spage%3D265%26epage%3D268" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qing  Liu</span>, <span class="hlFld-ContribAuthor ">Andreas  Herrmann</span>, <span class="hlFld-ContribAuthor ">Qiang  Huang</span>. </span><span class="cited-content_cbyCitation_article-title">Surface Binding Energy Landscapes Affect Phosphodiesterase Isoform-Specific Inhibitor Selectivity. </span><span class="cited-content_cbyCitation_journal-name">Computational and Structural Biotechnology Journal</span><span> <strong>2019,</strong> <em>17 </em>, 101-109. <a href="https://doi.org/10.1016/j.csbj.2018.11.009" title="DOI URL">https://doi.org/10.1016/j.csbj.2018.11.009</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.csbj.2018.11.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.csbj.2018.11.009%26sid%3Dliteratum%253Aachs%26jtitle%3DComputational%2520and%2520Structural%2520Biotechnology%2520Journal%26atitle%3DSurface%252BBinding%252BEnergy%252BLandscapes%252BAffect%252BPhosphodiesterase%252BIsoform-Specific%252BInhibitor%252BSelectivity%26aulast%3DLiu%26aufirst%3DQing%26date%3D2019%26volume%3D17%26spage%3D101%26epage%3D109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yosuke  Ota</span>, <span class="hlFld-ContribAuthor ">Takayoshi  Suzuki</span>. </span><span class="cited-content_cbyCitation_article-title">Drug Design Concepts for LSD1‐Selective Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">The Chemical Record</span><span> <strong>2018,</strong> <em>18 </em>
                                    (12)
                                     , 1782-1791. <a href="https://doi.org/10.1002/tcr.201810031" title="DOI URL">https://doi.org/10.1002/tcr.201810031</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/tcr.201810031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Ftcr.201810031%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Chemical%2520Record%26atitle%3DDrug%252BDesign%252BConcepts%252Bfor%252BLSD1%2525E2%252580%252590Selective%252BInhibitors%26aulast%3DOta%26aufirst%3DYosuke%26date%3D2018%26date%3D2018%26volume%3D18%26issue%3D12%26spage%3D1782%26epage%3D1791" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiaofang  Zuo</span>, <span class="hlFld-ContribAuthor ">Zhipeng  Huo</span>, <span class="hlFld-ContribAuthor ">Dongwei  Kang</span>, <span class="hlFld-ContribAuthor ">Gaochan  Wu</span>, <span class="hlFld-ContribAuthor ">Zhongxia  Zhou</span>, <span class="hlFld-ContribAuthor ">Xinyong  Liu</span>, <span class="hlFld-ContribAuthor ">Peng  Zhan</span>. </span><span class="cited-content_cbyCitation_article-title">Current insights into anti-HIV drug discovery and development: a review of recent patent literature (2014–2017). </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Patents</span><span> <strong>2018,</strong> <em>28 </em>
                                    (4)
                                     , 299-316. <a href="https://doi.org/10.1080/13543776.2018.1438410" title="DOI URL">https://doi.org/10.1080/13543776.2018.1438410</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/13543776.2018.1438410&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F13543776.2018.1438410%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Patents%26atitle%3DCurrent%252Binsights%252Binto%252Banti-HIV%252Bdrug%252Bdiscovery%252Band%252Bdevelopment%25253A%252Ba%252Breview%252Bof%252Brecent%252Bpatent%252Bliterature%252B%2525282014%2525E2%252580%2525932017%252529%26aulast%3DZuo%26aufirst%3DXiaofang%26date%3D2018%26date%3D2018%26volume%3D28%26issue%3D4%26spage%3D299%26epage%3D316" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Oscar  Méndez-Lucio</span>, <span class="hlFld-ContribAuthor ">J. Jesús  Naveja</span>, <span class="hlFld-ContribAuthor ">Hugo  Vite-Caritino</span>, <span class="hlFld-ContribAuthor ">Fernando D.  Prieto-Martínez</span>, <span class="hlFld-ContribAuthor ">José L.  Medina-Franco</span>. </span><span class="cited-content_cbyCitation_article-title">Polypharmacology in Drug Discovery. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 1-29. <a href="https://doi.org/10.1002/9783527674381.ch1" title="DOI URL">https://doi.org/10.1002/9783527674381.ch1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9783527674381.ch1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9783527674381.ch1%26sid%3Dliteratum%253Aachs%26atitle%3DPolypharmacology%252Bin%252BDrug%252BDiscovery%26aulast%3DM%25C3%25A9ndez-Lucio%26aufirst%3DOscar%26date%3D2017%26date%3D2017%26spage%3D1%26epage%3D29%26pub%3DWiley-VCH%2520Verlag%2520GmbH%2520%2526%2520Co.%2520KGaA%26atitle%3DDrug%252BSelectivity%26aulast%3DHandler%26aufirst%3DNorbert%26date%3D2017%26volume%3D58" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jingjing  Liu</span>, <span class="hlFld-ContribAuthor ">Jiaxi  Xu</span>, <span class="hlFld-ContribAuthor ">Zhenjiang  Li</span>, <span class="hlFld-ContribAuthor ">Yu  Huang</span>, <span class="hlFld-ContribAuthor ">Haixin  Wang</span>, <span class="hlFld-ContribAuthor ">Yu  Gao</span>, <span class="hlFld-ContribAuthor ">Tianfo  Guo</span>, <span class="hlFld-ContribAuthor ">Pingkai  Ouyang</span>, <span class="hlFld-ContribAuthor ">Kai  Guo</span>. </span><span class="cited-content_cbyCitation_article-title">Carbocation Organocatalysis in Interrupted Povarov Reactions to
              cis
              -Fused Pyrano- and Furanobenzodihydropyrans. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Organic Chemistry</span><span> <strong>2017,</strong> <em>2017 </em>
                                    (27)
                                     , 3996-4003. <a href="https://doi.org/10.1002/ejoc.201700634" title="DOI URL">https://doi.org/10.1002/ejoc.201700634</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ejoc.201700634&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fejoc.201700634%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DCarbocation%252BOrganocatalysis%252Bin%252BInterrupted%252BPovarov%252BReactions%252Bto%252Bcis%252B-Fused%252BPyrano-%252Band%252BFuranobenzodihydropyrans%26aulast%3DLiu%26aufirst%3DJingjing%26date%3D2017%26date%3D2017%26volume%3D2017%26issue%3D27%26spage%3D3996%26epage%3D4003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Vijaya Rao  Pidugu</span>, <span class="hlFld-ContribAuthor ">Nagendra Sastry  Yarla</span>, <span class="hlFld-ContribAuthor ">Srinivasa Rao  Pedada</span>, <span class="hlFld-ContribAuthor ">Arunasree M.  Kalle</span>, <span class="hlFld-ContribAuthor ">A. Krishna  Satya</span>. </span><span class="cited-content_cbyCitation_article-title">Design and synthesis of novel HDAC8 inhibitory 2,5-disubstituted-1,3,4-oxadiazoles containing glycine and alanine hybrids with anti cancer activity. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2016,</strong> <em>24 </em>
                                    (21)
                                     , 5611-5617. <a href="https://doi.org/10.1016/j.bmc.2016.09.022" title="DOI URL">https://doi.org/10.1016/j.bmc.2016.09.022</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2016.09.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2016.09.022%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDesign%252Band%252Bsynthesis%252Bof%252Bnovel%252BHDAC8%252Binhibitory%252B2%25252C5-disubstituted-1%25252C3%25252C4-oxadiazoles%252Bcontaining%252Bglycine%252Band%252Balanine%252Bhybrids%252Bwith%252Banti%252Bcancer%252Bactivity%26aulast%3DPidugu%26aufirst%3DVijaya%2BRao%26date%3D2016%26volume%3D24%26issue%3D21%26spage%3D5611%26epage%3D5617" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gervais  Bérubé</span>. </span><span class="cited-content_cbyCitation_article-title">An overview of molecular hybrids in drug discovery. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Drug Discovery</span><span> <strong>2016,</strong> <em>11 </em>
                                    (3)
                                     , 281-305. <a href="https://doi.org/10.1517/17460441.2016.1135125" title="DOI URL">https://doi.org/10.1517/17460441.2016.1135125</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1517/17460441.2016.1135125&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1517%2F17460441.2016.1135125%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Drug%2520Discovery%26atitle%3DAn%252Boverview%252Bof%252Bmolecular%252Bhybrids%252Bin%252Bdrug%252Bdiscovery%26aulast%3DB%25C3%25A9rub%25C3%25A9%26aufirst%3DGervais%26date%3D2016%26date%3D2016%26volume%3D11%26issue%3D3%26spage%3D281%26epage%3D305" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xueshun  Wang</span>, <span class="hlFld-ContribAuthor ">Boshi  Huang</span>, <span class="hlFld-ContribAuthor ">Xinyong  Liu</span>, <span class="hlFld-ContribAuthor ">Peng  Zhan</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of bioactive molecules from CuAAC click-chemistry-based combinatorial libraries. </span><span class="cited-content_cbyCitation_journal-name">Drug Discovery Today</span><span> <strong>2016,</strong> <em>21 </em>
                                    (1)
                                     , 118-132. <a href="https://doi.org/10.1016/j.drudis.2015.08.004" title="DOI URL">https://doi.org/10.1016/j.drudis.2015.08.004</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.drudis.2015.08.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.drudis.2015.08.004%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Discovery%2520Today%26atitle%3DDiscovery%252Bof%252Bbioactive%252Bmolecules%252Bfrom%252BCuAAC%252Bclick-chemistry-based%252Bcombinatorial%252Blibraries%26aulast%3DWang%26aufirst%3DXueshun%26date%3D2016%26volume%3D21%26issue%3D1%26spage%3D118%26epage%3D132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00229/20151002/images/medium/jm-2015-00229v_0033.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00229/20151002/images/large/jm-2015-00229v_0033.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00229&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00229/20151002/images/medium/jm-2015-00229v_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00229/20151002/images/large/jm-2015-00229v_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Schematic overview of medicinal–chemical strategies for discovery of target-specific or isoform-selective inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00229/20151002/images/large/jm-2015-00229v_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00229&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00229/20151002/images/medium/jm-2015-00229v_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00229/20151002/images/large/jm-2015-00229v_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Structure of inhibitor <b>1</b> (colored in yellow) complexed with nNOS (heme domain) (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3B3N">3B3N</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00229/20151002/images/large/jm-2015-00229v_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00229&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00229/20151002/images/medium/jm-2015-00229v_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00229/20151002/images/large/jm-2015-00229v_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Proposed mechanisms of (a) LSD1 catalysis and (b) activation of <b>2</b>, leading to inactivation of LSD1 by flavin modification.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00229/20151002/images/large/jm-2015-00229v_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00229&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00229/20151002/images/medium/jm-2015-00229v_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00229/20151002/images/large/jm-2015-00229v_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. (a) Crystallographic overlays of reduced FAD–<i>N</i>-propargyl lysine peptide conjugate (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2UXN">2UXN</a>) (green and blue) and FAD–PCPA conjugate (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2UXX">2UXX</a>) (magenta) in the catalytic site of LSD1. For the sake of clarity, amino acid residues in the catalytic site are omitted. (b) Chemical structures and in vitro inhibitory activities of compounds <b>3</b>–<b>5</b> toward LSD1 and MAO-A/B.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00229/20151002/images/large/jm-2015-00229v_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00229&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00229/20151002/images/medium/jm-2015-00229v_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00229/20151002/images/large/jm-2015-00229v_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Discovery of mechanism-based LSD1-selective inactivators.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00229/20151002/images/large/jm-2015-00229v_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00229&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00229/20151002/images/medium/jm-2015-00229v_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00229/20151002/images/large/jm-2015-00229v_0006.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Identification of carbonic acid isozyme-selective binders from a dynamic constitutional library. Target-driven self-screening of inhibitors occurs until the system reaches a thermodynamic minimum.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00229/20151002/images/large/jm-2015-00229v_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00229&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00229/20151002/images/medium/jm-2015-00229v_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00229/20151002/images/large/jm-2015-00229v_0007.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Target-guided assembly of selective binders via azide–alkyne 1,3-dipolar cycloaddition.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00229/20151002/images/large/jm-2015-00229v_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00229&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00229/20151002/images/medium/jm-2015-00229v_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00229/20151002/images/large/jm-2015-00229v_0008.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Discovery of HDAC8 inhibitor (<b>12</b>) via protein-templated click chemistry.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00229/20151002/images/large/jm-2015-00229v_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00229&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00229/20151002/images/medium/jm-2015-00229v_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00229/20151002/images/large/jm-2015-00229v_0009.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Selective aldo-keto reductase AKR1C1 and AKR1C3 inhibitor.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00229/20151002/images/large/jm-2015-00229v_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00229&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig10" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00229/20151002/images/medium/jm-2015-00229v_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00229/20151002/images/large/jm-2015-00229v_0010.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Crystal structure of compound (+)-<b>14</b> complexed with human BChE (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4TPK">4TPK</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00229/20151002/images/large/jm-2015-00229v_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00229&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig11" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00229/20151002/images/medium/jm-2015-00229v_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00229/20151002/images/large/jm-2015-00229v_0011.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. Substrate-based approach to design of isoform-selective inhibitors of epigenetic enzymes. The initial substrates <b>15</b> and <b>25</b> are used in the commercially available assay kits.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00229/20151002/images/large/jm-2015-00229v_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00229&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig12" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00229/20151002/images/medium/jm-2015-00229v_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00229/20151002/images/large/jm-2015-00229v_0012.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 12. Crystal structures of (a) human sirtuin homologue <b>5</b> complexed with <b>26</b> (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2NYR">2NYR</a>) and (b) sirtuin 2-deacetylated peptide complexed with <b>23</b> and 2′-<i>O</i>-acetyl adenosine-5-diphosphoribose (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2H4J">2H4J</a>). (c) Superposition of the binding modes of <b>22</b> and <b>23</b>. For the sake of clarity, amino acid residues in the active site are omitted.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00229/20151002/images/large/jm-2015-00229v_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00229&amp;id=fig12"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig13" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 13</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00229/20151002/images/medium/jm-2015-00229v_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00229/20151002/images/large/jm-2015-00229v_0013.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 13. Fragment-based approach to the design of substrate-derived STEP-selective inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00229/20151002/images/large/jm-2015-00229v_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00229&amp;id=fig13"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig14" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 14</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00229/20151002/images/medium/jm-2015-00229v_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00229/20151002/images/large/jm-2015-00229v_0014.jpeg" id="rightTab-gr14" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 14. Derivation of <b>31</b> from a virtual hit molecule <b>30</b> and structure of PDE2A complexed with <b>31</b> (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4HTX">4HTX</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00229/20151002/images/large/jm-2015-00229v_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00229&amp;id=fig14"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig15" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 15</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00229/20151002/images/medium/jm-2015-00229v_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00229/20151002/images/large/jm-2015-00229v_0015.jpeg" id="rightTab-gr15" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 15. Discovery of highly potent and selective fused pyrimidine-based MMP-13 inhibitors without any ZBG.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00229/20151002/images/large/jm-2015-00229v_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00229&amp;id=fig15"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig16" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Figure 16</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00229/20151002/images/medium/jm-2015-00229v_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00229/20151002/images/large/jm-2015-00229v_0016.jpeg" id="rightTab-gr16" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 16. Co-crystal structures of CDK2 with hit <b>35</b> (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3QQK">3QQK</a>) and diaminothiazole <b>36</b> (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3QXP">3QXP</a>), which is a highly selective inhibitor of CDK2/5.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00229/20151002/images/large/jm-2015-00229v_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00229&amp;id=fig16"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig17" data-index="17" class="article__inlineFigure"><h2 class="fig-label">Figure 17</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00229/20151002/images/medium/jm-2015-00229v_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00229/20151002/images/large/jm-2015-00229v_0017.jpeg" id="rightTab-gr17" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 17. Structure-based design of highly selective PDE9 inhibitor <b>38</b> from lead <b>37</b> (the selectivity panel data were not provided in the original paper) (a) and the crystal structure of the complex of the PDE9 catalytic domain with <b>38</b> (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4GH6">4GH6</a>); (b) for a surface presentation; (c) for a stick model. The Tyr424 is emphasized by large bold font.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00229/20151002/images/large/jm-2015-00229v_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00229&amp;id=fig17"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig18" data-index="18" class="article__inlineFigure"><h2 class="fig-label">Figure 18</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00229/20151002/images/medium/jm-2015-00229v_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00229/20151002/images/large/jm-2015-00229v_0018.jpeg" id="rightTab-gr18" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 18. Design of a potent and isoform-selective covalent PI3Kα inhibitor <b>40</b> and X-ray structure of the complex of PI3Kα with <b>40</b> (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3ZIM">3ZIM</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00229/20151002/images/large/jm-2015-00229v_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00229&amp;id=fig18"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig19" data-index="19" class="article__inlineFigure"><h2 class="fig-label">Figure 19</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00229/20151002/images/medium/jm-2015-00229v_0019.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00229/20151002/images/large/jm-2015-00229v_0019.jpeg" id="rightTab-gr19" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 19. Design of isoform-selective PI3Kβ inhibitor <b>42</b> targeting nonconserved Asp862 of PI3Kβ.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00229/20151002/images/large/jm-2015-00229v_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00229&amp;id=fig19"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig20" data-index="20" class="article__inlineFigure"><h2 class="fig-label">Figure 20</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00229/20151002/images/medium/jm-2015-00229v_0020.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00229/20151002/images/large/jm-2015-00229v_0020.jpeg" id="rightTab-gr20" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 20. (a) Design of novel hybrid molecule <b>45</b> as a PI3Kγ-selective inhibitor. (b) Superimposed complexes of PI3Kγ with <b>43</b> (pink, PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4ANV">4ANV</a>) and with <b>44</b> (green, PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4ANU">4ANU</a>). (c) Structure of <b>45</b> complexed with PI3Kγ (yellow, PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4ANW">4ANW</a>). (d) Superposition of all three X-ray crystal structures.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00229/20151002/images/large/jm-2015-00229v_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00229&amp;id=fig20"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig21" data-index="21" class="article__inlineFigure"><h2 class="fig-label">Figure 21</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00229/20151002/images/medium/jm-2015-00229v_0021.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00229/20151002/images/large/jm-2015-00229v_0021.jpeg" id="rightTab-gr21" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 21. Design of tetrahydropyrimidopyrimidinone-based selective Vps34 inhibitors and binding modes of compounds <b>47</b> and <b>48</b> complexed with VPS34 (PDB codes <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4OYS">4OYS</a> and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4UWL">4UWL</a>, respectively).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00229/20151002/images/large/jm-2015-00229v_0021.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00229&amp;id=fig21"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig22" data-index="22" class="article__inlineFigure"><h2 class="fig-label">Figure 22</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00229/20151002/images/medium/jm-2015-00229v_0022.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00229/20151002/images/large/jm-2015-00229v_0022.jpeg" id="rightTab-gr22" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 22. Design of a selective Grp94 inhibitor <b>50</b> targeting the unique π-rich pocket.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00229/20151002/images/large/jm-2015-00229v_0022.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00229&amp;id=fig22"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig23" data-index="23" class="article__inlineFigure"><h2 class="fig-label">Figure 23</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00229/20151002/images/medium/jm-2015-00229v_0023.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00229/20151002/images/large/jm-2015-00229v_0023.jpeg" id="rightTab-gr23" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 23. Design of thiazolopyrimidine <b>52</b>. The structure of the complex with Syk (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4FYO">4FYO</a>) is shown with Pro455 and Asn457 highlighted in red.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00229/20151002/images/large/jm-2015-00229v_0023.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00229&amp;id=fig23"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig24" data-index="24" class="article__inlineFigure"><h2 class="fig-label">Figure 24</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00229/20151002/images/medium/jm-2015-00229v_0024.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00229/20151002/images/large/jm-2015-00229v_0024.jpeg" id="rightTab-gr24" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 24. Design of TYK2 selective inhibitor <b>54</b> based on structural overlay of TYK2 (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4GIH">4GIH</a>) and JAK2 (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4GMY">4GMY</a>) complexes with lead compound <b>53</b> (TYK2 pink, JAK2 green), highlighting the discrepancy of P-loop conformations between TYK2 and JAK2 and the sequence difference (Arg901 versus Gln853) in the cyclopropylamide target site.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00229/20151002/images/large/jm-2015-00229v_0024.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00229&amp;id=fig24"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig25" data-index="25" class="article__inlineFigure"><h2 class="fig-label">Figure 25</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00229/20151002/images/medium/jm-2015-00229v_0025.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00229/20151002/images/large/jm-2015-00229v_0025.jpeg" id="rightTab-gr25" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 25. (a) X-ray structure of complex of <b>55</b> with JAK1 (blue, Glu966 from structure <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4EHZ">4EHZ</a>) overlaid with the corresponding structure of JAK2 (yellow, Asp939 from PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4F09">4F09</a>) to show the pivotal residue difference. (b) Design of imidazopyrrolopyridine (<b>56</b>) as a JAK1-selective inhibitor. (c) X-ray structure of the complex of <b>56</b> with JAK1 (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4IVB">4IVB</a>). (d) X-ray structure of the complex of <b>56</b> with JAK2 (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4IVA">4IVA</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00229/20151002/images/large/jm-2015-00229v_0025.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00229&amp;id=fig25"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig26" data-index="26" class="article__inlineFigure"><h2 class="fig-label">Figure 26</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00229/20151002/images/medium/jm-2015-00229v_0026.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00229/20151002/images/large/jm-2015-00229v_0026.jpeg" id="rightTab-gr26" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 26. Design of JAK3-selective inhibitor <b>59</b> via structure-based modification of initial phenyl ether.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00229/20151002/images/large/jm-2015-00229v_0026.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00229&amp;id=fig26"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig27" data-index="27" class="article__inlineFigure"><h2 class="fig-label">Figure 27</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00229/20151002/images/medium/jm-2015-00229v_0027.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00229/20151002/images/large/jm-2015-00229v_0027.jpeg" id="rightTab-gr27" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 27. Discovery of selective epigenetic inhibitors via structure-based drug design combined with homology modeling.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00229/20151002/images/large/jm-2015-00229v_0027.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00229&amp;id=fig27"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig28" data-index="28" class="article__inlineFigure"><h2 class="fig-label">Figure 28</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00229/20151002/images/medium/jm-2015-00229v_0028.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00229/20151002/images/large/jm-2015-00229v_0028.jpeg" id="rightTab-gr28" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 28. Design of highly selective salicylketoxime-based estrogen receptor β agonists.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00229/20151002/images/large/jm-2015-00229v_0028.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00229&amp;id=fig28"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig29" data-index="29" class="article__inlineFigure"><h2 class="fig-label">Figure 29</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00229/20151002/images/medium/jm-2015-00229v_0029.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00229/20151002/images/large/jm-2015-00229v_0029.jpeg" id="rightTab-gr29" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 29. Conformationally restricted bioactive molecules.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00229/20151002/images/large/jm-2015-00229v_0029.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00229&amp;id=fig29"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig30" data-index="30" class="article__inlineFigure"><h2 class="fig-label">Figure 30</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00229/20151002/images/medium/jm-2015-00229v_0030.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00229/20151002/images/large/jm-2015-00229v_0030.jpeg" id="rightTab-gr30" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 30. Schematic representation of conformationally restricted aminoglycosides.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00229/20151002/images/large/jm-2015-00229v_0030.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00229&amp;id=fig30"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig31" data-index="31" class="article__inlineFigure"><h2 class="fig-label">Figure 31</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00229/20151002/images/medium/jm-2015-00229v_0031.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00229/20151002/images/large/jm-2015-00229v_0031.jpeg" id="rightTab-gr31" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 31. Identification of highly selective and potent epigenetic inhibitors by using click chemistry-based combinatorial fragment assembly.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00229/20151002/images/large/jm-2015-00229v_0031.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00229&amp;id=fig31"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig32" data-index="32" class="article__inlineFigure"><h2 class="fig-label">Figure 32</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00229/20151002/images/medium/jm-2015-00229v_0032.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00229/20151002/images/large/jm-2015-00229v_0032.jpeg" id="rightTab-gr32" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 32. Application of the CuAAC reaction to construct a library of <b>83</b>-derived triazole derivatives, coupled with rapid screening.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00229/20151002/images/large/jm-2015-00229v_0032.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00229&amp;id=fig32"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i22">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_50853" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_50853" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 84 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Morphy, R.</span><span> </span><span class="NLM_article-title">Selectively nonselective kinase inhibition: striking the right balance</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">1413</span><span class="NLM_x">–</span> <span class="NLM_lpage">1437</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm901132v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00229&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtlWmtbfF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=1413-1437&author=R.+Morphy&title=Selectively+nonselective+kinase+inhibition%3A+striking+the+right+balance"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1aR"><div class="casContent"><span class="casTitleNuber">1a</span><div class="casTitle"><span class="NLM_cas:atitle">Selectively Nonselective Kinase Inhibition: Striking the Right Balance</span></div><div class="casAuthors">Morphy, Richard</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1413-1437</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Marketed kinase inhibitors (MKIs) can deliver superior efficacy compared to inhibitors with high specificity for a single kinase, and the recent introduction of several MKIs to the market opens the door to a new era of safer and effective anticancer therapy.  The key to combining high efficacy with acceptable safety is to inhibit multiple targets in a selectively nonselective fashion.  Strategies for intentionally designing MKIs are emerging, but the field is still in its infancy and we are as medicinal chemists currently on the steepest part of the learning curve.  MTDD can be time-consuming and expensive, and we need to become more proficient first at identifying disease-relevant target combinations and second at discovering MKIs that combine optimal physicochem. and biol. properties.  Bold and innovative medicinal chem. strategies are required to tackle "difficult combinations" where the disease rationale is compelling but where it is a struggle to combine all the desired attributes of an oral MKI drug into a single mol.  At present it is unclear to what extent MKIs with highly tuned selectivity profiles can be rationally designed, particularly for targets that are unrelated by sequence.  In addn. to the well-known selectivity challenge, the physicochem. property profiles of AT P-competitive MKIs can be inherently challenging and limited scope for patentability can also be a serious hindrance.  On the plus side, the amt. of kinase-specific structural information is growing very rapidly, and ultimately this may reveal distinct features and design rules that enable a medicinal chemist to rationally modify and refine the profile of MKIs.  In addn., increasing SAR knowledge is emerging from large scale panel screening with the binding profiles starting to reveal to medicinal chemists how chem. structure affects cross-reactivity across large parts of the kinome.  The merit of MKIs compared with single kinase inhibitors is a subject of controversy in drug discovery that is unlikely to be resolved in the near future.  At the start of a new MTDD project, a rigorous debate needs to take place as to whether it makes more sense to seek a combination of highly selective agents or a DML.  Many factors need to be taken into account in this decision such as the no., similarity, and promiscuity of the targets in the profile and the disease area.  Conformational plasticity and the occurrence of multiple binding modes complicate the in silico prediction of kinase polypharmacol. based solely upon protein structure.  The use of ligand-based similarity to assess the feasibility of a given combination can add real value.  Currently, serendipity plays a significant role in MKI discovery and many, if not most, MKIs have been discovered by chance during the search for selective inhibitors.  Medicinal chemists need to be alert to the possibilities when a surprising combination is found by chance.  To exploit such serendipity, you need a good appreciation of when you have a sufficiently high quality starting compd. and then you need to be able to make and test sufficient analogs to explore your new disease-based hypothesis.  MKIs are costly to develop and are consequently priced at a premium level, so they will need to show clear improvements in order to get reimbursement.  There have already been problems with reimbursement for some MKIs in some markets due to concerns from funding bodies over insufficient efficacy.  The true value of MKIs relative to other anticancer drugs still has to be established, and the results from recent clin. trials have been mixed.  Despite the broad activity profile of many MKIs, the patient response can be inconsistent and unpredictable.  The identification of predictive biomarkers of response or resistance is a crit. step to ascertain which specific combination of targets produces a significant clin. benefit with respect to specific tumor types.  More clin. feedback is needed to facilitate the design of the next generation of inhibitors with more precisely defined profiles.  Although it might seem immeasurably distant at the present time, the ultimate goal should be to derive the prerequisite knowledge and tools so that MTDD becomes a rational endeavor rather than a black box approach that relies upon serendipity.  This will help banish claims that MKIs are merely dirty, nonspecific drugs with insufficient specificity for treating a wider range of human diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-L-NWmtdikbVg90H21EOLACvtfcHk0lhGolriM_FG8A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtlWmtbfF&md5=3c915b5debf9d005993c8ad31c68bc2e</span></div><a href="/servlet/linkout?suffix=cit1a&amp;dbid=16384&amp;doi=10.1021%2Fjm901132v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901132v%26sid%3Dliteratum%253Aachs%26aulast%3DMorphy%26aufirst%3DR.%26atitle%3DSelectively%2520nonselective%2520kinase%2520inhibition%253A%2520striking%2520the%2520right%2520balance%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D1413%26epage%3D1437" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit1b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Jeong, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kwon, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hong, S.</span><span> </span><span class="NLM_article-title">Selective and potent small-molecule inhibitors of PI3Ks</span> <span class="citation_source-journal">Future Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">737</span><span class="NLM_x">–</span> <span class="NLM_lpage">756</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00229&amp;key=10.4155%2Ffmc.14.28" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00229&amp;key=24941870" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00229&amp;key=1%3ACAS%3A528%3ADC%252BC2cXpvFCrsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2014&pages=737-756&author=Y.+Jeongauthor=D.+Kwonauthor=S.+Hong&title=Selective+and+potent+small-molecule+inhibitors+of+PI3Ks"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1bR"><div class="casContent"><span class="casTitleNuber">1b</span><div class="casTitle"><span class="NLM_cas:atitle">Selective and potent small-molecule inhibitors of PI3Ks</span></div><div class="casAuthors">Jeong, Yujeong; Kwon, Daeil; Hong, Sungwoo</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">737-756</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">A review.  Class I PI3Ks are composed of four catalytic subunit variants (p110α, p110β, p110δ and p110γ).  The PI3K pathway is among the most frequently activated pathways in many diseases, and has emerged as an attractive target for drug development, in particular for the treatment of many human cancers including breast, prostate, ovarian, gastric, colon and hepatocellular cancers.  One of the challenges in the discovery of drugs that target kinases is designing small-mol. inhibitors that are sufficiently selective to minimize off-target activity and reduce the risk of potential toxicity.  This review explores the current landscape of PI3K-selective inhibitor development and highlights recent advances in achieving selectivity for PI3Ks over other protein kinases, with an emphasis on available structural information.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9ZY08eojS4bVg90H21EOLACvtfcHk0lhGolriM_FG8A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXpvFCrsb0%253D&md5=f683c444e4bfb9e325a43819617b39d3</span></div><a href="/servlet/linkout?suffix=cit1b&amp;dbid=16384&amp;doi=10.4155%2Ffmc.14.28&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc.14.28%26sid%3Dliteratum%253Aachs%26aulast%3DJeong%26aufirst%3DY.%26aulast%3DKwon%26aufirst%3DD.%26aulast%3DHong%26aufirst%3DS.%26atitle%3DSelective%2520and%2520potent%2520small-molecule%2520inhibitors%2520of%2520PI3Ks%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2014%26volume%3D6%26spage%3D737%26epage%3D756" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit1c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Hojjat-Farsangi, M.</span><span> </span><span class="NLM_article-title">Small-molecule inhibitors of the receptor tyrosine kinases: promising tools for targeted cancer therapies</span> <span class="citation_source-journal">Int. J. Mol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">13768</span><span class="NLM_x">–</span> <span class="NLM_lpage">13801</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00229&amp;key=10.3390%2Fijms150813768" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00229&amp;key=25110867" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00229&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhslyqu7zI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2014&pages=13768-13801&author=M.+Hojjat-Farsangi&title=Small-molecule+inhibitors+of+the+receptor+tyrosine+kinases%3A+promising+tools+for+targeted+cancer+therapies"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1cR"><div class="casContent"><span class="casTitleNuber">1c</span><div class="casTitle"><span class="NLM_cas:atitle">Small-molecule inhibitors of the receptor tyrosine kinases: promising tools for targeted cancer therapies</span></div><div class="casAuthors">Hojjat-Farsangi, Mohammad</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Molecular Sciences</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">13768-13801, 34</span>CODEN:
                <span class="NLM_cas:coden">IJMCFK</span>;
        ISSN:<span class="NLM_cas:issn">1422-0067</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">A review.  Chemotherapeutic and cytotoxic drugs are widely used in the treatment of cancer.  In spite of the improvements in the life quality of patients, their effectiveness is compromised by several disadvantages.  This represents a demand for developing new effective strategies with focusing on tumor cells and min. side effects.  Targeted cancer therapies and personalized medicine have been defined as a new type of emerging treatments.  Small mol. inhibitors (SMIs) are among the most effective drugs for targeted cancer therapy.  The growing no. of approved SMIs of receptor tyrosine kinases (RTKs) i.e., tyrosine kinase inhibitors (TKIs) in the clin. oncol. imply the increasing attention and application of these therapeutic tools.  Most of the current approved RTK-TKIs in preclin. and clin. settings are multi-targeted inhibitors with several side effects.  Only a few specific/selective RTK-TKIs have been developed for the treatment of cancer patients.  Specific/selective RTK-TKIs have shown less deleterious effects compared to multi-targeted inhibitors.  This review intends to highlight the importance of specific/selective TKIs for future development with less side effects and more manageable agents.  This article provides an overview of: (1) the characteristics and function of RTKs and TKIs; (2) the recent advances in the improvement of specific/selective RTK-TKIs in preclin. or clin. settings; and (3) emerging RTKs for targeted cancer therapies by TKIs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr0oFHs0APBNrVg90H21EOLACvtfcHk0lhfGyYPbVzf_A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhslyqu7zI&md5=08836c25f587f44f2843abc6b2d3587f</span></div><a href="/servlet/linkout?suffix=cit1c&amp;dbid=16384&amp;doi=10.3390%2Fijms150813768&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fijms150813768%26sid%3Dliteratum%253Aachs%26aulast%3DHojjat-Farsangi%26aufirst%3DM.%26atitle%3DSmall-molecule%2520inhibitors%2520of%2520the%2520receptor%2520tyrosine%2520kinases%253A%2520promising%2520tools%2520for%2520targeted%2520cancer%2520therapies%26jtitle%3DInt.%2520J.%2520Mol.%2520Sci.%26date%3D2014%26volume%3D15%26spage%3D13768%26epage%3D13801" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit1d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Dymock, B. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, E. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chu-Farseeva, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, L.</span><span> </span><span class="NLM_article-title">Selective JAK inhibitors</span> <span class="citation_source-journal">Future Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">1439</span><span class="NLM_x">–</span> <span class="NLM_lpage">1471</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00229&amp;key=10.4155%2Ffmc.14.92" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1d&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00229&amp;key=25329199" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00229&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhslOhu7jI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2014&pages=1439-1471&author=B.+W.+Dymockauthor=E.+G.+Yangauthor=Y.+Chu-Farseevaauthor=L.+Yao&title=Selective+JAK+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1dR"><div class="casContent"><span class="casTitleNuber">1d</span><div class="casTitle"><span class="NLM_cas:atitle">Selective JAK inhibitors</span></div><div class="casAuthors">Dymock, Brian W.; Yang, Eugene Guorong; Chu-Farseeva, Yuyi; Yao, Lianbin</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1439-1471</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">A review.  Consisting of four members, JAK1, JAK2, JAK3 and TYK2, the JAK kinases have emerged as important targets for proliferative and immune-inflammatory disorders.  Recent progress in the discovery of selective inhibitors has been significant, with selective compds. now reported for each isoform.  This article summarizes the current state-of-the-art with a discussion of the most recently described selective compds.  X-ray co-crystal structures reveal the mol. reasons for the obsd. biochem. selectivity.  A concluding anal. of JAK inhibitors in the clinic highlights increased clin. trial activity and diversity of indications.  Selective JAK inhibitors, as single agents or in combination regimens, have a very promising future in the treatment of oncol., immune and inflammatory diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo6G9eFT7Ww27Vg90H21EOLACvtfcHk0lhfGyYPbVzf_A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhslOhu7jI&md5=343aa75228918e6e4e063adb1fed96f1</span></div><a href="/servlet/linkout?suffix=cit1d&amp;dbid=16384&amp;doi=10.4155%2Ffmc.14.92&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc.14.92%26sid%3Dliteratum%253Aachs%26aulast%3DDymock%26aufirst%3DB.%2BW.%26aulast%3DYang%26aufirst%3DE.%2BG.%26aulast%3DChu-Farseeva%26aufirst%3DY.%26aulast%3DYao%26aufirst%3DL.%26atitle%3DSelective%2520JAK%2520inhibitors%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2014%26volume%3D6%26spage%3D1439%26epage%3D1471" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Falkenberg, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnstone, R. W.</span><span> </span><span class="NLM_article-title">Histone deacetylases and their inhibitors in cancer, neurological diseases and immune disorders</span> <span class="citation_source-journal">Nature Rev. Drug. Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">673</span><span class="NLM_x">–</span> <span class="NLM_lpage">691</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2014&pages=673-691&author=K.+J.+Falkenbergauthor=R.+W.+Johnstone&title=Histone+deacetylases+and+their+inhibitors+in+cancer%2C+neurological+diseases+and+immune+disorders"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFalkenberg%26aufirst%3DK.%2BJ.%26aulast%3DJohnstone%26aufirst%3DR.%2BW.%26atitle%3DHistone%2520deacetylases%2520and%2520their%2520inhibitors%2520in%2520cancer%252C%2520neurological%2520diseases%2520and%2520immune%2520disorders%26jtitle%3DNature%2520Rev.%2520Drug.%2520Discovery%26date%3D2014%26volume%3D13%26spage%3D673%26epage%3D691" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit2b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Suzuki, T.</span><span> </span><span class="NLM_article-title">Explorative study on isoform-selective histone deacetylase inhibitors</span> <span class="citation_source-journal">Chem. Pharm. Bull.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">897</span><span class="NLM_x">–</span> <span class="NLM_lpage">906</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2009&pages=897-906&author=T.+Suzuki&title=Explorative+study+on+isoform-selective+histone+deacetylase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSuzuki%26aufirst%3DT.%26atitle%3DExplorative%2520study%2520on%2520isoform-selective%2520histone%2520deacetylase%2520inhibitors%26jtitle%3DChem.%2520Pharm.%2520Bull.%26date%3D2009%26volume%3D57%26spage%3D897%26epage%3D906" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Alterio, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Fiore, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D’Ambrosio, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Supuran, C. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Simone, G.</span><span> </span><span class="NLM_article-title">Multiple binding modes of inhibitors to carbonic anhydrases: how to design specific drugs targeting 15 different isoforms?</span> <span class="citation_source-journal">Chem. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">112</span><span class="NLM_x">, </span> <span class="NLM_fpage">4421</span><span class="NLM_x">–</span> <span class="NLM_lpage">4468</span></span><div class="citationLinks">[<a href="/doi/10.1021/cr200176r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=112&publication_year=2012&pages=4421-4468&author=V.+Alterioauthor=A.+Di+Fioreauthor=K.+D%E2%80%99Ambrosioauthor=C.+T.+Supuranauthor=G.+De+Simone&title=Multiple+binding+modes+of+inhibitors+to+carbonic+anhydrases%3A+how+to+design+specific+drugs+targeting+15+different+isoforms%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1021%2Fcr200176r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr200176r%26sid%3Dliteratum%253Aachs%26aulast%3DAlterio%26aufirst%3DV.%26aulast%3DDi%2BFiore%26aufirst%3DA.%26aulast%3DD%25E2%2580%2599Ambrosio%26aufirst%3DK.%26aulast%3DSupuran%26aufirst%3DC.%2BT.%26aulast%3DDe%2BSimone%26aufirst%3DG.%26atitle%3DMultiple%2520binding%2520modes%2520of%2520inhibitors%2520to%2520carbonic%2520anhydrases%253A%2520how%2520to%2520design%2520specific%2520drugs%2520targeting%252015%2520different%2520isoforms%253F%26jtitle%3DChem.%2520Rev.%26date%3D2012%26volume%3D112%26spage%3D4421%26epage%3D4468" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Bhat, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tummalapalli, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rotella, D. P.</span><span> </span><span class="NLM_article-title">Progress in the discovery and development of heat shock protein 90 (Hsp90) Inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">8718</span><span class="NLM_x">–</span> <span class="NLM_lpage">8728</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm500823a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00229&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsVSnsrfK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=8718-8728&author=R.+Bhatauthor=S.+R.+Tummalapalliauthor=D.+P.+Rotella&title=Progress+in+the+discovery+and+development+of+heat+shock+protein+90+%28Hsp90%29+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Progress in the Discovery and Development of Heat Shock Protein 90 (Hsp90) Inhibitors</span></div><div class="casAuthors">Bhat, Rohit; Tummalapalli, Sreedhar R.; Rotella, David P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">8718-8728</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The discovery and clin. development of heat shock protein 90 (Hsp90) inhibitors continue to progress.  A no. of Hsp90 inhibitors are in clin. trials, and preclin. discoveries of new chemotypes that bind to distinct regions in the protein as well as isoform selective compds. are active areas of research.  This review will highlight progress in the field since 2010.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-SwLv_-B9xLVg90H21EOLACvtfcHk0lgaErxOFCgSjA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsVSnsrfK&md5=132784687bbbcf62cfa8fe04a22577ce</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1021%2Fjm500823a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm500823a%26sid%3Dliteratum%253Aachs%26aulast%3DBhat%26aufirst%3DR.%26aulast%3DTummalapalli%26aufirst%3DS.%2BR.%26aulast%3DRotella%26aufirst%3DD.%2BP.%26atitle%3DProgress%2520in%2520the%2520discovery%2520and%2520development%2520of%2520heat%2520shock%2520protein%252090%2520%2528Hsp90%2529%2520Inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D8718%26epage%3D8728" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Erdal, E. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Litzinger, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ji, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silverman, R. B.</span><span> </span><span class="NLM_article-title">Selective neuronal nitric oxide synthase inhibitors</span> <span class="citation_source-journal">Curr. Top Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">603</span><span class="NLM_x">–</span> <span class="NLM_lpage">624</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00229&amp;key=10.2174%2F1568026054679317" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00229&amp;key=16101423" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00229&amp;key=1%3ACAS%3A528%3ADC%252BD2MXpsFGhtr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2005&pages=603-624&author=E.+P.+Erdalauthor=E.+A.+Litzingerauthor=J.+Seoauthor=Y.+Zhuauthor=H.+Jiauthor=R.+B.+Silverman&title=Selective+neuronal+nitric+oxide+synthase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Selective neuronal nitric oxide synthase inhibitors</span></div><div class="casAuthors">Erdal, Erik P.; Litzinger, Elizabeth A.; Seo, Jiwon; Zhu, Yaoqiu; Ji, Haitao; Silverman, Richard B.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">603-624</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  This review includes the non-patent literature up to Oct. 2004 that deals with selective neuronal nitric oxide synthase inhibitors (highest potency is for the neuronal isoenzyme).  Some non-selective inhibitors or selective inducible nitric oxide synthase inhibitors are mentioned if they are related to compds. that are discussed; structures of these compds. generally are not given.  In vitro inhibition consts. are given either as IC50 values or as Ki values.  An IC50 value, the inhibitor concn. that produces 50% inhibition in the presence of a const. concn. of substrate, is obtained by extrapolation of several rate data points to 50% inhibition.  Ki values are derived from several types of plots that relate the concn. of inhibitor with enzyme velocity in the presence of a variety of substrate concns.  The Ki value can be estd. from the IC50 value.  Although the two inhibition consts. are related, they are not the same; generally, the reported Ki values tend to be lower than the IC50 values.  If specifics are desired about how the data were collected, then the reader will have to look in the literature cited.  No attempt was made to be exhaustive in citing all refs. related to specific inhibitors; rather, examples of literature refs. are given for each inhibitor described.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrD4wFCjsRzF7Vg90H21EOLACvtfcHk0liJDMjaazq9pQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXpsFGhtr4%253D&md5=c338f82141c7af37470fd1cf9afecc75</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.2174%2F1568026054679317&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568026054679317%26sid%3Dliteratum%253Aachs%26aulast%3DErdal%26aufirst%3DE.%2BP.%26aulast%3DLitzinger%26aufirst%3DE.%2BA.%26aulast%3DSeo%26aufirst%3DJ.%26aulast%3DZhu%26aufirst%3DY.%26aulast%3DJi%26aufirst%3DH.%26aulast%3DSilverman%26aufirst%3DR.%2BB.%26atitle%3DSelective%2520neuronal%2520nitric%2520oxide%2520synthase%2520inhibitors%26jtitle%3DCurr.%2520Top%2520Med.%2520Chem.%26date%3D2005%26volume%3D5%26spage%3D603%26epage%3D624" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Zhan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Itoh, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span> </span><span class="NLM_article-title">Recent advances in the structure-based rational design of TNKSIs</span> <span class="citation_source-journal">Mol. Biosyst.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">2783</span><span class="NLM_x">–</span> <span class="NLM_lpage">2799</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00229&amp;key=10.1039%2FC4MB00385C" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00229&amp;key=25211064" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00229&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsVersLbP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2014&pages=2783-2799&author=P.+Zhanauthor=Y.+Songauthor=Y.+Itohauthor=T.+Suzukiauthor=X.+Liu&title=Recent+advances+in+the+structure-based+rational+design+of+TNKSIs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Recent advances in the structure-based rational design of TNKSIs</span></div><div class="casAuthors">Zhan, Peng; Song, Yu'ning; Itoh, Yukihiro; Suzuki, Takayoshi; Liu, Xinyong</div><div class="citationInfo"><span class="NLM_cas:title">Molecular BioSystems</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2783-2799</span>CODEN:
                <span class="NLM_cas:coden">MBOIBW</span>;
        ISSN:<span class="NLM_cas:issn">1742-2051</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A review.  Human tankyrases 1 and 2 (TNKS1/2) are attractive pharmacol. biotargets, esp. for the treatment of specific types of cancer.  This article provides a fairly comprehensive overview of the structural biol. of the TNKS-inhibitor complex and the current medicinal chem. strategies being used in the structure-based rational design of tankyrase-specific inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoKsymkDwCMxLVg90H21EOLACvtfcHk0liJDMjaazq9pQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsVersLbP&md5=ff91450e15ffa81a39ef5667f300d77b</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1039%2FC4MB00385C&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC4MB00385C%26sid%3Dliteratum%253Aachs%26aulast%3DZhan%26aufirst%3DP.%26aulast%3DSong%26aufirst%3DY.%26aulast%3DItoh%26aufirst%3DY.%26aulast%3DSuzuki%26aufirst%3DT.%26aulast%3DLiu%26aufirst%3DX.%26atitle%3DRecent%2520advances%2520in%2520the%2520structure-based%2520rational%2520design%2520of%2520TNKSIs%26jtitle%3DMol.%2520Biosyst.%26date%3D2014%26volume%3D10%26spage%3D2783%26epage%3D2799" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Thinnes, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">England, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawamura, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chowdhury, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schofield, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hopkinson, R. J.</span><span> </span><span class="NLM_article-title">Targeting histone lysine demethylases—progress, challenges, and the future</span> <span class="citation_source-journal">Biochim. Biophys. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">1839</span><span class="NLM_x">, </span> <span class="NLM_fpage">1416</span><span class="NLM_x">–</span> <span class="NLM_lpage">1432</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1839&publication_year=2014&pages=1416-1432&author=C.+C.+Thinnesauthor=K.+S.+Englandauthor=A.+Kawamuraauthor=R.+Chowdhuryauthor=C.+J.+Schofieldauthor=R.+J.+Hopkinson&title=Targeting+histone+lysine+demethylases%E2%80%94progress%2C+challenges%2C+and+the+future"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DThinnes%26aufirst%3DC.%2BC.%26aulast%3DEngland%26aufirst%3DK.%2BS.%26aulast%3DKawamura%26aufirst%3DA.%26aulast%3DChowdhury%26aufirst%3DR.%26aulast%3DSchofield%26aufirst%3DC.%2BJ.%26aulast%3DHopkinson%26aufirst%3DR.%2BJ.%26atitle%3DTargeting%2520histone%2520lysine%2520demethylases%25E2%2580%2594progress%252C%2520challenges%252C%2520and%2520the%2520future%26jtitle%3DBiochim.%2520Biophys.%2520Acta%26date%3D2014%26volume%3D1839%26spage%3D1416%26epage%3D1432" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit7b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Højfeldt, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agger, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Helin, K.</span><span> </span><span class="NLM_article-title">Histone lysine demethylases as targets for anticancer therapy</span> <span class="citation_source-journal">Nature Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">917</span><span class="NLM_x">–</span> <span class="NLM_lpage">930</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2013&pages=917-930&author=J.+W.+H%C3%B8jfeldtauthor=K.+Aggerauthor=K.+Helin&title=Histone+lysine+demethylases+as+targets+for+anticancer+therapy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DH%25C3%25B8jfeldt%26aufirst%3DJ.%2BW.%26aulast%3DAgger%26aufirst%3DK.%26aulast%3DHelin%26aufirst%3DK.%26atitle%3DHistone%2520lysine%2520demethylases%2520as%2520targets%2520for%2520anticancer%2520therapy%26jtitle%3DNature%2520Rev.%2520Drug%2520Discovery%26date%3D2013%26volume%3D12%26spage%3D917%26epage%3D930" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Huggins, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sherman, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tidor, B.</span><span> </span><span class="NLM_article-title">Rational approaches to improving selectivity in drug design</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">1424</span><span class="NLM_x">–</span> <span class="NLM_lpage">1444</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm2010332" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00229&amp;key=1%3ACAS%3A528%3ADC%252BC38XmtFWktg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=1424-1444&author=D.+J.+Hugginsauthor=W.+Shermanauthor=B.+Tidor&title=Rational+approaches+to+improving+selectivity+in+drug+design"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Rational Approaches to Improving Selectivity in Drug Design</span></div><div class="casAuthors">Huggins, David J.; Sherman, Woody; Tidor, Bruce</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1424-1444</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Rational Approaches to improving selectivity in Drug Design are reviewed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJv9AbW-c3TbVg90H21EOLACvtfcHk0liJDMjaazq9pQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmtFWktg%253D%253D&md5=5b7bf49f9f96a05adad4d42f63739252</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1021%2Fjm2010332&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm2010332%26sid%3Dliteratum%253Aachs%26aulast%3DHuggins%26aufirst%3DD.%2BJ.%26aulast%3DSherman%26aufirst%3DW.%26aulast%3DTidor%26aufirst%3DB.%26atitle%3DRational%2520approaches%2520to%2520improving%2520selectivity%2520in%2520drug%2520design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D1424%26epage%3D1444" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Ji, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stanton, B. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Igarashi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martásek, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roman, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poulos, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silverman, R. B.</span><span> </span><span class="NLM_article-title">Minimal pharmacophoric elements and fragment hopping, an approach directed at molecular diversity and isozyme selectivity. Design of selective neuronal nitric oxide synthase inhibitors</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">130</span><span class="NLM_x">, </span> <span class="NLM_fpage">3900</span><span class="NLM_x">–</span> <span class="NLM_lpage">3914</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja0772041" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=130&publication_year=2008&pages=3900-3914&author=H.+Jiauthor=B.+Z.+Stantonauthor=J.+Igarashiauthor=H.+Liauthor=P.+Mart%C3%A1sekauthor=L.+J.+Romanauthor=T.+L.+Poulosauthor=R.+B.+Silverman&title=Minimal+pharmacophoric+elements+and+fragment+hopping%2C+an+approach+directed+at+molecular+diversity+and+isozyme+selectivity.+Design+of+selective+neuronal+nitric+oxide+synthase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1021%2Fja0772041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja0772041%26sid%3Dliteratum%253Aachs%26aulast%3DJi%26aufirst%3DH.%26aulast%3DStanton%26aufirst%3DB.%2BZ.%26aulast%3DIgarashi%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DMart%25C3%25A1sek%26aufirst%3DP.%26aulast%3DRoman%26aufirst%3DL.%2BJ.%26aulast%3DPoulos%26aufirst%3DT.%2BL.%26aulast%3DSilverman%26aufirst%3DR.%2BB.%26atitle%3DMinimal%2520pharmacophoric%2520elements%2520and%2520fragment%2520hopping%252C%2520an%2520approach%2520directed%2520at%2520molecular%2520diversity%2520and%2520isozyme%2520selectivity.%2520Design%2520of%2520selective%2520neuronal%2520nitric%2520oxide%2520synthase%2520inhibitors%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2008%26volume%3D130%26spage%3D3900%26epage%3D3914" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Ji, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martásek, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roman, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poulos, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silverman, R. B.</span><span> </span><span class="NLM_article-title">Discovery of highly potent and selective inhibitors of neuronal nitric oxide synthase by fragment hopping</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">779</span><span class="NLM_x">–</span> <span class="NLM_lpage">797</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm801220a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=779-797&author=H.+Jiauthor=H.+Liauthor=P.+Mart%C3%A1sekauthor=L.+J.+Romanauthor=T.+L.+Poulosauthor=R.+B.+Silverman&title=Discovery+of+highly+potent+and+selective+inhibitors+of+neuronal+nitric+oxide+synthase+by+fragment+hopping"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1021%2Fjm801220a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm801220a%26sid%3Dliteratum%253Aachs%26aulast%3DJi%26aufirst%3DH.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DMart%25C3%25A1sek%26aufirst%3DP.%26aulast%3DRoman%26aufirst%3DL.%2BJ.%26aulast%3DPoulos%26aufirst%3DT.%2BL.%26aulast%3DSilverman%26aufirst%3DR.%2BB.%26atitle%3DDiscovery%2520of%2520highly%2520potent%2520and%2520selective%2520inhibitors%2520of%2520neuronal%2520nitric%2520oxide%2520synthase%2520by%2520fragment%2520hopping%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D779%26epage%3D797" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Suzuki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyata, N.</span><span> </span><span class="NLM_article-title">Lysine demethylases inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">8236</span><span class="NLM_x">–</span> <span class="NLM_lpage">8250</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm201048w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00229&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht1OrtrnF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=8236-8250&author=T.+Suzukiauthor=N.+Miyata&title=Lysine+demethylases+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Lysine Demethylases Inhibitors</span></div><div class="casAuthors">Suzuki, Takayoshi; Miyata, Naoki</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">8236-8250</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review, on the use of lysine demethylases inhibitors in therapy of various diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGplp9MjSdvnn7Vg90H21EOLACvtfcHk0ljET2VrGj6peA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht1OrtrnF&md5=194d4bbc2e52672f5d5f019de0bb760c</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1021%2Fjm201048w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201048w%26sid%3Dliteratum%253Aachs%26aulast%3DSuzuki%26aufirst%3DT.%26aulast%3DMiyata%26aufirst%3DN.%26atitle%3DLysine%2520demethylases%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D8236%26epage%3D8250" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Khan, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyata, N.</span><span> </span><span class="NLM_article-title">An overview of phenylcyclopropylamine derivatives: biochemical and biological significance and recent developments</span> <span class="citation_source-journal">Med. Res. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">873</span><span class="NLM_x">–</span> <span class="NLM_lpage">910</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00229&amp;key=10.1002%2Fmed.21269" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00229&amp;key=22893613" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00229&amp;key=1%3ACAS%3A528%3ADC%252BC3sXptFersL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2013&pages=873-910&author=M.+N.+Khanauthor=T.+Suzukiauthor=N.+Miyata&title=An+overview+of+phenylcyclopropylamine+derivatives%3A+biochemical+and+biological+significance+and+recent+developments"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">An Overview of Phenylcyclopropylamine Derivatives: Biochemical and Biological Significance and Recent Developments</span></div><div class="casAuthors">Khan, Mohammed Naseer Ahmed; Suzuki, Takayoshi; Miyata, Naoki</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Research Reviews</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">873-910</span>CODEN:
                <span class="NLM_cas:coden">MRREDD</span>;
        ISSN:<span class="NLM_cas:issn">0198-6325</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review.  Trans-2-Phencylcyclopropylamine (2-PCPA), a potent, clin. used antidepressant, affects monoamine neurotransmitter levels by inhibiting the main metabolizing enzymes, monoamine oxidases (MAOs).  However, the antidepressant action of this compd. was not fully explained by its effects on MAOs due to its wide variety of biol. effects. 2-PCPA also affects depression-assocd. pathophysiol. pathways, and linked with increased levels of trace amines in brain, upregulation of GABAB receptors (where GABA is gamma amino butyric acid), modulation of phospholipid metab., and interference with various cytochrome P 450 (CYP) enzymes.  Consequently, despite its adverse effects and limited clin. applicability, 2-PCPA has attracted interest as a structural scaffold for the development of mechanism-based inhibitors of various enzymes, including lysine-specific demethylase 1 (LSD1), which is a possible target for cancer chemotherapy.  In the recent years, many reports have appeared in the literature based on 2-PCPA scaffold and their potential medicinal implications.  This review mainly focuses on the medicinal chem. aspects including drug design, structure-activity relationships (SAR), biol. and biochem. properties, and mechanism of actions of 2-PCPA and its derivs.  Furthermore, we also highlight recent advance in this area and discuss their future applications for beneficial therapeutic effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqIZJFRem7GlrVg90H21EOLACvtfcHk0ljET2VrGj6peA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXptFersL0%253D&md5=d257f3b954efb33ae6f824c254ae1c30</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1002%2Fmed.21269&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmed.21269%26sid%3Dliteratum%253Aachs%26aulast%3DKhan%26aufirst%3DM.%2BN.%26aulast%3DSuzuki%26aufirst%3DT.%26aulast%3DMiyata%26aufirst%3DN.%26atitle%3DAn%2520overview%2520of%2520phenylcyclopropylamine%2520derivatives%253A%2520biochemical%2520and%2520biological%2520significance%2520and%2520recent%2520developments%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D2013%26volume%3D33%26spage%3D873%26epage%3D910" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Culhane, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szewczuk, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Da, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marmorstein, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cole, P. A.</span><span> </span><span class="NLM_article-title">A mechanism-based inactivator for histone demethylase LSD1</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">128</span><span class="NLM_x">, </span> <span class="NLM_fpage">4536</span><span class="NLM_x">–</span> <span class="NLM_lpage">4537</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja0602748" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=128&publication_year=2006&pages=4536-4537&author=J.+C.+Culhaneauthor=L.+M.+Szewczukauthor=X.+Liuauthor=G.+Daauthor=R.+Marmorsteinauthor=P.+A.+Cole&title=A+mechanism-based+inactivator+for+histone+demethylase+LSD1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1021%2Fja0602748&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja0602748%26sid%3Dliteratum%253Aachs%26aulast%3DCulhane%26aufirst%3DJ.%2BC.%26aulast%3DSzewczuk%26aufirst%3DL.%2BM.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DDa%26aufirst%3DG.%26aulast%3DMarmorstein%26aufirst%3DR.%26aulast%3DCole%26aufirst%3DP.%2BA.%26atitle%3DA%2520mechanism-based%2520inactivator%2520for%2520histone%2520demethylase%2520LSD1%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2006%26volume%3D128%26spage%3D4536%26epage%3D4537" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Szewczuk, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Culhane, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Majumdar, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cole, P. A.</span><span> </span><span class="NLM_article-title">Mechanistic analysis of a suicide inactivator of histone demethylase LSD1</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">6892</span><span class="NLM_x">–</span> <span class="NLM_lpage">6902</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi700414b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00229&amp;key=1%3ACAS%3A528%3ADC%252BD2sXlsVSgt7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2007&pages=6892-6902&author=L.+M.+Szewczukauthor=J.+C.+Culhaneauthor=M.+Yangauthor=A.+Majumdarauthor=H.+Yuauthor=P.+A.+Cole&title=Mechanistic+analysis+of+a+suicide+inactivator+of+histone+demethylase+LSD1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanistic Analysis of a Suicide Inactivator of Histone Demethylase LSD1</span></div><div class="casAuthors">Szewczuk, Lawrence M.; Culhane, Jeffrey C.; Yang, Maojun; Majumdar, Ananya; Yu, Hongtao; Cole, Philip A.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">6892-6902</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Lysine-specific demethylase 1 (LSD1) is a transcriptional repressor and a flavin-dependent amine oxidase that is responsible for the removal of Me from lysine 4 of histone H3.  In this study, we characterize the mechanism and scope of LSD1 inhibition by a propargylamine-derivatized histone H3 substrate (1).  Unlike aziridinyl and cyclopropylamine-derivatized histone H3 peptide substrate analogs, compd. 1 appears to covalently modify and irreversibly inactivate LSD1 with high potency.  Accompanying this inactivation is a spectroscopic change, which shifts the absorbance max. to 392 nm.  Spectral changes assocd. with the 1-LSD1 complex and reactivity to decreased pH and sodium borohydride treatment were suggestive of a structure involving a flavin-linked inhibitor conjugate between N5 of the flavin and the terminal carbon of the inhibitor.  Using a 13C-labeled inhibitor, NMR anal. of the 1-flavin conjugate was consistent with this structural assignment.  Kinetic anal. of the spectroscopic shift induced by 1 showed that the flavin adduct formed in a reaction with kinetic consts. similar to those of the LSD1 inactivation process.  Taken together, these data support a mechanism of LSD1 inactivation by 1 involving amine oxidn. followed by Michael addn. to the propargylic imine.  We further examd. the potential for a biotinylated analog of 1 (1-Btn) to be used as a tool in affinity pulldown expts.  Using 1-Btn, it was feasible to selectively pull down spiked and endogenous LSD1 from HeLa cell nuclear exts., setting the stage for activity-based demethylase proteomics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo2nUlBCS3LG7Vg90H21EOLACvtfcHk0liFcopk8j10hw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXlsVSgt7Y%253D&md5=97eaa358443717b9f5b1214b4aebe807</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1021%2Fbi700414b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi700414b%26sid%3Dliteratum%253Aachs%26aulast%3DSzewczuk%26aufirst%3DL.%2BM.%26aulast%3DCulhane%26aufirst%3DJ.%2BC.%26aulast%3DYang%26aufirst%3DM.%26aulast%3DMajumdar%26aufirst%3DA.%26aulast%3DYu%26aufirst%3DH.%26aulast%3DCole%26aufirst%3DP.%2BA.%26atitle%3DMechanistic%2520analysis%2520of%2520a%2520suicide%2520inactivator%2520of%2520histone%2520demethylase%2520LSD1%26jtitle%3DBiochemistry%26date%3D2007%26volume%3D46%26spage%3D6892%26epage%3D6902" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Ueda, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mino, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsumoto, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakagawa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hasegawa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sasaki, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mizukami, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyata, N.</span><span> </span><span class="NLM_article-title">Identification of cell-active lysine specific demethylase 1-selective inhibitors</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">131</span><span class="NLM_x">, </span> <span class="NLM_fpage">17536</span><span class="NLM_x">–</span> <span class="NLM_lpage">17537</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja907055q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=131&publication_year=2009&pages=17536-17537&author=R.+Uedaauthor=T.+Suzukiauthor=K.+Minoauthor=H.+Tsumotoauthor=H.+Nakagawaauthor=M.+Hasegawaauthor=R.+Sasakiauthor=T.+Mizukamiauthor=N.+Miyata&title=Identification+of+cell-active+lysine+specific+demethylase+1-selective+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Fja907055q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja907055q%26sid%3Dliteratum%253Aachs%26aulast%3DUeda%26aufirst%3DR.%26aulast%3DSuzuki%26aufirst%3DT.%26aulast%3DMino%26aufirst%3DK.%26aulast%3DTsumoto%26aufirst%3DH.%26aulast%3DNakagawa%26aufirst%3DH.%26aulast%3DHasegawa%26aufirst%3DM.%26aulast%3DSasaki%26aufirst%3DR.%26aulast%3DMizukami%26aufirst%3DT.%26aulast%3DMiyata%26aufirst%3DN.%26atitle%3DIdentification%2520of%2520cell-active%2520lysine%2520specific%2520demethylase%25201-selective%2520inhibitors%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2009%26volume%3D131%26spage%3D17536%26epage%3D17537" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Ogasawara, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Itoh, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsumoto, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kakizawa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mino, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukuhara, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakagawa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hasegawa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sasaki, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mizukami, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyata, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, T.</span><span> </span><span class="NLM_article-title">Lysine-specific demethylase 1-selective inactivators: protein-targeted drug delivery mechanism</span> <span class="citation_source-journal">Angew. Chem., Int. Ed. Engl.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">8620</span><span class="NLM_x">–</span> <span class="NLM_lpage">8624</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2013&pages=8620-8624&author=D.+Ogasawaraauthor=Y.+Itohauthor=H.+Tsumotoauthor=T.+Kakizawaauthor=K.+Minoauthor=K.+Fukuharaauthor=H.+Nakagawaauthor=M.+Hasegawaauthor=R.+Sasakiauthor=T.+Mizukamiauthor=N.+Miyataauthor=T.+Suzuki&title=Lysine-specific+demethylase+1-selective+inactivators%3A+protein-targeted+drug+delivery+mechanism"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOgasawara%26aufirst%3DD.%26aulast%3DItoh%26aufirst%3DY.%26aulast%3DTsumoto%26aufirst%3DH.%26aulast%3DKakizawa%26aufirst%3DT.%26aulast%3DMino%26aufirst%3DK.%26aulast%3DFukuhara%26aufirst%3DK.%26aulast%3DNakagawa%26aufirst%3DH.%26aulast%3DHasegawa%26aufirst%3DM.%26aulast%3DSasaki%26aufirst%3DR.%26aulast%3DMizukami%26aufirst%3DT.%26aulast%3DMiyata%26aufirst%3DN.%26aulast%3DSuzuki%26aufirst%3DT.%26atitle%3DLysine-specific%2520demethylase%25201-selective%2520inactivators%253A%2520protein-targeted%2520drug%2520delivery%2520mechanism%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%2520Engl.%26date%3D2013%26volume%3D52%26spage%3D8620%26epage%3D8624" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Lewis, W. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, L. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grynszpan, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Radić, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carlier, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finn, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharpless, K. B.</span><span> </span><span class="NLM_article-title">Click chemistry in situ: acetylcholinesterase as a reaction vessel for the selective assembly of a femtomolar inhibitor from an array of building blocks</span> <span class="citation_source-journal">Angew. Chem., Int. Ed. Engl.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">1053</span><span class="NLM_x">–</span> <span class="NLM_lpage">1057</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2002&pages=1053-1057&author=W.+G.+Lewisauthor=L.+G.+Greenauthor=F.+Grynszpanauthor=Z.+Radi%C4%87author=P.+R.+Carlierauthor=P.+Taylorauthor=M.+G.+Finnauthor=K.+B.+Sharpless&title=Click+chemistry+in+situ%3A+acetylcholinesterase+as+a+reaction+vessel+for+the+selective+assembly+of+a+femtomolar+inhibitor+from+an+array+of+building+blocks"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLewis%26aufirst%3DW.%2BG.%26aulast%3DGreen%26aufirst%3DL.%2BG.%26aulast%3DGrynszpan%26aufirst%3DF.%26aulast%3DRadi%25C4%2587%26aufirst%3DZ.%26aulast%3DCarlier%26aufirst%3DP.%2BR.%26aulast%3DTaylor%26aufirst%3DP.%26aulast%3DFinn%26aufirst%3DM.%2BG.%26aulast%3DSharpless%26aufirst%3DK.%2BB.%26atitle%3DClick%2520chemistry%2520in%2520situ%253A%2520acetylcholinesterase%2520as%2520a%2520reaction%2520vessel%2520for%2520the%2520selective%2520assembly%2520of%2520a%2520femtomolar%2520inhibitor%2520from%2520an%2520array%2520of%2520building%2520blocks%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%2520Engl.%26date%3D2002%26volume%3D41%26spage%3D1053%26epage%3D1057" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Manetsch, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krasiński, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Radić, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raushel, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharpless, K. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolb, H. C.</span><span> </span><span class="NLM_article-title">In situ click chemistry: enzyme inhibitors made to their own specifications</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">126</span><span class="NLM_x">, </span> <span class="NLM_fpage">12809</span><span class="NLM_x">–</span> <span class="NLM_lpage">12818</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja046382g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00229&amp;key=1%3ACAS%3A528%3ADC%252BD2cXns1Kmtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=126&publication_year=2004&pages=12809-12818&author=R.+Manetschauthor=A.+Krasi%C5%84skiauthor=Z.+Radi%C4%87author=J.+Raushelauthor=P.+Taylorauthor=K.+B.+Sharplessauthor=H.+C.+Kolb&title=In+situ+click+chemistry%3A+enzyme+inhibitors+made+to+their+own+specifications"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">In Situ Click Chemistry: Enzyme Inhibitors Made to Their Own Specifications</span></div><div class="casAuthors">Manetsch, Roman; Krasinski, Antoni; Radic, Zoran; Raushel, Jessica; Taylor, Palmer; Sharpless, K. Barry; Kolb, Hartmuth C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">126</span>
        (<span class="NLM_cas:issue">40</span>),
    <span class="NLM_cas:pages">12809-12818</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The in situ click chem. approach to lead discovery employs the biol. target itself for assembling inhibitors from complementary building block reagents via irreversible connection chem.  The present publication discusses the optimization of this target-guided strategy using acetylcholinesterase (AChE) as a test system.  The application of liq. chromatog. with mass spectroscopic detection in the selected ion mode for product identification greatly enhanced the sensitivity and reliability of this method.  It enabled the testing of multicomponent mixts., which may dramatically increase the in situ screening throughput.  In addn. to the previously reported in situ product syn-TZ2PA6, the authors discovered three new inhibitors, syn-TZ2PA5, syn-TA2PZ6, and syn-TA2PZ5, derived from tacrine and phenylphenanthridinium azides and acetylenes, in the reactions with Electrophorus electricus and mouse AChE.  All in situ-generated compds. were extremely potent AChE inhibitors, because of the presence of multiple sites of interaction, which include the newly formed triazole nexus as a significant pharmacophore.  Safety issues in handling the potentially neurotoxic inhibitors are also discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpHHAh34oMn8LVg90H21EOLACvtfcHk0lg8_1nNOaLWDA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXns1Kmtb4%253D&md5=d5803f0257cab7958e1bd482b1f66313</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Fja046382g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja046382g%26sid%3Dliteratum%253Aachs%26aulast%3DManetsch%26aufirst%3DR.%26aulast%3DKrasi%25C5%2584ski%26aufirst%3DA.%26aulast%3DRadi%25C4%2587%26aufirst%3DZ.%26aulast%3DRaushel%26aufirst%3DJ.%26aulast%3DTaylor%26aufirst%3DP.%26aulast%3DSharpless%26aufirst%3DK.%2BB.%26aulast%3DKolb%26aufirst%3DH.%2BC.%26atitle%3DIn%2520situ%2520click%2520chemistry%253A%2520enzyme%2520inhibitors%2520made%2520to%2520their%2520own%2520specifications%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2004%26volume%3D126%26spage%3D12809%26epage%3D12818" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Nasr, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petit, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vullo, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winum, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Supuran, C. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barboiu, M.</span><span> </span><span class="NLM_article-title">Carbonic anhydrase-encoded dynamic constitutional libraries: toward the discovery of isozyme-specific inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">4853</span><span class="NLM_x">–</span> <span class="NLM_lpage">4859</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm900449v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00229&amp;key=1%3ACAS%3A528%3ADC%252BD1MXotF2ruro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=4853-4859&author=G.+Nasrauthor=E.+Petitauthor=D.+Vulloauthor=J.+Y.+Winumauthor=C.+T.+Supuranauthor=M.+Barboiu&title=Carbonic+anhydrase-encoded+dynamic+constitutional+libraries%3A+toward+the+discovery+of+isozyme-specific+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Carbonic Anhydrase-Encoded Dynamic Constitutional Libraries: Toward the Discovery of Isozyme-Specific Inhibitors</span></div><div class="casAuthors">Nasr, Gihane; Petit, Eddy; Vullo, Daniela; Winum, Jean-Yves; Supuran, Claudiu T.; Barboiu, Mihail</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">4853-4859</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A constitutional dynamic library (CDL) was generated under thermodn. control by using the amino-carbonyl/imine interconversion as reversible chem., combined with noncovalent bonding within the active site of the metalloenzyme carbonic anhydrase (CA, EC 4.2.1.1).  Considering the pharmacol. importance to find isoform-selective CA inhibitors (CAIs), two of the 15 human (h) isoform, i.e., hCAI and hCA II, have been subjected to a parallel screening of the same CDL.  The use of parallel constitutional screening of CDL chem. for the discovery of enzyme inhibitors is straightforward and it might provide initial insights toward the generation of efficient classes of selective, high affinity inhibitors.  We demonstrate here that the high selectivity and specificity of inhibiting the hCA I and hCA II isoenzymes with some of the detected hits may be used to describe a complex constitutional behavior through component selection from the dynamic library, driven by the selective binding to the specific isoform active site.  These results also point to the possibility of modulating the drug discovery methods by constitutional recomposition induced by a specific enzymic target.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoT_jl-EY6mgbVg90H21EOLACvtfcHk0lg8_1nNOaLWDA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXotF2ruro%253D&md5=1f928d3994682815692e117881d6e6d0</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fjm900449v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900449v%26sid%3Dliteratum%253Aachs%26aulast%3DNasr%26aufirst%3DG.%26aulast%3DPetit%26aufirst%3DE.%26aulast%3DVullo%26aufirst%3DD.%26aulast%3DWinum%26aufirst%3DJ.%2BY.%26aulast%3DSupuran%26aufirst%3DC.%2BT.%26aulast%3DBarboiu%26aufirst%3DM.%26atitle%3DCarbonic%2520anhydrase-encoded%2520dynamic%2520constitutional%2520libraries%253A%2520toward%2520the%2520discovery%2520of%2520isozyme-specific%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D4853%26epage%3D4859" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Yamauchi, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gomez, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grimster, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dufouil, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nemecz, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fotsing, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ho, K. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Talley, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharpless, K. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fokin, V. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, P.</span><span> </span><span class="NLM_article-title">Synthesis of selective agonists for the α7 nicotinic acetylcholine receptor with in situ click-chemistry on acetylcholine-binding protein templates</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">82</span><span class="NLM_x">, </span> <span class="NLM_fpage">687</span><span class="NLM_x">–</span> <span class="NLM_lpage">699</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=2012&pages=687-699&author=J.+G.+Yamauchiauthor=K.+Gomezauthor=N.+Grimsterauthor=M.+Dufouilauthor=A.+Nemeczauthor=J.+R.+Fotsingauthor=K.+Y.+Hoauthor=T.+T.+Talleyauthor=K.+B.+Sharplessauthor=V.+V.+Fokinauthor=P.+Taylor&title=Synthesis+of+selective+agonists+for+the+%CE%B17+nicotinic+acetylcholine+receptor+with+in+situ+click-chemistry+on+acetylcholine-binding+protein+templates"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYamauchi%26aufirst%3DJ.%2BG.%26aulast%3DGomez%26aufirst%3DK.%26aulast%3DGrimster%26aufirst%3DN.%26aulast%3DDufouil%26aufirst%3DM.%26aulast%3DNemecz%26aufirst%3DA.%26aulast%3DFotsing%26aufirst%3DJ.%2BR.%26aulast%3DHo%26aufirst%3DK.%2BY.%26aulast%3DTalley%26aufirst%3DT.%2BT.%26aulast%3DSharpless%26aufirst%3DK.%2BB.%26aulast%3DFokin%26aufirst%3DV.%2BV.%26aulast%3DTaylor%26aufirst%3DP.%26atitle%3DSynthesis%2520of%2520selective%2520agonists%2520for%2520the%2520%25CE%25B17%2520nicotinic%2520acetylcholine%2520receptor%2520with%2520in%2520situ%2520click-chemistry%2520on%2520acetylcholine-binding%2520protein%2520templates%26jtitle%3DMol.%2520Pharmacol.%26date%3D2012%26volume%3D82%26spage%3D687%26epage%3D699" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Suzuki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ota, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kasuya, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mutsuga, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawamura, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsumoto, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakagawa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finn, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyata, N.</span><span> </span><span class="NLM_article-title">An unexpected example of protein-templated click chemistry</span> <span class="citation_source-journal">Angew. Chem., Int. Ed. Engl.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">6817</span><span class="NLM_x">–</span> <span class="NLM_lpage">6820</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2010&pages=6817-6820&author=T.+Suzukiauthor=Y.+Otaauthor=Y.+Kasuyaauthor=M.+Mutsugaauthor=Y.+Kawamuraauthor=H.+Tsumotoauthor=H.+Nakagawaauthor=M.+G.+Finnauthor=N.+Miyata&title=An+unexpected+example+of+protein-templated+click+chemistry"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSuzuki%26aufirst%3DT.%26aulast%3DOta%26aufirst%3DY.%26aulast%3DKasuya%26aufirst%3DY.%26aulast%3DMutsuga%26aufirst%3DM.%26aulast%3DKawamura%26aufirst%3DY.%26aulast%3DTsumoto%26aufirst%3DH.%26aulast%3DNakagawa%26aufirst%3DH.%26aulast%3DFinn%26aufirst%3DM.%2BG.%26aulast%3DMiyata%26aufirst%3DN.%26atitle%3DAn%2520unexpected%2520example%2520of%2520protein-templated%2520click%2520chemistry%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%2520Engl.%26date%3D2010%26volume%3D49%26spage%3D6817%26epage%3D6820" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Danishuddin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khan, A. U.</span><span> </span><span class="NLM_article-title">Structure based virtual screening to discover putative drug candidates: necessary considerations and successful case studies</span> <span class="citation_source-journal">Methods</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">71C</span><span class="NLM_x">, </span> <span class="NLM_fpage">135</span><span class="NLM_x">–</span> <span class="NLM_lpage">145</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71C&publication_year=2015&pages=135-145&author=M.+Danishuddinauthor=A.+U.+Khan&title=Structure+based+virtual+screening+to+discover+putative+drug+candidates%3A+necessary+considerations+and+successful+case+studies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDanishuddin%26aufirst%3DM.%26aulast%3DKhan%26aufirst%3DA.%2BU.%26atitle%3DStructure%2520based%2520virtual%2520screening%2520to%2520discover%2520putative%2520drug%2520candidates%253A%2520necessary%2520considerations%2520and%2520successful%2520case%2520studies%26jtitle%3DMethods%26date%3D2015%26volume%3D71C%26spage%3D135%26epage%3D145" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Braga, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alves, V. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silva, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nascimento, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silva, F. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liao, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrade, C. H.</span><span> </span><span class="NLM_article-title">Virtual screening strategies in medicinal chemistry: the state of the art and current challenges</span> <span class="citation_source-journal">Curr. Top Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">1899</span><span class="NLM_x">–</span> <span class="NLM_lpage">1912</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00229&amp;key=10.2174%2F1568026614666140929120749" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00229&amp;key=25262801" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00229&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvVGgtL%252FF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2014&pages=1899-1912&author=R.+C.+Bragaauthor=V.+M.+Alvesauthor=A.+C.+Silvaauthor=M.+N.+Nascimentoauthor=F.+C.+Silvaauthor=L.+M.+Liaoauthor=C.+H.+Andrade&title=Virtual+screening+strategies+in+medicinal+chemistry%3A+the+state+of+the+art+and+current+challenges"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Virtual Screening Strategies in Medicinal Chemistry: The State of the Art and Current Challenges</span></div><div class="casAuthors">Braga, Rodolpho C.; Alves, Vinicius M.; Silva, Arthur C.; Nascimento, Marilia N.; Silva, Flavia C.; Liao, Luciano M.; Andrade, Carolina H.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">1899-1912</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Virtual screening (VS) techniques are well-established tools in the modern drug discovery process, mainly used for hit finding in drug discovery.  The availability of knowledge of structural information, which includes an increasing no. of 3D protein structures and the readiness of free databases of com. available small mols., provides a broad platform for VS.  This review summarizes the current developments in VS regarding chem. databases and highlights the achievements as well as the challenges with an emphasis on a recent example of the successful application for the identification of new hits for sterol 14α-demethylase (CYP51) of Trypanosoma cruzi.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpCv7qZgDBPl7Vg90H21EOLACvtfcHk0lgAaGM91128Nw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvVGgtL%252FF&md5=b2784bfe2b9e14f0fe87ff8b66a7db6e</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.2174%2F1568026614666140929120749&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568026614666140929120749%26sid%3Dliteratum%253Aachs%26aulast%3DBraga%26aufirst%3DR.%2BC.%26aulast%3DAlves%26aufirst%3DV.%2BM.%26aulast%3DSilva%26aufirst%3DA.%2BC.%26aulast%3DNascimento%26aufirst%3DM.%2BN.%26aulast%3DSilva%26aufirst%3DF.%2BC.%26aulast%3DLiao%26aufirst%3DL.%2BM.%26aulast%3DAndrade%26aufirst%3DC.%2BH.%26atitle%3DVirtual%2520screening%2520strategies%2520in%2520medicinal%2520chemistry%253A%2520the%2520state%2520of%2520the%2520art%2520and%2520current%2520challenges%26jtitle%3DCurr.%2520Top%2520Med.%2520Chem.%26date%3D2014%26volume%3D14%26spage%3D1899%26epage%3D1912" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Lionta, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spyrou, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vassilatis, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cournia, Z.</span><span> </span><span class="NLM_article-title">Structure-based virtual screening for drug discovery: principles, applications and recent advances</span> <span class="citation_source-journal">Curr. Top Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">1923</span><span class="NLM_x">–</span> <span class="NLM_lpage">1938</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00229&amp;key=10.2174%2F1568026614666140929124445" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00229&amp;key=25262799" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00229&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvVGgt7fJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2014&pages=1923-1938&author=E.+Liontaauthor=G.+Spyrouauthor=D.+K.+Vassilatisauthor=Z.+Cournia&title=Structure-based+virtual+screening+for+drug+discovery%3A+principles%2C+applications+and+recent+advances"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Based Virtual Screening for Drug Discovery: Principles, Applications and Recent Advances</span></div><div class="casAuthors">Lionta, Evanthia; Spyrou, George; Vassilatis, Demetrios K.; Cournia, Zoe</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">1923-1938</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Structure-based drug discovery (SBDD) is becoming an essential tool in assisting fast and cost-efficient lead discovery and optimization.  The application of rational, structure-based drug design is proven to be more efficient than the traditional way of drug discovery since it aims to understand the mol. basis of a disease and utilizes the knowledge of the three-dimensional structure of the biol. target in the process.  In this review, we focus on the principles and applications of Virtual Screening (VS) within the context of SBDD and examine different procedures ranging from the initial stages of the process that include receptor and library pre-processing, to docking, scoring and post-processing of top scoring hits.  Recent improvements in structure-based virtual screening (SBVS) efficiency through ensemble docking, induced fit and consensus docking are also discussed.  The review highlights advances in the field within the framework of several success studies that have led to nM inhibition directly from VS and provides recent trends in library design as well as discusses limitations of the method.  Applications of SBVS in the design of substrates for engineered proteins that enable the discovery of new metabolic and signal transduction pathways and the design of inhibitors of multifunctional proteins are also reviewed.  Finally, we contribute two promising VS protocols recently developed by us that aim to increase inhibitor selectivity.  In the first protocol, we describe the discovery of micromolar inhibitors through SBVS designed to inhibit the mutant H1047R PI3Kα kinase.  Second, we discuss a strategy for the identification of selective binders for the RXRα nuclear receptor.  In this protocol, a set of target structures is constructed for ensemble docking based on binding site shape characterization and clustering, aiming to enhance the hit rate of selective inhibitors for the desired protein target through the SBVS process.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGps80ptfisjzLVg90H21EOLACvtfcHk0lgAaGM91128Nw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvVGgt7fJ&md5=0550a396dd011adf52699b091548345b</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.2174%2F1568026614666140929124445&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568026614666140929124445%26sid%3Dliteratum%253Aachs%26aulast%3DLionta%26aufirst%3DE.%26aulast%3DSpyrou%26aufirst%3DG.%26aulast%3DVassilatis%26aufirst%3DD.%2BK.%26aulast%3DCournia%26aufirst%3DZ.%26atitle%3DStructure-based%2520virtual%2520screening%2520for%2520drug%2520discovery%253A%2520principles%252C%2520applications%2520and%2520recent%2520advances%26jtitle%3DCurr.%2520Top%2520Med.%2520Chem.%26date%3D2014%26volume%3D14%26spage%3D1923%26epage%3D1938" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Brožič, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turk, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adeniji, A. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Konc, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janežič, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Penning, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lanišnik Rižner, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gobec, S.</span><span> </span><span class="NLM_article-title">Selective inhibitors of aldo-keto reductases AKR1C1 and AKR1C3 discovered by virtual screening of a fragment library</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">7417</span><span class="NLM_x">–</span> <span class="NLM_lpage">7424</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm300841n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=7417-7424&author=P.+Bro%C5%BEi%C4%8Dauthor=S.+Turkauthor=A.+O.+Adenijiauthor=J.+Koncauthor=D.+Jane%C5%BEi%C4%8Dauthor=T.+M.+Penningauthor=T.+Lani%C5%A1nik+Ri%C5%BEnerauthor=S.+Gobec&title=Selective+inhibitors+of+aldo-keto+reductases+AKR1C1+and+AKR1C3+discovered+by+virtual+screening+of+a+fragment+library"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fjm300841n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300841n%26sid%3Dliteratum%253Aachs%26aulast%3DBro%25C5%25BEi%25C4%258D%26aufirst%3DP.%26aulast%3DTurk%26aufirst%3DS.%26aulast%3DAdeniji%26aufirst%3DA.%2BO.%26aulast%3DKonc%26aufirst%3DJ.%26aulast%3DJane%25C5%25BEi%25C4%258D%26aufirst%3DD.%26aulast%3DPenning%26aufirst%3DT.%2BM.%26aulast%3DLani%25C5%25A1nik%2BRi%25C5%25BEner%26aufirst%3DT.%26aulast%3DGobec%26aufirst%3DS.%26atitle%3DSelective%2520inhibitors%2520of%2520aldo-keto%2520reductases%2520AKR1C1%2520and%2520AKR1C3%2520discovered%2520by%2520virtual%2520screening%2520of%2520a%2520fragment%2520library%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D7417%26epage%3D7424" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Brus, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Košak, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turk, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pišlar, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coquelle, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kos, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stojan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colletier, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gobec, S.</span><span> </span><span class="NLM_article-title">Discovery, biological evaluation, and crystal structure of a novel nanomolar selective butyrylcholinesterase inhibitor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">8167</span><span class="NLM_x">–</span> <span class="NLM_lpage">8179</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm501195e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=8167-8179&author=B.+Brusauthor=U.+Ko%C5%A1akauthor=S.+Turkauthor=A.+Pi%C5%A1larauthor=N.+Coquelleauthor=J.+Kosauthor=J.+Stojanauthor=J.+P.+Colletierauthor=S.+Gobec&title=Discovery%2C+biological+evaluation%2C+and+crystal+structure+of+a+novel+nanomolar+selective+butyrylcholinesterase+inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fjm501195e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501195e%26sid%3Dliteratum%253Aachs%26aulast%3DBrus%26aufirst%3DB.%26aulast%3DKo%25C5%25A1ak%26aufirst%3DU.%26aulast%3DTurk%26aufirst%3DS.%26aulast%3DPi%25C5%25A1lar%26aufirst%3DA.%26aulast%3DCoquelle%26aufirst%3DN.%26aulast%3DKos%26aufirst%3DJ.%26aulast%3DStojan%26aufirst%3DJ.%26aulast%3DColletier%26aufirst%3DJ.%2BP.%26aulast%3DGobec%26aufirst%3DS.%26atitle%3DDiscovery%252C%2520biological%2520evaluation%252C%2520and%2520crystal%2520structure%2520of%2520a%2520novel%2520nanomolar%2520selective%2520butyrylcholinesterase%2520inhibitor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D8167%26epage%3D8179" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Chen, Y.</span><span> </span><span class="NLM_article-title">Beware of docking!</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">78</span><span class="NLM_x">–</span> <span class="NLM_lpage">95</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2015&pages=78-95&author=Y.+Chen&title=Beware+of+docking%21"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DY.%26atitle%3DBeware%2520of%2520docking%2521%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2015%26volume%3D36%26spage%3D78%26epage%3D95" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Wang, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Z. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, L. R.</span><span> </span><span class="NLM_article-title">Fragment-based drug discovery and molecular docking in drug design</span> <span class="citation_source-journal">Curr. Pharm. Biotechnol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">11</span><span class="NLM_x">–</span> <span class="NLM_lpage">25</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00229&amp;key=10.2174%2F1389201015666141122204532" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00229&amp;key=25420726" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00229&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtVSqtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2015&pages=11-25&author=T.+Wangauthor=M.+B.+Wuauthor=Z.+J.+Chenauthor=H.+Chenauthor=J.+P.+Linauthor=L.+R.+Yang&title=Fragment-based+drug+discovery+and+molecular+docking+in+drug+design"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Fragment-Based Drug Discovery and Molecular Docking in Drug Design</span></div><div class="casAuthors">Wang, Tao; Wu, Mian-Bin; Chen, Zheng-Jie; Chen, Hua; Lin, Jian-Ping; Yang, Li-Rong</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Biotechnology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">11-25</span>CODEN:
                <span class="NLM_cas:coden">CPBUBP</span>;
        ISSN:<span class="NLM_cas:issn">1389-2010</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Fragment-based drug discovery (FBDD) has caused a revolution in the process of drug discovery and design, with many FBDD leads being developed into clin. trials or approved in the past few years.  Compared with traditional high-throughput screening, it displays obvious advantages such as efficiently covering chem. space, achieving higher hit rates, and so forth.  In this review, we focus on the most recent developments of FBDD for improving drug discovery, illustrating the process and the importance of FBDD.  In particular, the computational strategies applied in the process of FBDD and mol.-docking programs are highlighted elaborately.  In most cases, docking is used for predicting the ligand-receptor interaction modes and hit identification by structure-based virtual screening.  The successful cases of typical significance and the hits identified most recently are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQSeYpk6Wbo7Vg90H21EOLACvtfcHk0lgY4wSeGXeMsg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtVSqtL0%253D&md5=78c46f9ca06912a710a5d9ed0a22fe37</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.2174%2F1389201015666141122204532&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1389201015666141122204532%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DT.%26aulast%3DWu%26aufirst%3DM.%2BB.%26aulast%3DChen%26aufirst%3DZ.%2BJ.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DLin%26aufirst%3DJ.%2BP.%26aulast%3DYang%26aufirst%3DL.%2BR.%26atitle%3DFragment-based%2520drug%2520discovery%2520and%2520molecular%2520docking%2520in%2520drug%2520design%26jtitle%3DCurr.%2520Pharm.%2520Biotechnol.%26date%3D2015%26volume%3D16%26spage%3D11%26epage%3D25" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Suzuki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kouketsu, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Itoh, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hisakawa, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maeda, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshida, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakagawa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyata, N.</span><span> </span><span class="NLM_article-title">Highly potent and selective histone deacetylase 6 inhibitors designed based on a small-molecular substrate</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">4809</span><span class="NLM_x">–</span> <span class="NLM_lpage">4812</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm060554y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=4809-4812&author=T.+Suzukiauthor=A.+Kouketsuauthor=Y.+Itohauthor=S.+Hisakawaauthor=S.+Maedaauthor=M.+Yoshidaauthor=H.+Nakagawaauthor=N.+Miyata&title=Highly+potent+and+selective+histone+deacetylase+6+inhibitors+designed+based+on+a+small-molecular+substrate"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Fjm060554y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060554y%26sid%3Dliteratum%253Aachs%26aulast%3DSuzuki%26aufirst%3DT.%26aulast%3DKouketsu%26aufirst%3DA.%26aulast%3DItoh%26aufirst%3DY.%26aulast%3DHisakawa%26aufirst%3DS.%26aulast%3DMaeda%26aufirst%3DS.%26aulast%3DYoshida%26aufirst%3DM.%26aulast%3DNakagawa%26aufirst%3DH.%26aulast%3DMiyata%26aufirst%3DN.%26atitle%3DHighly%2520potent%2520and%2520selective%2520histone%2520deacetylase%25206%2520inhibitors%2520designed%2520based%2520on%2520a%2520small-molecular%2520substrate%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D4809%26epage%3D4812" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Itoh, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kouketsu, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maeda, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshida, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakagawa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyata, N.</span><span> </span><span class="NLM_article-title">Design, synthesis, structure–selectivity relationship, and effect on human cancer cells of a novel series of histone deacetylase 6-selective inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">5425</span><span class="NLM_x">–</span> <span class="NLM_lpage">5438</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm7009217" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=5425-5438&author=Y.+Itohauthor=T.+Suzukiauthor=A.+Kouketsuauthor=N.+Suzukiauthor=S.+Maedaauthor=M.+Yoshidaauthor=H.+Nakagawaauthor=N.+Miyata&title=Design%2C+synthesis%2C+structure%E2%80%93selectivity+relationship%2C+and+effect+on+human+cancer+cells+of+a+novel+series+of+histone+deacetylase+6-selective+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Fjm7009217&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm7009217%26sid%3Dliteratum%253Aachs%26aulast%3DItoh%26aufirst%3DY.%26aulast%3DSuzuki%26aufirst%3DT.%26aulast%3DKouketsu%26aufirst%3DA.%26aulast%3DSuzuki%26aufirst%3DN.%26aulast%3DMaeda%26aufirst%3DS.%26aulast%3DYoshida%26aufirst%3DM.%26aulast%3DNakagawa%26aufirst%3DH.%26aulast%3DMiyata%26aufirst%3DN.%26atitle%3DDesign%252C%2520synthesis%252C%2520structure%25E2%2580%2593selectivity%2520relationship%252C%2520and%2520effect%2520on%2520human%2520cancer%2520cells%2520of%2520a%2520novel%2520series%2520of%2520histone%2520deacetylase%25206-selective%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D5425%26epage%3D5438" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Asaba, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ueda, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsumoto, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakagawa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyata, N.</span><span> </span><span class="NLM_article-title">Inhibition of human sirtuins by in situ generation of an acetylated lysine–ADP–ribose conjugate</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">131</span><span class="NLM_x">, </span> <span class="NLM_fpage">6989</span><span class="NLM_x">–</span> <span class="NLM_lpage">6996</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja807083y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=131&publication_year=2009&pages=6989-6996&author=T.+Asabaauthor=T.+Suzukiauthor=R.+Uedaauthor=H.+Tsumotoauthor=H.+Nakagawaauthor=N.+Miyata&title=Inhibition+of+human+sirtuins+by+in+situ+generation+of+an+acetylated+lysine%E2%80%93ADP%E2%80%93ribose+conjugate"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Fja807083y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja807083y%26sid%3Dliteratum%253Aachs%26aulast%3DAsaba%26aufirst%3DT.%26aulast%3DSuzuki%26aufirst%3DT.%26aulast%3DUeda%26aufirst%3DR.%26aulast%3DTsumoto%26aufirst%3DH.%26aulast%3DNakagawa%26aufirst%3DH.%26aulast%3DMiyata%26aufirst%3DN.%26atitle%3DInhibition%2520of%2520human%2520sirtuins%2520by%2520in%2520situ%2520generation%2520of%2520an%2520acetylated%2520lysine%25E2%2580%2593ADP%25E2%2580%2593ribose%2520conjugate%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2009%26volume%3D131%26spage%3D6989%26epage%3D6996" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Cui, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamal, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ai, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">More, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, L.</span><span> </span><span class="NLM_article-title">Discovery of potent and selective sirtuin 2 (SIRT2) inhibitors using a fragment-based approach</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">8340</span><span class="NLM_x">–</span> <span class="NLM_lpage">8357</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm500777s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00229&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsFCjsLfL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=8340-8357&author=H.+Cuiauthor=Z.+Kamalauthor=T.+Aiauthor=Y.+Xuauthor=S.+S.+Moreauthor=D.+J.+Wilsonauthor=L.+Chen&title=Discovery+of+potent+and+selective+sirtuin+2+%28SIRT2%29+inhibitors+using+a+fragment-based+approach"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Potent and Selective Sirtuin 2 (SIRT2) Inhibitors Using a Fragment-Based Approach</span></div><div class="casAuthors">Cui, Huaqing; Kamal, Zeeshan; Ai, Teng; Xu, Yanli; More, Swati S.; Wilson, Daniel J.; Chen, Liqiang</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">8340-8357</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Sirtuin 2 (SIRT2) is one of the sirtuins, a family of NAD+-dependent deacetylases that act on a variety of histone and non-histone substrates.  Accumulating biol. functions and potential therapeutic applications have drawn interest in the discovery and development of SIRT2 inhibitors.  Herein we report our discovery of novel SIRT2 inhibitors using a fragment-based approach.  Inspired by the purported close binding proximity of suramin and nicotinamide, we prepd. two sets of fragments, namely, the naphthylamide sulfonic acids and the naphthalene-benzamides and -nicotinamides.  Biochem. evaluation of these two series provided structure-activity relationship (SAR) information, which led to the design of (5-benzamidonaphthalen-1/2-yloxy)nicotinamide derivs.  Among these inhibitors, one compd. exhibited high anti-SIRT2 activity (48 nM) and excellent selectivity for SIRT2 over SIRT1 and SIRT3.  In vitro, it also increased the acetylation level of α-tubulin, a well-established SIRT2 substrate, in both concn.- and time-dependent manners.  Further kinetic studies revealed that this compd. behaves as a competitive inhibitor against the peptide substrate and most likely as a noncompetitive inhibitor against NAD+.  Taken together, these results indicate that we have discovered a potent and selective SIRT2 inhibitor whose novel structure merits further exploration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgdLtR3ic38bVg90H21EOLACvtfcHk0liii_JAWiuI6w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsFCjsLfL&md5=6831830798aa6518ca02e3780c49b4cd</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Fjm500777s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm500777s%26sid%3Dliteratum%253Aachs%26aulast%3DCui%26aufirst%3DH.%26aulast%3DKamal%26aufirst%3DZ.%26aulast%3DAi%26aufirst%3DT.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DMore%26aufirst%3DS.%2BS.%26aulast%3DWilson%26aufirst%3DD.%2BJ.%26aulast%3DChen%26aufirst%3DL.%26atitle%3DDiscovery%2520of%2520potent%2520and%2520selective%2520sirtuin%25202%2520%2528SIRT2%2529%2520inhibitors%2520using%2520a%2520fragment-based%2520approach%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D8340%26epage%3D8357" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Pilka, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">James, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lisztwan, J. H.</span><span> </span><span class="NLM_article-title">Structural definitions of Jumonji family demethylase selectivity</span> <span class="citation_source-journal">Drug Discovery Today.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">743</span><span class="NLM_x">–</span> <span class="NLM_lpage">749</span><span class="refDoi"> DOI: 10.1016/j.drudis.2014.12.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00229&amp;key=10.1016%2Fj.drudis.2014.12.013" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2014&pages=743-749&author=E.+S.+Pilkaauthor=T.+Jamesauthor=J.+H.+Lisztwan&title=Structural+definitions+of+Jumonji+family+demethylase+selectivity&doi=10.1016%2Fj.drudis.2014.12.013"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2014.12.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2014.12.013%26sid%3Dliteratum%253Aachs%26aulast%3DPilka%26aufirst%3DE.%2BS.%26aulast%3DJames%26aufirst%3DT.%26aulast%3DLisztwan%26aufirst%3DJ.%2BH.%26atitle%3DStructural%2520definitions%2520of%2520Jumonji%2520family%2520demethylase%2520selectivity%26jtitle%3DDrug%2520Discovery%2520Today.%26date%3D2014%26volume%3D20%26spage%3D743%26epage%3D749%26doi%3D10.1016%2Fj.drudis.2014.12.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Luo, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kubicek, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Myllyharju, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tumber, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ng, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Che, K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Podoll, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heightman, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oppermann, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schreiber, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span> </span><span class="NLM_article-title">A selective inhibitor and probe of the cellular functions of Jumonji C domain-containing histone demethylases</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">133</span><span class="NLM_x">, </span> <span class="NLM_fpage">9451</span><span class="NLM_x">–</span> <span class="NLM_lpage">9456</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja201597b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00229&amp;key=1%3ACAS%3A528%3ADC%252BC3MXmslGmurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=133&publication_year=2011&pages=9451-9456&author=X.+Luoauthor=Y.+Liuauthor=S.+Kubicekauthor=J.+Myllyharjuauthor=A.+Tumberauthor=S.+Ngauthor=K.+H.+Cheauthor=J.+Podollauthor=T.+D.+Heightmanauthor=U.+Oppermannauthor=S.+L.+Schreiberauthor=X.+Wang&title=A+selective+inhibitor+and+probe+of+the+cellular+functions+of+Jumonji+C+domain-containing+histone+demethylases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">A Selective Inhibitor and Probe of the Cellular Functions of Jumonji C Domain-Containing Histone Demethylases</span></div><div class="casAuthors">Luo, Xue-Lai; Liu, Yong-Xiang; Kubicek, Stefan; Myllyharju, Johanna; Tumber, Anthony; Ng, Stanley; Che, Ka-Hing; Podoll, Jessica; Heightman, Tom D.; Oppermann, Udo; Schreiber, Stuart L.; Wang, Xiang</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">133</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">9451-9456</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Histone methylations are important chromatin marks that regulate gene expression, genomic stability, DNA repair, and genomic imprinting.  Histone demethylases are the most recent family of histone-modifying enzymes discovered.  Here, we report the characterization of a small-mol. inhibitor of Jumonji C domain-contg. histone demethylases.  The inhibitor derives from a structure-based design and preferentially inhibits the subfamily of tri-Me lysine demethylases.  Its Me ester prodrug, methylstat, selectively inhibits Jumonji C domain-contg. his-tone demethylases in cells and may be a useful small-mol. probe of chromatin and its role in epigenetics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrcmCdVvaIpq7Vg90H21EOLACvtfcHk0liii_JAWiuI6w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXmslGmurg%253D&md5=ad50a692dfab85e1bcce77acc14b7b5a</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Fja201597b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja201597b%26sid%3Dliteratum%253Aachs%26aulast%3DLuo%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DKubicek%26aufirst%3DS.%26aulast%3DMyllyharju%26aufirst%3DJ.%26aulast%3DTumber%26aufirst%3DA.%26aulast%3DNg%26aufirst%3DS.%26aulast%3DChe%26aufirst%3DK.%2BH.%26aulast%3DPodoll%26aufirst%3DJ.%26aulast%3DHeightman%26aufirst%3DT.%2BD.%26aulast%3DOppermann%26aufirst%3DU.%26aulast%3DSchreiber%26aufirst%3DS.%2BL.%26aulast%3DWang%26aufirst%3DX.%26atitle%3DA%2520selective%2520inhibitor%2520and%2520probe%2520of%2520the%2520cellular%2520functions%2520of%2520Jumonji%2520C%2520domain-containing%2520histone%2520demethylases%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2011%26volume%3D133%26spage%3D9451%26epage%3D9456" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Baguley, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, H. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chatterjee, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nairn, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lombroso, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellman, J. A.</span><span> </span><span class="NLM_article-title">Substrate-based fragment identification for the development of selective, nonpeptidic inhibitors of striatal-enriched protein tyrosine phosphatase</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">7636</span><span class="NLM_x">–</span> <span class="NLM_lpage">7650</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm401037h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=7636-7650&author=T.+D.+Baguleyauthor=H.+C.+Xuauthor=M.+Chatterjeeauthor=A.+C.+Nairnauthor=P.+J.+Lombrosoauthor=J.+A.+Ellman&title=Substrate-based+fragment+identification+for+the+development+of+selective%2C+nonpeptidic+inhibitors+of+striatal-enriched+protein+tyrosine+phosphatase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35a&amp;dbid=16384&amp;doi=10.1021%2Fjm401037h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401037h%26sid%3Dliteratum%253Aachs%26aulast%3DBaguley%26aufirst%3DT.%2BD.%26aulast%3DXu%26aufirst%3DH.%2BC.%26aulast%3DChatterjee%26aufirst%3DM.%26aulast%3DNairn%26aufirst%3DA.%2BC.%26aulast%3DLombroso%26aufirst%3DP.%2BJ.%26aulast%3DEllman%26aufirst%3DJ.%2BA.%26atitle%3DSubstrate-based%2520fragment%2520identification%2520for%2520the%2520development%2520of%2520selective%252C%2520nonpeptidic%2520inhibitors%2520of%2520striatal-enriched%2520protein%2520tyrosine%2520phosphatase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D7636%26epage%3D7650" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit35b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Baguley, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, H. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chatterjee, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nairn, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lombroso, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellman, J. A.</span><span> </span><span class="NLM_article-title">Correction to substrate-based fragment identification for the development of selective, nonpeptidic inhibitors of striatal-enriched protein tyrosine phosphatase</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">10564</span><span class="NLM_x">–</span> <span class="NLM_lpage">10564</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm5018847" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=10564-10564&author=T.+D.+Baguleyauthor=H.+C.+Xuauthor=M.+Chatterjeeauthor=A.+C.+Nairnauthor=P.+J.+Lombrosoauthor=J.+A.+Ellman&title=Correction+to+substrate-based+fragment+identification+for+the+development+of+selective%2C+nonpeptidic+inhibitors+of+striatal-enriched+protein+tyrosine+phosphatase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35b&amp;dbid=16384&amp;doi=10.1021%2Fjm5018847&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm5018847%26sid%3Dliteratum%253Aachs%26aulast%3DBaguley%26aufirst%3DT.%2BD.%26aulast%3DXu%26aufirst%3DH.%2BC.%26aulast%3DChatterjee%26aufirst%3DM.%26aulast%3DNairn%26aufirst%3DA.%2BC.%26aulast%3DLombroso%26aufirst%3DP.%2BJ.%26aulast%3DEllman%26aufirst%3DJ.%2BA.%26atitle%3DCorrection%2520to%2520substrate-based%2520fragment%2520identification%2520for%2520the%2520development%2520of%2520selective%252C%2520nonpeptidic%2520inhibitors%2520of%2520striatal-enriched%2520protein%2520tyrosine%2520phosphatase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D10564%26epage%3D10564" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Lavogina, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Enkvist, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uri, A.</span><span> </span><span class="NLM_article-title">Bisubstrate inhibitors of protein kinases: from principle to practical applications</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">23</span><span class="NLM_x">–</span> <span class="NLM_lpage">34</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2010&pages=23-34&author=D.+Lavoginaauthor=E.+Enkvistauthor=A.+Uri&title=Bisubstrate+inhibitors+of+protein+kinases%3A+from+principle+to+practical+applications"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLavogina%26aufirst%3DD.%26aulast%3DEnkvist%26aufirst%3DE.%26aulast%3DUri%26aufirst%3DA.%26atitle%3DBisubstrate%2520inhibitors%2520of%2520protein%2520kinases%253A%2520from%2520principle%2520to%2520practical%2520applications%26jtitle%3DChemMedChem%26date%3D2010%26volume%3D5%26spage%3D23%26epage%3D34" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Lamba, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghosh, I.</span><span> </span><span class="NLM_article-title">New directions in targeting protein kinases: focusing upon true allosteric and bivalent inhibitors</span> <span class="citation_source-journal">Curr. Pharm. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">2936</span><span class="NLM_x">–</span> <span class="NLM_lpage">2945</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00229&amp;key=10.2174%2F138161212800672813" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00229&amp;key=22571662" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00229&amp;key=1%3ACAS%3A528%3ADC%252BC38XovFaltrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2012&pages=2936-2945&author=V.+Lambaauthor=I.+Ghosh&title=New+directions+in+targeting+protein+kinases%3A+focusing+upon+true+allosteric+and+bivalent+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">New directions in targeting protein kinases: focusing upon true allosteric and bivalent inhibitors</span></div><div class="casAuthors">Lamba, Vandana; Ghosh, Indraneel</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">2936-2945</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Over the past decade, therapeutics that target subsets of the 518 human protein kinases have played a vital role in the fight against cancer.  Protein kinases are typically targeted at the ATP-binding cleft by type I and II inhibitors; however, the high sequence and structural homol. shared by protein kinases, esp. at the ATP-binding site, inherently leads to polypharmacol.  In order to discover or design truly selective protein kinase inhibitors as both pharmacol. reagents and safer therapeutic leads, new efforts are needed to target kinases outside the ATP cleft.  Recent advances include the serendipitous discovery of type III inhibitors that bind a site proximal to the ATP pocket as well as the truly allosteric type IV inhibitors that target protein kinases distal to the substrate-binding pocket.  These new classes of inhibitors are often selective, but usually display moderate affinities.  Here, the authors discuss the different classes of inhibitors with an emphasis on bisubstrate and bivalent inhibitors (type V) that combine different inhibitor classes.  These inhibitors have the potential to couple the high affinity and potency of traditional active site-targeted small-mol. inhibitors with the selectivity of inhibitors that target the protein kinase surface outside ATP cleft.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpkIIgeMxhCrrVg90H21EOLACvtfcHk0lhiRvkHt-R7Iw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XovFaltrk%253D&md5=36a44e36709507b5053bfdfe7d09e5e9</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.2174%2F138161212800672813&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138161212800672813%26sid%3Dliteratum%253Aachs%26aulast%3DLamba%26aufirst%3DV.%26aulast%3DGhosh%26aufirst%3DI.%26atitle%3DNew%2520directions%2520in%2520targeting%2520protein%2520kinases%253A%2520focusing%2520upon%2520true%2520allosteric%2520and%2520bivalent%2520inhibitors%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2012%26volume%3D18%26spage%3D2936%26epage%3D2945" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Ekambaram, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Enkvist, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaasa, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kasari, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raidaru, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knapp, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uri, A.</span><span> </span><span class="NLM_article-title">Selective bisubstrate inhibitors with sub-nanomolar affinity for protein kinase Pim-1</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">909</span><span class="NLM_x">–</span> <span class="NLM_lpage">913</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=909-913&author=R.+Ekambaramauthor=E.+Enkvistauthor=A.+Vaasaauthor=M.+Kasariauthor=G.+Raidaruauthor=S.+Knappauthor=A.+Uri&title=Selective+bisubstrate+inhibitors+with+sub-nanomolar+affinity+for+protein+kinase+Pim-1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEkambaram%26aufirst%3DR.%26aulast%3DEnkvist%26aufirst%3DE.%26aulast%3DVaasa%26aufirst%3DA.%26aulast%3DKasari%26aufirst%3DM.%26aulast%3DRaidaru%26aufirst%3DG.%26aulast%3DKnapp%26aufirst%3DS.%26aulast%3DUri%26aufirst%3DA.%26atitle%3DSelective%2520bisubstrate%2520inhibitors%2520with%2520sub-nanomolar%2520affinity%2520for%2520protein%2520kinase%2520Pim-1%26jtitle%3DChemMedChem%26date%3D2013%26volume%3D8%26spage%3D909%26epage%3D913" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">van Wandelen, L. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Ameijde, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ismail-Ali, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Ufford, H. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vijftigschild, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beekman, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, N. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruijtenbeek, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liskamp, R. M.</span><span> </span><span class="NLM_article-title">Cell-penetrating bisubstrate-based protein kinase C inhibitors</span> <span class="citation_source-journal">ACS Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">1479</span><span class="NLM_x">–</span> <span class="NLM_lpage">1487</span></span><div class="citationLinks">[<a href="/doi/10.1021/cb300709g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=1479-1487&author=L.+T.+van+Wandelenauthor=J.+van+Ameijdeauthor=A.+F.+Ismail-Aliauthor=H.+C.+van+Uffordauthor=L.+A.+Vijftigschildauthor=J.+M.+Beekmanauthor=N.+I.+Martinauthor=R.+Ruijtenbeekauthor=R.+M.+Liskamp&title=Cell-penetrating+bisubstrate-based+protein+kinase+C+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Fcb300709g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb300709g%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2BWandelen%26aufirst%3DL.%2BT.%26aulast%3Dvan%2BAmeijde%26aufirst%3DJ.%26aulast%3DIsmail-Ali%26aufirst%3DA.%2BF.%26aulast%3Dvan%2BUfford%26aufirst%3DH.%2BC.%26aulast%3DVijftigschild%26aufirst%3DL.%2BA.%26aulast%3DBeekman%26aufirst%3DJ.%2BM.%26aulast%3DMartin%26aufirst%3DN.%2BI.%26aulast%3DRuijtenbeek%26aufirst%3DR.%26aulast%3DLiskamp%26aufirst%3DR.%2BM.%26atitle%3DCell-penetrating%2520bisubstrate-based%2520protein%2520kinase%2520C%2520inhibitors%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2013%26volume%3D8%26spage%3D1479%26epage%3D1487" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Poot, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Ameijde, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slijper, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van den Berg, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hilhorst, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruijtenbeek, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rijkers, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liskamp, R. M.</span><span> </span><span class="NLM_article-title">Development of selective bisubstrate-based inhibitors against protein kinase C (PKC) isozymes by using dynamic peptide microarrays</span> <span class="citation_source-journal">ChemBioChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">2042</span><span class="NLM_x">–</span> <span class="NLM_lpage">2051</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2009&pages=2042-2051&author=A.+J.+Pootauthor=J.+van+Ameijdeauthor=M.+Slijperauthor=A.+van+den+Bergauthor=R.+Hilhorstauthor=R.+Ruijtenbeekauthor=D.+T.+Rijkersauthor=R.+M.+Liskamp&title=Development+of+selective+bisubstrate-based+inhibitors+against+protein+kinase+C+%28PKC%29+isozymes+by+using+dynamic+peptide+microarrays"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPoot%26aufirst%3DA.%2BJ.%26aulast%3Dvan%2BAmeijde%26aufirst%3DJ.%26aulast%3DSlijper%26aufirst%3DM.%26aulast%3Dvan%2Bden%2BBerg%26aufirst%3DA.%26aulast%3DHilhorst%26aufirst%3DR.%26aulast%3DRuijtenbeek%26aufirst%3DR.%26aulast%3DRijkers%26aufirst%3DD.%2BT.%26aulast%3DLiskamp%26aufirst%3DR.%2BM.%26atitle%3DDevelopment%2520of%2520selective%2520bisubstrate-based%2520inhibitors%2520against%2520protein%2520kinase%2520C%2520%2528PKC%2529%2520isozymes%2520by%2520using%2520dynamic%2520peptide%2520microarrays%26jtitle%3DChemBioChem%26date%3D2009%26volume%3D10%26spage%3D2042%26epage%3D2051" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">van Wandelen, L. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Ameijde, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mady, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wammes, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bode, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poot, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruijtenbeek, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liskamp, R. M.</span><span> </span><span class="NLM_article-title">Directed modulation of protein kinase C isozyme selectivity with bisubstrate-based inhibitors</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">2113</span><span class="NLM_x">–</span> <span class="NLM_lpage">2121</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=2113-2121&author=L.+T.+van+Wandelenauthor=J.+van+Ameijdeauthor=A.+S.+Madyauthor=A.+E.+Wammesauthor=A.+Bodeauthor=A.+J.+Pootauthor=R.+Ruijtenbeekauthor=R.+M.+Liskamp&title=Directed+modulation+of+protein+kinase+C+isozyme+selectivity+with+bisubstrate-based+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2BWandelen%26aufirst%3DL.%2BT.%26aulast%3Dvan%2BAmeijde%26aufirst%3DJ.%26aulast%3DMady%26aufirst%3DA.%2BS.%26aulast%3DWammes%26aufirst%3DA.%2BE.%26aulast%3DBode%26aufirst%3DA.%26aulast%3DPoot%26aufirst%3DA.%2BJ.%26aulast%3DRuijtenbeek%26aufirst%3DR.%26aulast%3DLiskamp%26aufirst%3DR.%2BM.%26atitle%3DDirected%2520modulation%2520of%2520protein%2520kinase%2520C%2520isozyme%2520selectivity%2520with%2520bisubstrate-based%2520inhibitors%26jtitle%3DChemMedChem%26date%3D2012%26volume%3D7%26spage%3D2113%26epage%3D2121" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Song, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rai, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Clercq, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span> </span><span class="NLM_article-title">Multivalent agents: a novel concept and preliminary practice in anti-HIV drug discovery</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">815</span><span class="NLM_x">–</span> <span class="NLM_lpage">832</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00229&amp;key=23116144" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00229&amp;key=1%3ACAS%3A528%3ADC%252BC3sXlt1Ggs7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2013&pages=815-832&author=Y.+Songauthor=P.+Zhanauthor=X.+Liauthor=D.+Raiauthor=E.+De+Clercqauthor=X.+Liu&title=Multivalent+agents%3A+a+novel+concept+and+preliminary+practice+in+anti-HIV+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Multivalent agents: a novel concept and preliminary practice in anti-HIV drug discovery</span></div><div class="casAuthors">Song, Yu-ning; Zhan, Peng; Li, Xiao; Rai, Diwakar; De Clercq, Erik; Liu, Xinyong</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">815-832</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The term multivalency (polyvalency) in the biol. science is defined as the simultaneous binding of multiple ligands to one receptor (or multiple receptors to one ligand).  The possibility of gaining potency and selectivity was significantly increased through the use of multivalent ligand as a homo- or hetero-dimer, thus multivalent ligands provided a more attractive strategy to design novel anti-HIV agents with therapeutic applications.  Moreover, similar to phenomenon of multivalency, an alternative strategy is called the "mixed sites inhibitor", viz. a single mol. that possesses enough chem. space to maximize interactions with its complementary binding pocket, or to bind simultaneously in more than one regions in a target.  Actually, the addn. of a third heterocyclic nucleus to the parent compd. resulted in "mixed sites" anti-HIV agents with broad spectrum of activities against the mutant HIV-1 strains.  Based on current representative examples, the present article provided a brief review on the rationale for the design of different classes of multivalency anti-HIV agents and also discussed the advantages over their monomeric counterparts, providing a novel paradigm to facilitate the development of anti-HIV/AIDS therapeutic agents in treatment of HIV infected community.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfeQQtvZeCCbVg90H21EOLACvtfcHk0lhiRvkHt-R7Iw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXlt1Ggs7o%253D&md5=118fe3f5df6cced753c2e27fdcf77112</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSong%26aufirst%3DY.%26aulast%3DZhan%26aufirst%3DP.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DRai%26aufirst%3DD.%26aulast%3DDe%2BClercq%26aufirst%3DE.%26aulast%3DLiu%26aufirst%3DX.%26atitle%3DMultivalent%2520agents%253A%2520a%2520novel%2520concept%2520and%2520preliminary%2520practice%2520in%2520anti-HIV%2520drug%2520discovery%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2013%26volume%3D20%26spage%3D815%26epage%3D832" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Zhu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dai, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Q.</span><span> </span><span class="NLM_article-title">X-ray crystal structure of phosphodiesterase 2 in complex with a highly selective, nanomolar inhibitor reveals a binding-induced pocket important for selectivity</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">135</span><span class="NLM_x">, </span> <span class="NLM_fpage">11708</span><span class="NLM_x">–</span> <span class="NLM_lpage">11711</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja404449g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=135&publication_year=2013&pages=11708-11711&author=J.+Zhuauthor=Q.+Yangauthor=D.+Daiauthor=Q.+Huang&title=X-ray+crystal+structure+of+phosphodiesterase+2+in+complex+with+a+highly+selective%2C+nanomolar+inhibitor+reveals+a+binding-induced+pocket+important+for+selectivity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1021%2Fja404449g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja404449g%26sid%3Dliteratum%253Aachs%26aulast%3DZhu%26aufirst%3DJ.%26aulast%3DYang%26aufirst%3DQ.%26aulast%3DDai%26aufirst%3DD.%26aulast%3DHuang%26aufirst%3DQ.%26atitle%3DX-ray%2520crystal%2520structure%2520of%2520phosphodiesterase%25202%2520in%2520complex%2520with%2520a%2520highly%2520selective%252C%2520nanomolar%2520inhibitor%2520reveals%2520a%2520binding-induced%2520pocket%2520important%2520for%2520selectivity%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2013%26volume%3D135%26spage%3D11708%26epage%3D11711" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">Fabre, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramos, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Pascual-Teresa, B.</span><span> </span><span class="NLM_article-title">Targeting matrix metalloproteinases: exploring the dynamics of the S1′ pocket in the design of selective, small molecule inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">10205</span><span class="NLM_x">–</span> <span class="NLM_lpage">10219</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm500505f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=10205-10219&author=B.+Fabreauthor=A.+Ramosauthor=B.+de+Pascual-Teresa&title=Targeting+matrix+metalloproteinases%3A+exploring+the+dynamics+of+the+S1%E2%80%B2+pocket+in+the+design+of+selective%2C+small+molecule+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1021%2Fjm500505f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm500505f%26sid%3Dliteratum%253Aachs%26aulast%3DFabre%26aufirst%3DB.%26aulast%3DRamos%26aufirst%3DA.%26aulast%3Dde%2BPascual-Teresa%26aufirst%3DB.%26atitle%3DTargeting%2520matrix%2520metalloproteinases%253A%2520exploring%2520the%2520dynamics%2520of%2520the%2520S1%25E2%2580%25B2%2520pocket%2520in%2520the%2520design%2520of%2520selective%252C%2520small%2520molecule%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D10205%26epage%3D10219" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Nara, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sato, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naito, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mototani, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oki, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamoto, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuno, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santou, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kanzaki, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terauchi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uchikawa, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kori, M.</span><span> </span><span class="NLM_article-title">Discovery of novel, highly potent and selective quinazoline-2-carboxamide-based matrix metalloproteinase (MMP)-13 inhibitors without zinc binding group using structure-based design approach</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">8886</span><span class="NLM_x">–</span> <span class="NLM_lpage">8902</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm500981k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=8886-8902&author=H.+Naraauthor=K.+Satoauthor=T.+Naitoauthor=H.+Mototaniauthor=H.+Okiauthor=Y.+Yamamotoauthor=H.+Kunoauthor=T.+Santouauthor=N.+Kanzakiauthor=J.+Terauchiauthor=O.+Uchikawaauthor=M.+Kori&title=Discovery+of+novel%2C+highly+potent+and+selective+quinazoline-2-carboxamide-based+matrix+metalloproteinase+%28MMP%29-13+inhibitors+without+zinc+binding+group+using+structure-based+design+approach"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1021%2Fjm500981k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm500981k%26sid%3Dliteratum%253Aachs%26aulast%3DNara%26aufirst%3DH.%26aulast%3DSato%26aufirst%3DK.%26aulast%3DNaito%26aufirst%3DT.%26aulast%3DMototani%26aufirst%3DH.%26aulast%3DOki%26aufirst%3DH.%26aulast%3DYamamoto%26aufirst%3DY.%26aulast%3DKuno%26aufirst%3DH.%26aulast%3DSantou%26aufirst%3DT.%26aulast%3DKanzaki%26aufirst%3DN.%26aulast%3DTerauchi%26aufirst%3DJ.%26aulast%3DUchikawa%26aufirst%3DO.%26aulast%3DKori%26aufirst%3DM.%26atitle%3DDiscovery%2520of%2520novel%252C%2520highly%2520potent%2520and%2520selective%2520quinazoline-2-carboxamide-based%2520matrix%2520metalloproteinase%2520%2528MMP%2529-13%2520inhibitors%2520without%2520zinc%2520binding%2520group%2520using%2520structure-based%2520design%2520approach%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D8886%26epage%3D8902" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group">Nara, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sato, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naito, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mototani, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oki, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamoto, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuno, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santou, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kanzaki, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terauchi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uchikawa, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kori, M.</span><span> </span><span class="NLM_article-title">Thieno[2,3-<i>d</i>]pyrimidine-2-carboxamides bearing a carboxybenzene group at 5-position: highly potent, selective, and orally available MMP-13 inhibitors interacting with the S1″ binding site</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">5487</span><span class="NLM_x">–</span> <span class="NLM_lpage">5505</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2014&pages=5487-5505&author=H.+Naraauthor=K.+Satoauthor=T.+Naitoauthor=H.+Mototaniauthor=H.+Okiauthor=Y.+Yamamotoauthor=H.+Kunoauthor=T.+Santouauthor=N.+Kanzakiauthor=J.+Terauchiauthor=O.+Uchikawaauthor=M.+Kori&title=Thieno%5B2%2C3-d%5Dpyrimidine-2-carboxamides+bearing+a+carboxybenzene+group+at+5-position%3A+highly+potent%2C+selective%2C+and+orally+available+MMP-13+inhibitors+interacting+with+the+S1%E2%80%B3+binding+site"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNara%26aufirst%3DH.%26aulast%3DSato%26aufirst%3DK.%26aulast%3DNaito%26aufirst%3DT.%26aulast%3DMototani%26aufirst%3DH.%26aulast%3DOki%26aufirst%3DH.%26aulast%3DYamamoto%26aufirst%3DY.%26aulast%3DKuno%26aufirst%3DH.%26aulast%3DSantou%26aufirst%3DT.%26aulast%3DKanzaki%26aufirst%3DN.%26aulast%3DTerauchi%26aufirst%3DJ.%26aulast%3DUchikawa%26aufirst%3DO.%26aulast%3DKori%26aufirst%3DM.%26atitle%3DThieno%255B2%252C3-d%255Dpyrimidine-2-carboxamides%2520bearing%2520a%2520carboxybenzene%2520group%2520at%25205-position%253A%2520highly%2520potent%252C%2520selective%252C%2520and%2520orally%2520available%2520MMP-13%2520inhibitors%2520interacting%2520with%2520the%2520S1%25E2%2580%25B3%2520binding%2520site%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2014%26volume%3D22%26spage%3D5487%26epage%3D5505" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group">Schonbrunn, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Betzi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alam, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Becker, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Francis, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chakrasali, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jakkaraj, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kazi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sebti, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cubitt, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gebhard, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hazlehurst, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tash, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Georg, G. I.</span><span> </span><span class="NLM_article-title">Development of highly potent and selective diaminothiazole inhibitors of cyclin-dependent kinases</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">3768</span><span class="NLM_x">–</span> <span class="NLM_lpage">3782</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm301234k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00229&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmtF2jtb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=3768-3782&author=E.+Schonbrunnauthor=S.+Betziauthor=R.+Alamauthor=M.+P.+Martinauthor=A.+Beckerauthor=H.+Hanauthor=R.+Francisauthor=R.+Chakrasaliauthor=S.+Jakkarajauthor=A.+Kaziauthor=S.+M.+Sebtiauthor=C.+L.+Cubittauthor=A.+W.+Gebhardauthor=L.+A.+Hazlehurstauthor=J.+S.+Tashauthor=G.+I.+Georg&title=Development+of+highly+potent+and+selective+diaminothiazole+inhibitors+of+cyclin-dependent+kinases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Development of Highly Potent and Selective Diaminothiazole Inhibitors of Cyclin-Dependent Kinases</span></div><div class="casAuthors">Schonbrunn, Ernst; Betzi, Stephane; Alam, Riazul; Martin, Mathew P.; Becker, Andreas; Han, Huijong; Francis, Rawle; Chakrasali, Ramappa; Jakkaraj, Sudhakar; Kazi, Aslamuzzaman; Sebti, Said M.; Cubitt, Christopher L.; Gebhard, Anthony W.; Hazlehurst, Lori A.; Tash, Joseph S.; Georg, Gunda I.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">3768-3782</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Diaminothiazoles such as I were prepd. as inhibitors of cyclin-dependent kinase 2 (CDK2) for potential use as antitumor agents and as male contraceptive agents based on the optimization of a hit compd. with weak inhibitory activity (IC50 = 15 μM) discovered by high-throughput screening.  Using cocrystal structures of 35 diaminothiazoles with CDK2, the structure-activity relations of diaminothiazoles for CDK2 inhibition were detd. and used to find I.  I was tested for inhibition against a panel of 339 kinases; cyclin-dependent kinases were inhibited selectively, particularly CDK2 and CDK5 over CDK9, CDK1, CDK4, and CDK6.  I inhibited the proliferation of 13 out of 15 cancer cell lines with IC50 values of 0.27-6.9 μM; the antiproliferative activity correlated to complete suppression of retinoblastoma phosphorylation and the onset of apoptosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpeM-VFFhEenrVg90H21EOLACvtfcHk0lhYgd3fFTIW4g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmtF2jtb8%253D&md5=067bdf2349f9cd853b83d19131e0770f</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1021%2Fjm301234k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301234k%26sid%3Dliteratum%253Aachs%26aulast%3DSchonbrunn%26aufirst%3DE.%26aulast%3DBetzi%26aufirst%3DS.%26aulast%3DAlam%26aufirst%3DR.%26aulast%3DMartin%26aufirst%3DM.%2BP.%26aulast%3DBecker%26aufirst%3DA.%26aulast%3DHan%26aufirst%3DH.%26aulast%3DFrancis%26aufirst%3DR.%26aulast%3DChakrasali%26aufirst%3DR.%26aulast%3DJakkaraj%26aufirst%3DS.%26aulast%3DKazi%26aufirst%3DA.%26aulast%3DSebti%26aufirst%3DS.%2BM.%26aulast%3DCubitt%26aufirst%3DC.%2BL.%26aulast%3DGebhard%26aufirst%3DA.%2BW.%26aulast%3DHazlehurst%26aufirst%3DL.%2BA.%26aulast%3DTash%26aufirst%3DJ.%2BS.%26aulast%3DGeorg%26aufirst%3DG.%2BI.%26atitle%3DDevelopment%2520of%2520highly%2520potent%2520and%2520selective%2520diaminothiazole%2520inhibitors%2520of%2520cyclin-dependent%2520kinases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D3768%26epage%3D3782" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group">Meng, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hou, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shao, Y. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, P. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cai, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, H. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wan, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ke, H.</span><span> </span><span class="NLM_article-title">Structure-based discovery of highly selective phosphodiesterase-9A inhibitors and implications for inhibitor design</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">8549</span><span class="NLM_x">–</span> <span class="NLM_lpage">8558</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm301189c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00229&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtlGktbzJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=8549-8558&author=F.+Mengauthor=J.+Houauthor=Y.+X.+Shaoauthor=P.+Y.+Wuauthor=M.+Huangauthor=X.+Zhuauthor=Y.+Caiauthor=Z.+Liauthor=J.+Xuauthor=P.+Liuauthor=H.+B.+Luoauthor=Y.+Wanauthor=H.+Ke&title=Structure-based+discovery+of+highly+selective+phosphodiesterase-9A+inhibitors+and+implications+for+inhibitor+design"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Based Discovery of Highly Selective Phosphodiesterase-9A Inhibitors and Implications for Inhibitor Design</span></div><div class="casAuthors">Meng, Fei; Hou, Jing; Shao, Yong-Xian; Wu, Pei-Ying; Huang, Manna; Zhu, Xinhai; Cai, Yonghong; Li, Zhe; Xu, Jie; Liu, Peiqing; Luo, Hai-Bin; Wan, Yiqian; Ke, Hengming</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">8549-8558</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A new series of phosphodiesterase-9 (PDE9) inhibitors that contain a scaffold of 6-amino-pyrazolopyrimidinone have been discovered by a combination of structure-based design and computational docking.  This procedure significantly saved the load of chem. synthesis and is an effective method for the discovery of inhibitors.  The best compd. 28 (I) has an IC50 of 21 nM and 3.3 μM, resp., for PDE9 and PDE5 and about 3 orders of magnitude of selectivity against other PDE families.  The crystal structure of the PDE9 catalytic domain in complex with 28 has been detd. and shows a hydrogen bond between 28 and Tyr424.  This hydrogen bond may account for the 860-fold selectivity of 28 against PDE1B, in comparison with about 30-fold selectivity of BAY73-6691.  Thus, our studies suggest that Tyr424, a unique residue of PDE8 and PDE9, is a potential target for improvement of selectivity of PDE9 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXPtJ-cQVCabVg90H21EOLACvtfcHk0liq0fjCKPRcLg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtlGktbzJ&md5=ed8c37d784c80b040c51c9e2b40e2d99</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1021%2Fjm301189c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301189c%26sid%3Dliteratum%253Aachs%26aulast%3DMeng%26aufirst%3DF.%26aulast%3DHou%26aufirst%3DJ.%26aulast%3DShao%26aufirst%3DY.%2BX.%26aulast%3DWu%26aufirst%3DP.%2BY.%26aulast%3DHuang%26aufirst%3DM.%26aulast%3DZhu%26aufirst%3DX.%26aulast%3DCai%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DXu%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DP.%26aulast%3DLuo%26aufirst%3DH.%2BB.%26aulast%3DWan%26aufirst%3DY.%26aulast%3DKe%26aufirst%3DH.%26atitle%3DStructure-based%2520discovery%2520of%2520highly%2520selective%2520phosphodiesterase-9A%2520inhibitors%2520and%2520implications%2520for%2520inhibitor%2520design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D8549%26epage%3D8558" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Folkes, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahmadi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alderton, W. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alix, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baker, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Box, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chuckowree, I. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clarke, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Depledge, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eccles, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friedman, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayes, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hancox, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kugendradas, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lensun, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olivero, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pergl-Wilson, G. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raynaud, F. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saghir, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salphati, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sohal, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ultsch, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valenti, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wallweber, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wan, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiesmann, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Workman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhyvoloup, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zvelebil, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shuttleworth, S. J.</span><span> </span><span class="NLM_article-title">The identification of 2-(1<i>H</i>-indazol-4-yl)-6-(4-methanesulfonyl-piperazin-1-ylmethyl)-4-morpholin-4-yl-thieno[3,2-<i>d</i>]pyrimidine (GDC-0941) as a potent, selective, orally bioavailable inhibitor of class I PI3 kinase for the treatment of cancer</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">5522</span><span class="NLM_x">–</span> <span class="NLM_lpage">5532</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm800295d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref49/cit49a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00229&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtVCmsr7E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=5522-5532&author=A.+J.+Folkesauthor=K.+Ahmadiauthor=W.+K.+Aldertonauthor=S.+Alixauthor=S.+J.+Bakerauthor=G.+Boxauthor=I.+S.+Chuckowreeauthor=P.+A.+Clarkeauthor=P.+Depledgeauthor=S.+A.+Ecclesauthor=L.+S.+Friedmanauthor=A.+Hayesauthor=T.+C.+Hancoxauthor=A.+Kugendradasauthor=L.+Lensunauthor=P.+Mooreauthor=A.+G.+Oliveroauthor=J.+Pangauthor=S.+Patelauthor=G.+H.+Pergl-Wilsonauthor=F.+I.+Raynaudauthor=A.+Robsonauthor=N.+Saghirauthor=L.+Salphatiauthor=S.+Sohalauthor=M.+H.+Ultschauthor=M.+Valentiauthor=H.+J.+Wallweberauthor=N.+C.+Wanauthor=C.+Wiesmannauthor=P.+Workmanauthor=A.+Zhyvoloupauthor=M.+J.+Zvelebilauthor=S.+J.+Shuttleworth&title=The+identification+of+2-%281H-indazol-4-yl%29-6-%284-methanesulfonyl-piperazin-1-ylmethyl%29-4-morpholin-4-yl-thieno%5B3%2C2-d%5Dpyrimidine+%28GDC-0941%29+as+a+potent%2C+selective%2C+orally+bioavailable+inhibitor+of+class+I+PI3+kinase+for+the+treatment+of+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49aR"><div class="casContent"><span class="casTitleNuber">49a</span><div class="casTitle"><span class="NLM_cas:atitle">The identification of 2-(1H-indazol-4-yl)-6-(4-methanesulfonyl-piperazin-1-ylmethyl)-4-morpholin-4-yl-thieno[3,2-d]pyrimidine (GDC-0941) as a potent, selective, orally bioavailable inhibitor of class I PI3 kinase for the treatment of cancer</span></div><div class="casAuthors">Folkes, Adrian J.; Ahmadi, Khatereh; Alderton, Wendy K.; Alix, Sonia; Baker, Stewart J.; Box, Gary; Chuckowree, Irina S.; Clarke, Paul A.; Depledge, Paul; Eccles, Suzanne A.; Friedman, Lori S.; Hayes, Angela; Hancox, Timothy C.; Kugendradas, Arumugam; Lensun, Letitia; Moore, Pauline; Olivero, Alan G.; Pang, Jodie; Patel, Sonal; Pergl-Wilson, Giles H.; Raynaud, Florence I.; Robson, Anthony; Saghir, Nahid; Salphati, Laurent; Sohal, Sukhjit; Ultsch, Mark H.; Valenti, Melanie; Wallweber, Heidi J. A.; Wan, Nan Chi; Wiesmann, Christian; Workman, Paul; Zhyvoloup, Alexander; Zvelebil, Marketa J.; Shuttleworth, Stephen J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">5522-5532</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Phosphatidylinositol-3-kinase (PI3K) is an important target in cancer due to the deregulation of the PI3K/Akt signaling pathway in a wide variety of tumors.  A series of thieno[3,2-d]pyrimidine derivs. were prepd. and evaluated as inhibitors of PI3 kinase p110α.  The synthesis, biol. activity, and further profiling of these compds. are described.  This work resulted in the discovery of GDC-0941 (I) which is a potent, selective, orally bioavailable inhibitor of PI3K and is currently being evaluated in human clin. trials for the treatment of cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojkFv29FXqO7Vg90H21EOLACvtfcHk0liq0fjCKPRcLg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtVCmsr7E&md5=742084954685353ceaf18660ab3a0703</span></div><a href="/servlet/linkout?suffix=cit49a&amp;dbid=16384&amp;doi=10.1021%2Fjm800295d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800295d%26sid%3Dliteratum%253Aachs%26aulast%3DFolkes%26aufirst%3DA.%2BJ.%26aulast%3DAhmadi%26aufirst%3DK.%26aulast%3DAlderton%26aufirst%3DW.%2BK.%26aulast%3DAlix%26aufirst%3DS.%26aulast%3DBaker%26aufirst%3DS.%2BJ.%26aulast%3DBox%26aufirst%3DG.%26aulast%3DChuckowree%26aufirst%3DI.%2BS.%26aulast%3DClarke%26aufirst%3DP.%2BA.%26aulast%3DDepledge%26aufirst%3DP.%26aulast%3DEccles%26aufirst%3DS.%2BA.%26aulast%3DFriedman%26aufirst%3DL.%2BS.%26aulast%3DHayes%26aufirst%3DA.%26aulast%3DHancox%26aufirst%3DT.%2BC.%26aulast%3DKugendradas%26aufirst%3DA.%26aulast%3DLensun%26aufirst%3DL.%26aulast%3DMoore%26aufirst%3DP.%26aulast%3DOlivero%26aufirst%3DA.%2BG.%26aulast%3DPang%26aufirst%3DJ.%26aulast%3DPatel%26aufirst%3DS.%26aulast%3DPergl-Wilson%26aufirst%3DG.%2BH.%26aulast%3DRaynaud%26aufirst%3DF.%2BI.%26aulast%3DRobson%26aufirst%3DA.%26aulast%3DSaghir%26aufirst%3DN.%26aulast%3DSalphati%26aufirst%3DL.%26aulast%3DSohal%26aufirst%3DS.%26aulast%3DUltsch%26aufirst%3DM.%2BH.%26aulast%3DValenti%26aufirst%3DM.%26aulast%3DWallweber%26aufirst%3DH.%2BJ.%26aulast%3DWan%26aufirst%3DN.%2BC.%26aulast%3DWiesmann%26aufirst%3DC.%26aulast%3DWorkman%26aufirst%3DP.%26aulast%3DZhyvoloup%26aufirst%3DA.%26aulast%3DZvelebil%26aufirst%3DM.%2BJ.%26aulast%3DShuttleworth%26aufirst%3DS.%2BJ.%26atitle%3DThe%2520identification%2520of%25202-%25281H-indazol-4-yl%2529-6-%25284-methanesulfonyl-piperazin-1-ylmethyl%2529-4-morpholin-4-yl-thieno%255B3%252C2-d%255Dpyrimidine%2520%2528GDC-0941%2529%2520as%2520a%2520potent%252C%2520selective%252C%2520orally%2520bioavailable%2520inhibitor%2520of%2520class%2520I%2520PI3%2520kinase%2520for%2520the%2520treatment%2520of%2520cancer%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D5522%26epage%3D5532" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit49b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Nacht, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qiao, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheets, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, T.,  St</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Labenski, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mazdiyasni, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karp, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaturvedi, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhavsar, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niu, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Westlin, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petter, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Medikonda, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, J.</span><span> </span><span class="NLM_article-title">Discovery of a potent and isoform-selective targeted covalent inhibitor of the lipid kinase PI3Kα</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">712</span><span class="NLM_x">–</span> <span class="NLM_lpage">721</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm3008745" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref49/cit49b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00229&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhslWjsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=712-721&author=M.+Nachtauthor=L.+Qiaoauthor=M.+P.+Sheetsauthor=T.+Martinauthor=M.+Labenskiauthor=H.+Mazdiyasniauthor=R.+Karpauthor=Z.+Zhuauthor=P.+Chaturvediauthor=D.+Bhavsarauthor=D.+Niuauthor=W.+Westlinauthor=R.+C.+Petterauthor=A.+P.+Medikondaauthor=J.+Singh&title=Discovery+of+a+potent+and+isoform-selective+targeted+covalent+inhibitor+of+the+lipid+kinase+PI3K%CE%B1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49bR"><div class="casContent"><span class="casTitleNuber">49b</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a Potent and Isoform-Selective Targeted Covalent Inhibitor of the Lipid Kinase PI3Kα</span></div><div class="casAuthors">Nacht, Mariana; Qiao, Lixin; Sheets, Michael P.; St. Martin, Thia; Labenski, Matthew; Mazdiyasni, Hormoz; Karp, Russell; Zhu, Zhendong; Chaturvedi, Prasoon; Bhavsar, Deepa; Niu, Deqiang; Westlin, William; Petter, Russell C.; Medikonda, Aravind Prasad; Singh, Juswinder</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">712-721</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">PI3Kα has been identified as an oncogene in human tumors.  By use of rational drug design, a targeted covalent inhibitor 3 (CNX-1351) was created that potently and specifically inhibits PI3Kα.  We demonstrate, using mass spectrometry and X-ray crystallog., that the selective inhibitor covalently modifies PI3Kα on cysteine 862 (C862), an amino acid unique to the α isoform, and that PI3Kβ, -γ, and -δ are not covalently modified. 3 is able to potently (EC50 < 100 nM) and specifically inhibit signaling in PI3Kα-dependent cancer cell lines, and this leads to a potent antiproliferative effect (GI50 < 100 nM).  A covalent probe, 8 (CNX-1220), which selectively bonds to PI3Kα, was used to investigate the duration of occupancy of 3 with PI3Kα in vivo.  This is the first report of a PI3Kα-selective inhibitor, and these data demonstrate the biol. impact of selectively targeting PI3Kα.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpGrGxtOJ4wQbVg90H21EOLACvtfcHk0liq0fjCKPRcLg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhslWjsr4%253D&md5=42bf6d9221fdb9eafe010064807d22b9</span></div><a href="/servlet/linkout?suffix=cit49b&amp;dbid=16384&amp;doi=10.1021%2Fjm3008745&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm3008745%26sid%3Dliteratum%253Aachs%26aulast%3DNacht%26aufirst%3DM.%26aulast%3DQiao%26aufirst%3DL.%26aulast%3DSheets%26aufirst%3DM.%2BP.%26aulast%3DMartin%26aufirst%3DT.%26aulast%3DLabenski%26aufirst%3DM.%26aulast%3DMazdiyasni%26aufirst%3DH.%26aulast%3DKarp%26aufirst%3DR.%26aulast%3DZhu%26aufirst%3DZ.%26aulast%3DChaturvedi%26aufirst%3DP.%26aulast%3DBhavsar%26aufirst%3DD.%26aulast%3DNiu%26aufirst%3DD.%26aulast%3DWestlin%26aufirst%3DW.%26aulast%3DPetter%26aufirst%3DR.%2BC.%26aulast%3DMedikonda%26aufirst%3DA.%2BP.%26aulast%3DSingh%26aufirst%3DJ.%26atitle%3DDiscovery%2520of%2520a%2520potent%2520and%2520isoform-selective%2520targeted%2520covalent%2520inhibitor%2520of%2520the%2520lipid%2520kinase%2520PI3K%25CE%25B1%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D712%26epage%3D721" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group">Schröder, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klinger, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oellien, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marhöfer, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duszenko, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selzer, P. M.</span><span> </span><span class="NLM_article-title">Docking-based virtual screening of covalently binding ligands: an orthogonal lead discovery approach</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">1478</span><span class="NLM_x">–</span> <span class="NLM_lpage">1490</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm3013932" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=1478-1490&author=J.+Schr%C3%B6derauthor=A.+Klingerauthor=F.+Oellienauthor=R.+J.+Marh%C3%B6ferauthor=M.+Duszenkoauthor=P.+M.+Selzer&title=Docking-based+virtual+screening+of+covalently+binding+ligands%3A+an+orthogonal+lead+discovery+approach"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1021%2Fjm3013932&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm3013932%26sid%3Dliteratum%253Aachs%26aulast%3DSchr%25C3%25B6der%26aufirst%3DJ.%26aulast%3DKlinger%26aufirst%3DA.%26aulast%3DOellien%26aufirst%3DF.%26aulast%3DMarh%25C3%25B6fer%26aufirst%3DR.%2BJ.%26aulast%3DDuszenko%26aufirst%3DM.%26aulast%3DSelzer%26aufirst%3DP.%2BM.%26atitle%3DDocking-based%2520virtual%2520screening%2520of%2520covalently%2520binding%2520ligands%253A%2520an%2520orthogonal%2520lead%2520discovery%2520approach%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D1478%26epage%3D1490" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group">Pinson, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chalmers, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jennings, I. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, P. E.</span><span> </span><span class="NLM_article-title"><span class="smallcaps smallerCapital">l</span>-Aminoacyl-triazine derivatives are isoform-selective PI3Kβ inhibitors that target non-conserved Asp862 of PI3Kβ</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">206</span><span class="NLM_x">–</span> <span class="NLM_lpage">210</span></span><div class="citationLinks">[<a href="/doi/10.1021/ml300336j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=206-210&author=J.+A.+Pinsonauthor=Z.+Zhengauthor=M.+S.+Millerauthor=D.+K.+Chalmersauthor=I.+G.+Jenningsauthor=P.+E.+Thompson&title=l-Aminoacyl-triazine+derivatives+are+isoform-selective+PI3K%CE%B2+inhibitors+that+target+non-conserved+Asp862+of+PI3K%CE%B2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1021%2Fml300336j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml300336j%26sid%3Dliteratum%253Aachs%26aulast%3DPinson%26aufirst%3DJ.%2BA.%26aulast%3DZheng%26aufirst%3DZ.%26aulast%3DMiller%26aufirst%3DM.%2BS.%26aulast%3DChalmers%26aufirst%3DD.%2BK.%26aulast%3DJennings%26aufirst%3DI.%2BG.%26aulast%3DThompson%26aufirst%3DP.%2BE.%26atitle%3Dl-Aminoacyl-triazine%2520derivatives%2520are%2520isoform-selective%2520PI3K%25CE%25B2%2520inhibitors%2520that%2520target%2520non-conserved%2520Asp862%2520of%2520PI3K%25CE%25B2%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D4%26spage%3D206%26epage%3D210" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group">Leahy, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buhr, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, H. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, B. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baik, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cannoy, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forsyth, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeong, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noson, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nuss, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brooks, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foster, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goon, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heald, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holst, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jaeger, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lam, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lougheed, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plonowski, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stout, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yakes, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamb, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raeber, O.</span><span> </span><span class="NLM_article-title">Discovery of a novel series of potent and orally bioavailable phosphoinositide 3-kinase γ inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">5467</span><span class="NLM_x">–</span> <span class="NLM_lpage">5482</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm300403a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=5467-5482&author=J.+W.+Leahyauthor=C.+A.+Buhrauthor=H.+W.+Johnsonauthor=B.+G.+Kimauthor=T.+Baikauthor=J.+Cannoyauthor=T.+P.+Forsythauthor=J.+W.+Jeongauthor=M.+S.+Leeauthor=S.+Maauthor=K.+Nosonauthor=L.+Wangauthor=M.+Williamsauthor=J.+M.+Nussauthor=E.+Brooksauthor=P.+Fosterauthor=L.+Goonauthor=N.+Healdauthor=C.+Holstauthor=C.+Jaegerauthor=S.+Lamauthor=J.+Lougheedauthor=L.+Nguyenauthor=A.+Plonowskiauthor=J.+Songauthor=T.+Stoutauthor=X.+Wuauthor=M.+F.+Yakesauthor=P.+Yuauthor=W.+Zhangauthor=P.+Lambauthor=O.+Raeber&title=Discovery+of+a+novel+series+of+potent+and+orally+bioavailable+phosphoinositide+3-kinase+%CE%B3+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1021%2Fjm300403a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300403a%26sid%3Dliteratum%253Aachs%26aulast%3DLeahy%26aufirst%3DJ.%2BW.%26aulast%3DBuhr%26aufirst%3DC.%2BA.%26aulast%3DJohnson%26aufirst%3DH.%2BW.%26aulast%3DKim%26aufirst%3DB.%2BG.%26aulast%3DBaik%26aufirst%3DT.%26aulast%3DCannoy%26aufirst%3DJ.%26aulast%3DForsyth%26aufirst%3DT.%2BP.%26aulast%3DJeong%26aufirst%3DJ.%2BW.%26aulast%3DLee%26aufirst%3DM.%2BS.%26aulast%3DMa%26aufirst%3DS.%26aulast%3DNoson%26aufirst%3DK.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DWilliams%26aufirst%3DM.%26aulast%3DNuss%26aufirst%3DJ.%2BM.%26aulast%3DBrooks%26aufirst%3DE.%26aulast%3DFoster%26aufirst%3DP.%26aulast%3DGoon%26aufirst%3DL.%26aulast%3DHeald%26aufirst%3DN.%26aulast%3DHolst%26aufirst%3DC.%26aulast%3DJaeger%26aufirst%3DC.%26aulast%3DLam%26aufirst%3DS.%26aulast%3DLougheed%26aufirst%3DJ.%26aulast%3DNguyen%26aufirst%3DL.%26aulast%3DPlonowski%26aufirst%3DA.%26aulast%3DSong%26aufirst%3DJ.%26aulast%3DStout%26aufirst%3DT.%26aulast%3DWu%26aufirst%3DX.%26aulast%3DYakes%26aufirst%3DM.%2BF.%26aulast%3DYu%26aufirst%3DP.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DLamb%26aufirst%3DP.%26aulast%3DRaeber%26aufirst%3DO.%26atitle%3DDiscovery%2520of%2520a%2520novel%2520series%2520of%2520potent%2520and%2520orally%2520bioavailable%2520phosphoinositide%25203-kinase%2520%25CE%25B3%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D5467%26epage%3D5482" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group">Bago, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malik, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munson, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prescott, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sommer, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shpiro, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cross, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ganley, I. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alessi, D. R.</span><span> </span><span class="NLM_article-title">Characterization of VPS34-IN1, a selective inhibitor of Vps34, reveals that the phosphatidylinositol 3-phosphate-binding SGK3 protein kinase is a downstream target of class III phosphoinositide 3-kinase</span> <span class="citation_source-journal">Biochem. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">463</span><span class="NLM_x">, </span> <span class="NLM_fpage">413</span><span class="NLM_x">–</span> <span class="NLM_lpage">427</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=463&publication_year=2014&pages=413-427&author=R.+Bagoauthor=N.+Malikauthor=M.+J.+Munsonauthor=A.+R.+Prescottauthor=P.+Daviesauthor=E.+Sommerauthor=N.+Shpiroauthor=R.+Wardauthor=D.+Crossauthor=I.+G.+Ganleyauthor=D.+R.+Alessi&title=Characterization+of+VPS34-IN1%2C+a+selective+inhibitor+of+Vps34%2C+reveals+that+the+phosphatidylinositol+3-phosphate-binding+SGK3+protein+kinase+is+a+downstream+target+of+class+III+phosphoinositide+3-kinase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBago%26aufirst%3DR.%26aulast%3DMalik%26aufirst%3DN.%26aulast%3DMunson%26aufirst%3DM.%2BJ.%26aulast%3DPrescott%26aufirst%3DA.%2BR.%26aulast%3DDavies%26aufirst%3DP.%26aulast%3DSommer%26aufirst%3DE.%26aulast%3DShpiro%26aufirst%3DN.%26aulast%3DWard%26aufirst%3DR.%26aulast%3DCross%26aufirst%3DD.%26aulast%3DGanley%26aufirst%3DI.%2BG.%26aulast%3DAlessi%26aufirst%3DD.%2BR.%26atitle%3DCharacterization%2520of%2520VPS34-IN1%252C%2520a%2520selective%2520inhibitor%2520of%2520Vps34%252C%2520reveals%2520that%2520the%2520phosphatidylinositol%25203-phosphate-binding%2520SGK3%2520protein%2520kinase%2520is%2520a%2520downstream%2520target%2520of%2520class%2520III%2520phosphoinositide%25203-kinase%26jtitle%3DBiochem.%2520J.%26date%3D2014%26volume%3D463%26spage%3D413%26epage%3D427" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group">Ronan, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flamand, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vescovi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dureuil, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Durand, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fassy, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bachelot, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamberton, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathieu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertrand, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marquette, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">El-Ahmad, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Filoche-Romme, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schio, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia-Echeverria, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goulaouic, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pasquier, B.</span><span> </span><span class="NLM_article-title">A highly potent and selective Vps34 inhibitor alters vesicle trafficking and autophagy</span> <span class="citation_source-journal">Nature Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">1013</span><span class="NLM_x">–</span> <span class="NLM_lpage">1019</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00229&amp;key=10.1038%2Fnchembio.1681" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00229&amp;key=25326666" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00229&amp;key=1%3ACAS%3A280%3ADC%252BC2M3hs1entQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2014&pages=1013-1019&author=B.+Ronanauthor=O.+Flamandauthor=L.+Vescoviauthor=C.+Dureuilauthor=L.+Durandauthor=F.+Fassyauthor=M.+F.+Bachelotauthor=A.+Lambertonauthor=M.+Mathieuauthor=T.+Bertrandauthor=J.+P.+Marquetteauthor=Y.+El-Ahmadauthor=B.+Filoche-Rommeauthor=L.+Schioauthor=C.+Garcia-Echeverriaauthor=H.+Goulaouicauthor=B.+Pasquier&title=A+highly+potent+and+selective+Vps34+inhibitor+alters+vesicle+trafficking+and+autophagy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">A highly potent and selective Vps34 inhibitor alters vesicle trafficking and autophagy</span></div><div class="casAuthors">Ronan Baptiste; Flamand Odile; Vescovi Lionel; Dureuil Christine; Durand Laurence; Fassy Florence; Bachelot Marie-France; Lamberton Annabelle; El-Ahmad Youssef; Filoche-Romme Bruno; Schio Laurent; Garcia-Echeverria Carlos; Goulaouic Helene; Pasquier Benoit; Mathieu Magali; Bertrand Thomas; Marquette Jean-Pierre</div><div class="citationInfo"><span class="NLM_cas:title">Nature chemical biology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1013-9</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Vps34 is a phosphoinositide 3-kinase (PI3K) class III isoform that has attracted major attention over the recent years because of its role in autophagy.  Herein we describe the biological characterization of SAR405, which is a low-molecular-mass kinase inhibitor of Vps34 (KD 1.5 nM).  This compound has an exquisite protein and lipid kinase selectivity profile that is explained by its unique binding mode and molecular interactions within the ATP binding cleft of human Vps34.  To the best of our knowledge, this is the first potent and specific Vps34 inhibitor described so far.  Our results demonstrate that inhibition of Vps34 kinase activity by SAR405 affects both late endosome-lysosome compartments and prevents autophagy.  Moreover, we show that the concomitant inhibition of Vps34 and mTOR, with SAR405 and the US Food and Drug Administration-approved mTOR inhibitor everolimus, results in synergistic antiproliferative activity in renal tumor cell lines, indicating a potential clinical application in cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT3zbvEvL2MUGxpATR2EQURfW6udTcc2eYH0m7rM175zrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2M3hs1entQ%253D%253D&md5=78caac15b0577c3d834dbd7951ded33b</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.1681&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.1681%26sid%3Dliteratum%253Aachs%26aulast%3DRonan%26aufirst%3DB.%26aulast%3DFlamand%26aufirst%3DO.%26aulast%3DVescovi%26aufirst%3DL.%26aulast%3DDureuil%26aufirst%3DC.%26aulast%3DDurand%26aufirst%3DL.%26aulast%3DFassy%26aufirst%3DF.%26aulast%3DBachelot%26aufirst%3DM.%2BF.%26aulast%3DLamberton%26aufirst%3DA.%26aulast%3DMathieu%26aufirst%3DM.%26aulast%3DBertrand%26aufirst%3DT.%26aulast%3DMarquette%26aufirst%3DJ.%2BP.%26aulast%3DEl-Ahmad%26aufirst%3DY.%26aulast%3DFiloche-Romme%26aufirst%3DB.%26aulast%3DSchio%26aufirst%3DL.%26aulast%3DGarcia-Echeverria%26aufirst%3DC.%26aulast%3DGoulaouic%26aufirst%3DH.%26aulast%3DPasquier%26aufirst%3DB.%26atitle%3DA%2520highly%2520potent%2520and%2520selective%2520Vps34%2520inhibitor%2520alters%2520vesicle%2520trafficking%2520and%2520autophagy%26jtitle%3DNature%2520Chem.%2520Biol.%26date%3D2014%26volume%3D10%26spage%3D1013%26epage%3D1019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group">Pasquier, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">El-Ahmad, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Filoche-Rommé, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dureuil, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fassy, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abecassis, P. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathieu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertrand, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benard, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrière, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">El Batti, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Letallec, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sonnefraud, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brollo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delbarre, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loyau, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pilorge, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richepin, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arigon, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Labrosse, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clément, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Durand, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Combet, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perraut, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leroy, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gay, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lefrançois, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bretin, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marquette, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michot, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caron, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castell, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schio, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCort, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goulaouic, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia-Echeverria, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ronan, B.</span><span> </span><span class="NLM_article-title">Discovery of (2<i>S</i>)-8-[(3<i>R</i>)-3-methylmorpholin-4-yl]-1-(3-methyl-2-oxobutyl)-2-(trifluoromethyl)-3,4-dihydro-2<i>H</i>-pyrimido[1,2-<i>a</i>]pyrimidin-6-one: a novel potent and selective inhibitor of Vps34 for the treatment of solid tumors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">376</span><span class="NLM_x">–</span> <span class="NLM_lpage">400</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm5013352" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=376-400&author=B.+Pasquierauthor=Y.+El-Ahmadauthor=B.+Filoche-Romm%C3%A9author=C.+Dureuilauthor=F.+Fassyauthor=P.+Y.+Abecassisauthor=M.+Mathieuauthor=T.+Bertrandauthor=T.+Benardauthor=C.+Barri%C3%A8reauthor=S.+El+Battiauthor=J.+P.+Letallecauthor=V.+Sonnefraudauthor=M.+Brolloauthor=L.+Delbarreauthor=V.+Loyauauthor=F.+Pilorgeauthor=L.+Bertinauthor=P.+Richepinauthor=J.+Arigonauthor=J.+R.+Labrosseauthor=J.+Cl%C3%A9mentauthor=F.+Durandauthor=R.+Combetauthor=P.+Perrautauthor=V.+Leroyauthor=F.+Gayauthor=D.+Lefran%C3%A7oisauthor=F.+Bretinauthor=J.+P.+Marquetteauthor=N.+Michotauthor=A.+Caronauthor=C.+Castellauthor=L.+Schioauthor=G.+McCortauthor=H.+Goulaouicauthor=C.+Garcia-Echeverriaauthor=B.+Ronan&title=Discovery+of+%282S%29-8-%5B%283R%29-3-methylmorpholin-4-yl%5D-1-%283-methyl-2-oxobutyl%29-2-%28trifluoromethyl%29-3%2C4-dihydro-2H-pyrimido%5B1%2C2-a%5Dpyrimidin-6-one%3A+a+novel+potent+and+selective+inhibitor+of+Vps34+for+the+treatment+of+solid+tumors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1021%2Fjm5013352&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm5013352%26sid%3Dliteratum%253Aachs%26aulast%3DPasquier%26aufirst%3DB.%26aulast%3DEl-Ahmad%26aufirst%3DY.%26aulast%3DFiloche-Romm%25C3%25A9%26aufirst%3DB.%26aulast%3DDureuil%26aufirst%3DC.%26aulast%3DFassy%26aufirst%3DF.%26aulast%3DAbecassis%26aufirst%3DP.%2BY.%26aulast%3DMathieu%26aufirst%3DM.%26aulast%3DBertrand%26aufirst%3DT.%26aulast%3DBenard%26aufirst%3DT.%26aulast%3DBarri%25C3%25A8re%26aufirst%3DC.%26aulast%3DEl%2BBatti%26aufirst%3DS.%26aulast%3DLetallec%26aufirst%3DJ.%2BP.%26aulast%3DSonnefraud%26aufirst%3DV.%26aulast%3DBrollo%26aufirst%3DM.%26aulast%3DDelbarre%26aufirst%3DL.%26aulast%3DLoyau%26aufirst%3DV.%26aulast%3DPilorge%26aufirst%3DF.%26aulast%3DBertin%26aufirst%3DL.%26aulast%3DRichepin%26aufirst%3DP.%26aulast%3DArigon%26aufirst%3DJ.%26aulast%3DLabrosse%26aufirst%3DJ.%2BR.%26aulast%3DCl%25C3%25A9ment%26aufirst%3DJ.%26aulast%3DDurand%26aufirst%3DF.%26aulast%3DCombet%26aufirst%3DR.%26aulast%3DPerraut%26aufirst%3DP.%26aulast%3DLeroy%26aufirst%3DV.%26aulast%3DGay%26aufirst%3DF.%26aulast%3DLefran%25C3%25A7ois%26aufirst%3DD.%26aulast%3DBretin%26aufirst%3DF.%26aulast%3DMarquette%26aufirst%3DJ.%2BP.%26aulast%3DMichot%26aufirst%3DN.%26aulast%3DCaron%26aufirst%3DA.%26aulast%3DCastell%26aufirst%3DC.%26aulast%3DSchio%26aufirst%3DL.%26aulast%3DMcCort%26aufirst%3DG.%26aulast%3DGoulaouic%26aufirst%3DH.%26aulast%3DGarcia-Echeverria%26aufirst%3DC.%26aulast%3DRonan%26aufirst%3DB.%26atitle%3DDiscovery%2520of%2520%25282S%2529-8-%255B%25283R%2529-3-methylmorpholin-4-yl%255D-1-%25283-methyl-2-oxobutyl%2529-2-%2528trifluoromethyl%2529-3%252C4-dihydro-2H-pyrimido%255B1%252C2-a%255Dpyrimidin-6-one%253A%2520a%2520novel%2520potent%2520and%2520selective%2520inhibitor%2520of%2520Vps34%2520for%2520the%2520treatment%2520of%2520solid%2520tumors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D376%26epage%3D400" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group">Duerfeldt, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peterson, L. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maynard, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ng, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eletto, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ostrovsky, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shinogle, H. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Argon, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicchitta, C. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blagg, B. S.</span><span> </span><span class="NLM_article-title">Development of a Grp94 inhibitor</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">134</span><span class="NLM_x">, </span> <span class="NLM_fpage">9796</span><span class="NLM_x">–</span> <span class="NLM_lpage">9804</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja303477g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00229&amp;key=1%3ACAS%3A528%3ADC%252BC38XnslGqsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=134&publication_year=2012&pages=9796-9804&author=A.+S.+Duerfeldtauthor=L.+B.+Petersonauthor=J.+C.+Maynardauthor=C.+L.+Ngauthor=D.+Elettoauthor=O.+Ostrovskyauthor=H.+E.+Shinogleauthor=D.+S.+Mooreauthor=Y.+Argonauthor=C.+V.+Nicchittaauthor=B.+S.+Blagg&title=Development+of+a+Grp94+inhibitor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Development of a Grp94 inhibitor</span></div><div class="casAuthors">Duerfeldt, Adam S.; Peterson, Laura B.; Maynard, Jason C.; Ng, Chun Leung; Eletto, Davide; Ostrovsky, Olga; Shinogle, Heather E.; Moore, David S.; Argon, Yair; Nicchitta, Christopher V.; Blagg, Brian S. J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">134</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">9796-9804</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Heat shock protein 90 (Hsp90) represents a promising therapeutic target for the treatment of cancer and other diseases.  Unfortunately, results from clin. trials have been disappointing as off-target effects and toxicities have been obsd.  These detriments may be a consequence of pan-Hsp90 inhibition, as all clin. evaluated Hsp90 inhibitors simultaneously disrupt all four human Hsp90 isoforms.  Using a structure-based approach, we designed an inhibitor of Grp94, the ER-resident Hsp90.  The effect manifested by compd. (I) on several Grp94 and Hsp90α/β (cytosolic isoforms) clients were investigated.  Compd. I prevented intracellular trafficking of the Toll receptor, inhibited the secretion of IGF-II, affected the conformation of Grp94, and suppressed Drosophila larval growth, all Grp94-dependent processes.  In contrast, compd. I had no effect on cell viability or cytosolic Hsp90α/β client proteins at similar concns.  The design, synthesis, and evaluation of I are described herein.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoayCAvZU_mzrVg90H21EOLACvtfcHk0ljqpPkiyp1MEg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XnslGqsLw%253D&md5=00c0b3f15f2cfd04658225c8a6fb708d</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1021%2Fja303477g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja303477g%26sid%3Dliteratum%253Aachs%26aulast%3DDuerfeldt%26aufirst%3DA.%2BS.%26aulast%3DPeterson%26aufirst%3DL.%2BB.%26aulast%3DMaynard%26aufirst%3DJ.%2BC.%26aulast%3DNg%26aufirst%3DC.%2BL.%26aulast%3DEletto%26aufirst%3DD.%26aulast%3DOstrovsky%26aufirst%3DO.%26aulast%3DShinogle%26aufirst%3DH.%2BE.%26aulast%3DMoore%26aufirst%3DD.%2BS.%26aulast%3DArgon%26aufirst%3DY.%26aulast%3DNicchitta%26aufirst%3DC.%2BV.%26aulast%3DBlagg%26aufirst%3DB.%2BS.%26atitle%3DDevelopment%2520of%2520a%2520Grp94%2520inhibitor%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2012%26volume%3D134%26spage%3D9796%26epage%3D9804" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group">Lucas, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldstein, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hermann, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuglstatter, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luk, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Padilla, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slade, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villaseñor, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wanner, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liao, C.</span><span> </span><span class="NLM_article-title">Rational design of highly selective spleen tyrosine kinase inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">10414</span><span class="NLM_x">–</span> <span class="NLM_lpage">10423</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm301367c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=10414-10423&author=M.+C.+Lucasauthor=D.+M.+Goldsteinauthor=J.+C.+Hermannauthor=A.+Kuglstatterauthor=W.+Liuauthor=K.+C.+Lukauthor=F.+Padillaauthor=M.+Sladeauthor=A.+G.+Villase%C3%B1orauthor=J.+Wannerauthor=W.+Xieauthor=X.+Zhangauthor=C.+Liao&title=Rational+design+of+highly+selective+spleen+tyrosine+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1021%2Fjm301367c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301367c%26sid%3Dliteratum%253Aachs%26aulast%3DLucas%26aufirst%3DM.%2BC.%26aulast%3DGoldstein%26aufirst%3DD.%2BM.%26aulast%3DHermann%26aufirst%3DJ.%2BC.%26aulast%3DKuglstatter%26aufirst%3DA.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DLuk%26aufirst%3DK.%2BC.%26aulast%3DPadilla%26aufirst%3DF.%26aulast%3DSlade%26aufirst%3DM.%26aulast%3DVillase%25C3%25B1or%26aufirst%3DA.%2BG.%26aulast%3DWanner%26aufirst%3DJ.%26aulast%3DXie%26aufirst%3DW.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DLiao%26aufirst%3DC.%26atitle%3DRational%2520design%2520of%2520highly%2520selective%2520spleen%2520tyrosine%2520kinase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D10414%26epage%3D10423" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group">Liang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Abbema, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balazs, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrett, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berezhkovsky, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blair, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delarosa, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeVoss, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Driscoll, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eigenbrot, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghilardi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibbons, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halladay, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohli, P. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyssikatos, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mantik, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menghrajani, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sambrone, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shia, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shin, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sohn, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsui, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ultsch, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, B. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magnuson, S.</span><span> </span><span class="NLM_article-title">Lead optimization of a 4-aminopyridine benzamide scaffold to identify potent, selective, and orally bioavailable TYK2 inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">4521</span><span class="NLM_x">–</span> <span class="NLM_lpage">4536</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm400266t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=4521-4536&author=J.+Liangauthor=A.+van+Abbemaauthor=M.+Balazsauthor=K.+Barrettauthor=L.+Berezhkovskyauthor=W.+Blairauthor=C.+Changauthor=D.+Delarosaauthor=J.+DeVossauthor=J.+Driscollauthor=C.+Eigenbrotauthor=N.+Ghilardiauthor=P.+Gibbonsauthor=J.+Halladayauthor=A.+Johnsonauthor=P.+B.+Kohliauthor=Y.+Laiauthor=Y.+Liuauthor=J.+Lyssikatosauthor=P.+Mantikauthor=K.+Menghrajaniauthor=J.+Murrayauthor=I.+Pengauthor=A.+Sambroneauthor=S.+Shiaauthor=Y.+Shinauthor=J.+Smithauthor=S.+Sohnauthor=V.+Tsuiauthor=M.+Ultschauthor=L.+C.+Wuauthor=Y.+Xiaoauthor=W.+Yangauthor=J.+Youngauthor=B.+Zhangauthor=B.+Y.+Zhuauthor=S.+Magnuson&title=Lead+optimization+of+a+4-aminopyridine+benzamide+scaffold+to+identify+potent%2C+selective%2C+and+orally+bioavailable+TYK2+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1021%2Fjm400266t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400266t%26sid%3Dliteratum%253Aachs%26aulast%3DLiang%26aufirst%3DJ.%26aulast%3Dvan%2BAbbema%26aufirst%3DA.%26aulast%3DBalazs%26aufirst%3DM.%26aulast%3DBarrett%26aufirst%3DK.%26aulast%3DBerezhkovsky%26aufirst%3DL.%26aulast%3DBlair%26aufirst%3DW.%26aulast%3DChang%26aufirst%3DC.%26aulast%3DDelarosa%26aufirst%3DD.%26aulast%3DDeVoss%26aufirst%3DJ.%26aulast%3DDriscoll%26aufirst%3DJ.%26aulast%3DEigenbrot%26aufirst%3DC.%26aulast%3DGhilardi%26aufirst%3DN.%26aulast%3DGibbons%26aufirst%3DP.%26aulast%3DHalladay%26aufirst%3DJ.%26aulast%3DJohnson%26aufirst%3DA.%26aulast%3DKohli%26aufirst%3DP.%2BB.%26aulast%3DLai%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DLyssikatos%26aufirst%3DJ.%26aulast%3DMantik%26aufirst%3DP.%26aulast%3DMenghrajani%26aufirst%3DK.%26aulast%3DMurray%26aufirst%3DJ.%26aulast%3DPeng%26aufirst%3DI.%26aulast%3DSambrone%26aufirst%3DA.%26aulast%3DShia%26aufirst%3DS.%26aulast%3DShin%26aufirst%3DY.%26aulast%3DSmith%26aufirst%3DJ.%26aulast%3DSohn%26aufirst%3DS.%26aulast%3DTsui%26aufirst%3DV.%26aulast%3DUltsch%26aufirst%3DM.%26aulast%3DWu%26aufirst%3DL.%2BC.%26aulast%3DXiao%26aufirst%3DY.%26aulast%3DYang%26aufirst%3DW.%26aulast%3DYoung%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DB.%26aulast%3DZhu%26aufirst%3DB.%2BY.%26aulast%3DMagnuson%26aufirst%3DS.%26atitle%3DLead%2520optimization%2520of%2520a%25204-aminopyridine%2520benzamide%2520scaffold%2520to%2520identify%2520potent%252C%2520selective%252C%2520and%2520orally%2520bioavailable%2520TYK2%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D4521%26epage%3D4536" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group">Zak, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hurley, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, S. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergeron, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrett, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balazs, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blair, W. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bull, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chakravarty, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crackett, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deshmukh, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeVoss, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dragovich, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eigenbrot, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellwood, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaines, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghilardi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibbons, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gradl, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gribling, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamman, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harstad, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hewitt, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kenny, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koehler, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bir Kohli, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Labadie, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, W. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liimatta, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mendonca, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narukulla, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pulk, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reeve, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Savage, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shia, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steffek, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ubhayakar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Abbema, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aliagas, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Avitabile-Woo, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kulagowski, J. J.</span><span> </span><span class="NLM_article-title">Identification of C-2 hydroxyethyl imidazopyrrolopyridines as potent JAK1 inhibitors with favorable physicochemical properties and high selectivity over JAK2</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">4764</span><span class="NLM_x">–</span> <span class="NLM_lpage">4785</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm4004895" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=4764-4785&author=M.+Zakauthor=C.+A.+Hurleyauthor=S.+I.+Wardauthor=P.+Bergeronauthor=K.+Barrettauthor=M.+Balazsauthor=W.+S.+Blairauthor=R.+Bullauthor=P.+Chakravartyauthor=C.+Changauthor=P.+Crackettauthor=G.+Deshmukhauthor=J.+DeVossauthor=P.+S.+Dragovichauthor=C.+Eigenbrotauthor=C.+Ellwoodauthor=S.+Gainesauthor=N.+Ghilardiauthor=P.+Gibbonsauthor=S.+Gradlauthor=P.+Griblingauthor=C.+Hammanauthor=E.+Harstadauthor=P.+Hewittauthor=A.+Johnsonauthor=T.+Johnsonauthor=J.+R.+Kennyauthor=M.+F.+Koehlerauthor=P.+Bir+Kohliauthor=S.+Labadieauthor=W.+P.+Leeauthor=J.+Liaoauthor=M.+Liimattaauthor=R.+Mendoncaauthor=R.+Narukullaauthor=R.+Pulkauthor=A.+Reeveauthor=S.+Savageauthor=S.+Shiaauthor=M.+Steffekauthor=S.+Ubhayakarauthor=A.+van+Abbemaauthor=I.+Aliagasauthor=B.+Avitabile-Wooauthor=Y.+Xiaoauthor=J.+Yangauthor=J.+J.+Kulagowski&title=Identification+of+C-2+hydroxyethyl+imidazopyrrolopyridines+as+potent+JAK1+inhibitors+with+favorable+physicochemical+properties+and+high+selectivity+over+JAK2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1021%2Fjm4004895&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm4004895%26sid%3Dliteratum%253Aachs%26aulast%3DZak%26aufirst%3DM.%26aulast%3DHurley%26aufirst%3DC.%2BA.%26aulast%3DWard%26aufirst%3DS.%2BI.%26aulast%3DBergeron%26aufirst%3DP.%26aulast%3DBarrett%26aufirst%3DK.%26aulast%3DBalazs%26aufirst%3DM.%26aulast%3DBlair%26aufirst%3DW.%2BS.%26aulast%3DBull%26aufirst%3DR.%26aulast%3DChakravarty%26aufirst%3DP.%26aulast%3DChang%26aufirst%3DC.%26aulast%3DCrackett%26aufirst%3DP.%26aulast%3DDeshmukh%26aufirst%3DG.%26aulast%3DDeVoss%26aufirst%3DJ.%26aulast%3DDragovich%26aufirst%3DP.%2BS.%26aulast%3DEigenbrot%26aufirst%3DC.%26aulast%3DEllwood%26aufirst%3DC.%26aulast%3DGaines%26aufirst%3DS.%26aulast%3DGhilardi%26aufirst%3DN.%26aulast%3DGibbons%26aufirst%3DP.%26aulast%3DGradl%26aufirst%3DS.%26aulast%3DGribling%26aufirst%3DP.%26aulast%3DHamman%26aufirst%3DC.%26aulast%3DHarstad%26aufirst%3DE.%26aulast%3DHewitt%26aufirst%3DP.%26aulast%3DJohnson%26aufirst%3DA.%26aulast%3DJohnson%26aufirst%3DT.%26aulast%3DKenny%26aufirst%3DJ.%2BR.%26aulast%3DKoehler%26aufirst%3DM.%2BF.%26aulast%3DBir%2BKohli%26aufirst%3DP.%26aulast%3DLabadie%26aufirst%3DS.%26aulast%3DLee%26aufirst%3DW.%2BP.%26aulast%3DLiao%26aufirst%3DJ.%26aulast%3DLiimatta%26aufirst%3DM.%26aulast%3DMendonca%26aufirst%3DR.%26aulast%3DNarukulla%26aufirst%3DR.%26aulast%3DPulk%26aufirst%3DR.%26aulast%3DReeve%26aufirst%3DA.%26aulast%3DSavage%26aufirst%3DS.%26aulast%3DShia%26aufirst%3DS.%26aulast%3DSteffek%26aufirst%3DM.%26aulast%3DUbhayakar%26aufirst%3DS.%26aulast%3Dvan%2BAbbema%26aufirst%3DA.%26aulast%3DAliagas%26aufirst%3DI.%26aulast%3DAvitabile-Woo%26aufirst%3DB.%26aulast%3DXiao%26aufirst%3DY.%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DKulagowski%26aufirst%3DJ.%2BJ.%26atitle%3DIdentification%2520of%2520C-2%2520hydroxyethyl%2520imidazopyrrolopyridines%2520as%2520potent%2520JAK1%2520inhibitors%2520with%2520favorable%2520physicochemical%2520properties%2520and%2520high%2520selectivity%2520over%2520JAK2%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D4764%26epage%3D4785" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group">Jaime-Figueroa, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Vicente, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hermann, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jahangir, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuglstatter, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lynch, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menke, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shao, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soth, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vu, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yee, C.</span><span> </span><span class="NLM_article-title">Discovery of a series of novel 5<i>H</i>-pyrrolo[2,3-<i>b</i>]pyrazine-2-phenyl ethers, as potent JAK3 kinase inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem, Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">2522</span><span class="NLM_x">–</span> <span class="NLM_lpage">2526</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=2522-2526&author=S.+Jaime-Figueroaauthor=J.+De+Vicenteauthor=J.+Hermannauthor=A.+Jahangirauthor=S.+Jinauthor=A.+Kuglstatterauthor=S.+M.+Lynchauthor=J.+Menkeauthor=L.+Niuauthor=V.+Patelauthor=A.+Shaoauthor=M.+Sothauthor=M.+D.+Vuauthor=C.+Yee&title=Discovery+of+a+series+of+novel+5H-pyrrolo%5B2%2C3-b%5Dpyrazine-2-phenyl+ethers%2C+as+potent+JAK3+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJaime-Figueroa%26aufirst%3DS.%26aulast%3DDe%2BVicente%26aufirst%3DJ.%26aulast%3DHermann%26aufirst%3DJ.%26aulast%3DJahangir%26aufirst%3DA.%26aulast%3DJin%26aufirst%3DS.%26aulast%3DKuglstatter%26aufirst%3DA.%26aulast%3DLynch%26aufirst%3DS.%2BM.%26aulast%3DMenke%26aufirst%3DJ.%26aulast%3DNiu%26aufirst%3DL.%26aulast%3DPatel%26aufirst%3DV.%26aulast%3DShao%26aufirst%3DA.%26aulast%3DSoth%26aufirst%3DM.%26aulast%3DVu%26aufirst%3DM.%2BD.%26aulast%3DYee%26aufirst%3DC.%26atitle%3DDiscovery%2520of%2520a%2520series%2520of%2520novel%25205H-pyrrolo%255B2%252C3-b%255Dpyrazine-2-phenyl%2520ethers%252C%2520as%2520potent%2520JAK3%2520kinase%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem%252C%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D2522%26epage%3D2526" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group">Butler, K. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brochier, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vistoli, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Langley, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kozikowski, A. P.</span><span> </span><span class="NLM_article-title">Rational design and simple chemistry yield a superior, neuroprotective HDAC6 inhibitor, tubastatin A</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">132</span><span class="NLM_x">, </span> <span class="NLM_fpage">10842</span><span class="NLM_x">–</span> <span class="NLM_lpage">10846</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja102758v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00229&amp;key=1%3ACAS%3A528%3ADC%252BC3cXos1ers7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=132&publication_year=2010&pages=10842-10846&author=K.+V.+Butlerauthor=J.+Kalinauthor=C.+Brochierauthor=G.+Vistoliauthor=B.+Langleyauthor=A.+P.+Kozikowski&title=Rational+design+and+simple+chemistry+yield+a+superior%2C+neuroprotective+HDAC6+inhibitor%2C+tubastatin+A"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Rational Design and Simple Chemistry Yield a Superior, Neuroprotective HDAC6 Inhibitor, Tubastatin A</span></div><div class="casAuthors">Butler, Kyle V.; Kalin, Jay; Brochier, Camille; Vistoli, Guilio; Langley, Brett; Kozikowski, Alan P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">132</span>
        (<span class="NLM_cas:issue">31</span>),
    <span class="NLM_cas:pages">10842-10846</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Structure-based drug design combined with homol. modeling techniques were used to develop potent inhibitors of HDAC6 that display superior selectivity for the HDAC6 isoenzyme compared to other inhibitors.  These inhibitors can be assembled in a few synthetic steps, and thus are readily scaled up for in vivo studies.  An optimized compd. from this series, designated Tubastatin A, was tested in primary cortical neuron cultures in which it was found to induce elevated levels of acetylated α-tubulin, but not histone, consistent with its HDAC6 selectivity.  Tubastatin A also conferred dose-dependent protection in primary cortical neuron cultures against glutathione depletion-induced oxidative stress.  Importantly, when given alone at all concns. tested, this hydroxamate-contg. HDAC6-selective compd. displayed no neuronal toxicity, thus, forecasting the potential application of this agent and its analogs to neurodegenerative conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGruEaJPWQfjH7Vg90H21EOLACvtfcHk0ljdaJiEXVSreA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXos1ers7k%253D&md5=f0cc68bb68f94ad1ef48f88cc6b57129</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1021%2Fja102758v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja102758v%26sid%3Dliteratum%253Aachs%26aulast%3DButler%26aufirst%3DK.%2BV.%26aulast%3DKalin%26aufirst%3DJ.%26aulast%3DBrochier%26aufirst%3DC.%26aulast%3DVistoli%26aufirst%3DG.%26aulast%3DLangley%26aufirst%3DB.%26aulast%3DKozikowski%26aufirst%3DA.%2BP.%26atitle%3DRational%2520design%2520and%2520simple%2520chemistry%2520yield%2520a%2520superior%252C%2520neuroprotective%2520HDAC6%2520inhibitor%252C%2520tubastatin%2520A%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2010%26volume%3D132%26spage%3D10842%26epage%3D10846" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group">Hamada, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mino, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koseki, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oehme, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flamme, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ozasa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Itoh, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogasawara, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Komaarashi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kato, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsumoto, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakagawa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hasegawa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sasaki, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mizukami, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyata, N.</span><span> </span><span class="NLM_article-title">Design, synthesis, enzyme-inhibitory activity, and effect on human cancer cells of a novel series of jumonji domain-containing protein 2 histone demethylase inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">5629</span><span class="NLM_x">–</span> <span class="NLM_lpage">5638</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm1003655" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00229&amp;key=1%3ACAS%3A528%3ADC%252BC3cXovVCis7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=5629-5638&author=S.+Hamadaauthor=T.+Suzukiauthor=K.+Minoauthor=K.+Kosekiauthor=F.+Oehmeauthor=I.+Flammeauthor=H.+Ozasaauthor=Y.+Itohauthor=D.+Ogasawaraauthor=H.+Komaarashiauthor=A.+Katoauthor=H.+Tsumotoauthor=H.+Nakagawaauthor=M.+Hasegawaauthor=R.+Sasakiauthor=T.+Mizukamiauthor=N.+Miyata&title=Design%2C+synthesis%2C+enzyme-inhibitory+activity%2C+and+effect+on+human+cancer+cells+of+a+novel+series+of+jumonji+domain-containing+protein+2+histone+demethylase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Design, Synthesis, Enzyme-Inhibitory Activity, and Effect on Human Cancer Cells of a Novel Series of Jumonji Domain-Containing Protein 2 Histone Demethylase Inhibitors</span></div><div class="casAuthors">Hamada, Shohei; Suzuki, Takayoshi; Mino, Koshiki; Koseki, Koichi; Oehme, Felix; Flamme, Ingo; Ozasa, Hiroki; Itoh, Yukihiro; Ogasawara, Daisuke; Komaarashi, Haruka; Kato, Aiko; Tsumoto, Hiroki; Nakagawa, Hidehiko; Hasegawa, Makoto; Sasaki, Ryuzo; Mizukami, Tamio; Miyata, Naoki</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">5629-5638</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Selective inhibitors of Jumonji domain-contg. protein (JMJD) histone demethylases are candidate anticancer agents as well as potential tools for elucidating the biol. functions of JMJDs.  On the basis of the crystal structure of JMJD2A and a homol. model of JMJD2C, we designed and prepd. a series of hydroxamate analogs bearing a tertiary amine.  Enzyme assays using JMJD2C, JMJD2A, and prolyl hydroxylases revealed that hydroxamate analog 8 is a potent and selective JMJD2 inhibitor, showing 500-fold greater JMJD2C-inhibitory activity and more than 9100-fold greater JMJD2C-selectivity compared with the lead compd. N-oxalylglycine 2.  Compds. 17 and 18, prodrugs of compd. 8, each showed synergistic growth inhibition of cancer cells in combination with an inhibitor of lysine-specific demethylase 1 (LSD1).  These findings suggest that combination treatment with JMJD2 inhibitors and LSD1 inhibitors may represent a novel strategy for anticancer chemotherapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoT6G3YdmcF_bVg90H21EOLACvtfcHk0lgbf2RM1gbgjw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXovVCis7o%253D&md5=f4ab3a75cb995d88668dd8527f554ea0</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1021%2Fjm1003655&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm1003655%26sid%3Dliteratum%253Aachs%26aulast%3DHamada%26aufirst%3DS.%26aulast%3DSuzuki%26aufirst%3DT.%26aulast%3DMino%26aufirst%3DK.%26aulast%3DKoseki%26aufirst%3DK.%26aulast%3DOehme%26aufirst%3DF.%26aulast%3DFlamme%26aufirst%3DI.%26aulast%3DOzasa%26aufirst%3DH.%26aulast%3DItoh%26aufirst%3DY.%26aulast%3DOgasawara%26aufirst%3DD.%26aulast%3DKomaarashi%26aufirst%3DH.%26aulast%3DKato%26aufirst%3DA.%26aulast%3DTsumoto%26aufirst%3DH.%26aulast%3DNakagawa%26aufirst%3DH.%26aulast%3DHasegawa%26aufirst%3DM.%26aulast%3DSasaki%26aufirst%3DR.%26aulast%3DMizukami%26aufirst%3DT.%26aulast%3DMiyata%26aufirst%3DN.%26atitle%3DDesign%252C%2520synthesis%252C%2520enzyme-inhibitory%2520activity%252C%2520and%2520effect%2520on%2520human%2520cancer%2520cells%2520of%2520a%2520novel%2520series%2520of%2520jumonji%2520domain-containing%2520protein%25202%2520histone%2520demethylase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D5629%26epage%3D5638" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group">Suzuki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khan, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawada, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Imai, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Itoh, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamatsuta, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tokuda, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takeuchi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seko, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakagawa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyata, N.</span><span> </span><span class="NLM_article-title">Design, synthesis, and biological activity of a novel series of human sirtuin-2-selective inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">5760</span><span class="NLM_x">–</span> <span class="NLM_lpage">5773</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm3002108" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=5760-5773&author=T.+Suzukiauthor=M.+N.+Khanauthor=H.+Sawadaauthor=E.+Imaiauthor=Y.+Itohauthor=K.+Yamatsutaauthor=N.+Tokudaauthor=J.+Takeuchiauthor=T.+Sekoauthor=H.+Nakagawaauthor=N.+Miyata&title=Design%2C+synthesis%2C+and+biological+activity+of+a+novel+series+of+human+sirtuin-2-selective+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1021%2Fjm3002108&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm3002108%26sid%3Dliteratum%253Aachs%26aulast%3DSuzuki%26aufirst%3DT.%26aulast%3DKhan%26aufirst%3DM.%2BN.%26aulast%3DSawada%26aufirst%3DH.%26aulast%3DImai%26aufirst%3DE.%26aulast%3DItoh%26aufirst%3DY.%26aulast%3DYamatsuta%26aufirst%3DK.%26aulast%3DTokuda%26aufirst%3DN.%26aulast%3DTakeuchi%26aufirst%3DJ.%26aulast%3DSeko%26aufirst%3DT.%26aulast%3DNakagawa%26aufirst%3DH.%26aulast%3DMiyata%26aufirst%3DN.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520biological%2520activity%2520of%2520a%2520novel%2520series%2520of%2520human%2520sirtuin-2-selective%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D5760%26epage%3D5773" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group">Paterni, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertini, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Granchi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tuccinardi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macchia, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinelli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caligiuri, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toffoli, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rizzolio, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carlson, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katzenellenbogen, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katzenellenbogen, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minutolo, F.</span><span> </span><span class="NLM_article-title">Highly selective salicylketoxime-based estrogen receptor β agonists display antiproliferative activities in a glioma model</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">1184</span><span class="NLM_x">–</span> <span class="NLM_lpage">1194</span><span class="refDoi"> DOI: 10.1021/jm501829f</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501829f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=1184-1194&author=I.+Paterniauthor=S.+Bertiniauthor=C.+Granchiauthor=T.+Tuccinardiauthor=M.+Macchiaauthor=A.+Martinelliauthor=I.+Caligiuriauthor=G.+Toffoliauthor=F.+Rizzolioauthor=K.+E.+Carlsonauthor=B.+S.+Katzenellenbogenauthor=J.+A.+Katzenellenbogenauthor=F.+Minutolo&title=Highly+selective+salicylketoxime-based+estrogen+receptor+%CE%B2+agonists+display+antiproliferative+activities+in+a+glioma+model&doi=10.1021%2Fjm501829f"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1021%2Fjm501829f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501829f%26sid%3Dliteratum%253Aachs%26aulast%3DPaterni%26aufirst%3DI.%26aulast%3DBertini%26aufirst%3DS.%26aulast%3DGranchi%26aufirst%3DC.%26aulast%3DTuccinardi%26aufirst%3DT.%26aulast%3DMacchia%26aufirst%3DM.%26aulast%3DMartinelli%26aufirst%3DA.%26aulast%3DCaligiuri%26aufirst%3DI.%26aulast%3DToffoli%26aufirst%3DG.%26aulast%3DRizzolio%26aufirst%3DF.%26aulast%3DCarlson%26aufirst%3DK.%2BE.%26aulast%3DKatzenellenbogen%26aufirst%3DB.%2BS.%26aulast%3DKatzenellenbogen%26aufirst%3DJ.%2BA.%26aulast%3DMinutolo%26aufirst%3DF.%26atitle%3DHighly%2520selective%2520salicylketoxime-based%2520estrogen%2520receptor%2520%25CE%25B2%2520agonists%2520display%2520antiproliferative%2520activities%2520in%2520a%2520glioma%2520model%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D1184%26epage%3D1194%26doi%3D10.1021%2Fjm501829f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit65"><span><span class="NLM_contrib-group">Fang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span> </span><span class="NLM_article-title">Conformational restriction: an effective tactic in ‘follow-on’-based drug discovery</span> <span class="citation_source-journal">Future Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">885</span><span class="NLM_x">–</span> <span class="NLM_lpage">901</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00229&amp;key=10.4155%2Ffmc.14.50" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00229&amp;key=24962281" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00229&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtVemsrzE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2014&pages=885-901&author=Z.+Fangauthor=Y.+Songauthor=P.+Zhanauthor=Q.+Zhangauthor=X.+Liu&title=Conformational+restriction%3A+an+effective+tactic+in+%E2%80%98follow-on%E2%80%99-based+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">Conformational restriction: an effective tactic in 'follow-on'-based drug discovery</span></div><div class="casAuthors">Fang, Zengjun; Song, Yu'ning; Zhan, Peng; Zhang, Qingzhu; Liu, Xinyong</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">885-901</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">A review.  The conformational restriction (rigidification) of a flexible ligand has often been a commonly used strategy in drug design, as it can minimize the entropic loss assocd. with the ligand adopting a preferred conformation for binding, which leads to enhanced potency for a given physiol. target, improved selectivity for isoforms and reduced the possibility of drug metab.  Therefore, the application of conformational restriction strategy is a core aspect of drug discovery and development that is widely practiced by medicinal chemists either deliberately or subliminally.  The present review will highlight current representative examples and a brief overview on the rational design of conformationally restricted agents as well as discuss its advantages over the flexible counterparts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoupMomfg9J_bVg90H21EOLACvtfcHk0lgbf2RM1gbgjw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtVemsrzE&md5=dcf5fa6cead84c77b3603c7e0800f49b</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.4155%2Ffmc.14.50&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc.14.50%26sid%3Dliteratum%253Aachs%26aulast%3DFang%26aufirst%3DZ.%26aulast%3DSong%26aufirst%3DY.%26aulast%3DZhan%26aufirst%3DP.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DLiu%26aufirst%3DX.%26atitle%3DConformational%2520restriction%253A%2520an%2520effective%2520tactic%2520in%2520%25E2%2580%2598follow-on%25E2%2580%2599-based%2520drug%2520discovery%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2014%26volume%3D6%26spage%3D885%26epage%3D901" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit66"><span><span class="NLM_contrib-group">Kobayashi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suemasa, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Igawa, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ide, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukuda, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abe, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arisawa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minami, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shuto, S.</span><span> </span><span class="NLM_article-title">Conformationally restricted GABA with bicyclo[3.1.0]hexane backbone as the first highly selective BGT-1 inhibitor</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">889</span><span class="NLM_x">–</span> <span class="NLM_lpage">893</span></span><div class="citationLinks">[<a href="/doi/10.1021/ml500134k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=889-893&author=T.+Kobayashiauthor=A.+Suemasaauthor=A.+Igawaauthor=S.+Ideauthor=H.+Fukudaauthor=H.+Abeauthor=M.+Arisawaauthor=M.+Minamiauthor=S.+Shuto&title=Conformationally+restricted+GABA+with+bicyclo%5B3.1.0%5Dhexane+backbone+as+the+first+highly+selective+BGT-1+inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1021%2Fml500134k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml500134k%26sid%3Dliteratum%253Aachs%26aulast%3DKobayashi%26aufirst%3DT.%26aulast%3DSuemasa%26aufirst%3DA.%26aulast%3DIgawa%26aufirst%3DA.%26aulast%3DIde%26aufirst%3DS.%26aulast%3DFukuda%26aufirst%3DH.%26aulast%3DAbe%26aufirst%3DH.%26aulast%3DArisawa%26aufirst%3DM.%26aulast%3DMinami%26aufirst%3DM.%26aulast%3DShuto%26aufirst%3DS.%26atitle%3DConformationally%2520restricted%2520GABA%2520with%2520bicyclo%255B3.1.0%255Dhexane%2520backbone%2520as%2520the%2520first%2520highly%2520selective%2520BGT-1%2520inhibitor%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D5%26spage%3D889%26epage%3D893" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref67"><div class="reference"><strong class="refLabel"><a href="#ref67" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-cit67"><span><span class="NLM_contrib-group">Hay, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fedorov, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singleton, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tallant, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wells, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Picaud, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Philpott, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monteiro, O. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogers, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conway, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rooney, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tumber, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yapp, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Filippakopoulos, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bunnage, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Müller, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knapp, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schofield, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brennan, P. E.</span><span> </span><span class="NLM_article-title">Discovery and optimization of small-molecule ligands for the CBP/p300 bromodomains</span> <span class="citation_source-journal">J. Am. Chem, Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">136</span><span class="NLM_x">, </span> <span class="NLM_fpage">9308</span><span class="NLM_x">–</span> <span class="NLM_lpage">9319</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja412434f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00229&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtVShsLvP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=136&publication_year=2014&pages=9308-9319&author=D.+A.+Hayauthor=O.+Fedorovauthor=S.+Martinauthor=D.+C.+Singletonauthor=C.+Tallantauthor=C.+Wellsauthor=S.+Picaudauthor=M.+Philpottauthor=O.+P.+Monteiroauthor=C.+M.+Rogersauthor=S.+J.+Conwayauthor=T.+P.+Rooneyauthor=A.+Tumberauthor=C.+Yappauthor=P.+Filippakopoulosauthor=M.+E.+Bunnageauthor=S.+M%C3%BCllerauthor=S.+Knappauthor=C.+J.+Schofieldauthor=P.+E.+Brennan&title=Discovery+and+optimization+of+small-molecule+ligands+for+the+CBP%2Fp300+bromodomains"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and Optimization of Small-Molecule Ligands for the CBP/p300 Bromodomains</span></div><div class="casAuthors">Hay, Duncan A.; Fedorov, Oleg; Martin, Sarah; Singleton, Dean C.; Tallant, Cynthia; Wells, Christopher; Picaud, Sarah; Philpott, Martin; Monteiro, Octovia P.; Rogers, Catherine M.; Conway, Stuart J.; Rooney, Timothy P. C.; Tumber, Anthony; Yapp, Clarence; Filippakopoulos, Panagis; Bunnage, Mark E.; Muller, Susanne; Knapp, Stefan; Schofield, Christopher J.; Brennan, Paul E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">136</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">9308-9319</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Small-mol. inhibitors that target bromodomains outside of the bromodomain and extra-terminal (BET) sub-family are lacking.  Here, the authors describe highly potent and selective ligands for the bromodomain module of the human lysine acetyl transferase CBP/p300, developed from a series of 5-isoxazolyl-benzimidazoles.  The starting point was a fragment hit, which was optimized into a more potent and selective lead using parallel synthesis employing Suzuki couplings, benzimidazole-forming reactions, and reductive aminations.  The selectivity of the lead compd. against other bromodomain family members was investigated using a thermal stability assay, which revealed some inhibition of the structurally related BET family members.  To address the BET selectivity issue, x-ray crystal structures of the lead compd. bound to the CREB binding protein (CBP) and the first bromodomain of BRD4 (BRD4(1)) were used to guide the design of more selective compds.  The crystal structures obtained revealed two distinct binding modes.  By varying the aryl substitution pattern and developing conformationally constrained analogs, selectivity for CBP over BRD4(1) was increased.  The optimized compd. is highly potent (Kd = 21 nM) and selective, displaying 40-fold selectivity over BRD4(1).  Cellular activity was demonstrated using fluorescence recovery after photo-bleaching (FRAP) and a p53 reporter assay.  The optimized compds. are cell-active and have nanomolar affinity for CBP/p300; therefore, they should be useful in studies investigating the biol. roles of CBP and p300 and to validate the CBP and p300 bromodomains as therapeutic targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqFzgs1DD4QZLVg90H21EOLACvtfcHk0liNYwPph1EUIg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtVShsLvP&md5=e5da3e96a4d234453a481c7ee5e788f2</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1021%2Fja412434f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja412434f%26sid%3Dliteratum%253Aachs%26aulast%3DHay%26aufirst%3DD.%2BA.%26aulast%3DFedorov%26aufirst%3DO.%26aulast%3DMartin%26aufirst%3DS.%26aulast%3DSingleton%26aufirst%3DD.%2BC.%26aulast%3DTallant%26aufirst%3DC.%26aulast%3DWells%26aufirst%3DC.%26aulast%3DPicaud%26aufirst%3DS.%26aulast%3DPhilpott%26aufirst%3DM.%26aulast%3DMonteiro%26aufirst%3DO.%2BP.%26aulast%3DRogers%26aufirst%3DC.%2BM.%26aulast%3DConway%26aufirst%3DS.%2BJ.%26aulast%3DRooney%26aufirst%3DT.%2BP.%26aulast%3DTumber%26aufirst%3DA.%26aulast%3DYapp%26aufirst%3DC.%26aulast%3DFilippakopoulos%26aufirst%3DP.%26aulast%3DBunnage%26aufirst%3DM.%2BE.%26aulast%3DM%25C3%25BCller%26aufirst%3DS.%26aulast%3DKnapp%26aufirst%3DS.%26aulast%3DSchofield%26aufirst%3DC.%2BJ.%26aulast%3DBrennan%26aufirst%3DP.%2BE.%26atitle%3DDiscovery%2520and%2520optimization%2520of%2520small-molecule%2520ligands%2520for%2520the%2520CBP%252Fp300%2520bromodomains%26jtitle%3DJ.%2520Am.%2520Chem%252C%2520Soc.%26date%3D2014%26volume%3D136%26spage%3D9308%26epage%3D9319" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref68"><div class="reference"><strong class="refLabel"><a href="#ref68" class="rightTabRefNumLink">68</a></strong><div class="NLM_citation" id="rightTab-cit68"><span><span class="NLM_contrib-group">Saupe, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steinmetzer, T.</span><span> </span><span class="NLM_article-title">A new strategy for the development of highly potent and selective plasmin inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">1171</span><span class="NLM_x">–</span> <span class="NLM_lpage">1180</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm2011996" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00229&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1Ohs7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=1171-1180&author=S.+M.+Saupeauthor=T.+Steinmetzer&title=A+new+strategy+for+the+development+of+highly+potent+and+selective+plasmin+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">A New Strategy for the Development of Highly Potent and Selective Plasmin Inhibitors</span></div><div class="casAuthors">Saupe, Sebastian M.; Steinmetzer, Torsten</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1171-1180</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A new structure-based strategy for the design of potent and selective plasmin inhibitors was developed.  These compds. could be prepd. by cyclizations between the P3 and P2 amino acid residues of substrate-analog inhibitors using metathesis or a copper-catalyzed azide alkyne cycloaddn. in combination with std. peptide couplings.  The most potent bis-triazole deriv. 10 inhibits plasmin and plasma kallikrein with Ki of 0.77 and 2.4 nM, resp., whereas it has poor activity against the related trypsin-like serine proteases thrombin, factor Xa, or activated protein C.  Modeling expts. revealed that inhibitor 10 adopts a compact and rigid structure that fits well into the relatively open active site of plasmin and plasma kallikrein, while it is rejected from sterically demanding residues present in loops of the other enzymes.  These results from modeling confirm the selectivity profile found for inhibitor 10 in enzyme kinetic studies.  Such compds. might be useful lead structures for the development of new antifibrinolytic drugs for use in cardiac surgery with cardiopulmonary bypass or organ transplantations to reduce bleeding complications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGquMb45usCgsrVg90H21EOLACvtfcHk0liNYwPph1EUIg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1Ohs7k%253D&md5=d1e496b75545ee3ee4665ffdabe2f228</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1021%2Fjm2011996&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm2011996%26sid%3Dliteratum%253Aachs%26aulast%3DSaupe%26aufirst%3DS.%2BM.%26aulast%3DSteinmetzer%26aufirst%3DT.%26atitle%3DA%2520new%2520strategy%2520for%2520the%2520development%2520of%2520highly%2520potent%2520and%2520selective%2520plasmin%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D1171%26epage%3D1180" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref69"><div class="reference"><strong class="refLabel"><a href="#ref69" class="rightTabRefNumLink">69</a></strong><div class="NLM_citation" id="rightTab-cit69"><span><span class="NLM_contrib-group">Bastida, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hidalgo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiara, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Torrado, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corzana, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pérez-Cañadillas, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Groves, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia-Junceda, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzalez, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jimenez-Barbero, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asensio, J. L.</span><span> </span><span class="NLM_article-title">Exploring the use of conformationally locked aminoglycosides as a new strategy to overcome bacterial resistance</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">128</span><span class="NLM_x">, </span> <span class="NLM_fpage">100</span><span class="NLM_x">–</span> <span class="NLM_lpage">116</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja0543144" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=128&publication_year=2006&pages=100-116&author=A.+Bastidaauthor=A.+Hidalgoauthor=J.+L.+Chiaraauthor=M.+Torradoauthor=F.+Corzanaauthor=J.+M.+P%C3%A9rez-Ca%C3%B1adillasauthor=P.+Grovesauthor=E.+Garcia-Juncedaauthor=C.+Gonzalezauthor=J.+Jimenez-Barberoauthor=J.+L.+Asensio&title=Exploring+the+use+of+conformationally+locked+aminoglycosides+as+a+new+strategy+to+overcome+bacterial+resistance"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1021%2Fja0543144&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja0543144%26sid%3Dliteratum%253Aachs%26aulast%3DBastida%26aufirst%3DA.%26aulast%3DHidalgo%26aufirst%3DA.%26aulast%3DChiara%26aufirst%3DJ.%2BL.%26aulast%3DTorrado%26aufirst%3DM.%26aulast%3DCorzana%26aufirst%3DF.%26aulast%3DP%25C3%25A9rez-Ca%25C3%25B1adillas%26aufirst%3DJ.%2BM.%26aulast%3DGroves%26aufirst%3DP.%26aulast%3DGarcia-Junceda%26aufirst%3DE.%26aulast%3DGonzalez%26aufirst%3DC.%26aulast%3DJimenez-Barbero%26aufirst%3DJ.%26aulast%3DAsensio%26aufirst%3DJ.%2BL.%26atitle%3DExploring%2520the%2520use%2520of%2520conformationally%2520locked%2520aminoglycosides%2520as%2520a%2520new%2520strategy%2520to%2520overcome%2520bacterial%2520resistance%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2006%26volume%3D128%26spage%3D100%26epage%3D116" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref70"><div class="reference"><strong class="refLabel"><a href="#ref70" class="rightTabRefNumLink">70</a></strong><div class="NLM_citation" id="rightTab-cit70"><span><span class="NLM_contrib-group">Kim, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, S. B.</span><span> </span><span class="NLM_article-title">Privileged structures: efficient chemical “navigators” toward unexplored biologically relevant chemical spaces</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">136</span><span class="NLM_x">, </span> <span class="NLM_fpage">14629</span><span class="NLM_x">–</span> <span class="NLM_lpage">14638</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja508343a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=136&publication_year=2014&pages=14629-14638&author=J.+Kimauthor=H.+Kimauthor=S.+B.+Park&title=Privileged+structures%3A+efficient+chemical+%E2%80%9Cnavigators%E2%80%9D+toward+unexplored+biologically+relevant+chemical+spaces"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1021%2Fja508343a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja508343a%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DJ.%26aulast%3DKim%26aufirst%3DH.%26aulast%3DPark%26aufirst%3DS.%2BB.%26atitle%3DPrivileged%2520structures%253A%2520efficient%2520chemical%2520%25E2%2580%259Cnavigators%25E2%2580%259D%2520toward%2520unexplored%2520biologically%2520relevant%2520chemical%2520spaces%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2014%26volume%3D136%26spage%3D14629%26epage%3D14638" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref71"><div class="reference"><strong class="refLabel"><a href="#ref71" class="rightTabRefNumLink">71</a></strong><div class="NLM_citation" id="rightTab-cit71"><span><span class="NLM_contrib-group">Olsen, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghadiri, M. R.</span><span> </span><span class="NLM_article-title">Discovery of potent and selective histone deacetylase inhibitors via focused combinatorial libraries of cyclic alpha3beta-tetrapeptides</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">7836</span><span class="NLM_x">–</span> <span class="NLM_lpage">7846</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm900850t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=7836-7846&author=C.+A.+Olsenauthor=M.+R.+Ghadiri&title=Discovery+of+potent+and+selective+histone+deacetylase+inhibitors+via+focused+combinatorial+libraries+of+cyclic+alpha3beta-tetrapeptides"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1021%2Fjm900850t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900850t%26sid%3Dliteratum%253Aachs%26aulast%3DOlsen%26aufirst%3DC.%2BA.%26aulast%3DGhadiri%26aufirst%3DM.%2BR.%26atitle%3DDiscovery%2520of%2520potent%2520and%2520selective%2520histone%2520deacetylase%2520inhibitors%2520via%2520focused%2520combinatorial%2520libraries%2520of%2520cyclic%2520alpha3beta-tetrapeptides%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D7836%26epage%3D7846" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref72"><div class="reference"><strong class="refLabel"><a href="#ref72" class="rightTabRefNumLink">72</a></strong><div class="NLM_citation" id="rightTab-cit72"><span><span class="NLM_contrib-group">Baud, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leiser, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haus, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samlal, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petrucci, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunaratnam, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hughes, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buluwela, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turlais, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neidle, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyer-Almes, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fuchter, M. J.</span><span> </span><span class="NLM_article-title">Defining the mechanism of action and enzymatic selectivity of psammaplin A against its epigenetic targets</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">1731</span><span class="NLM_x">–</span> <span class="NLM_lpage">1750</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm2016182" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=1731-1750&author=M.+G.+Baudauthor=T.+Leiserauthor=P.+Hausauthor=S.+Samlalauthor=A.+C.+Wongauthor=R.+J.+Woodauthor=V.+Petrucciauthor=M.+Gunaratnamauthor=S.+M.+Hughesauthor=L.+Buluwelaauthor=F.+Turlaisauthor=S.+Neidleauthor=F.+J.+Meyer-Almesauthor=A.+J.+Whiteauthor=M.+J.+Fuchter&title=Defining+the+mechanism+of+action+and+enzymatic+selectivity+of+psammaplin+A+against+its+epigenetic+targets"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1021%2Fjm2016182&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm2016182%26sid%3Dliteratum%253Aachs%26aulast%3DBaud%26aufirst%3DM.%2BG.%26aulast%3DLeiser%26aufirst%3DT.%26aulast%3DHaus%26aufirst%3DP.%26aulast%3DSamlal%26aufirst%3DS.%26aulast%3DWong%26aufirst%3DA.%2BC.%26aulast%3DWood%26aufirst%3DR.%2BJ.%26aulast%3DPetrucci%26aufirst%3DV.%26aulast%3DGunaratnam%26aufirst%3DM.%26aulast%3DHughes%26aufirst%3DS.%2BM.%26aulast%3DBuluwela%26aufirst%3DL.%26aulast%3DTurlais%26aufirst%3DF.%26aulast%3DNeidle%26aufirst%3DS.%26aulast%3DMeyer-Almes%26aufirst%3DF.%2BJ.%26aulast%3DWhite%26aufirst%3DA.%2BJ.%26aulast%3DFuchter%26aufirst%3DM.%2BJ.%26atitle%3DDefining%2520the%2520mechanism%2520of%2520action%2520and%2520enzymatic%2520selectivity%2520of%2520psammaplin%2520A%2520against%2520its%2520epigenetic%2520targets%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D1731%26epage%3D1750" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref73"><div class="reference"><strong class="refLabel"><a href="#ref73" class="rightTabRefNumLink">73</a></strong><div class="NLM_citation" id="rightTab-cit73"><span><span class="NLM_contrib-group">Holub, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirshenbaum, K.</span><span> </span><span class="NLM_article-title">Tricks with clicks: modification of peptidomimetic oligomers via copper-catalyzed azide–alkyne [3 + 2] cycloaddition</span> <span class="citation_source-journal">Chem. Soc. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">1325</span><span class="NLM_x">–</span> <span class="NLM_lpage">1337</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2010&pages=1325-1337&author=J.+M.+Holubauthor=K.+Kirshenbaum&title=Tricks+with+clicks%3A+modification+of+peptidomimetic+oligomers+via+copper-catalyzed+azide%E2%80%93alkyne+%5B3+%2B+2%5D+cycloaddition"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHolub%26aufirst%3DJ.%2BM.%26aulast%3DKirshenbaum%26aufirst%3DK.%26atitle%3DTricks%2520with%2520clicks%253A%2520modification%2520of%2520peptidomimetic%2520oligomers%2520via%2520copper-catalyzed%2520azide%25E2%2580%2593alkyne%2520%255B3%2520%252B%25202%255D%2520cycloaddition%26jtitle%3DChem.%2520Soc.%2520Rev.%26date%3D2010%26volume%3D39%26spage%3D1325%26epage%3D1337" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref74"><div class="reference"><strong class="refLabel"><a href="#ref74" class="rightTabRefNumLink">74</a></strong><div class="NLM_citation" id="rightTab-cit74"><span><span class="NLM_contrib-group">Bose, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dai, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grant, S.</span><span> </span><span class="NLM_article-title">Histone deacetylase inhibitor (HDACI) mechanisms of action: emerging insights</span> <span class="citation_source-journal">Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">143</span><span class="NLM_x">, </span> <span class="NLM_fpage">323</span><span class="NLM_x">–</span> <span class="NLM_lpage">336</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00229&amp;key=10.1016%2Fj.pharmthera.2014.04.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00229&amp;key=24769080" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00229&amp;key=1%3ACAS%3A528%3ADC%252BC2cXnslGnt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=143&publication_year=2014&pages=323-336&author=P.+Boseauthor=Y.+Daiauthor=S.+Grant&title=Histone+deacetylase+inhibitor+%28HDACI%29+mechanisms+of+action%3A+emerging+insights"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit74R"><div class="casContent"><span class="casTitleNuber">74</span><div class="casTitle"><span class="NLM_cas:atitle">Histone deacetylase inhibitor (HDACI) mechanisms of action: Emerging insights</span></div><div class="casAuthors">Bose, Prithviraj; Dai, Yun; Grant, Steven</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">143</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">323-336</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Initially regarded as "epigenetic modifiers" acting predominantly through chromatin remodeling via histone acetylation, HDACIs, alternatively referred to as lysine deacetylase or simply deacetylase inhibitors, have since been recognized to exert multiple cytotoxic actions in cancer cells, often through acetylation of non-histone proteins.  Some well-recognized mechanisms of HDACI lethality include, in addn. to relaxation of DNA and de-repression of gene transcription, interference with chaperone protein function, free radical generation, induction of DNA damage, up-regulation of endogenous inhibitors of cell cycle progression, e.g., p21, and promotion of apoptosis.  Intriguingly, this class of agents is relatively selective for transformed cells, at least in pre-clin. studies.  In recent years, addnl. mechanisms of action of these agents have been uncovered.  For example, HDACIs interfere with multiple DNA repair processes, as well as disrupt cell cycle checkpoints, crit. to the maintenance of genomic integrity in the face of diverse genotoxic insults.  Despite their pre-clin. potential, the clin. use of HDACIs remains restricted to certain subsets of T-cell lymphoma.  Currently, it appears likely that the ultimate role of these agents will lie in rational combinations, only a few of which have been pursued in the clinic to date.  This review focuses on relatively recently identified mechanisms of action of HDACIs, with particular emphasis on those that relate to the DNA damage response (DDR), and discusses synergistic strategies combining HDACIs with several novel targeted agents that disrupt the DDR or antagonize anti-apoptotic proteins that could have implications for the future use of HDACIs in patients with cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr0OwGAuPo0CbVg90H21EOLACvtfcHk0lg4LPdFMUfLmw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXnslGnt7o%253D&md5=4ca75e79d226c760e847a876737a4f04</span></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1016%2Fj.pharmthera.2014.04.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pharmthera.2014.04.004%26sid%3Dliteratum%253Aachs%26aulast%3DBose%26aufirst%3DP.%26aulast%3DDai%26aufirst%3DY.%26aulast%3DGrant%26aufirst%3DS.%26atitle%3DHistone%2520deacetylase%2520inhibitor%2520%2528HDACI%2529%2520mechanisms%2520of%2520action%253A%2520emerging%2520insights%26jtitle%3DPharmacol.%2520Ther.%26date%3D2014%26volume%3D143%26spage%3D323%26epage%3D336" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref75"><div class="reference"><strong class="refLabel"><a href="#ref75" class="rightTabRefNumLink">75</a></strong><div class="NLM_citation" id="rightTab-cit75"><span><span class="NLM_contrib-group">Suzuki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ota, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ri, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bando, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gotoh, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Itoh, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsumoto, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tatum, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mizukami, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakagawa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iida, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ueda, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shirahige, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyata, N.</span><span> </span><span class="NLM_article-title">Rapid discovery of highly potent and selective inhibitors of histone deacetylase 8 using click chemistry to generate candidate libraries</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">9562</span><span class="NLM_x">–</span> <span class="NLM_lpage">9575</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm300837y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00229&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsF2qtrfI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=9562-9575&author=T.+Suzukiauthor=Y.+Otaauthor=M.+Riauthor=M.+Bandoauthor=A.+Gotohauthor=Y.+Itohauthor=H.+Tsumotoauthor=P.+R.+Tatumauthor=T.+Mizukamiauthor=H.+Nakagawaauthor=S.+Iidaauthor=R.+Uedaauthor=K.+Shirahigeauthor=N.+Miyata&title=Rapid+discovery+of+highly+potent+and+selective+inhibitors+of+histone+deacetylase+8+using+click+chemistry+to+generate+candidate+libraries"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">Rapid Discovery of Highly Potent and Selective Inhibitors of Histone Deacetylase 8 Using Click Chemistry to Generate Candidate Libraries</span></div><div class="casAuthors">Suzuki, Takayoshi; Ota, Yosuke; Ri, Masaki; Bando, Masashige; Gotoh, Aogu; Itoh, Yukihiro; Tsumoto, Hiroki; Tatum, Prima R.; Mizukami, Tamio; Nakagawa, Hidehiko; Iida, Shinsuke; Ueda, Ryuzo; Shirahige, Katsuhiko; Miyata, Naoki</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">9562-9575</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">To find HDAC8-selective inhibitors, we designed a library of HDAC inhibitor candidates, each contg. a zinc-binding group that coordinates with the active-site zinc ion, linked via a triazole moiety to a capping structure that interacts with residues on the rim of the active site.  These compds. were synthesized by using click chem.  Screening identified HDAC8-selective inhibitors including (I) (IC50 = 0.070 μM), which was more potent than PCI-34058 (IC50 = 0.31 μM), a known HDAC8 inhibitor.  Mol. modeling suggested that the phenylthiomethyl group of I binds to a unique hydrophobic pocket of HDAC8, and the orientation of the phenylthiomethyl and hydroxamate moieties (fixed by the triazole moiety) is important for the potency and selectivity.  The inhibitors caused selective acetylation of cohesin in cells and exerted growth-inhibitory effects on T-cell lymphoma and neuroblastoma cells (GI50 = 3-80 μM).  These findings suggest that HDAC8-selective inhibitors have potential as anticancer agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpGB7i5Bnw337Vg90H21EOLACvtfcHk0lg4LPdFMUfLmw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsF2qtrfI&md5=9b730c0469b62c3ebd93a5e58c520a12</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1021%2Fjm300837y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300837y%26sid%3Dliteratum%253Aachs%26aulast%3DSuzuki%26aufirst%3DT.%26aulast%3DOta%26aufirst%3DY.%26aulast%3DRi%26aufirst%3DM.%26aulast%3DBando%26aufirst%3DM.%26aulast%3DGotoh%26aufirst%3DA.%26aulast%3DItoh%26aufirst%3DY.%26aulast%3DTsumoto%26aufirst%3DH.%26aulast%3DTatum%26aufirst%3DP.%2BR.%26aulast%3DMizukami%26aufirst%3DT.%26aulast%3DNakagawa%26aufirst%3DH.%26aulast%3DIida%26aufirst%3DS.%26aulast%3DUeda%26aufirst%3DR.%26aulast%3DShirahige%26aufirst%3DK.%26aulast%3DMiyata%26aufirst%3DN.%26atitle%3DRapid%2520discovery%2520of%2520highly%2520potent%2520and%2520selective%2520inhibitors%2520of%2520histone%2520deacetylase%25208%2520using%2520click%2520chemistry%2520to%2520generate%2520candidate%2520libraries%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D9562%26epage%3D9575" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref76"><div class="reference"><strong class="refLabel"><a href="#ref76" class="rightTabRefNumLink">76</a></strong><div class="NLM_citation" id="rightTab-cit76"><span><span class="NLM_contrib-group">Suzuki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kasuya, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Itoh, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ota, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asamitsu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakagawa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okamoto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyata, N.</span><span> </span><span class="NLM_article-title">Identification of highly selective and potent histone deacetylase 3 inhibitors using click chemistry-based combinatorial fragment assembly</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">e68669</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00229&amp;key=10.1371%2Fjournal.pone.0068669" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00229&amp;key=23874714" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00229&amp;key=1%3ACAS%3A528%3ADC%252BC3sXht1SgsrjF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=e68669&author=T.+Suzukiauthor=Y.+Kasuyaauthor=Y.+Itohauthor=Y.+Otaauthor=P.+Zhanauthor=K.+Asamitsuauthor=H.+Nakagawaauthor=T.+Okamotoauthor=N.+Miyata&title=Identification+of+highly+selective+and+potent+histone+deacetylase+3+inhibitors+using+click+chemistry-based+combinatorial+fragment+assembly"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit76R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of highly selective and potent histone deacetylase 3 inhibitors using click chemistry-based combinatorial fragment assembly</span></div><div class="casAuthors">Suzuki, Takayoshi; Kasuya, Yuki; Itoh, Yukihiro; Ota, Yosuke; Zhan, Peng; Asamitsu, Kaori; Nakagawa, Hidehiko; Okamoto, Takashi; Miyata, Naoki</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">e68669</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">To find histone deacetylase 3 (HDAC3)-selective inhibitors, a series of 504 candidates was assembled using "click chem.", by reacting nine alkynes bearing a zinc-binding group with 56 azide building blocks in the presence of Cu(I) catalyst.  Screening of the 504-member triazole library against HDAC3 and other HDAC isoenzymes led to the identification of potent and selective HDAC3 inhibitors T247 and T326.  These compds. showed potent HDAC3 inhibition with submicromolar IC50s, whereas they did not strongly inhibit other isoenzymes.  Compds. T247 and T326 also induced a dose-dependent selective increase of NF-κB acetylation in human colon cancer HCT116 cells, indicating selective inhibition of HDAC3 in the cells.  In addn., these HDAC3-selective inhibitors induced growth inhibition of cancer cells, and activated HIV gene expression in latent HIV-infected cells.  These findings indicate that HDAC3-selective inhibitors are promising candidates for anticancer drugs and antiviral agents.  This work also suggests the usefulness of the click chem. approach to find isoenzyme-selective HDAC inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr4CvS43ILxQLVg90H21EOLACvtfcHk0lg4LPdFMUfLmw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXht1SgsrjF&md5=74d12c8fb1f06f8e00691415434fd929</span></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0068669&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0068669%26sid%3Dliteratum%253Aachs%26aulast%3DSuzuki%26aufirst%3DT.%26aulast%3DKasuya%26aufirst%3DY.%26aulast%3DItoh%26aufirst%3DY.%26aulast%3DOta%26aufirst%3DY.%26aulast%3DZhan%26aufirst%3DP.%26aulast%3DAsamitsu%26aufirst%3DK.%26aulast%3DNakagawa%26aufirst%3DH.%26aulast%3DOkamoto%26aufirst%3DT.%26aulast%3DMiyata%26aufirst%3DN.%26atitle%3DIdentification%2520of%2520highly%2520selective%2520and%2520potent%2520histone%2520deacetylase%25203%2520inhibitors%2520using%2520click%2520chemistry-based%2520combinatorial%2520fragment%2520assembly%26jtitle%3DPLoS%2520One%26date%3D2013%26volume%3D8%26spage%3De68669" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref77"><div class="reference"><strong class="refLabel"><a href="#ref77" class="rightTabRefNumLink">77</a></strong><div class="NLM_citation" id="rightTab-cit77"><span><span class="NLM_contrib-group">Tatum, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawada, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ota, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Itoh, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ieda, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakagawa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyata, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, T.</span><span> </span><span class="NLM_article-title">Identification of novel SIRT2-selective inhibitors using a click chemistry approach</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">1871</span><span class="NLM_x">–</span> <span class="NLM_lpage">1874</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00229&amp;key=10.1016%2Fj.bmcl.2014.03.026" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00229&amp;key=24675380" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00229&amp;key=1%3ACAS%3A528%3ADC%252BC2cXltFKms7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2014&pages=1871-1874&author=P.+R.+Tatumauthor=H.+Sawadaauthor=Y.+Otaauthor=Y.+Itohauthor=P.+Zhanauthor=N.+Iedaauthor=H.+Nakagawaauthor=N.+Miyataauthor=T.+Suzuki&title=Identification+of+novel+SIRT2-selective+inhibitors+using+a+click+chemistry+approach"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit77R"><div class="casContent"><span class="casTitleNuber">77</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of novel SIRT2-selective inhibitors using a click chemistry approach</span></div><div class="casAuthors">Tatum, Prima R.; Sawada, Hideyuki; Ota, Yosuke; Itoh, Yukihiro; Zhan, Peng; Ieda, Naoya; Nakagawa, Hidehiko; Miyata, Naoki; Suzuki, Takayoshi</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1871-1874</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A series of 114 SIRT inhibitor candidates was assembled using 'click chem.', by reacting two alkynes bearing 2-anilinobenzamide pharmacophore with 57 azide building blocks in the presence of Cu(I) catalyst.  Screening identified two SIRT2-selective inhibitors, which were more SIRT2-selective than AGK2, a known SIRT2 inhibitor.  These findings will be useful for further development of SIRT2-selective inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqE99y-vBC6lLVg90H21EOLACvtfcHk0ljtZiaa-Tg9VQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXltFKms7s%253D&md5=59676924d20f19655d23b39f4799769a</span></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2014.03.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2014.03.026%26sid%3Dliteratum%253Aachs%26aulast%3DTatum%26aufirst%3DP.%2BR.%26aulast%3DSawada%26aufirst%3DH.%26aulast%3DOta%26aufirst%3DY.%26aulast%3DItoh%26aufirst%3DY.%26aulast%3DZhan%26aufirst%3DP.%26aulast%3DIeda%26aufirst%3DN.%26aulast%3DNakagawa%26aufirst%3DH.%26aulast%3DMiyata%26aufirst%3DN.%26aulast%3DSuzuki%26aufirst%3DT.%26atitle%3DIdentification%2520of%2520novel%2520SIRT2-selective%2520inhibitors%2520using%2520a%2520click%2520chemistry%2520approach%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D24%26spage%3D1871%26epage%3D1874" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref78"><div class="reference"><strong class="refLabel"><a href="#ref78" class="rightTabRefNumLink">78</a></strong><div class="NLM_citation" id="rightTab-cit78"><span><span class="NLM_contrib-group">Gehringer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forster, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laufer, S. A.</span><span> </span><span class="NLM_article-title">Solution-phase parallel synthesis of Ruxolitinib-derived janus kinase inhibitors via copper catalyzed azide–alkyne cycloaddition</span> <span class="citation_source-journal">ACS Comb. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">5</span><span class="NLM_x">–</span> <span class="NLM_lpage">10</span></span><div class="citationLinks">[<a href="/doi/10.1021/co500122h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00229&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvFCisbnI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2015&pages=5-10&author=M.+Gehringerauthor=M.+Forsterauthor=S.+A.+Laufer&title=Solution-phase+parallel+synthesis+of+Ruxolitinib-derived+janus+kinase+inhibitors+via+copper+catalyzed+azide%E2%80%93alkyne+cycloaddition"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit78R"><div class="casContent"><span class="casTitleNuber">78</span><div class="casTitle"><span class="NLM_cas:atitle">Solution-Phase Parallel Synthesis of Ruxolitinib-Derived Janus Kinase Inhibitors via Copper-Catalyzed Azide-Alkyne Cycloaddition</span></div><div class="casAuthors">Gehringer, Matthias; Forster, Michael; Laufer, Stefan A.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Combinatorial Science</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">5-10</span>CODEN:
                <span class="NLM_cas:coden">ACSCCC</span>;
        ISSN:<span class="NLM_cas:issn">2156-8944</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A soln.-phase parallel synthesis of triazole-derived ruxolitinib analogs, e.g. I, was developed in the current study.  The method employs copper-catalyzed azide-alkyne cycloaddn. to build up the central triazole template.  Product isolation by pptn. and centrifugation is straightforward and yields high purity compds. suited for biol. profiling.  A simple protocol for accessing the terminal alkyne precursors in high yields was established and a library of ruxolitinib-like triazoles featuring diverse functional groups was prepd.  In addn., a model for the binding mode of ruxolitinib to Janus kinase (JAK) 2 is proposed.  In contrast to previous models, the pose explains the compd. selectivity for JAK1/JAK2 and is in accordance with published structure-activity data.  On this basis, a structure-based design hypothesis for inverting the selectivity profile of ruxolitinib is deduced.  Application of this strategy identified a moderately potent JAK3 inhibitor (35 nM) with high selectivity against other JAKs, potentially exploiting a covalent binding mode.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpm6Ts9duWGG7Vg90H21EOLACvtfcHk0ljtZiaa-Tg9VQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvFCisbnI&md5=5d2999fedb2dfef332c2e860a9e376e4</span></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1021%2Fco500122h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fco500122h%26sid%3Dliteratum%253Aachs%26aulast%3DGehringer%26aufirst%3DM.%26aulast%3DForster%26aufirst%3DM.%26aulast%3DLaufer%26aufirst%3DS.%2BA.%26atitle%3DSolution-phase%2520parallel%2520synthesis%2520of%2520Ruxolitinib-derived%2520janus%2520kinase%2520inhibitors%2520via%2520copper%2520catalyzed%2520azide%25E2%2580%2593alkyne%2520cycloaddition%26jtitle%3DACS%2520Comb.%2520Sci.%26date%3D2015%26volume%3D17%26spage%3D5%26epage%3D10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref79"><div class="reference"><strong class="refLabel"><a href="#ref79" class="rightTabRefNumLink">79</a></strong><div class="NLM_citation" id="rightTab-cit79"><span><span class="NLM_contrib-group">Chen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shoichet, B. K.</span><span> </span><span class="NLM_article-title">Molecular docking and ligand specificity in fragment-based inhibitor discovery</span> <span class="citation_source-journal">Nature Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">358</span><span class="NLM_x">–</span> <span class="NLM_lpage">364</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00229&amp;key=10.1038%2Fnchembio.155" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00229&amp;key=19305397" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00229&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjsVCqt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2009&pages=358-364&author=Y.+Chenauthor=B.+K.+Shoichet&title=Molecular+docking+and+ligand+specificity+in+fragment-based+inhibitor+discovery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit79R"><div class="casContent"><span class="casTitleNuber">79</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular docking and ligand specificity in fragment-based inhibitor discovery</span></div><div class="casAuthors">Chen, Yu; Shoichet, Brian K.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">358-364</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Fragment screens have successfully identified new scaffolds in drug discovery, often with relatively high hit rates (5%) using small screening libraries (1,000-10,000 compds.).  This raises two questions: would other noteworthy chemotypes be found were one to screen all com. available fragments (>300,000), and does the success rate imply low specificity of fragments.  We used mol. docking to screen large libraries of fragments against CTX-M β-lactamase.  We identified ten millimolar-range inhibitors from the 69 compds. tested.  The docking poses corresponded closely to the crystallog. structures subsequently detd.  Notably, these initial low-affinity hits showed little specificity between CTX-M and an unrelated β-lactamase, AmpC, which is unusual among β-lactamase inhibitors.  This is consistent with the idea that the high hit rates among fragments correlate to a low initial specificity.  As the inhibitors were progressed, both specificity and affinity rose together, yielding to our knowledge the first micromolar-range noncovalent inhibitors against a class A β-lactamase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqO8zTkq9kMAbVg90H21EOLACvtfcHk0ljtZiaa-Tg9VQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjsVCqt7k%253D&md5=6ee8dd19d0b99599ea74eaf735483b1d</span></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.155&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.155%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DY.%26aulast%3DShoichet%26aufirst%3DB.%2BK.%26atitle%3DMolecular%2520docking%2520and%2520ligand%2520specificity%2520in%2520fragment-based%2520inhibitor%2520discovery%26jtitle%3DNature%2520Chem.%2520Biol.%26date%3D2009%26volume%3D5%26spage%3D358%26epage%3D364" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref80"><div class="reference"><strong class="refLabel"><a href="#ref80" class="rightTabRefNumLink">80</a></strong><div class="NLM_citation" id="rightTab-cit80"><span><span class="NLM_contrib-group">Wagner, F. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fass, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joseph, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gale, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weïwer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCarren, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fisher, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaya, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, W. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reis, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hennig, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lemercier, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guan, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moyer, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scolnick, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haggarty, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsai, L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holson, E. B.</span><span> </span><span class="NLM_article-title">Kinetically selective inhibitors of histone deacetylase 2 (HDAC2) as cognition enhancers</span> <span class="citation_source-journal">Chem. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">804</span><span class="NLM_x">–</span> <span class="NLM_lpage">815</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00229&amp;key=10.1039%2FC4SC02130D" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00229&amp;key=25642316" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00229&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhslaqsLvO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=804-815&author=F.+F.+Wagnerauthor=Y.+L.+Zhangauthor=D.+M.+Fassauthor=N.+Josephauthor=J.+P.+Galeauthor=M.+We%C3%AFwerauthor=P.+McCarrenauthor=S.+L.+Fisherauthor=T.+Kayaauthor=W.+N.+Zhaoauthor=S.+A.+Reisauthor=K.+M.+Hennigauthor=M.+Thomasauthor=B.+C.+Lemercierauthor=M.+C.+Lewisauthor=J.+S.+Guanauthor=M.+P.+Moyerauthor=E.+Scolnickauthor=S.+J.+Haggartyauthor=L.+H.+Tsaiauthor=E.+B.+Holson&title=Kinetically+selective+inhibitors+of+histone+deacetylase+2+%28HDAC2%29+as+cognition+enhancers"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit80R"><div class="casContent"><span class="casTitleNuber">80</span><div class="casTitle"><span class="NLM_cas:atitle">Kinetically selective inhibitors of histone deacetylase 2 (HDAC2) as cognition enhancers</span></div><div class="casAuthors">Wagner, F. F.; Zhang, Y.-L.; Fass, D. M.; Joseph, N.; Gale, J. P.; Weiwer, M.; McCarren, P.; Fisher, S. L.; Kaya, T.; Zhao, W.-N.; Reis, S. A.; Hennig, K. M.; Thomas, M.; Lemercier, B. C.; Lewis, M. C.; Guan, J. S.; Moyer, M. P.; Scolnick, E.; Haggarty, S. J.; Tsai, L.-H.; Holson, E. B.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Science</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">804-815</span>CODEN:
                <span class="NLM_cas:coden">CSHCCN</span>;
        ISSN:<span class="NLM_cas:issn">2041-6520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Aiming towards the development of novel nootropic therapeutics to address the cognitive impairment common to a range of brain disorders, we set out to develop highly selective small mol. inhibitors of HDAC2, a chromatin modifying histone deacetylase implicated in memory formation and synaptic plasticity.  Novel ortho-aminoanilide inhibitors were designed and evaluated for their ability to selectively inhibit HDAC2 vs. the other Class I HDACs.  Kinetic and thermodn. binding properties were essential elements of our design strategy and two novel classes of ortho-aminoanilides, that exhibit kinetic selectivity (biased residence time) for HDAC2 vs. the highly homologous isoform HDAC1, were identified.  These kinetically selective HDAC2 inhibitors (BRD6688 and BRD4884) increased H4K12 and H3K9 histone acetylation in primary mouse neuronal cell culture assays, in the hippocampus of CK-p25 mice, a model of neurodegenerative disease, and rescued the assocd. memory deficits of these mice in a cognition behavioral model.  These studies demonstrate for the first time that selective pharmacol. inhibition of HDAC2 is feasible and that inhibition of the catalytic activity of this enzyme may serve as a therapeutic approach towards enhancing the learning and memory processes that are affected in many neurol. and psychiatric disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrwKZmK_p8gHrVg90H21EOLACvtfcHk0ljMZ2wLxB1kIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhslaqsLvO&md5=1389a020df73e5bf79566c64c0bdd14c</span></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.1039%2FC4SC02130D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC4SC02130D%26sid%3Dliteratum%253Aachs%26aulast%3DWagner%26aufirst%3DF.%2BF.%26aulast%3DZhang%26aufirst%3DY.%2BL.%26aulast%3DFass%26aufirst%3DD.%2BM.%26aulast%3DJoseph%26aufirst%3DN.%26aulast%3DGale%26aufirst%3DJ.%2BP.%26aulast%3DWe%25C3%25AFwer%26aufirst%3DM.%26aulast%3DMcCarren%26aufirst%3DP.%26aulast%3DFisher%26aufirst%3DS.%2BL.%26aulast%3DKaya%26aufirst%3DT.%26aulast%3DZhao%26aufirst%3DW.%2BN.%26aulast%3DReis%26aufirst%3DS.%2BA.%26aulast%3DHennig%26aufirst%3DK.%2BM.%26aulast%3DThomas%26aufirst%3DM.%26aulast%3DLemercier%26aufirst%3DB.%2BC.%26aulast%3DLewis%26aufirst%3DM.%2BC.%26aulast%3DGuan%26aufirst%3DJ.%2BS.%26aulast%3DMoyer%26aufirst%3DM.%2BP.%26aulast%3DScolnick%26aufirst%3DE.%26aulast%3DHaggarty%26aufirst%3DS.%2BJ.%26aulast%3DTsai%26aufirst%3DL.%2BH.%26aulast%3DHolson%26aufirst%3DE.%2BB.%26atitle%3DKinetically%2520selective%2520inhibitors%2520of%2520histone%2520deacetylase%25202%2520%2528HDAC2%2529%2520as%2520cognition%2520enhancers%26jtitle%3DChem.%2520Sci.%26date%3D2015%26volume%3D6%26spage%3D804%26epage%3D815" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref81"><div class="reference"><strong class="refLabel"><a href="#ref81" class="rightTabRefNumLink">81</a></strong><div class="NLM_citation" id="rightTab-cit81"><span><span class="NLM_contrib-group">Zhou, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, H. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, R.</span><span> </span><span class="NLM_article-title">Computational design of a time-dependent histone deacetylase 2 selective Inhibitor</span> <span class="citation_source-journal">ACS Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">687</span><span class="NLM_x">–</span> <span class="NLM_lpage">692</span><span class="refDoi"> DOI: 10.1021/cb500767c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cb500767c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00229&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsFGltw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&pages=687-692&author=J.+Zhouauthor=M.+Liauthor=N.+Chenauthor=S.+Wangauthor=H.+B.+Luoauthor=Y.+Zhangauthor=R.+Wu&title=Computational+design+of+a+time-dependent+histone+deacetylase+2+selective+Inhibitor&doi=10.1021%2Fcb500767c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit81R"><div class="casContent"><span class="casTitleNuber">81</span><div class="casTitle"><span class="NLM_cas:atitle">Computational Design of a Time-Dependent Histone Deacetylase 2 Selective Inhibitor</span></div><div class="casAuthors">Zhou, Jingwei; Li, Min; Chen, Nanhao; Wang, Shenglong; Luo, Hai-Bin; Zhang, Yingkai; Wu, Ruibo</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">687-692</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Development of isoform-selective histone deacetylase (HDAC) inhibitors is of great biol. and medical interest.  Among 11 zinc-dependent HDAC isoforms, it is particularly challenging to achieve isoform inhibition selectivity between HDAC1 and HDAC2 due to their very high structural similarities.  In this work, by developing and applying a novel de novo reaction-mechanism-based inhibitor design strategy to exploit the reactivity difference, the authors have discovered the first HDAC2-selective inhibitor, β-hydroxymethyl chalcone.  The bioassay expts. show that this new compd. has a unique time-dependent selective inhibition on HDAC2, leading to about 20-fold isoform-selectivity against HDAC1.  Furthermore, the ab initio QM/MM mol. dynamics simulations, a state-of-the-art approach to study reactions in biol. systems, have elucidated how the β-hydroxymethyl chalcone can achieve the distinct time-dependent inhibition toward HDAC2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoy6QHzO4UKiLVg90H21EOLACvtfcHk0ljMZ2wLxB1kIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsFGltw%253D%253D&md5=0b924dd39e0a267dde2dbb166ac68177</span></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.1021%2Fcb500767c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb500767c%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DM.%26aulast%3DChen%26aufirst%3DN.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DLuo%26aufirst%3DH.%2BB.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DWu%26aufirst%3DR.%26atitle%3DComputational%2520design%2520of%2520a%2520time-dependent%2520histone%2520deacetylase%25202%2520selective%2520Inhibitor%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2015%26volume%3D10%26spage%3D687%26epage%3D692%26doi%3D10.1021%2Fcb500767c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref82"><div class="reference"><strong class="refLabel"><a href="#ref82" class="rightTabRefNumLink">82</a></strong><div class="NLM_citation" id="rightTab-cit82"><span><span class="NLM_contrib-group">Jöst, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nitsche, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scholz, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roux, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klein, C. D.</span><span> </span><span class="NLM_article-title">Promiscuity and selectivity in covalent enzyme inhibition: a systematic study of electrophilic fragments</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">7590</span><span class="NLM_x">–</span> <span class="NLM_lpage">7599</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm5006918" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=7590-7599&author=C.+J%C3%B6stauthor=C.+Nitscheauthor=T.+Scholzauthor=L.+Rouxauthor=C.+D.+Klein&title=Promiscuity+and+selectivity+in+covalent+enzyme+inhibition%3A+a+systematic+study+of+electrophilic+fragments"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1021%2Fjm5006918&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm5006918%26sid%3Dliteratum%253Aachs%26aulast%3DJ%25C3%25B6st%26aufirst%3DC.%26aulast%3DNitsche%26aufirst%3DC.%26aulast%3DScholz%26aufirst%3DT.%26aulast%3DRoux%26aufirst%3DL.%26aulast%3DKlein%26aufirst%3DC.%2BD.%26atitle%3DPromiscuity%2520and%2520selectivity%2520in%2520covalent%2520enzyme%2520inhibition%253A%2520a%2520systematic%2520study%2520of%2520electrophilic%2520fragments%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D7590%26epage%3D7599" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref83"><div class="reference"><strong class="refLabel"><a href="#ref83" class="rightTabRefNumLink">83</a></strong><div class="NLM_citation" id="rightTab-cit83"><span><span class="NLM_contrib-group">Arrowsmith, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bountra, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fish, P. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schapira, M.</span><span> </span><span class="NLM_article-title">Epigenetic protein families: a new frontier for drug discovery</span> <span class="citation_source-journal">Nature Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">384</span><span class="NLM_x">–</span> <span class="NLM_lpage">400</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2012&pages=384-400&author=C.+H.+Arrowsmithauthor=C.+Bountraauthor=P.+V.+Fishauthor=K.+Leeauthor=M.+Schapira&title=Epigenetic+protein+families%3A+a+new+frontier+for+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DArrowsmith%26aufirst%3DC.%2BH.%26aulast%3DBountra%26aufirst%3DC.%26aulast%3DFish%26aufirst%3DP.%2BV.%26aulast%3DLee%26aufirst%3DK.%26aulast%3DSchapira%26aufirst%3DM.%26atitle%3DEpigenetic%2520protein%2520families%253A%2520a%2520new%2520frontier%2520for%2520drug%2520discovery%26jtitle%3DNature%2520Rev.%2520Drug%2520Discovery%26date%3D2012%26volume%3D11%26spage%3D384%26epage%3D400" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref84"><div class="reference"><strong class="refLabel"><a href="#ref84" class="rightTabRefNumLink">84</a></strong><div class="NLM_citation" id="rightTab-cit84a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Itoh, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyata, N.</span><span> </span><span class="NLM_article-title">Small-molecular modulators of cancer-associated epigenetic mechanisms</span> <span class="citation_source-journal">Mol. Biosyst.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">873</span><span class="NLM_x">–</span> <span class="NLM_lpage">96</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref84/cit84a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00229&amp;key=10.1039%2Fc3mb25410k" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref84/cit84a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00229&amp;key=23511667" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref84/cit84a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00229&amp;key=1%3ACAS%3A528%3ADC%252BC3sXltVOlsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2013&pages=873-96&author=Y.+Itohauthor=T.+Suzukiauthor=N.+Miyata&title=Small-molecular+modulators+of+cancer-associated+epigenetic+mechanisms"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit84aR"><div class="casContent"><span class="casTitleNuber">84a</span><div class="casTitle"><span class="NLM_cas:atitle">Small-molecular modulators of cancer-associated epigenetic mechanisms</span></div><div class="casAuthors">Itoh, Yukihiro; Suzuki, Takayoshi; Miyata, Naoki</div><div class="citationInfo"><span class="NLM_cas:title">Molecular BioSystems</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">873-896</span>CODEN:
                <span class="NLM_cas:coden">MBOIBW</span>;
        ISSN:<span class="NLM_cas:issn">1742-2051</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A review.  DNA methylation and posttranslational histone modifications regulate expression of various genes independently of changes in the DNA sequence.  Such epigenetic mechanisms play important roles in controlling cellular functions, including the cell cycle, immunoresponses and signal transduction.  On the other hand, epigenetic aberrations are assocd. with oncogenesis and proliferation of cancer cells, and epigenetic alterations have been identified in many human cancer cells.  Furthermore, chem.-biol. approaches have uncovered relationships between epigenetic dysregulation and cancer, and several small mols. that modulate epigenetic mechanisms have already been approved for cancer therapy.  In this review, we deal with chem. epigenetics relevant to cancer therapy, focusing esp. on small mols. that regulate epigenetic mechanisms related to DNA methylation and histone modification.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo76xFXo9kCe7Vg90H21EOLACvtfcHk0ljMZ2wLxB1kIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXltVOlsr4%253D&md5=ecc7cd46637f6010872510329d51ac90</span></div><a href="/servlet/linkout?suffix=cit84a&amp;dbid=16384&amp;doi=10.1039%2Fc3mb25410k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc3mb25410k%26sid%3Dliteratum%253Aachs%26aulast%3DItoh%26aufirst%3DY.%26aulast%3DSuzuki%26aufirst%3DT.%26aulast%3DMiyata%26aufirst%3DN.%26atitle%3DSmall-molecular%2520modulators%2520of%2520cancer-associated%2520epigenetic%2520mechanisms%26jtitle%3DMol.%2520Biosyst.%26date%3D2013%26volume%3D9%26spage%3D873%26epage%3D96" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit84b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Suzuki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyata, N.</span><span> </span><span class="NLM_article-title">Epigenetic control using natural products and synthetic molecules</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">935</span><span class="NLM_x">–</span> <span class="NLM_lpage">958</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref84/cit84b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00229&amp;key=10.2174%2F092986706776361067" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref84/cit84b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00229&amp;key=16611076" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref84/cit84b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00229&amp;key=1%3ACAS%3A528%3ADC%252BD28Xislygsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2006&pages=935-958&author=T.+Suzukiauthor=N.+Miyata&title=Epigenetic+control+using+natural+products+and+synthetic+molecules"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit84bR"><div class="casContent"><span class="casTitleNuber">84b</span><div class="casTitle"><span class="NLM_cas:atitle">Epigenetic control using natural products and synthetic molecules</span></div><div class="casAuthors">Suzuki, Takayoshi; Miyata, Naoki</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">935-958</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The term epigenetics is defined as heritable changes in gene expression that occur without changes in DNA sequence.  Recently, it has been revealed that DNA methylation and histone modifications such as acetylation, methylation, and phosphorylation are epigenetic mechanisms according to this definition.  In other words, these posttranslational modifications are important factors in detg. when and where a gene will be expressed.  To date, several enzymes that catalyze DNA or histone modifications have been identified, such as DNA methyltransferases and histone deacetylases.  Inhibitors and activators of enzymes controlling epigenetic modifications are considered useful not only as tools for the elucidation of cellular and biol. phenomena, but also as therapeutic agents, since disruption of the balance of epigenetic networks is known to cause some disease states such as cancer.  In this review, the authors present natural products and synthetic mols. that inhibit or activate enzymes catalyzing DNA methylation or histone modifications, and discuss the potential of epigenetic therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqov1OglRSHGrVg90H21EOLACvtfcHk0lj05MySNIdT5Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xislygsbo%253D&md5=ba01be1244ce77f37d2fa55913618269</span></div><a href="/servlet/linkout?suffix=cit84b&amp;dbid=16384&amp;doi=10.2174%2F092986706776361067&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986706776361067%26sid%3Dliteratum%253Aachs%26aulast%3DSuzuki%26aufirst%3DT.%26aulast%3DMiyata%26aufirst%3DN.%26atitle%3DEpigenetic%2520control%2520using%2520natural%2520products%2520and%2520synthetic%2520molecules%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2006%26volume%3D13%26spage%3D935%26epage%3D958" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3B3N" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3B3N','PDB','3B3N'); return false;">PDB: 3B3N</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2UXX" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2UXX','PDB','2UXX'); return false;">PDB: 2UXX</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2UXN" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2UXN','PDB','2UXN'); return false;">PDB: 2UXN</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4TPK" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4TPK','PDB','4TPK'); return false;">PDB: 4TPK</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2NYR" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2NYR','PDB','2NYR'); return false;">PDB: 2NYR</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2H4J" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2H4J','PDB','2H4J'); return false;">PDB: 2H4J</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4HTZ" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4HTZ','PDB','4HTZ'); return false;">PDB: 4HTZ</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4HTX" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4HTX','PDB','4HTX'); return false;">PDB: 4HTX</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3WV2" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3WV2','PDB','3WV2'); return false;">PDB: 3WV2</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3QQK" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3QQK','PDB','3QQK'); return false;">PDB: 3QQK</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3QXP" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3QXP','PDB','3QXP'); return false;">PDB: 3QXP</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4GH6" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4GH6','PDB','4GH6'); return false;">PDB: 4GH6</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3ZIM" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3ZIM','PDB','3ZIM'); return false;">PDB: 3ZIM</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2Y3A" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2Y3A','PDB','2Y3A'); return false;">PDB: 2Y3A</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4ANV" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4ANV','PDB','4ANV'); return false;">PDB: 4ANV</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4ANU" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4ANU','PDB','4ANU'); return false;">PDB: 4ANU</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4ANW" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4ANW','PDB','4ANW'); return false;">PDB: 4ANW</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4OYS" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4OYS','PDB','4OYS'); return false;">PDB: 4OYS</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4UWL" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4UWL','PDB','4UWL'); return false;">PDB: 4UWL</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2FXS" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2FXS','PDB','2FXS'); return false;">PDB: 2FXS</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4FYO" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4FYO','PDB','4FYO'); return false;">PDB: 4FYO</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4GIH" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4GIH','PDB','4GIH'); return false;">PDB: 4GIH</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4GMY" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4GMY','PDB','4GMY'); return false;">PDB: 4GMY</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4EHZ" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4EHZ','PDB','4EHZ'); return false;">PDB: 4EHZ</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4F09" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4F09','PDB','4F09'); return false;">PDB: 4F09</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4IVB" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4IVB','PDB','4IVB'); return false;">PDB: 4IVB</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4IVA" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4IVA','PDB','4IVA'); return false;">PDB: 4IVA</a></li></ul></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.5b00229&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.5b00229%3Bwebsite%3Awebsite%3Aacspubs%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2015.58.issue-19%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.5b00229" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                4MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-b425991822a79ada59b3.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-fb88834b824b41b135ad.js"></script>

<script type="text/javascript" src="/wro/ke1q~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"66797d64caf924cb","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.6.0","si":10}'></script>
</body>
</html>
